Atherosclerosis SupplementsAtherosclerosis Supplements RSS feed: Current Issue. http://www.atherosclerosis-supplements.com/?rss=yesElsevier Inc.en © 2010 Published by Elsevier Inc. All rights reserved. Atherosclerosis Supplements1567-5688112June 2010 © 2010 Published by Elsevier Inc. All rights reserved. healthpermissions@elsevier.comEditorial Boardhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810021434/abstract?rss=yesEditorial Board10.1016/S1567-5688(10)02143-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4iiiiiiW1 FIRST DEMONSTRATION BY IMMUNO-ELECTRON MICROSCOPY THAT BOTH HEPATIC AND INTESTINAL LIPOPROTEINS CONTRIBUTE TO HUMAN ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700027/abstract?rss=yesW1 FIRST DEMONSTRATION BY IMMUNO-ELECTRON MICROSCOPY THAT BOTH HEPATIC AND INTESTINAL LIPOPROTEINS CONTRIBUTE TO HUMAN ATHEROSCLEROSISJ.G. Vazquez Figueroa, S. Rinehart, A. Mc Cree, H. Yi, P. Battey, T. Teramoto, T. Matsushima, M. Kinoshita, I. Marvasty, S. Voros10.1016/S1567-5688(10)70002-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations11W2 A NOVEL HDL-ASSOCIATED PROTEIN, PROGRANULIN, MAY PLAY AN ATHEROPROTECTIVE ROLE BY ENHANCING REVERSE CHOLESTEROL TRANSPORThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700039/abstract?rss=yesW2 A NOVEL HDL-ASSOCIATED PROTEIN, PROGRANULIN, MAY PLAY AN ATHEROPROTECTIVE ROLE BY ENHANCING REVERSE CHOLESTEROL TRANSPORTT. Ohama, R. Kawase, A. Matsuyama, H. Okura, T. Matsuwaki, M. Yuasa-Kawase, K. Nakatani, M. Inagaki, J. Sandoval, K. Tsubakio-Yamamoto, D. Masuda, Y. Nakagawa-Toyama, M. Nishida, M. Ishigami, Y. Ohmoto, N. Masugi, I. Komuro, S. Yamashita10.1016/S1567-5688(10)70003-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations11W3 MITOCHONDRIAL CHOLESTEROL TRAFFICKING PROTEIN, 18 kDa mitoTSPO, REGULATES CHOLESTEROL EFFLUX IN HUMAN MACROPHAGEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700040/abstract?rss=yesW3 MITOCHONDRIAL CHOLESTEROL TRAFFICKING PROTEIN, 18 kDa mitoTSPO, REGULATES CHOLESTEROL EFFLUX IN HUMAN MACROPHAGESJ. Taylor, A. Graham10.1016/S1567-5688(10)70004-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations11W4 ADIPOSE TRIGLYCERIDE LIPASE DEFICIENCY AFFECTS MACROPHAGE MORPHOLOGY AND FUNCTION AND SIGNIFICANTLY REDUCES ATHEROSCLEROSIS IN LDLR−/− MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700052/abstract?rss=yesW4 ADIPOSE TRIGLYCERIDE LIPASE DEFICIENCY AFFECTS MACROPHAGE MORPHOLOGY AND FUNCTION AND SIGNIFICANTLY REDUCES ATHEROSCLEROSIS IN LDLR−/− MICEP. Chandak, B. Lammers, B. Radovic, E. Aflaki, M. Buchebner, G. Haemmerle, R. Zechner, M. van Eck, D. Kratky10.1016/S1567-5688(10)70005-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations11W5 DEFICIENCY OF THE LONG PENTRAXIN PTX3 PROMOTES VASCULAR INFLAMMATION AND ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700064/abstract?rss=yesW5 DEFICIENCY OF THE LONG PENTRAXIN PTX3 PROMOTES VASCULAR INFLAMMATION AND ATHEROSCLEROSISG. Norata, C. Garlanda, A. Mantovani, A. Catapano10.1016/S1567-5688(10)70006-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations22W6 SUBSTANCE P MEDIATED ADVENTITIAL MAST CELL ACTIVATION INDUCES INTRAPLAQUE HEMORRHAGE IN ADVANCED ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700076/abstract?rss=yesW6 SUBSTANCE P MEDIATED ADVENTITIAL MAST CELL ACTIVATION INDUCES INTRAPLAQUE HEMORRHAGE IN ADVANCED ATHEROSCLEROSISI. Bot, S.C.A. de Jager, M. Bot, S.H. van Heiningen, T.J.C. van Berkel, J.H. von der Thüsen, E.A.L. Biessen10.1016/S1567-5688(10)70007-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations22W7 DEFICIENT CD40-TRAF6 SIGNALING IN LEUKOCYTES PREVENTS ATHEROSCLEROSIS BY SKEWING THE IMMUNE RESPONSE TOWARDS AN ANTI-INFLAMMATORY PROFILEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700088/abstract?rss=yesW7 DEFICIENT CD40-TRAF6 SIGNALING IN LEUKOCYTES PREVENTS ATHEROSCLEROSIS BY SKEWING THE IMMUNE RESPONSE TOWARDS AN ANTI-INFLAMMATORY PROFILED. Lievens, L. Beckers, E. Wijnands, O. Soehnlein, A. Zernecke, T. Seijkens, D. Engel, S. Naik, L. Boon, A. Oufella, Z. Mallat, R. Noelle, M. de Winther, M. Daemen, E. Biessen, C. Weber, E. Lutgens10.1016/S1567-5688(10)70008-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations22W8 CD137 DEFICIENCY AMELIORATES ATHEROSCLEROSIS IN THE APOLIPOPROTEIN E NULL MICEhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070009X/abstract?rss=yesW8 CD137 DEFICIENCY AMELIORATES ATHEROSCLEROSIS IN THE APOLIPOPROTEIN E NULL MICEI.-H. Jung, M.-N. Lee, J.-G. Park, J.-Y. Yoo, S.-J. Jeong, S. Jeon, M.R. Cho, E.J. Lee, G.T. Oh10.1016/S1567-5688(10)70009-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations22W9 LIPID GOAL ATTAINMENT IN EUROPEAN ADULTS WITH DYSLIPIDAEMIA: AN ANALYSIS OF THE LIPID TREATMENT ASSESSMENT PROJECT (L-TAP) 2http://www.atherosclerosis-supplements.com/article/PIIS1567568810700106/abstract?rss=yesW9 LIPID GOAL ATTAINMENT IN EUROPEAN ADULTS WITH DYSLIPIDAEMIA: AN ANALYSIS OF THE LIPID TREATMENT ASSESSMENT PROJECT (L-TAP) 2C. Brotons, J. Ferrières, J.W. Jukema, D.D. Waters, M. Messig, L. Tarasenko10.1016/S1567-5688(10)70010-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations22W10 NEW AND OLD CRITERIA FOR THE DIAGNOSIS OF DIABETES MELLITUS IN PATIENTS WITH CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700118/abstract?rss=yesW10 NEW AND OLD CRITERIA FOR THE DIAGNOSIS OF DIABETES MELLITUS IN PATIENTS WITH CORONARY ARTERY DISEASEP. Rein, C.H. Saely, A. Vonbank, C. Boehnel, V. Jankovic, J. Breuss, M. Woess, S. Beer, H. Drexel10.1016/S1567-5688(10)70011-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations33W11 FAMP, A NOVEL APOA-I MIMETIC PEPTIDE PROMOTES HDL VIA ABCA1-DEPENDENT CHOLESTEROL EFFLUXhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070012X/abstract?rss=yesW11 FAMP, A NOVEL APOA-I MIMETIC PEPTIDE PROMOTES HDL VIA ABCA1-DEPENDENT CHOLESTEROL EFFLUXY. Uehara, S. Ando, K. Oniki, S. Abe, E. Yahiro, H. Tanigawa, S.-I. Miura, K. Saku10.1016/S1567-5688(10)70012-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations33W12 PIOGLITAZONE TREATMENT REDUCES VASCULAR SENESCENCE MARKERS AND CONFERS ANTI-APOPTOTIC EFFECTS IN THE AORTIC ENDOTHELIUM IN MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700131/abstract?rss=yesW12 PIOGLITAZONE TREATMENT REDUCES VASCULAR SENESCENCE MARKERS AND CONFERS ANTI-APOPTOTIC EFFECTS IN THE AORTIC ENDOTHELIUM IN MICEC. Werner, C. Gensch, J. Pöss, M. Böhm, U. Laufs10.1016/S1567-5688(10)70013-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations33W13 A ROLE FOR SCAVENGER RECEPTOR BI IN HUMAN BIOLOGYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700143/abstract?rss=yesW13 A ROLE FOR SCAVENGER RECEPTOR BI IN HUMAN BIOLOGYM. Vergeer, S.J.A. Korporaal, R. Franssen, I. Meurs, R. Out, G.K. Hovingh, J.A. Sierts, G.M. Dallinga, A.G. Holleboom, T.J.C. van Berkel, J.J.P. Kastelein, M. van Eck, J.A. Kuivenhoven10.1016/S1567-5688(10)70014-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations33W14 A COMMON POLYMORPHISM IN LDL-RECEPTOR GENE IS A PREDICTOR OF FACTOR VIII ACTIVITY AND IS ASSOCIATED WITH CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700155/abstract?rss=yesW14 A COMMON POLYMORPHISM IN LDL-RECEPTOR GENE IS A PREDICTOR OF FACTOR VIII ACTIVITY AND IS ASSOCIATED WITH CORONARY ARTERY DISEASEN. Martinelli, B. Lunghi, D. Girelli, M. Pinotti, G. Marchetti, M. Bisi, F. Manzato, R. Corrocher, O. Olivieri, F. Bernardi10.1016/S1567-5688(10)70015-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations33W15 THE ANTIPROLIFERATIVE EFFECT OF LRP6 AND ITS IMPAIRMENT BY R611C MUTATION ARE MEDIATED BY INDEPENDENT INTERMEDIATES OF THE PDGF PATHWAYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700167/abstract?rss=yesW15 THE ANTIPROLIFERATIVE EFFECT OF LRP6 AND ITS IMPAIRMENT BY R611C MUTATION ARE MEDIATED BY INDEPENDENT INTERMEDIATES OF THE PDGF PATHWAYA. Keramati, R. Singh, W. Liu, S. Faramarzi, T. Nottoli, G. Tellides, A. Mani10.1016/S1567-5688(10)70016-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations44W16 HIGH SPEED INTRAVITAL MICROSCOPY VISUALIZES THE UPTAKE OF NANOCRYSTALS-LABELLED TRIGLYCERIDE-RICH LIPOPROTEINS IN STELLATE CELLS IN VIVOhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700179/abstract?rss=yesW16 HIGH SPEED INTRAVITAL MICROSCOPY VISUALIZES THE UPTAKE OF NANOCRYSTALS-LABELLED TRIGLYCERIDE-RICH LIPOPROTEINS IN STELLATE CELLS IN VIVOO. Bruns, A. Bartelt, M. Calvo, C. Enrich, C. Waurisch, A. Eychmüller, R. Reimer, H. Hohenberg, U. Beisiegel, J. Heeren10.1016/S1567-5688(10)70017-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations44W17 INTERLEUKIN-6 STIMULATES ABCA1-MEDIATED CHOLESTEROL EFFLUX AND PHAGOCYTOSIS OF APOPTOTIC CELLS IN HUMAN MACROPHAGES AND PROMOTES AN ANTI-INFLAMMATORY M2 PHENOTYPEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700180/abstract?rss=yesW17 INTERLEUKIN-6 STIMULATES ABCA1-MEDIATED CHOLESTEROL EFFLUX AND PHAGOCYTOSIS OF APOPTOTIC CELLS IN HUMAN MACROPHAGES AND PROMOTES AN ANTI-INFLAMMATORY M2 PHENOTYPEE. Frisdal, P. Lesnik, M. Olivier, P. Robillard, M.J. Chapman, M. Guerin, W. Le Goff10.1016/S1567-5688(10)70018-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations44W18 ADVERSE MATRIX METALLOPROTEINASE PRODUCTION IN CLASSICALLY COMPARED TO ALTERNATIVELY ACTIVATED HUMAN MACROPHAGEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700192/abstract?rss=yesW18 ADVERSE MATRIX METALLOPROTEINASE PRODUCTION IN CLASSICALLY COMPARED TO ALTERNATIVELY ACTIVATED HUMAN MACROPHAGESW.-C. Huang, G.B. Sala-Newby, A.C. Newby10.1016/S1567-5688(10)70019-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations44W19 ROLE OF FC EFFECTS OF C-REACTIVE PROTEIN ON HUMAN ENDOTHELIAL CELLShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700209/abstract?rss=yesW19 ROLE OF FC EFFECTS OF C-REACTIVE PROTEIN ON HUMAN ENDOTHELIAL CELLSD. Raaz-Schrauder, A.B. Ekici, I. Cicha, L. Klinghammer, M. Herrmann, W.G. Daniel, A. Reis, C.D. Garlichs10.1016/S1567-5688(10)70020-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations44W20 NFkB2-DEFICIENCY IS ASSOCIATED WITH INCREASED ATHEROSCLEROSIS IN APoE−/− AND LDLR−/− MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700210/abstract?rss=yesW20 NFkB2-DEFICIENCY IS ASSOCIATED WITH INCREASED ATHEROSCLEROSIS IN APoE−/− AND LDLR−/− MICES. Dühring, L. Holdt, J. Ernst, F. Weih, J. Thiery, D. Teupser10.1016/S1567-5688(10)70021-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations55W21 LONG-TERM RESIDENTIAL EXPOSURE TO FINE PARTICULATE MATTER AND TRAFFIC INDEPENDENTLY INCREASE ARTERIAL BLOOD PRESSUREhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700222/abstract?rss=yesW21 LONG-TERM RESIDENTIAL EXPOSURE TO FINE PARTICULATE MATTER AND TRAFFIC INDEPENDENTLY INCREASE ARTERIAL BLOOD PRESSUREK. Fuks, A. Viehmann, S. Möhlenkamp, S. Moebus, H. Jakobs, C. Kessler, R. Erbel, K.-H. Jöckel, B. Hoffmann10.1016/S1567-5688(10)70022-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations55W22 QUALITY OF LIFE OF CHILDREN WITH FAMILIAL HYPERLIPIDEMIAS AFTER QUANTITATIVE OR QUALITATIVE DIETARY RESTRICTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700234/abstract?rss=yesW22 QUALITY OF LIFE OF CHILDREN WITH FAMILIAL HYPERLIPIDEMIAS AFTER QUANTITATIVE OR QUALITATIVE DIETARY RESTRICTIONA. Cicero, B. Gerocarni, G. Derosa, C. Borghi10.1016/S1567-5688(10)70023-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations55W23 PERSISTENT DEPRESSIVE SYMPTOMS ARE ASSOCIATED WITH CORONARY ARTERY CALCIFICATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700246/abstract?rss=yesW23 PERSISTENT DEPRESSIVE SYMPTOMS ARE ASSOCIATED WITH CORONARY ARTERY CALCIFICATIONM. Hamer, M. Kivimaki, A. Lahiri, A. Steptoe10.1016/S1567-5688(10)70024-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations55W24 CAROTID INTIMA-MEDIA THICKNESS IS NOT INDEPENDENTLY PREDICTIVE FOR HARD CORONARY EVENTS IN MEN AND WOMEN – THE HEINZ NIXDORF RECALL STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700258/abstract?rss=yesW24 CAROTID INTIMA-MEDIA THICKNESS IS NOT INDEPENDENTLY PREDICTIVE FOR HARD CORONARY EVENTS IN MEN AND WOMEN – THE HEINZ NIXDORF RECALL STUDYM. Bauer, B. Hoffmann, S. Möhlenkamp, N. Lehmann, U. Roggenbuck, A. Schmermund, S. Moebus, N. Dragano, M. Bröcker-Preuss, A. Stang, K. Mann, J. Siegrist, K.-H. Jöckel, R. Erbel10.1016/S1567-5688(10)70025-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations56W25 LIMITS IN DETECTION OF HIGH-RISK ATHEROSCLEROTIC PLAQUES WITH USPIO-ENHANCED MRI AT 3 T IN AN ANIMAL MODEL OF ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070026X/abstract?rss=yesW25 LIMITS IN DETECTION OF HIGH-RISK ATHEROSCLEROTIC PLAQUES WITH USPIO-ENHANCED MRI AT 3 T IN AN ANIMAL MODEL OF ATHEROSCLEROSISH. Ittrich, C. Jahntz, K. Peldschus, B. Misselwitz, C. Weber, G. Adam10.1016/S1567-5688(10)70026-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations66W26 DISCORDANCE BETWEEN LDL CHOLESTEROL AND LDL PARTICLE CONCENTRATION IN RELATION TO INCIDENT CVD EVENTS IN 27673 WOMENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700271/abstract?rss=yesW26 DISCORDANCE BETWEEN LDL CHOLESTEROL AND LDL PARTICLE CONCENTRATION IN RELATION TO INCIDENT CVD EVENTS IN 27673 WOMENS. Mora, J. Otvos, P. Ridker10.1016/S1567-5688(10)70027-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations66W27 LIPID LOWERING THERAPY INDUCES A SIGNIFICANT UPREGULATION OF THE PLASMA LIPIDOME IN FH PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700283/abstract?rss=yesW27 LIPID LOWERING THERAPY INDUCES A SIGNIFICANT UPREGULATION OF THE PLASMA LIPIDOME IN FH PATIENTSR. Laaksonen, M. Jänis, K. Tarasov, R. Hurme, D. Marais, K. Ekroos10.1016/S1567-5688(10)70028-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations66W28 ATGL-DEFICIENT MICE OVEREXPRESSING ATGL IN HEART ARE RESISTANT TO DIET-INDUCED OBESITY AND INSULIN RESISTANCEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700295/abstract?rss=yesW28 ATGL-DEFICIENT MICE OVEREXPRESSING ATGL IN HEART ARE RESISTANT TO DIET-INDUCED OBESITY AND INSULIN RESISTANCER. Schreiber, R. Zimmermann, G. Haemmerle, R. Zechner10.1016/S1567-5688(10)70029-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations66W29 BROWN ADIPOSE TISSUE IS A MAJOR DETERMINANT OF PLASMA CLEARANCE AND ORGAN UPTAKE OF TRIGLYCERIDE-RICH LIPOPROTEINShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700301/abstract?rss=yesW29 BROWN ADIPOSE TISSUE IS A MAJOR DETERMINANT OF PLASMA CLEARANCE AND ORGAN UPTAKE OF TRIGLYCERIDE-RICH LIPOPROTEINSA. Bartelt, O.T. Bruns, K. Peldschus, H. Ittrich, U.I. Tromsdorf, M. Merkel, J. Heeren10.1016/S1567-5688(10)70030-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations77W30 GLUCAGON-LIKE PEPTIDES (GLP-1 AND GLP-2) AS CRITICAL REGULATORS OF INTESTINAL LIPID ABSORPTION AND CHYLOMICRON PRODUCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700313/abstract?rss=yesW30 GLUCAGON-LIKE PEPTIDES (GLP-1 AND GLP-2) AS CRITICAL REGULATORS OF INTESTINAL LIPID ABSORPTION AND CHYLOMICRON PRODUCTIONJ. Hsieh, K. Adeli10.1016/S1567-5688(10)70031-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations77W31 HIGH DENSITY LIPOPROTEIN PROTECTION AGAINST PRIMARY CARDIAC RISK IS LOST WITH ENHANCED LOW GRADE CHRONIC INFLAMMATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700325/abstract?rss=yesW31 HIGH DENSITY LIPOPROTEIN PROTECTION AGAINST PRIMARY CARDIAC RISK IS LOST WITH ENHANCED LOW GRADE CHRONIC INFLAMMATIONR. Dullaart, R. Gansevoort, C. Sparks, J. Corsetti10.1016/S1567-5688(10)70032-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations77W32 A NOVEL METHOD FOR THE MEASUREMENT OF PRE AND αHDL KINETICS WITH STABLE ISOTOPIC LABELLING TECHNIQUEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700337/abstract?rss=yesW32 A NOVEL METHOD FOR THE MEASUREMENT OF PRE AND αHDL KINETICS WITH STABLE ISOTOPIC LABELLING TECHNIQUESX. Li, M. Stolinski, N.C. Jackson, M.A. Umpleby10.1016/S1567-5688(10)70033-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations77W33 CHANGES OF PROINFLAMMATORY CYTOKINES, CHEMOATTRACTANTS AND DESTRUCTIVE METALLOPROTEINASES CONTENTS DURING UNSTABLE ATHEROSCLEROTIC PLAQUE FORMATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700349/abstract?rss=yesW33 CHANGES OF PROINFLAMMATORY CYTOKINES, CHEMOATTRACTANTS AND DESTRUCTIVE METALLOPROTEINASES CONTENTS DURING UNSTABLE ATHEROSCLEROTIC PLAQUE FORMATIONY. Ragino, A. Chernjavski, Y. Polonskaja, A. Volkov, E. Semaeva, S. Tcimbal, M. Voevoda10.1016/S1567-5688(10)70034-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations78W34 FVIIA PLASMA LEVELS: INFLUENCE OF F7, F10 AND EPCR (ENDOTHELIAL PROTEIN C RECEPTOR) SNPShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700350/abstract?rss=yesW34 FVIIA PLASMA LEVELS: INFLUENCE OF F7, F10 AND EPCR (ENDOTHELIAL PROTEIN C RECEPTOR) SNPSI. Kalies, M. Knutsson, A. Siegbahn, A.-C. Syvänen, L. Lind, R. Kerb10.1016/S1567-5688(10)70035-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations88W35 CAN ECCENTRIC ARTERIAL PLAQUES ALONE CAUSE FLOW STAGNATION POINTS AND FAVOUR THROMBUS INCORPORATION?http://www.atherosclerosis-supplements.com/article/PIIS1567568810700362/abstract?rss=yesW35 CAN ECCENTRIC ARTERIAL PLAQUES ALONE CAUSE FLOW STAGNATION POINTS AND FAVOUR THROMBUS INCORPORATION?S.G. Ramos, C.T. Beneli, P.F. Barbosa, E.M. Floriano, J. Elias, F.S. Ramalho, M.A. Rossi10.1016/S1567-5688(10)70036-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations88W36 SIGNIFICANT ASSOCIATION BETWEEN GENETIC POLYMORPHISMS IN VITAMIN K EPOXIDE REDUCTASE GENE AND THE RISK OF ISCHEMIC STROKEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700374/abstract?rss=yesW36 SIGNIFICANT ASSOCIATION BETWEEN GENETIC POLYMORPHISMS IN VITAMIN K EPOXIDE REDUCTASE GENE AND THE RISK OF ISCHEMIC STROKEF.-I. Hsieh, Y.-C. Hsieh, C.-W. Chang, C.-H. Bai, L.-M. Lien, J.-S. Jeng, H.-J. Lin, H.-P. Tseng, W.-C. Lo, Y.-L. Li, H.-Y. Chiou10.1016/S1567-5688(10)70037-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations88W37 TIMP3: A SWITCH THAT CONTROLS HIGH FAT DIET-INDUCED INFLAMMATION, DIABETES AND STEATOSIS IN MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700386/abstract?rss=yesW37 TIMP3: A SWITCH THAT CONTROLS HIGH FAT DIET-INDUCED INFLAMMATION, DIABETES AND STEATOSIS IN MICER. Menghini, V. Casagrande, M. Cavalera, V. Marzano, S. Menini, G. Pugliese, A. Urbani, R. Lauro, M. Federici10.1016/S1567-5688(10)70038-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations88W38 GENETIC VARIATION IN LIVER X RECEPTOR ALPHA AND RISK OF ISCHEMIC VASCULAR DISEASE IN THE GENERAL POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700398/abstract?rss=yesW38 GENETIC VARIATION IN LIVER X RECEPTOR ALPHA AND RISK OF ISCHEMIC VASCULAR DISEASE IN THE GENERAL POPULATIONS. Stender, R. Frikke-Schmidt, A.A. Sethi, B.G. Nordestgaard, A. Tybjærg-Hansen10.1016/S1567-5688(10)70039-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations89W39 EXPRESSION OF A RETINOIC ACID SIGNATURE IN CIRCULATING CD34 CELLS FROM CORONARY ARTERY DISEASE PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700404/abstract?rss=yesW39 EXPRESSION OF A RETINOIC ACID SIGNATURE IN CIRCULATING CD34 CELLS FROM CORONARY ARTERY DISEASE PATIENTST.C.T.M. van der Pouw Kraan, S.H. Schirmer, J.O. Fledderus, P.D. Moerland, J.M. Baggen, T.A. Leyen, A.M. van der Laan, J.J. Piek, N. van Royen, A.J.G. Horrevoets10.1016/S1567-5688(10)70040-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations88W40 FXR-DEFICIENCY IMPROVES GLUCOSE AND ENERGY HOMEOSTASIS IN GENETIC OBESITYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700416/abstract?rss=yesW40 FXR-DEFICIENCY IMPROVES GLUCOSE AND ENERGY HOMEOSTASIS IN GENETIC OBESITYJ. Prawitt, M. Abdelkarim, J. Dumont, H. Duez, J.H.M. Stroeve, T.H. van Dijk, E. Bouchaert, F. Kuipers, B. Cariou, S. Caron, B. Staels10.1016/S1567-5688(10)70041-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations99W41 MICE DOUBLE-DEFICIENT FOR APOLIPOPROTEIN E AND BIGLYCAN SHOW ENHANCED ATHEROSCLEROSIS ON NORMAL CHOWhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700428/abstract?rss=yesW41 MICE DOUBLE-DEFICIENT FOR APOLIPOPROTEIN E AND BIGLYCAN SHOW ENHANCED ATHEROSCLEROSIS ON NORMAL CHOWA. Melchior-Becker, J.W. Fischer10.1016/S1567-5688(10)70042-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations99W42 EFFECT OF GDF-15 (GROWTH DIFFERENTIATION FACTOR 15) IN THE PROGRESSION OF ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070043X/abstract?rss=yesW42 EFFECT OF GDF-15 (GROWTH DIFFERENTIATION FACTOR 15) IN THE PROGRESSION OF ATHEROSCLEROSISS. Zügel, S. Vorwald, G. Bendner, G.A. Bonaterra, J. Strelau, R. Kinscherf10.1016/S1567-5688(10)70043-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations99W43 GENETIC DEFICIENCY IN FUNCTIONAL MMP-10 REDUCES PROGRESSION OF ATHEROSCLEROSIS IN APOLIPOPROTEIN E-KNOCKOUT MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700441/abstract?rss=yesW43 GENETIC DEFICIENCY IN FUNCTIONAL MMP-10 REDUCES PROGRESSION OF ATHEROSCLEROSIS IN APOLIPOPROTEIN E-KNOCKOUT MICEA. Purroy, M. Belzunce, J. Orbe, J. Barrenetxe, J.A. Páramo, J.A. Rodríguez10.1016/S1567-5688(10)70044-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations910W44 GEOMETRY OF THE VULNERABLE PLAQUE: LONGITUDINAL ASYMMETRY IS PREDICTIVE FOR RUPTUREhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700453/abstract?rss=yesW44 GEOMETRY OF THE VULNERABLE PLAQUE: LONGITUDINAL ASYMMETRY IS PREDICTIVE FOR RUPTUREI. Cicha, K. Beronov, M. Klein, D. Raithel, W.G. Daniel, C.D. Garlichs10.1016/S1567-5688(10)70045-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1010W45 VISCERAL OBESITY CAUSED BY OVEREXPRESSING SREBP-1C IN LIVERhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700465/abstract?rss=yesW45 VISCERAL OBESITY CAUSED BY OVEREXPRESSING SREBP-1C IN LIVERB. Knebel, J. Haas, S. Jacob, U. Nitzgen, D. Müller-Wieland, J. Kotzka10.1016/S1567-5688(10)70046-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1010W46 ROLE OF LIPOPROTEINS IN PANCREATIC BETA-CELL SURVIVAL, PROLIFERATION AND FUNCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700477/abstract?rss=yesW46 ROLE OF LIPOPROTEINS IN PANCREATIC BETA-CELL SURVIVAL, PROLIFERATION AND FUNCTIONR.A. Sibler, S. Rütti, J.A. Ehses, R. Prazak, D.T. Meier, L. Rohrer, M.Y. Donath, A. von Eckardstein10.1016/S1567-5688(10)70047-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1010W47 NON-ALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH INCREASED VISCERAL FAT AND INSULIN RESISTANCEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700489/abstract?rss=yesW47 NON-ALCOHOLIC FATTY LIVER DISEASE IS ASSOCIATED WITH INCREASED VISCERAL FAT AND INSULIN RESISTANCEV. Dimitrijevic-Sreckovic, B. Sreckovic, P. Djordjevic, M. Civcic, V. Barac, I. Soldatovic, M. Stojanovic10.1016/S1567-5688(10)70048-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1010W48 GENETIC VARIATION WITHIN ADIPONUTRIN IS ASSOCIATED WITH LIPOPROTEIN METABOLISM AND LIVER FUNCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700490/abstract?rss=yesW48 GENETIC VARIATION WITHIN ADIPONUTRIN IS ASSOCIATED WITH LIPOPROTEIN METABOLISM AND LIVER FUNCTIONB. Kollerits, S. Coassin, N.D. Beckmann, A. Teumer, S. Kiechl, A. Döring, M. Kavousi, S.C. Hunt, C. Lamina, B. Paulweber, Z. Kutalik, M. Nauck, C.M. van Duijn, I.M. Heid, J. Willeit, A. Brandstätter, T.D. Adams, V. Mooser, Y.S. Aulchenko, H. Völzke, F. Kronenberg10.1016/S1567-5688(10)70049-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1111W49 RVX-208 GIVEN ORALLY RAISES PLASMA apoA-I AND HDL IN HUMAN CLINICAL TRIALShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700507/abstract?rss=yesW49 RVX-208 GIVEN ORALLY RAISES PLASMA apoA-I AND HDL IN HUMAN CLINICAL TRIALSA. Gordon, J. Johansson, G. Wagner, F. Chiacchia, N. Wong10.1016/S1567-5688(10)70050-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1111W50 INHIBITION OF HEPATIC SR-BI BY RNA INTERFERENCE PROTECTS FROM ATHEROSCLEROSIS IN RABBITShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700519/abstract?rss=yesW50 INHIBITION OF HEPATIC SR-BI BY RNA INTERFERENCE PROTECTS FROM ATHEROSCLEROSIS IN RABBITSE. Demetz, I. Tancevski, U. Stanzl, K. Duwensee, W. Schgoer, A. Ritsch, C. Heim, E. Huber, J.R. Patsch, P. Eller10.1016/S1567-5688(10)70051-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1111W51 THE CXCR7 LIGAND CCX771 REDUCES NEOINTIMA FORMATION AFTER VASCULAR INJURY AND ATHEROSCLEROSIS IN ApoE−/− MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700520/abstract?rss=yesW51 THE CXCR7 LIGAND CCX771 REDUCES NEOINTIMA FORMATION AFTER VASCULAR INJURY AND ATHEROSCLEROSIS IN ApoE−/− MICEX. Li, M. Penfold, T.J. Schall, C. Weber, A. Schober10.1016/S1567-5688(10)70052-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1111W52 PROTECTION AGAINST ATHEROSCLEROSIS IN CAV-1 IS DUE TO CAV-1−/− IN NON-HEMATOPOIETIC CELLShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700532/abstract?rss=yesW52 PROTECTION AGAINST ATHEROSCLEROSIS IN CAV-1 IS DUE TO CAV-1−/− IN NON-HEMATOPOIETIC CELLSD. Engel, L. Beckers, E. Wijnands, M.J.A.P. Daemen, R. Stan, E.A.L. Biessen, E. Lutgens10.1016/S1567-5688(10)70053-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1112W53 UROKINASE RECEPTOR MEDIATES MOBILIZATION, MIGRATION AND DIFFERENTIATION OF MESENCHYMAL STEM CELLShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700544/abstract?rss=yesW53 UROKINASE RECEPTOR MEDIATES MOBILIZATION, MIGRATION AND DIFFERENTIATION OF MESENCHYMAL STEM CELLSK. Vallabhaneni, S. Tkachuk, J. Kiyan, N. Shushakova, I. Dumler, G. Eden10.1016/S1567-5688(10)70054-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1212W54 HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL IS A STRONG DETERMINANT OF ENDOTHELIAL PROGENITOR CELLS NUMBER AND FUNCTION IN HYPERCHOLESTEROLEMIC SUBJECTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700556/abstract?rss=yesW54 HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL IS A STRONG DETERMINANT OF ENDOTHELIAL PROGENITOR CELLS NUMBER AND FUNCTION IN HYPERCHOLESTEROLEMIC SUBJECTSF. Rossi, C. Bertone, F. Montanile, F. Miglietta, C. Lubrano, V. Santiemma10.1016/S1567-5688(10)70055-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1212W55 RATIO OF MICROPARTICLES TO ENDOTHELIAL PROGENITOR CELLS, A MARKER OF VASCULAR DYSFUNCTION INDUCED BY COMBINED HYPERTENSION AND HYPERCHOLESTEROLEMIA; IRBERSARTAN EFFECThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700568/abstract?rss=yesW55 RATIO OF MICROPARTICLES TO ENDOTHELIAL PROGENITOR CELLS, A MARKER OF VASCULAR DYSFUNCTION INDUCED BY COMBINED HYPERTENSION AND HYPERCHOLESTEROLEMIA; IRBERSARTAN EFFECTA. Georgescu, N. Alexandru, D. Popov, E. Andrei, I. Titorencu, E. Dragan, C. Tarziu, S. Ghiorghe, E. Badila, D. Bartos, M. Simionescu10.1016/S1567-5688(10)70056-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1212W56 TELOMERES ARE SHORTER IN PATIENTS WITH POLYGENIC AND MONOGENIC FORMS OF CORONARY HEART DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070057X/abstract?rss=yesW56 TELOMERES ARE SHORTER IN PATIENTS WITH POLYGENIC AND MONOGENIC FORMS OF CORONARY HEART DISEASEC.G. Maubaret, K.D. Salpea, A. Jain, J.A. Cooper, A. Hamsten, J. Sanders, H. Montgomery, A. Neil, D. Nair, S.E. Humphries10.1016/S1567-5688(10)70057-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1212W57 INCREASED ATHEROSCLEROSIS SEVERITY AT CHROMOSOME 9P21http://www.atherosclerosis-supplements.com/article/PIIS1567568810700581/abstract?rss=yesW57 INCREASED ATHEROSCLEROSIS SEVERITY AT CHROMOSOME 9P21L. Holdt, F. Beutner, M. Scholz, S. Gielen, G. Gäbel, H. Bergert, G. Schuler, J. Thiery, D. Teupser10.1016/S1567-5688(10)70058-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1313W58 COMMON GENETIC VARIANTS ASSOCIATED WITH LOW Lp(a) KRINGLE-IV COPY NUMBER, HIGH Lp(a) CONCENTRATION, AND INCREASED RISK OF CORONARY HEART DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700593/abstract?rss=yesW58 COMMON GENETIC VARIANTS ASSOCIATED WITH LOW Lp(a) KRINGLE-IV COPY NUMBER, HIGH Lp(a) CONCENTRATION, AND INCREASED RISK OF CORONARY HEART DISEASEU. Seedorf, J. Peden, J. Hopewell, T. Kyriakou, A. Goel, S. Heath, S. Parish, S. Barlera, M. Grazia, S. Rust, D. Bennett, A. Silveira, A. Malarstig, F. Green, M. Lathrop, B. Gigante, K. Leander, U. de Faire, R. Clarke, A. Hamsten, R. Collins, H. Watkins10.1016/S1567-5688(10)70059-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1313W59 RISK PREDICTION OF MYOCARDIAL INFARCTION USING A WEIGHTED GENETIC SCORE – THE GERMAN MI FAMILY STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070060X/abstract?rss=yesW59 RISK PREDICTION OF MYOCARDIAL INFARCTION USING A WEIGHTED GENETIC SCORE – THE GERMAN MI FAMILY STUDYP. Linsel-Nitschke, C. Willenborg, A. Schaefer, S. Schreiber, C. Hengstenberg, H. Schunkert, J. Erdmann10.1016/S1567-5688(10)70060-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1313L1 Tie1 ATTENUATION RESULTS IN A LOCATION-SPECIFIC AND SHEAR STRESS-DEFINED REDUCTION IN ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700611/abstract?rss=yesL1 Tie1 ATTENUATION RESULTS IN A LOCATION-SPECIFIC AND SHEAR STRESS-DEFINED REDUCTION IN ATHEROSCLEROSISK.V. Woo, X. Qu, V. Babaev, M. Linton, R. Guzman, S. Fazio, H.S. Baldwin10.1016/S1567-5688(10)70061-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1313L2 VISUALISING INFLAMED ATHEROSCLEROTIC PLAQUES: MOLECULAR IMAGING USING MRI AND TARGETED ULTRASMALL SUPERPARAMAGNETIC PARTICLES OF IRON OXIDE (USPIO)http://www.atherosclerosis-supplements.com/article/PIIS1567568810700623/abstract?rss=yesL2 VISUALISING INFLAMED ATHEROSCLEROTIC PLAQUES: MOLECULAR IMAGING USING MRI AND TARGETED ULTRASMALL SUPERPARAMAGNETIC PARTICLES OF IRON OXIDE (USPIO)J. Chan, C. Monaco, K. Bhakoo, R. Gibbs10.1016/S1567-5688(10)70062-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1314L3 THE GUIDANCE CUE NETRIN-1 PROMOTES ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700635/abstract?rss=yesL3 THE GUIDANCE CUE NETRIN-1 PROMOTES ATHEROSCLEROSISJ.M. van Gils, M.C. Stewart, K.J. Rayner, L.R. Fernandes, T.O. McDonald, K.D. O'Brien, K.J. Moore10.1016/S1567-5688(10)70063-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1414L4 BASELINE CHARACTERISTICS OF PATIENTS IN THE SATURN STUDY, A COMPARISON OF ROSUVASTATIN VERSUS ATORVASTATIN ON CORONARY ATHEROSCLEROTIC DISEASE BURDENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700647/abstract?rss=yesL4 BASELINE CHARACTERISTICS OF PATIENTS IN THE SATURN STUDY, A COMPARISON OF ROSUVASTATIN VERSUS ATORVASTATIN ON CORONARY ATHEROSCLEROTIC DISEASE BURDENP.J. Barter, J. Chapman, C. Ballantyne, R. Erbel, P. Libby, S. Nicholls, J. Raichlen, V. Cain, S. Nissen10.1016/S1567-5688(10)70064-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1414L5 PHASE 3 STUDY OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITOR (MTP-I) LOMITAPIDE IN SUBJECTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH): 56-WEEK RESULTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700659/abstract?rss=yesL5 PHASE 3 STUDY OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITOR (MTP-I) LOMITAPIDE IN SUBJECTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HOFH): 56-WEEK RESULTSM. Cuchel, E. Meagher, A.D. Marais, D.J. Blom, H. du Toit Theron, P.K. Shah, R.A. Hegele, L.T. Bloeden, W.J. Sasiela, D.J. Rader10.1016/S1567-5688(10)70065-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1414L6 EFFICACY OF 15 YEARS OF GENETIC CASCADE SCREENING FOR FAMILIAL HYPERCHOLESTEROLEMIA IN THE NETHERLANDS IN PREVENTION OF CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700660/abstract?rss=yesL6 EFFICACY OF 15 YEARS OF GENETIC CASCADE SCREENING FOR FAMILIAL HYPERCHOLESTEROLEMIA IN THE NETHERLANDS IN PREVENTION OF CORONARY ARTERY DISEASER. Huijgen, J. Versmissen, D.M. Oosterveer, I. Kindt, E.J.G. Sijbrands, J.J.P. Kastelein10.1016/S1567-5688(10)70066-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1414L7 RESULTS OF FIRST FOLLOW UP STUDY WITH GENE THERAPY WITH ALIPOGENE TIPARVOVEC (AMT-011) IN LIPOPROTEIN LIPASE DEFICIENCY (LPLD)http://www.atherosclerosis-supplements.com/article/PIIS1567568810700672/abstract?rss=yesL7 RESULTS OF FIRST FOLLOW UP STUDY WITH GENE THERAPY WITH ALIPOGENE TIPARVOVEC (AMT-011) IN LIPOPROTEIN LIPASE DEFICIENCY (LPLD)D. Gaudet, J. de Wal, D. Brisson, N. van den Bulk, S. Greentree, J. Méthot10.1016/S1567-5688(10)70067-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Workshop Presentations1515P1 ADENO-ASSOCIATED VIRUS 9 VECTOR IN THE GENE THERAPY OF OCCLUSIVE VASCULAR DISEASEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700684/abstract?rss=yesP1 ADENO-ASSOCIATED VIRUS 9 VECTOR IN THE GENE THERAPY OF OCCLUSIVE VASCULAR DISEASESD. Agrawal, D. Pankajakshan, M. Del Core, I. Pipinos, G. Hatzoudis10.1016/S1567-5688(10)70068-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations1717P2 ANGIOTENSIN CONVERTING ENZYME POLYMORPHISM IN FAMILIAL HYPERCHOLESTEROLEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700696/abstract?rss=yesP2 ANGIOTENSIN CONVERTING ENZYME POLYMORPHISM IN FAMILIAL HYPERCHOLESTEROLEMIAF. Sbrana, F. Bigazzi, M. Puntoni, I. Fossa, B. dal Pino, D. Pianu, D. Iori, M.G. Andreassi, T. Sampietro10.1016/S1567-5688(10)70069-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations1717P3 TOWARDS TARGETED IMAGING OF ATHEROSCLEROSIS BY USING PEThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700702/abstract?rss=yesP3 TOWARDS TARGETED IMAGING OF ATHEROSCLEROSIS BY USING PETB. Gustafsson, K. Caidahl10.1016/S1567-5688(10)70070-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations1717P4 A NOVEL METHOD OF CLINICAL ULTRASOUND EVALUATION OF VERY EARLY STAGES OF ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700714/abstract?rss=yesP4 A NOVEL METHOD OF CLINICAL ULTRASOUND EVALUATION OF VERY EARLY STAGES OF ATHEROSCLEROSISY. Ashikhmin, O. Dikur, O. Drapkina10.1016/S1567-5688(10)70071-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations1717P5 COMMON CAROTID INTIMA MEDIA THICKNESS IS INDEPENDENTLY ASSOCIATED WITH PERIPHERAL ARTERIAL DISEASE IN UK 1ST GENERATION ASIAN AND BLACK MIGRANTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700726/abstract?rss=yesP5 COMMON CAROTID INTIMA MEDIA THICKNESS IS INDEPENDENTLY ASSOCIATED WITH PERIPHERAL ARTERIAL DISEASE IN UK 1ST GENERATION ASIAN AND BLACK MIGRANTSP. Bennett, S. Silverman, P. Gill, G. Lip10.1016/S1567-5688(10)70072-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations1818P6 IDENTIFICATION AND CHARACTERIZATION OF CORONARY PLAQUES WITH CT VIRTUAL INTRAVASCULAR ENDOSCOPY: A PICTORIAL REVIEWhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700738/abstract?rss=yesP6 IDENTIFICATION AND CHARACTERIZATION OF CORONARY PLAQUES WITH CT VIRTUAL INTRAVASCULAR ENDOSCOPY: A PICTORIAL REVIEWT. Chaichana, Z. Sun10.1016/S1567-5688(10)70073-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations1818P7 MAGNETIC RESONANCE IMAGING OF HIGH RISK ATHEROSCLEROTIC PLAQUES USING GADOFLUORINE M IN A HYPERLIPIDEMIC ANIMAL MODEL AT 3 Thttp://www.atherosclerosis-supplements.com/article/PIIS156756881070074X/abstract?rss=yesP7 MAGNETIC RESONANCE IMAGING OF HIGH RISK ATHEROSCLEROTIC PLAQUES USING GADOFLUORINE M IN A HYPERLIPIDEMIC ANIMAL MODEL AT 3 TH. Ittrich, T. Nielsen, K. Peldschus, S. Tobias, B. Misselwitz, H.-J. Weinmann, C. Weber, G. Adam10.1016/S1567-5688(10)70074-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations1818P8 SYNTHESIS, PHYSICOCHEMICAL AND TOXICOLOGICAL CHARACTERIZATION OF 59FE-LABELLED NANOPARTICLES FOR TARGETING ARTERIOSCLEROTIC LESIONShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700751/abstract?rss=yesP8 SYNTHESIS, PHYSICOCHEMICAL AND TOXICOLOGICAL CHARACTERIZATION OF 59FE-LABELLED NANOPARTICLES FOR TARGETING ARTERIOSCLEROTIC LESIONSB. Freund, A. Giemsa, H. Ittrich, O. Bruns, U. Tromsdorf, J. Heeren, H. Weller, H. Hohenberg, G. Adam, U. Beisiegel, P. Nielsen10.1016/S1567-5688(10)70075-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations1818P9 ATHEROSCLEROTIC BURDEN IN ASYMPTOMATIC PATIENTS WITH METABOLIC SYNDROME EVALUATED BY COMPUTED TOMOGRAPHY ANGIOGRAPHYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700763/abstract?rss=yesP9 ATHEROSCLEROTIC BURDEN IN ASYMPTOMATIC PATIENTS WITH METABOLIC SYNDROME EVALUATED BY COMPUTED TOMOGRAPHY ANGIOGRAPHYM. Arca, G. Pigna, F. Zaccagna, B. Cavallo Marincola, A. Montali, L. Iuliano, A. Napoli, C. Catalano10.1016/S1567-5688(10)70076-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations1818P10 TARGETED STERICALLY STABILIZED LIPOSOMES FOR DIAGNOSTIC IMAGING OF ATHEROSCLEROTIC PLAQUEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700775/abstract?rss=yesP10 TARGETED STERICALLY STABILIZED LIPOSOMES FOR DIAGNOSTIC IMAGING OF ATHEROSCLEROTIC PLAQUESR. Prassl, G. Almer, M. Saba-Lepek, D. Frascione, J. Kellner, A. Gries, C. Diwoky, R. Stollberger, H. Mangge10.1016/S1567-5688(10)70077-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations1919P11 WHHLMI RABBIT IS AN ANIMAL MODEL FOR ANGINA AND/OR CORONARY SPASMShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700787/abstract?rss=yesP11 WHHLMI RABBIT IS AN ANIMAL MODEL FOR ANGINA AND/OR CORONARY SPASMST. Kobayashi, T. Ito, S. Yamada, N. Hirayama, K. Hirata, T. Ishida, M. Shiomi10.1016/S1567-5688(10)70078-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations1919P12 PREVENTION OF ACTIVATED MACROPHAGE-INDUCED ADHESION MOLECULES BY CHLORELLA EXTRACT IN ENDOTHELIAL SEVC CELLShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700799/abstract?rss=yesP12 PREVENTION OF ACTIVATED MACROPHAGE-INDUCED ADHESION MOLECULES BY CHLORELLA EXTRACT IN ENDOTHELIAL SEVC CELLSM.-F. Shih, J.-Y. Cherng10.1016/S1567-5688(10)70079-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations1919P13 CILOSTAZOL AMELIORATES METABOLIC ABNORMALITIES IN A DB/DB MOUSE MODEL OF TYPE 2 DIABETES VIA ACTIVATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORγ TRANSCRIPTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700805/abstract?rss=yesP13 CILOSTAZOL AMELIORATES METABOLIC ABNORMALITIES IN A DB/DB MOUSE MODEL OF TYPE 2 DIABETES VIA ACTIVATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORγ TRANSCRIPTIONS.Y. Park, K.W. Hong, W.S. Lee, C.D. Kim10.1016/S1567-5688(10)70080-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations1919P14 PREVENTION OF DOCA/SALT HYPERTENSION-INDUCED RAT RENAL INJURY BY ANTIOXIDANT THERAPYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700817/abstract?rss=yesP14 PREVENTION OF DOCA/SALT HYPERTENSION-INDUCED RAT RENAL INJURY BY ANTIOXIDANT THERAPYM. Kadkhodaee, B. Seifi, S.M. Karimian, M. Zahmatkesh, E. Bakhshi10.1016/S1567-5688(10)70081-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations1919P15 SERUM LEVELS OF LEPTIN AND LIPID PROFILES FOLLOWING LOVASTATIN THERAPY IN DIABETIC NEPHROPATHYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700829/abstract?rss=yesP15 SERUM LEVELS OF LEPTIN AND LIPID PROFILES FOLLOWING LOVASTATIN THERAPY IN DIABETIC NEPHROPATHYN. Rashtchizadeh, A. Ghorbanihaghjo, H. Argani, J. Safa, M. Rahbaninoubar10.1016/S1567-5688(10)70082-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2020P16 AEROBIC TRAINING REDUCED LEPTIN LEVELS IN ADOLESCENTS WITH DOWN SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700830/abstract?rss=yesP16 AEROBIC TRAINING REDUCED LEPTIN LEVELS IN ADOLESCENTS WITH DOWN SYNDROMEF.J. Ordonez, I. Rosety, M.A. Rosety, A. Camacho, G. Fornieles, M. Bernardi, M. Rosety-Rodriguez10.1016/S1567-5688(10)70083-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2020P17 ARTERIAL STRUCTION AND FUNCTION IN FAMILIAL HYPERCHOLESTEROLEMIA: A META-ANALYSIS OF CASE–CONTROL STUDIEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700842/abstract?rss=yesP17 ARTERIAL STRUCTION AND FUNCTION IN FAMILIAL HYPERCHOLESTEROLEMIA: A META-ANALYSIS OF CASE–CONTROL STUDIESC. Masoura, K. Aznaouridis, C. Pitsavos, I. Skoumas, C. Vlachopoulos, C. Stefanadis10.1016/S1567-5688(10)70084-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2020P18 COMPARISON OF ADIPOSE TISSUE GENE EXPRESSION OF ADIPONECTIN, TUMOR NECROSIS FACTOR-α AND LEPTIN IN PATIENTS WITH AND WITHOUT METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700854/abstract?rss=yesP18 COMPARISON OF ADIPOSE TISSUE GENE EXPRESSION OF ADIPONECTIN, TUMOR NECROSIS FACTOR-α AND LEPTIN IN PATIENTS WITH AND WITHOUT METABOLIC SYNDROMES. Görmez, A. Demirkan, B. Çaynak, F. Atalar, D. Günay, B. Akpinar, U. Özbek, V. Aytekin, N. Yazicioğlu, A.S. Büyükdevrim10.1016/S1567-5688(10)70085-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2020P19 ORPHAN NUCLEAR RECEPTOR NUR77 SUPPRESSES INFLAMMATORY RESPONSE PARTIALLY DEPENDENT ON COX-2 IN MACROPHAGES INDUCED BY OXIDIZED LOW-DENSITY LIPOPROTEINhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700866/abstract?rss=yesP19 ORPHAN NUCLEAR RECEPTOR NUR77 SUPPRESSES INFLAMMATORY RESPONSE PARTIALLY DEPENDENT ON COX-2 IN MACROPHAGES INDUCED BY OXIDIZED LOW-DENSITY LIPOPROTEINS. Qin, S. Linghong, H. Ben10.1016/S1567-5688(10)70086-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2021P20 PLATELET COUNT IS INDEPENDENTLY ASSOCIATED TO ASYMPTOMATIC PERIPHERAL ARTERIAL DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700878/abstract?rss=yesP20 PLATELET COUNT IS INDEPENDENTLY ASSOCIATED TO ASYMPTOMATIC PERIPHERAL ARTERIAL DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUSJ. Mancera, F. Paniagua-Gómez, A. Baca-Osorio, L. Ginel-Mendoza, M.L. Fernández-Tapia, P. González-Santos, P. Valdivielso10.1016/S1567-5688(10)70087-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2121P21 CAROTID-FEMORAL ARTERIAL INDEX AND SEVERITY OF CORONARY ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070088X/abstract?rss=yesP21 CAROTID-FEMORAL ARTERIAL INDEX AND SEVERITY OF CORONARY ATHEROSCLEROSISM. Soliman, H. Hassan, T. Gazy, W. Fareed, A. Reda, S. Shalaby10.1016/S1567-5688(10)70088-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2121P22 ASCENDING AORTA ATHEROSCLEROSIS IS INDEPENDENT OF CAROTID AND FEMORAL ARTERIES ATHEROSCLEROTIC INVOLVEMENThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700891/abstract?rss=yesP22 ASCENDING AORTA ATHEROSCLEROSIS IS INDEPENDENT OF CAROTID AND FEMORAL ARTERIES ATHEROSCLEROTIC INVOLVEMENTM.K. Tarzamni, N. Nezami, A. Afrasiabi, A.T. Eftekharsadat, N. Eshragi10.1016/S1567-5688(10)70089-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2121P23 NONINVASIVE DETECTION AND EVALUATION OF CORONARY ARTERY PLAQUES WITH MULTISLICE COMPUTED TOMOGRAPHY CORONARY ANGIOGRAPHY IN DIABETIC PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700908/abstract?rss=yesP23 NONINVASIVE DETECTION AND EVALUATION OF CORONARY ARTERY PLAQUES WITH MULTISLICE COMPUTED TOMOGRAPHY CORONARY ANGIOGRAPHY IN DIABETIC PATIENTSF. Aboul-Enein10.1016/S1567-5688(10)70090-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2121P24 EFFECT OF TELMISARTAN ON THE ARTERIOVENOUS INDEX IN RETINAL MICROVASCULARIZATIONhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070091X/abstract?rss=yesP24 EFFECT OF TELMISARTAN ON THE ARTERIOVENOUS INDEX IN RETINAL MICROVASCULARIZATIONJ.A. Díaz Peromingo, J.M. Fernández Villaverde, A. Carballo Vicente, I. Echebarrieta Gorostiaga, G. Múgico Sánchez, V. Parga García, M.A. Pérez Llamas, M. Rodríguez Blanco, M. Pena Seijo, A. Pose Reino10.1016/S1567-5688(10)70091-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2122P25 PHOTOTHERMAL NANODESTRUCTION VERSUS STROMA ABLATION WITH LENTIVIRAL VECTOR EXPRESSING DIPHTHERIA TOXIN FOR THE MANAGEMENT OF ATHEROSCLEROTIC PLAQUEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700921/abstract?rss=yesP25 PHOTOTHERMAL NANODESTRUCTION VERSUS STROMA ABLATION WITH LENTIVIRAL VECTOR EXPRESSING DIPHTHERIA TOXIN FOR THE MANAGEMENT OF ATHEROSCLEROTIC PLAQUEA. Kharlamov, J.L. Gabinsky10.1016/S1567-5688(10)70092-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2222P26 MODULATION OF ANRIL EXPRESSION MAY MEDIATE THE ASSOCIATION OF CHROMOSOME 9P21 VARIANTS WITH CORONARY ARTERY DISEASE AND STROKEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700933/abstract?rss=yesP26 MODULATION OF ANRIL EXPRESSION MAY MEDIATE THE ASSOCIATION OF CHROMOSOME 9P21 VARIANTS WITH CORONARY ARTERY DISEASE AND STROKEM. Cunnington, M. Santibanez Koref, B. Mayosi, J. Burn, B. Keavney10.1016/S1567-5688(10)70093-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2222P27 NEW FINDINGS SUPPORTING PAPP-A ROLE IN ATHEROSCLEROTIC PLAQUE DESTABILIZATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700945/abstract?rss=yesP27 NEW FINDINGS SUPPORTING PAPP-A ROLE IN ATHEROSCLEROTIC PLAQUE DESTABILIZATIONT. Solovyeva, A. Postnikov, D. Serebryanaya, A. Kharitonov, A. Arutyunov, A. Katrukha10.1016/S1567-5688(10)70094-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2222P28 RESVERATROL PROTECTS AGAINST ATHEROSCLEROSIS DEVELOPMENT IN APOE*3-LEIDEN.CETP MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700957/abstract?rss=yesP28 RESVERATROL PROTECTS AGAINST ATHEROSCLEROSIS DEVELOPMENT IN APOE*3-LEIDEN.CETP MICEJ. Berbée, M.-C. Wong, Y. Wang, J. van der Hoorn, H. Romijn, L. Havekes, H. Princen, P. Rensen10.1016/S1567-5688(10)70095-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2222P29 THE ROLE OF EXERCISE AND ENDOCANNABINOID SYSTEM IN ATHEROSCLEROTIC PLAQUE STABILITY – EXPERIMENTAL STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700969/abstract?rss=yesP29 THE ROLE OF EXERCISE AND ENDOCANNABINOID SYSTEM IN ATHEROSCLEROTIC PLAQUE STABILITY – EXPERIMENTAL STUDYM. Katsimpoulas, N. Kadoglou, A. Kapelouzou, P. Moustardas, I. Botis, E. Dede, N. Kostomitsopoulos, C. Liapis, P. Karayannacos10.1016/S1567-5688(10)70096-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2223P30 ATORVASTATIN REDUCES MACROPHAGE ACCUMULATION IN THE ATHEROSCLEROTIC PLAQUE IN PATIENTS UNDERGOING CAROTID ENDARTERECTOMY: A COMPARISON VERSUS NON-STATIN BASED REGIMENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700970/abstract?rss=yesP30 ATORVASTATIN REDUCES MACROPHAGE ACCUMULATION IN THE ATHEROSCLEROTIC PLAQUE IN PATIENTS UNDERGOING CAROTID ENDARTERECTOMY: A COMPARISON VERSUS NON-STATIN BASED REGIMENM. Puato, F. Elisabetta, M. Rattazzi, F. Cipollone, A. Zambon, F. Grego, A. Mezzetti, P. Pauletto10.1016/S1567-5688(10)70097-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2323P31 HIGH-THROUGHPUT SERUM NMR METABONOMICS – METABOLIC PHENOTYPING FOR SCREENING AND PROGNOSTICS OF VASCULAR DISEASES AND THEIR COMPLICATIONShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700982/abstract?rss=yesP31 HIGH-THROUGHPUT SERUM NMR METABONOMICS – METABOLIC PHENOTYPING FOR SCREENING AND PROGNOSTICS OF VASCULAR DISEASES AND THEIR COMPLICATIONSM. Savolainen, T. Salonurmi, M.-R. Järvelin, T. Tukiainen, P. Wurtz, A. Kangas, P. Soininen, M. Ala-Korpela10.1016/S1567-5688(10)70098-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2323P32 EVALUATION OF SYSTEMIC INFLAMMATION IN FAMILIAL HYPERCHOLESTEROLEMIA BY BIOMARKER PROFILING ON BIOCHIP ARRAYS: IMPACT OF LDL-APHERESIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810700994/abstract?rss=yesP32 EVALUATION OF SYSTEMIC INFLAMMATION IN FAMILIAL HYPERCHOLESTEROLEMIA BY BIOMARKER PROFILING ON BIOCHIP ARRAYS: IMPACT OF LDL-APHERESISM.J. Chapman, P. Robillard, A. Orsoni, S. Saheb, M. Atassi, A. Kontush, J. Lamont, E. Bruckert10.1016/S1567-5688(10)70099-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2323P33 A NUTRIGENOMIC APPROACH TO STUDY THE EFFECT OF HERBAL POLYPHENOLS ON ATHEROGENIC TRANSCRIPTOMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701008/abstract?rss=yesP33 A NUTRIGENOMIC APPROACH TO STUDY THE EFFECT OF HERBAL POLYPHENOLS ON ATHEROGENIC TRANSCRIPTOMEV. Dhawan, N. Malik, A. Shukla, K. Sikand, A. Bahl, D. Kaul10.1016/S1567-5688(10)70100-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2324P34 LIPID-LOWERING EFFECT OF METHANOLIC EXTRACT OF VERNONIA AMYGDALINA LEAVES IN RATS FED ON HIGH CHOLESTEROL DIEThttp://www.atherosclerosis-supplements.com/article/PIIS156756881070101X/abstract?rss=yesP34 LIPID-LOWERING EFFECT OF METHANOLIC EXTRACT OF VERNONIA AMYGDALINA LEAVES IN RATS FED ON HIGH CHOLESTEROL DIETO. Adaramoye, J. Achem, O. Akintayo, M.A. Fafunso10.1016/S1567-5688(10)70101-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2424P35 EVALUATION OF DIABETIC ANGIOPATHIES BY DIGITAL THERMOGRAPHYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701021/abstract?rss=yesP35 EVALUATION OF DIABETIC ANGIOPATHIES BY DIGITAL THERMOGRAPHYV. Anestiadi, Z. Anestiadi, V. Anestiadis10.1016/S1567-5688(10)70102-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2424P36 PLASMA LIPIDOMIC ANALYSIS OF STABLE AND UNSTABLE CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701033/abstract?rss=yesP36 PLASMA LIPIDOMIC ANALYSIS OF STABLE AND UNSTABLE CORONARY ARTERY DISEASEP. Meikle, D. Tsorotes, C. Barlow, J. Weir, G. MacIntosh, M. Barber, B. Goudey, J. Bedo, L. Stern, A. Kowalczyk, I. Haviv, A. White, A. Dart, S. Duffy, B. Kingwell10.1016/S1567-5688(10)70103-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2424P37 DECREASE OF INSULIN SENSITIVITY FOLLOWS THE DISORDERS – FROM OBESITY, THROUGH PRE-DIABETES, TO NEWLY DIAGNOSED DIABETEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701045/abstract?rss=yesP37 DECREASE OF INSULIN SENSITIVITY FOLLOWS THE DISORDERS – FROM OBESITY, THROUGH PRE-DIABETES, TO NEWLY DIAGNOSED DIABETESV. Dimitrijevic-Sreckovic, P. Djordjevic, B. Sreckovic, S. Popovic, D. Gostiljac, M. Ilic, G. Milic, T. Nisic, I. Soldatovic, G. Markovic10.1016/S1567-5688(10)70104-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2424P38 GENERATION OF RECOMBINANT ANTIBODIES TO NITROTYROSINE TO FACILITATE THE IDENTIFICATION OF NOVEL PROTEIN BIOMARKERS OF ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701057/abstract?rss=yesP38 GENERATION OF RECOMBINANT ANTIBODIES TO NITROTYROSINE TO FACILITATE THE IDENTIFICATION OF NOVEL PROTEIN BIOMARKERS OF ATHEROSCLEROSISD. Hof, S. Decasper, A. von Eckardstein10.1016/S1567-5688(10)70105-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2425P39 ASSESSMENT OF SUBCLINICAL CORONARY ATHEROSCLEROSIS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH MULTISLICE COMPUTED TOMOGRAPHYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701069/abstract?rss=yesP39 ASSESSMENT OF SUBCLINICAL CORONARY ATHEROSCLEROSIS IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH MULTISLICE COMPUTED TOMOGRAPHYM. Franco, F. Carreras, R. Leta, A. Duran, G. Pons-Lladó10.1016/S1567-5688(10)70106-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2525P40 CAROTID ATHEROSCLEROSIS OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA NO LONGER DIFFERS FROM UNAFFECTED RELATIVES ALREADY WITHIN 18 MONTHS AFTER IDENTIFICATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701070/abstract?rss=yesP40 CAROTID ATHEROSCLEROSIS OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA NO LONGER DIFFERS FROM UNAFFECTED RELATIVES ALREADY WITHIN 18 MONTHS AFTER IDENTIFICATIONR. Huijgen, B.A. Hutten, I. Kindt, E. de Groot, J.J.P. Kastelein, M.N. Vissers10.1016/S1567-5688(10)70107-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2525P41 CHARACTERIZATION OF PATIENTS WITH VERY HIGH PLASMA HDL-CHOLESTEROL, WITH AND WITHOUT VASCULAR PATHOLOGYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701082/abstract?rss=yesP41 CHARACTERIZATION OF PATIENTS WITH VERY HIGH PLASMA HDL-CHOLESTEROL, WITH AND WITHOUT VASCULAR PATHOLOGYG. Sarwal, A. Al-Sarraf, C. Taraboanta, J. Frohlich10.1016/S1567-5688(10)70108-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2525P42 MODERATE-SEVERE BLEEDING COMPLICATIONS AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME; AN ANALYSIS FROM SIX MIDDLE EASTERN COUNTRIEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701094/abstract?rss=yesP42 MODERATE-SEVERE BLEEDING COMPLICATIONS AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROME; AN ANALYSIS FROM SIX MIDDLE EASTERN COUNTRIESD. Shakir, M. Al Mallah, M. Zubaid, W. Al Mahamed, A.A. Alsheikh-Ali, J. Al Suwaidid10.1016/S1567-5688(10)70109-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2525P43 N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE BUT NOT HIGH-SENSITIVITY C-REACTIVE PROTEIN IS RELATED TO SEVERITY OF CORONARY STENOSIS IN ACUTE CORONARY SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701100/abstract?rss=yesP43 N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE BUT NOT HIGH-SENSITIVITY C-REACTIVE PROTEIN IS RELATED TO SEVERITY OF CORONARY STENOSIS IN ACUTE CORONARY SYNDROMES. Li, Z. Sun, J. Wang, T. Yang10.1016/S1567-5688(10)70110-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2526P44 SYSTEMIC HYPOXIA PROMOTES THROMBIN GENERATION BY ENHANCING RELEASE OF MONOCYTE-DERIVED MICROPARTICLES DURING EXERCISEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701112/abstract?rss=yesP44 SYSTEMIC HYPOXIA PROMOTES THROMBIN GENERATION BY ENHANCING RELEASE OF MONOCYTE-DERIVED MICROPARTICLES DURING EXERCISEJ.-S. Wang10.1016/S1567-5688(10)70111-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2626P45 ASSOCIATION OF ET-1, MMP-9, AND MYELOPEROXIDASE WITH CORONARY MORPHOLOGY DETECTED BY CT ANGIOGRAPHY IN MODERATE–HIGH RISK ASYMPTOMATIC SUBJECTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701124/abstract?rss=yesP45 ASSOCIATION OF ET-1, MMP-9, AND MYELOPEROXIDASE WITH CORONARY MORPHOLOGY DETECTED BY CT ANGIOGRAPHY IN MODERATE–HIGH RISK ASYMPTOMATIC SUBJECTSY. Ben Moshe, E. Lubovich, Y. Rivlin, I. Maor, R. Zeina, U. Rosenschein, E. Goldhammer10.1016/S1567-5688(10)70112-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2626P46 THE ANTI-INFLAMMATORY EFFECTS OF EXERCISE TRAINING PROMOTE ATHEROSCLEROTIC PLAQUE STABILIZATION IN apoE-KNOCKOUT MICE WITH DIABETIC ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701136/abstract?rss=yesP46 THE ANTI-INFLAMMATORY EFFECTS OF EXERCISE TRAINING PROMOTE ATHEROSCLEROTIC PLAQUE STABILIZATION IN apoE-KNOCKOUT MICE WITH DIABETIC ATHEROSCLEROSISN. Kadoglou, A. Kapelouzou, P. Moustardas, M. Katsimpoulas, A. Giagini, E. Dede, N. Kostomitsopoulos, C. Liapis, P. Karayannakos10.1016/S1567-5688(10)70113-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2626P47 ELEVATED ADVANCED GLYCOSYLATION ENDPRODUCTS (AGE) IN NON-DIABETIC SUBJECTS WITH ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701148/abstract?rss=yesP47 ELEVATED ADVANCED GLYCOSYLATION ENDPRODUCTS (AGE) IN NON-DIABETIC SUBJECTS WITH ATHEROSCLEROSISS.A. Bovenberg, A. Westzaan, S. Martinez-Hervas, G.J. van de Geijn, H. Janssen, T.L. Njo, R. van Mechelen, A. Smit, J.W.F. Elte, M. Castro Cabezas10.1016/S1567-5688(10)70114-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2626P48 OXLDL/beta2GPI COMPLEX AS AN EARLY MARKER OF ATHEROSCLEROSIS INITIATION IN HEALTHY MIDDLE-AGED MEN WITH ABDOMINAL OBESITYhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070115X/abstract?rss=yesP48 OXLDL/beta2GPI COMPLEX AS AN EARLY MARKER OF ATHEROSCLEROSIS INITIATION IN HEALTHY MIDDLE-AGED MEN WITH ABDOMINAL OBESITYP.J. Kraml, P. Syrovátka, J. Potočková, M. Anděl10.1016/S1567-5688(10)70115-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2627P49 AN ERYTHROPOIETIN RECEPTOR (EPOR) IN HUMAN ADIPOSE TISSUE (AT)http://www.atherosclerosis-supplements.com/article/PIIS1567568810701161/abstract?rss=yesP49 AN ERYTHROPOIETIN RECEPTOR (EPOR) IN HUMAN ADIPOSE TISSUE (AT)K. Möller, E. Piella, P. Algenstaedt, D.E. Müller-Wiefel10.1016/S1567-5688(10)70116-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2727P50 VARIANT IN KIF6 PREDICTS CORONARY EVENTS AND EVENT REDUCTION FROM STATIN THERAPY: CARE, WOSCOPS, PROSPER AND PROVE IT-TIMI 22 STUDIEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701173/abstract?rss=yesP50 VARIANT IN KIF6 PREDICTS CORONARY EVENTS AND EVENT REDUCTION FROM STATIN THERAPY: CARE, WOSCOPS, PROSPER AND PROVE IT-TIMI 22 STUDIESO. Iakoubova10.1016/S1567-5688(10)70117-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2727P51 HOMOCYSTEINE AS A CARDIOVASCULAR RISK MARKER IN POLYCYSTIC OVARY SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701185/abstract?rss=yesP51 HOMOCYSTEINE AS A CARDIOVASCULAR RISK MARKER IN POLYCYSTIC OVARY SYNDROMEA. Atanasova, G. Dimitrov, S. Biljali10.1016/S1567-5688(10)70118-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2727P52 INFLUENCE OF ARTERIAL STIFFNESS, BODY CONSISTENCY AND SECONDHAND SMOKE EXPOSURE ON CHRONIC VALVE DISEASE AND MYOCARDIAL INFARCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701197/abstract?rss=yesP52 INFLUENCE OF ARTERIAL STIFFNESS, BODY CONSISTENCY AND SECONDHAND SMOKE EXPOSURE ON CHRONIC VALVE DISEASE AND MYOCARDIAL INFARCTIONA. Domonkos Tarnoki, D.L. Tarnoki, Z. Garami, G. Veress10.1016/S1567-5688(10)70119-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2727P53 CARDIOPROTECTIVE EFFECT OF RED WINEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701203/abstract?rss=yesP53 CARDIOPROTECTIVE EFFECT OF RED WINEA. Novakovic, L. Gojkovic Bukarica, D. Nezic, M. Peric, V. Kanjuh10.1016/S1567-5688(10)70120-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2728P54 MATRIX METALLOPROTEINASE-9 (MMP-9), ITS TISSUE INHIBITOR TIMP-1 AND NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN AS NEW ATHEROSCLEROSIS MARKERS IN CHRONICALLY DIALYZED PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701215/abstract?rss=yesP54 MATRIX METALLOPROTEINASE-9 (MMP-9), ITS TISSUE INHIBITOR TIMP-1 AND NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN AS NEW ATHEROSCLEROSIS MARKERS IN CHRONICALLY DIALYZED PATIENTSK. Musial, D. Zwolinska10.1016/S1567-5688(10)70121-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2828P55 THE TREATMENT OF COLESTERYL STORAGE DISEASE (CESD) BY EZETIMIBE MONOTHERAPYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701227/abstract?rss=yesP55 THE TREATMENT OF COLESTERYL STORAGE DISEASE (CESD) BY EZETIMIBE MONOTHERAPYF. Abello, O. Guardamagna, V. Baracco, R. Bonardi10.1016/S1567-5688(10)70122-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2828P56 INFLUENCE OF PHYSICAL TRAININGS ON BLOOD OXYGEN TRANSPORT INDICES AND ENDOTHELIAL FUNCTION IN PATIENTS WITH STABLE ANGINAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701239/abstract?rss=yesP56 INFLUENCE OF PHYSICAL TRAININGS ON BLOOD OXYGEN TRANSPORT INDICES AND ENDOTHELIAL FUNCTION IN PATIENTS WITH STABLE ANGINAL. Yankovskaya10.1016/S1567-5688(10)70123-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2828P57 LIPO-RETRO-D-PEPTIDES: NEXT GENERATION OF THE HIGHMOST SELECTIVE THROMBIN INHIBITORShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701240/abstract?rss=yesP57 LIPO-RETRO-D-PEPTIDES: NEXT GENERATION OF THE HIGHMOST SELECTIVE THROMBIN INHIBITORSA. Poyarkov, S. Poyarkova10.1016/S1567-5688(10)70124-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2828P58 DETERMINATION OF THE PROOXIDANT–ANTIOXIDANT BALANCE IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY AND IN RENAL TRANSPLANT PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701252/abstract?rss=yesP58 DETERMINATION OF THE PROOXIDANT–ANTIOXIDANT BALANCE IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY AND IN RENAL TRANSPLANT PATIENTSV. Markovic, T. Gojkovic, M. Kostic10.1016/S1567-5688(10)70125-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2828P59 PROINFLAMMATORY CIRCULATING FACTORS IN NON-ALCOHOLIC FATTY LIVER DISEASE ASSOCIATED TO METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701264/abstract?rss=yesP59 PROINFLAMMATORY CIRCULATING FACTORS IN NON-ALCOHOLIC FATTY LIVER DISEASE ASSOCIATED TO METABOLIC SYNDROMED. Lucero, V. Zago, G. López, V. Miksztowicz, H. Fainboim, M. Graffigna, L. Gómez Rosso, G. Berg, R. Wikinski, F. Brites, L. Schreier10.1016/S1567-5688(10)70126-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2929P60 PARAMETERS OF OXIDATIVE STRESS AND ANTIOXIDATIVE PROTECTION IN PLASMA OF FANCONI ANEMIA PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701276/abstract?rss=yesP60 PARAMETERS OF OXIDATIVE STRESS AND ANTIOXIDATIVE PROTECTION IN PLASMA OF FANCONI ANEMIA PATIENTSJ. Joksic10.1016/S1567-5688(10)70127-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2929P61 ACUTE DECREASE OF ANTI-HEAT SHOCK PROTEIN 27 AND ACUTE INCREASE OF HIGH SENSITIVE C-REACTIVE PROTEIN AFTER PERCUTANEOUS CORONARY INTERVENTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701288/abstract?rss=yesP61 ACUTE DECREASE OF ANTI-HEAT SHOCK PROTEIN 27 AND ACUTE INCREASE OF HIGH SENSITIVE C-REACTIVE PROTEIN AFTER PERCUTANEOUS CORONARY INTERVENTIONM. Ghayour-Mobarhan, M. Mouhebati, H. Falsoleiman, S. Tavallei, R. Paydar, H. Pourghadamyari, G. Ferns10.1016/S1567-5688(10)70128-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2929P62 HAEMODYNAMIC EFFECTS OF LACTOTRIPEPTIDES FROM CASEIN HYDROLYSATE IN MEDITERRANEAN HEALTHY SUBJECTS: A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER TRIALhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070129X/abstract?rss=yesP62 HAEMODYNAMIC EFFECTS OF LACTOTRIPEPTIDES FROM CASEIN HYDROLYSATE IN MEDITERRANEAN HEALTHY SUBJECTS: A RANDOMIZED, DOUBLE-BLIND, CROSS-OVER TRIALA. Cicero, M. Rosticci, M. Veronesi, S. Bacchelli, E. Strocchi, E. Grandi, C. Borghi10.1016/S1567-5688(10)70129-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2929P63 EFFECT OF HYPERCHOLESTEROLEMIA AND TREATMENT WITH STATINS ON THE ANTIHYPERTENSIVE EFFICACY TO OLMESARTAN AND AMLODIPINE: A RETROSPECTIVE CLINICAL TRIALhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701306/abstract?rss=yesP63 EFFECT OF HYPERCHOLESTEROLEMIA AND TREATMENT WITH STATINS ON THE ANTIHYPERTENSIVE EFFICACY TO OLMESARTAN AND AMLODIPINE: A RETROSPECTIVE CLINICAL TRIALF. Imola, A. Cicero, M. Veronesi, E. Strocchi, E. Tartagni, C. Borghi10.1016/S1567-5688(10)70130-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations2929P64 MOBILIZATION OF CD133+ PROGENITOR CELLS AND ITS CORRELATION TO INTERLEUKIN-8 IN ACUTE CEREBRAL INFARCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701318/abstract?rss=yesP64 MOBILIZATION OF CD133+ PROGENITOR CELLS AND ITS CORRELATION TO INTERLEUKIN-8 IN ACUTE CEREBRAL INFARCTIOND. Franz, D. Sepp, I. Ott, P. Zepper, S. Sadikovic, R. Feurer, L. Esposito, B. Hemmer, H. Poppert10.1016/S1567-5688(10)70131-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3030P65 ARTERIAL STIFFNESS IN PAROXYSMAL ATRIAL FIBRILLATION: RELATIONSHIP WITH MICRO- AND MACROVASCULAR ENDOTHELIAL DYSFUNCTION AND CARDIOVASCULAR DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070132X/abstract?rss=yesP65 ARTERIAL STIFFNESS IN PAROXYSMAL ATRIAL FIBRILLATION: RELATIONSHIP WITH MICRO- AND MACROVASCULAR ENDOTHELIAL DYSFUNCTION AND CARDIOVASCULAR DISEASES. Krishnamoorty, C. Khoo, H.S. Lim, G.Y. Lip10.1016/S1567-5688(10)70132-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3030P66 VITAMIN K2 SUPPLEMENTATION REDUCES THE ELEVATED INACTIVE FORM OF THE CALCIFICATION INHIBITOR MATRIX Gla PROTEIN IN HEMODIALYSIS PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701331/abstract?rss=yesP66 VITAMIN K2 SUPPLEMENTATION REDUCES THE ELEVATED INACTIVE FORM OF THE CALCIFICATION INHIBITOR MATRIX Gla PROTEIN IN HEMODIALYSIS PATIENTST. Krueger, R. Westenfeld, G. Schlieper, E. Cranenburg, S. Heidenreich, S. Holzmann, C. Vermeer, M. Ketteler, J. Floege, L. Schurgers10.1016/S1567-5688(10)70133-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3030P67 THE LEVEL OF ATHEROSCLEROTIC DAMAGE OF THE MAGISTRAL AND PERIPHERAL ARTERIES IN CHRONIC RENAL FAILURE PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701343/abstract?rss=yesP67 THE LEVEL OF ATHEROSCLEROTIC DAMAGE OF THE MAGISTRAL AND PERIPHERAL ARTERIES IN CHRONIC RENAL FAILURE PATIENTSI. Frolova, O. Kuryata10.1016/S1567-5688(10)70134-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3030P68 SIMVASTATIN RETARDS PROGRESSION OF AORTIC VALVE STENOSIS IN THE ELDERLY PATIENTS WITH CHRONIC HEART FAILURE AND PRESERVED SYSTOLIC FUNCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701355/abstract?rss=yesP68 SIMVASTATIN RETARDS PROGRESSION OF AORTIC VALVE STENOSIS IN THE ELDERLY PATIENTS WITH CHRONIC HEART FAILURE AND PRESERVED SYSTOLIC FUNCTIONO. Mytrokhina, O. Kuryata10.1016/S1567-5688(10)70135-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3031P69 RAPID AND ACCURATE GENETIC DIAGNOSIS BY LIPOCHIP® IN UK FH PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701367/abstract?rss=yesP69 RAPID AND ACCURATE GENETIC DIAGNOSIS BY LIPOCHIP® IN UK FH PATIENTSL. Palacios, M. Stef, A. Taylor, S.E. Humphries, N. Cuevas, C. McAnulty, D. Bourn, D. Tejedor, R.D. Neely10.1016/S1567-5688(10)70136-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3131P70 THE EFFECT OF ALISKIREN ON ATHEROSCLEROSIS DEVELOPMENT IN APOE*3LEIDEN.CETP TRANSGENIC MICE WITH AND WITHOUT TREATMENT WITH ATORVASTATINhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701379/abstract?rss=yesP70 THE EFFECT OF ALISKIREN ON ATHEROSCLEROSIS DEVELOPMENT IN APOE*3LEIDEN.CETP TRANSGENIC MICE WITH AND WITHOUT TREATMENT WITH ATORVASTATINS. Jordaan, J.W.A. van der Hoorn, L.M. Havekes, G. Liau, J.W. Jukema, H.M.G. Princen10.1016/S1567-5688(10)70137-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3131P71 RECONSTITUTED HIGH DENSITY LIPOPROTEIN INHIBITS RESTENOSIS IN BALLOON-INJURED RAT CAROTID ARTERYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701380/abstract?rss=yesP71 RECONSTITUTED HIGH DENSITY LIPOPROTEIN INHIBITS RESTENOSIS IN BALLOON-INJURED RAT CAROTID ARTERYJ.W. Yi Lee, J.Y. Lee, J.Y. Kim, H.J. Ku, B.-S. Lee, J.E. Park, K.-Y. Kim10.1016/S1567-5688(10)70138-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3131P72 FUNCTIONAL AND STRUCTURAL PROFILING OF THE HUMAN THROMBOPOIETIN GENE PROMOTERhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701392/abstract?rss=yesP72 FUNCTIONAL AND STRUCTURAL PROFILING OF THE HUMAN THROMBOPOIETIN GENE PROMOTERC. Dördelmann, R. Telgmann, S. Hasenkamp, B. Schröer, C. Hagedorn, P. Baumgart, P. Kleine-Katthöfer, M. Paul, E. Brand, S.-M. Brand-Herrmann10.1016/S1567-5688(10)70139-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3131P73 RELATIONSHIP BETWEEN LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 AND INFLAMMATION IN CORONARY HEART DISEASEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701409/abstract?rss=yesP73 RELATIONSHIP BETWEEN LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 AND INFLAMMATION IN CORONARY HEART DISEASESG. Tian, G. Xig10.1016/S1567-5688(10)70140-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3132P74 ROLES OF THE METABOLIC SYNDROME AND CORONARY ATHEROSCLEROSIS IN SUBCLINICAL INFLAMMATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701410/abstract?rss=yesP74 ROLES OF THE METABOLIC SYNDROME AND CORONARY ATHEROSCLEROSIS IN SUBCLINICAL INFLAMMATIONP. Rein, C.H. Saely, S. Beer, A. Vonbank, H. Drexel10.1016/S1567-5688(10)70141-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3232P75 A NOVEL ANTHROPOMETRIC MEASURE FOR PREDICTING ALL-CAUSE MORTALITYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701422/abstract?rss=yesP75 A NOVEL ANTHROPOMETRIC MEASURE FOR PREDICTING ALL-CAUSE MORTALITYA. Rosenblad, J. Leppert, G. Nilsson10.1016/S1567-5688(10)70142-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3232P76 PREGNANCY OUTCOMES IN FAMILIAL HYPERCHOLESTEROLEMIA WITH SPECIAL EMPHASIS ON PRETERM DELIVERY, BIRTH WEIGHT AND CONGENITAL MALFORMATIONS. A REGISTRY-BASED STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701434/abstract?rss=yesP76 PREGNANCY OUTCOMES IN FAMILIAL HYPERCHOLESTEROLEMIA WITH SPECIAL EMPHASIS ON PRETERM DELIVERY, BIRTH WEIGHT AND CONGENITAL MALFORMATIONS. A REGISTRY-BASED STUDYI. Toleikyte, K. Retterstøl, T.P. Leren, P.O. Iversen10.1016/S1567-5688(10)70143-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3232P77 PROTHROMBOGENESIS IN SUBJECTS WITH METABOLIC SYNDROME AND CENTRAL OBESITYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701446/abstract?rss=yesP77 PROTHROMBOGENESIS IN SUBJECTS WITH METABOLIC SYNDROME AND CENTRAL OBESITYA.A. Razak, T.S. Tengku Ismail, M.R. Mohamad Taib, M. Mustafa Kamal, S. Abd Muid, M.T. Osman, K. Yusoff, H. Nawawi10.1016/S1567-5688(10)70144-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3232P78 METABOLIC SYNDROME AND SUBCLINICAL ATHEROSCLEROSIS IN YOUNG ADULTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701458/abstract?rss=yesP78 METABOLIC SYNDROME AND SUBCLINICAL ATHEROSCLEROSIS IN YOUNG ADULTSE.E. Babes, V.V. Babes, M.I. Popescu, A. Ardelean10.1016/S1567-5688(10)70145-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3233P79 ATHEROSCLEROTIC DISEASE LOCATION AND DISPARITIES IN THE CONTROL AND TREATMENT OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH TYPE 2 DIABETEShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070146X/abstract?rss=yesP79 ATHEROSCLEROTIC DISEASE LOCATION AND DISPARITIES IN THE CONTROL AND TREATMENT OF CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH TYPE 2 DIABETESI. Gouni-Berthold, K. Bestehorn, W. Krone, H.K. Berthold10.1016/S1567-5688(10)70146-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3333P80 XANTHELASMAS PREDICT RISK OF ISCHEMIC HEART DISEASE, MYOCARDIAL INFARCTION, AND OVERALL DEATH IN THE GENERAL POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701471/abstract?rss=yesP80 XANTHELASMAS PREDICT RISK OF ISCHEMIC HEART DISEASE, MYOCARDIAL INFARCTION, AND OVERALL DEATH IN THE GENERAL POPULATIONM. Christoffersen, R. Frikke-Schmidt, P. Schnohr, B.G. Nordestgaard, A. Tybjærg-Hansen10.1016/S1567-5688(10)70147-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3333P81 MIF-DEFICIENCY REDUCES CHRONIC INFLAMMATION IN ADIPOSE TISSUE AND IMPAIRS INSULIN RESISTANCE AND ASSOCIATED ATHEROSCLEROSIS IN A MODEL OF COMBINED DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701483/abstract?rss=yesP81 MIF-DEFICIENCY REDUCES CHRONIC INFLAMMATION IN ADIPOSE TISSUE AND IMPAIRS INSULIN RESISTANCE AND ASSOCIATED ATHEROSCLEROSIS IN A MODEL OF COMBINED DISEASER. Kleemann, L. Verschuren, P.Y. Wielinga, P. Voshol, M. van Erk, G. Fingerle-Rowson, K. Willems van Dijk, M. Ouwens, J. Bernhagen, R. Bucala, T. Kooistra10.1016/S1567-5688(10)70148-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3333P82 THE CLINICAL STUDY OF HEART RATE VARIABILITY AND THE SERIOUS EXTENT OF CORONARY ARTERY LESIONS IN CORONARY HEART DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701495/abstract?rss=yesP82 THE CLINICAL STUDY OF HEART RATE VARIABILITY AND THE SERIOUS EXTENT OF CORONARY ARTERY LESIONS IN CORONARY HEART DISEASEG. Tian10.1016/S1567-5688(10)70149-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3333P83 LDL-CHOLESTEROL AND CARDIOVASCULAR EVENTS IN PATIENTS WITH DIABETES MELLITUS TYPE 2http://www.atherosclerosis-supplements.com/article/PIIS1567568810701501/abstract?rss=yesP83 LDL-CHOLESTEROL AND CARDIOVASCULAR EVENTS IN PATIENTS WITH DIABETES MELLITUS TYPE 2C. Tudor, A. Iana, R.A. Jeberean, A. Petrus, R. Buzas10.1016/S1567-5688(10)70150-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3334P84 THE UCL LDLR, PCSK9 & LDLRAP1 VARIANT DATABASES: UPDATE, ANALYSIS & OVERVIEW OF THREE PUBLICLY AVAILABLE FAMILIAL HYPERCHOLESTEROLEMIA GENE DATABASEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701513/abstract?rss=yesP84 THE UCL LDLR, PCSK9 & LDLRAP1 VARIANT DATABASES: UPDATE, ANALYSIS & OVERVIEW OF THREE PUBLICLY AVAILABLE FAMILIAL HYPERCHOLESTEROLEMIA GENE DATABASESS. Leigh, T. Jakubcova, R.A. Whittall, S.E. Humphries10.1016/S1567-5688(10)70151-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3434P85 A MUTATION IN SREBF2 GENE IS INVOLVED IN HYPERCHOLESTEROLEMIA AND HYPERGLYCEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701525/abstract?rss=yesP85 A MUTATION IN SREBF2 GENE IS INVOLVED IN HYPERCHOLESTEROLEMIA AND HYPERGLYCEMIAA.B. Garcia Garcia, S. Martinez-Hervas, S. Vernia, C. Ivorra, S. Blesa, J.C. Martin-Escudero, J.F. Ascaso, R. Carmena, M. Casado, J.T. Real, F.J. Chaves10.1016/S1567-5688(10)70152-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3434P86 PARAOXONASE-2 GENE (PON2) S311C POLYMORPHISM ASSOCIATED WITH TYPE 2 DIABETIC MELLITUS AND CORONARY HEART DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701537/abstract?rss=yesP86 PARAOXONASE-2 GENE (PON2) S311C POLYMORPHISM ASSOCIATED WITH TYPE 2 DIABETIC MELLITUS AND CORONARY HEART DISEASET. Peerapatdit, A. Likidlilid, N. Hobang, D. Tresukosol, S. Ratanamaneechat10.1016/S1567-5688(10)70153-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3434P87 CAROTID ATHEROSCLEROSIS ASSOCIATED WITH LATE-ONSET DEPRESSIVE DISORDERS: RESULTS FROM A LARGE COHORT STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701549/abstract?rss=yesP87 CAROTID ATHEROSCLEROSIS ASSOCIATED WITH LATE-ONSET DEPRESSIVE DISORDERS: RESULTS FROM A LARGE COHORT STUDYA. Seldenrijk, H. van Hout, H. van Marwijk, E. de Groot, J. Gort, C. Rustemeijer, M. Diamant, B. Penninx10.1016/S1567-5688(10)70154-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3435P88 CARDIOVASCULAR FUNCTION AND PSYCHOLOGICAL DISTRESS IN URBANISED BLACK SOUTH AFRICANS: THE SABPA STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701550/abstract?rss=yesP88 CARDIOVASCULAR FUNCTION AND PSYCHOLOGICAL DISTRESS IN URBANISED BLACK SOUTH AFRICANS: THE SABPA STUDYN. Mashele, J.M. Van Rooyen, L. Malan, J.C. Potgieter10.1016/S1567-5688(10)70155-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3535P89 FATTY ACIDS IN SERUM PHOSPHOLIPIDS AND CAROTID INTIMA-MEDIA THICKNESS IN SPANISH SUBJECTS WITH PRIMARY DYSLIPIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701562/abstract?rss=yesP89 FATTY ACIDS IN SERUM PHOSPHOLIPIDS AND CAROTID INTIMA-MEDIA THICKNESS IN SPANISH SUBJECTS WITH PRIMARY DYSLIPIDEMIAA. Sala-Vila, M. Cofán, A. Pérez-Heras, I. Núñez, R. Gilabert, M. Junyent, R. Mateo-Gallego, A. Cenarro, F. Civeira, E. Ros10.1016/S1567-5688(10)70156-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3535P90 RECLASSIFICIATION OF 10 YEAR CHD RISK COMPARED BY PRESENCE OF CAROTID PLAQUE AND HIGH CRPhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701574/abstract?rss=yesP90 RECLASSIFICIATION OF 10 YEAR CHD RISK COMPARED BY PRESENCE OF CAROTID PLAQUE AND HIGH CRPV. Gudnason, S. Halldorsdottir, B. Thorsson, T. Aspelund10.1016/S1567-5688(10)70157-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3535P91 INSTABILITY OF CORONARY PLAQUES IS CLINICALLY AND ANGIOGRAPHICALLY ASSOCIATED WITH SPECIFIC CRP-RECEPTOR SUBTYPEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701586/abstract?rss=yesP91 INSTABILITY OF CORONARY PLAQUES IS CLINICALLY AND ANGIOGRAPHICALLY ASSOCIATED WITH SPECIFIC CRP-RECEPTOR SUBTYPED. Raaz-Schrauder, L. Klinghammer, A.B. Ekici, M. Herrmann, W.G. Daniel, A. Reis, C.D. Garlichs10.1016/S1567-5688(10)70158-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3535P92 ENDOTHELIAL FUNCTION ASSESSED BY PERIPHERAL ARTERY TONOMETRY IS A DETERMINANT OF CAROTID INTIMAE-MEDIA THICKNESS REGARDLESS OF FRAMINGHAM RISK SCOREhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701598/abstract?rss=yesP92 ENDOTHELIAL FUNCTION ASSESSED BY PERIPHERAL ARTERY TONOMETRY IS A DETERMINANT OF CAROTID INTIMAE-MEDIA THICKNESS REGARDLESS OF FRAMINGHAM RISK SCORER. Ferré, G. Aragonès, N. Plana, J. Merino, M. Heras, B. Coll, R. Cos, L. Masana10.1016/S1567-5688(10)70159-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3536P93 OPTIMISING THE SELECTION OF GENETIC MARKERS FOR MENDELIAN RANDOMISATION EXPERIMENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701604/abstract?rss=yesP93 OPTIMISING THE SELECTION OF GENETIC MARKERS FOR MENDELIAN RANDOMISATION EXPERIMENTSD. Swerdlow, R. Sofat, T. Shah, K. Kuchenbaecker, J. Mindell, M. Kumari, M. Kivimaki, J.P. Casas, E. Brunner, A. Hingorani10.1016/S1567-5688(10)70160-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3636P94 INTERACTION OF SELECTED ABCG1 GENE SINGLE NUCLEOTIDE POLYMORPHISMS WITH DIETARY PUFAS TO MODULATE HDL-CHOLESTEROL CONCENTRATIONS IN THE POPULATION-BASED HORTEGA STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701616/abstract?rss=yesP94 INTERACTION OF SELECTED ABCG1 GENE SINGLE NUCLEOTIDE POLYMORPHISMS WITH DIETARY PUFAS TO MODULATE HDL-CHOLESTEROL CONCENTRATIONS IN THE POPULATION-BASED HORTEGA STUDYR. Abellan, M.L. Mansego, S. Martínez-Hervás, J.C. Martín-Escudero, R. Carmena, J.T. Real, J. Redon, M. Pineda, F.J. Chaves10.1016/S1567-5688(10)70161-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3636P95 MRAS – A STRONG CANDIDATE GENE (SCG) FOR CORONARY ARTERY DISEASE (CAD)http://www.atherosclerosis-supplements.com/article/PIIS1567568810701628/abstract?rss=yesP95 MRAS – A STRONG CANDIDATE GENE (SCG) FOR CORONARY ARTERY DISEASE (CAD)J. Freyer, A.K. Wagner, H. Schunkert, J.-J. Zwaginga, Z. Aherrahrou, P. Linsel-Nitschke, J. Erdmann10.1016/S1567-5688(10)70162-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3636P96 MODEL OF TYPE 2 DIABETES COMBINED WITH HYPERCHOLESTEROLEMIA INDUCED BY DIET PROMOTES TARGET ORGAN LESIONS IN NEW ZEALAND RABBITShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070163X/abstract?rss=yesP96 MODEL OF TYPE 2 DIABETES COMBINED WITH HYPERCHOLESTEROLEMIA INDUCED BY DIET PROMOTES TARGET ORGAN LESIONS IN NEW ZEALAND RABBITST. Helfenstein, F. Fonseca, S. Ihara, J. Bottos, M. Farah, F. Moreira, D. Pomaro, H. Pott, L. Godoy, R. Povoa, A. Carvalho, M. Izar10.1016/S1567-5688(10)70163-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3636P97 INCREASED ERYTHROCYTE AGGREGABILITY IN PATIENTS WITH SLOW CORONARY FLOWhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701641/abstract?rss=yesP97 INCREASED ERYTHROCYTE AGGREGABILITY IN PATIENTS WITH SLOW CORONARY FLOWK. Ergun Cagli, E.I. Gurel, O. Ozeke, N. Seringec, A. Yalcinkaya, S. Kocabeyoglu, F.N. Basar, N. Sen, K. Cagli, N. Dikmenoglu10.1016/S1567-5688(10)70164-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3637P98 INVOLVEMENT OF Na+–Ca2+ EXCHANGER IN THE ENDOTHELIUM-INDEPENDENT VASORELAXATION INDUCED BY Curcuma longa L. IN RAT MESENTERIC ARTERYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701653/abstract?rss=yesP98 INVOLVEMENT OF Na+–Ca2+ EXCHANGER IN THE ENDOTHELIUM-INDEPENDENT VASORELAXATION INDUCED BY Curcuma longa L. IN RAT MESENTERIC ARTERYO. Adaramoye, I.A. Medeiros10.1016/S1567-5688(10)70165-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3737P99 BODY MASS INDEX IS A MAJOR DETERMINANT FOR NON-ALCOHOLIC STEATOHEPATITIS IN NON-DIABETIC HYPERTENSION PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701665/abstract?rss=yesP99 BODY MASS INDEX IS A MAJOR DETERMINANT FOR NON-ALCOHOLIC STEATOHEPATITIS IN NON-DIABETIC HYPERTENSION PATIENTSC.-H. Chou, W.-C. Tsai10.1016/S1567-5688(10)70166-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3737P100 INCREASED LEVELS OF ADMA AS MEASURE OF ENDOTHELIAL DYSFUNCTION IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701677/abstract?rss=yesP100 INCREASED LEVELS OF ADMA AS MEASURE OF ENDOTHELIAL DYSFUNCTION IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATIONI. Seljeflot, S. Ulimoen, S. Enger, H. Arnesen, A. Tveit10.1016/S1567-5688(10)70167-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3737P101 AORTIC STIFFNESS AS A RISK FACTOR FOR RECURRENT CARDIOVASCULAR EVENTS IN VERY HIGH RISK DIABETIC MENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701689/abstract?rss=yesP101 AORTIC STIFFNESS AS A RISK FACTOR FOR RECURRENT CARDIOVASCULAR EVENTS IN VERY HIGH RISK DIABETIC MEND. Levisianou, A. Melidonis, S. Foussas, E. Adamopoulou, E. Skopelitis, A. Destounis, T. Xenopoulou, I. Skoularigis, G. Koukoulis, F. Triposkiadis10.1016/S1567-5688(10)70168-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3737P102 GENETIC VARIATION AT THE CD36 LOCUS AND RISK OF CORONARY HEART DISEASE IN WOMEN AND MENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701690/abstract?rss=yesP102 GENETIC VARIATION AT THE CD36 LOCUS AND RISK OF CORONARY HEART DISEASE IN WOMEN AND MENM.K. Jensen, K.J. Mukamal, C.J. Girman, C. Chen, A. Handberg, K.M. Rexrode, E.B. Rimm10.1016/S1567-5688(10)70169-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3738P103 HETEROZYGOSITY FOR R1141X IN ABCC6 AND RISK OF ISCHEMIC VASCULAR DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701707/abstract?rss=yesP103 HETEROZYGOSITY FOR R1141X IN ABCC6 AND RISK OF ISCHEMIC VASCULAR DISEASEL.S. Hornstrup, A. Tybjærg-Hansen, C. Lundegaard Haase, B.G. Nordestgaard, P. Grande, R. Frikke-Schmidt10.1016/S1567-5688(10)70170-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3838P104 TCF7L2: A GENETIC LINK BETWEEN DIABETOGENICITY AND ATHEROGENICITY?http://www.atherosclerosis-supplements.com/article/PIIS1567568810701719/abstract?rss=yesP104 TCF7L2: A GENETIC LINK BETWEEN DIABETOGENICITY AND ATHEROGENICITY?A. Muendlein, C.H. Saely, S. Geller-Rhomberg, G. Sonderegger, P. Rein, T. Winder, S. Beer, J. Breuss, A. Vonbank, H. Drexel10.1016/S1567-5688(10)70171-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3838P105 CORONARY ARTERY DISEASE GENOME-WIDE REPLICATION AND META-ANALYSIS (CARDIOGRAM) – DESIGN OF A PROSPECTIVE META-ANALYSIS OF 14 GENOME-WIDE ASSOCIATION STUDIEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701720/abstract?rss=yesP105 CORONARY ARTERY DISEASE GENOME-WIDE REPLICATION AND META-ANALYSIS (CARDIOGRAM) – DESIGN OF A PROSPECTIVE META-ANALYSIS OF 14 GENOME-WIDE ASSOCIATION STUDIESJ. Erdmann10.1016/S1567-5688(10)70172-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3838P106 IDENTIFICATION AND FUNCTIONAL ANALYSES OF MOLECULAR HAPLOTYPES OF THE HUMAN OSTEOPROTEGERIN GENE PROMOTERhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701732/abstract?rss=yesP106 IDENTIFICATION AND FUNCTIONAL ANALYSES OF MOLECULAR HAPLOTYPES OF THE HUMAN OSTEOPROTEGERIN GENE PROMOTERC. Hagedorn, R. Telgmann, C. Dördelmann, B. Schmitz, S. Hasenkamp, F. Cambien, M. Paul, E. Brand, S.-M. Brand-Herrmann10.1016/S1567-5688(10)70173-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3838P107 TNFα-M-RAS-LFA-1 PATHWAY ANALYSIS IN GENOME-WIDE SNP DATA ON PATIENTS WITH MYOCARDIAL INFARCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701744/abstract?rss=yesP107 TNFα-M-RAS-LFA-1 PATHWAY ANALYSIS IN GENOME-WIDE SNP DATA ON PATIENTS WITH MYOCARDIAL INFARCTIONA. Wagner, J. Freyer, A. Medack, C. Willenborg, C. Loley, J. Nahrstedt, M. Preuss, I.R. König, H. Schunkert, J. Erdmann10.1016/S1567-5688(10)70174-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3839P108 MOLECULAR GENETIC ANALYSIS OF A HUMAN IGF1 PROMOTER P1 VARIATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701756/abstract?rss=yesP108 MOLECULAR GENETIC ANALYSIS OF A HUMAN IGF1 PROMOTER P1 VARIATIONR. Telgmann, C. Dördelmann, E. Brand, V. Nicaud, H. Pavenstädt, F. Cambien, L. Tiret, M. Paul, S.-M. Brand-Herrmann10.1016/S1567-5688(10)70175-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3939P109 FUNCTIONAL ANALYSES OF THE HUMAN LEUKOTRIENE C4 SYNTHASE GENE PROMOTER MOLECULAR HAPLOTYPEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701768/abstract?rss=yesP109 FUNCTIONAL ANALYSES OF THE HUMAN LEUKOTRIENE C4 SYNTHASE GENE PROMOTER MOLECULAR HAPLOTYPESF. Bruns, R.-G. Telgmann, B. Schröer, B. Schmitz, F. Cambien, P. Amarenco, E. Brand, S.-M. Brand-Herrmann10.1016/S1567-5688(10)70176-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3939P110 CORONARY ARTERY CALCIUM SCORE IS A MORE SENSITIVE INDICATOR OF SUBCLINICAL ATHEROSCLEROSIS THAN ANKLE-BRACHIAL INDEXhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070177X/abstract?rss=yesP110 CORONARY ARTERY CALCIUM SCORE IS A MORE SENSITIVE INDICATOR OF SUBCLINICAL ATHEROSCLEROSIS THAN ANKLE-BRACHIAL INDEXA. Kalvelis, I. Stukena, G. Bahs, L. Zvaigzne, A. Lejnieks10.1016/S1567-5688(10)70177-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3939P111 LEPTIN TO ADIPONECTIN RATIO IS MODIFIED BY ADIPONECTIN RECEPTOR GENES POLYMORPHISM AND DIEThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701781/abstract?rss=yesP111 LEPTIN TO ADIPONECTIN RATIO IS MODIFIED BY ADIPONECTIN RECEPTOR GENES POLYMORPHISM AND DIETI. Wybranska, M. Malczewska-Malec, I. Leszczynska-Golabek, B. Kiec-Wilk, M. Kwasniak, C. Defort, J. McMonagle, H. Roche, A. Dembinska-Kiec10.1016/S1567-5688(10)70178-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations3939P112 TIME-SERIES AND GENE CO-EXPRESSION ANALYSES OF TRANSCRIPTIONAL CHANGES IN HUMAN MONOCYTES AFTER ACUTE MYOCARDIAL INFARCTION: THE GERMAN MI FAMILY STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701793/abstract?rss=yesP112 TIME-SERIES AND GENE CO-EXPRESSION ANALYSES OF TRANSCRIPTIONAL CHANGES IN HUMAN MONOCYTES AFTER ACUTE MYOCARDIAL INFARCTION: THE GERMAN MI FAMILY STUDYP. Linsel-Nitschke, H. Sager, S. Maouche, J. Brocheton, J. Erdmann, Z. Aherrarhou, F. Cambien, H. Schunkert10.1016/S1567-5688(10)70179-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4040P113 ATHEROGENIC DYSLIPIDEMIA IN ADULT CHILDREN OF PATIENTS WITH PREMATURE CORONARY HEART DISEASE. RELATION TO OWN AND PARENTAL RISK FACTORShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070180X/abstract?rss=yesP113 ATHEROGENIC DYSLIPIDEMIA IN ADULT CHILDREN OF PATIENTS WITH PREMATURE CORONARY HEART DISEASE. RELATION TO OWN AND PARENTAL RISK FACTORSM. Konnov, L. Dobordzhginidze, A. Deev, N. Gratsiansky10.1016/S1567-5688(10)70180-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4040P114 ADIPOKINES AND SEX HORMONES ARE DIFFERENTLY ASSOCIATED TO CARDIOMETABOLIC RISK FACTORS IN A RANDOMIZED SAMPLE OF ADULT-ELDERLY HEALTHY SUBJECTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701811/abstract?rss=yesP114 ADIPOKINES AND SEX HORMONES ARE DIFFERENTLY ASSOCIATED TO CARDIOMETABOLIC RISK FACTORS IN A RANDOMIZED SAMPLE OF ADULT-ELDERLY HEALTHY SUBJECTSA. Cicero10.1016/S1567-5688(10)70181-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4040P115 RISK FACTORS ASSOCIATED TO SUBCLINICAL ATHEROSCLEROSIS IN ADOLESCENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701823/abstract?rss=yesP115 RISK FACTORS ASSOCIATED TO SUBCLINICAL ATHEROSCLEROSIS IN ADOLESCENTSE. Silva, L. Chacin, J. Villasmil, G. Ferrer, A. Gonzalez, M. Bracho, C. Esis10.1016/S1567-5688(10)70182-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4040P116 FIRST APPLICATION OF RISK ADVANCEMENT PERIODS TO LIPID RATIOShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701835/abstract?rss=yesP116 FIRST APPLICATION OF RISK ADVANCEMENT PERIODS TO LIPID RATIOSK.J. Krobot, U. Siebert10.1016/S1567-5688(10)70183-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4041P117 N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE AND METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701847/abstract?rss=yesP117 N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE AND METABOLIC SYNDROMEJ.-W. Lin, F.-C. Chiu, J.-J. Hwang10.1016/S1567-5688(10)70184-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4141P118 CYANIDIN-3-O-β-GLUCOSIDE AND PROTOCATECHUIC ACID STIMULATE GLUT4-MEDIATED GLUCOSE UPTAKE BY UP-REGULATING PPARγ ACTIVITY IN HUMAN OMENTAL ADIPOCYTEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701859/abstract?rss=yesP118 CYANIDIN-3-O-β-GLUCOSIDE AND PROTOCATECHUIC ACID STIMULATE GLUT4-MEDIATED GLUCOSE UPTAKE BY UP-REGULATING PPARγ ACTIVITY IN HUMAN OMENTAL ADIPOCYTESR. Masella, B. Scazzocchio, A. Pucciarmati, C. Filesi, R. Varì, M. D'Archivio, C. Santangelo, A. Iacovelli, F. Galvano, C. Giovannini10.1016/S1567-5688(10)70185-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4141P119 THE KYNURENINES ARE ASSOCIATED WITH OXIDATIVE STRESS, INFLAMMATION AND THE PREVALENCE OF CARDIOVASCULAR DISEASE IN PATIENTS WITH END-STAGE RENAL DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701860/abstract?rss=yesP119 THE KYNURENINES ARE ASSOCIATED WITH OXIDATIVE STRESS, INFLAMMATION AND THE PREVALENCE OF CARDIOVASCULAR DISEASE IN PATIENTS WITH END-STAGE RENAL DISEASED. Pawlak, T. Domaniewski, M. Mysliwiec, K. Pawlak10.1016/S1567-5688(10)70186-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4141P120 OXIDIZED-LDL/β2-GLYCOPROTEIN I COMPLEXES AND ANTIPHOSPHOLIPID ANTIBODIES ARE ASSOCIATED WITH DISEASE SEVERITY AND RISK FOR ADVERSE OUTCOMES IN ACUTE CORONARY SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701872/abstract?rss=yesP120 OXIDIZED-LDL/β2-GLYCOPROTEIN I COMPLEXES AND ANTIPHOSPHOLIPID ANTIBODIES ARE ASSOCIATED WITH DISEASE SEVERITY AND RISK FOR ADVERSE OUTCOMES IN ACUTE CORONARY SYNDROMEL. Lopez, T. Greco, A.M. Conti-Kelly, R. Anthony, J. Geske, M. Boisen, E. Matsuura10.1016/S1567-5688(10)70187-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4141P121 THE PROTECTIVE ROLE OF SPECIFIC PROTEIN-1 AGAINST BENZO(A)PYRENE-INDUCED ATHEROGENESIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701884/abstract?rss=yesP121 THE PROTECTIVE ROLE OF SPECIFIC PROTEIN-1 AGAINST BENZO(A)PYRENE-INDUCED ATHEROGENESISZ. Guo, T. Tang, X. Lin, H. Yang10.1016/S1567-5688(10)70188-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4142P122 COLLAGENASE MATRIX METALLOPROTEINASE-8 EXPRESSED IN ATHEROSCLEROTIC CAROTID PLAQUES IS ASSOCIATED WITH SYSTEMIC CARDIOVASCULAR OUTCOMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701896/abstract?rss=yesP122 COLLAGENASE MATRIX METALLOPROTEINASE-8 EXPRESSED IN ATHEROSCLEROTIC CAROTID PLAQUES IS ASSOCIATED WITH SYSTEMIC CARDIOVASCULAR OUTCOMEW. Peeters, F. Moll, D. de Kleijn, J.P. de Vries, A. Newby, G. Pasterkamp10.1016/S1567-5688(10)70189-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4242P123 ASSOCIATION BETWEEN CHANGE IN HDL AND VASCULAR EVENTS IN STATIN TREATED PATIENTS: REPORT FROM THE UK GENERAL PRACTICE RESEARCH DATABASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701902/abstract?rss=yesP123 ASSOCIATION BETWEEN CHANGE IN HDL AND VASCULAR EVENTS IN STATIN TREATED PATIENTS: REPORT FROM THE UK GENERAL PRACTICE RESEARCH DATABASEL. Bash, B. Ambegaonkar, C. Wenworth, C. May10.1016/S1567-5688(10)70190-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4242P124 INTERLEUKIN-6 IS STRONGER ASSOCIATED WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITY THAN C-REACTIVE PROTEIN, SERUM AMYLOID A AND FIBRINOGEN (THE LURIC STUDY)http://www.atherosclerosis-supplements.com/article/PIIS1567568810701914/abstract?rss=yesP124 INTERLEUKIN-6 IS STRONGER ASSOCIATED WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITY THAN C-REACTIVE PROTEIN, SERUM AMYLOID A AND FIBRINOGEN (THE LURIC STUDY)H. Scharnagl, T. Stojakovic, G. Weihrauch, B.R. Winkelmann, B.O. Boehm, W. Maerz10.1016/S1567-5688(10)70191-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4242P125 LIPOPROTEIN(a) AND THE RISK OF CARDIOVASCULAR DISEASE – SYSTEMATIC REVIEW AND META ANALYSIS OF PROSPECTIVE STUDIES INCLUDING 161222 INDIVIDUALShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701926/abstract?rss=yesP125 LIPOPROTEIN(a) AND THE RISK OF CARDIOVASCULAR DISEASE – SYSTEMATIC REVIEW AND META ANALYSIS OF PROSPECTIVE STUDIES INCLUDING 161222 INDIVIDUALSB. Genser, K. Dias, R. Siekmeier, T. Stojakovic, T. Grammer, W. März10.1016/S1567-5688(10)70192-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4242P126 FASTING SERUM APOLIPOPROTEIN B/A-I RATIO PREFERENTIALLY PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS IN THE GENERAL POPULATION INDEPENDENTLY OF ALBUMINURIA AND CRPhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701938/abstract?rss=yesP126 FASTING SERUM APOLIPOPROTEIN B/A-I RATIO PREFERENTIALLY PREDICTS MAJOR ADVERSE CARDIOVASCULAR EVENTS IN THE GENERAL POPULATION INDEPENDENTLY OF ALBUMINURIA AND CRPP.J.W.H. Kappelle, R.T. Gansevoort, B.H.R. Wolffenbuttel, R.P.F. Dullaart10.1016/S1567-5688(10)70193-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4343P127 MARKERS OF CHOLESTEROL METABOLISM ARE ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070194X/abstract?rss=yesP127 MARKERS OF CHOLESTEROL METABOLISM ARE ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESSO. Weingärtner, D. Lütjohann, K. Rogacev, L. Blömer, Y. Grenner, S. Gräber, C. Ulrich, M. Girndt, M. Böhm, D. Fliser, U. Laufs, G. Heine10.1016/S1567-5688(10)70194-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4343P128 THE ASSOCIATION OF METABOLIC SYNDROME WITH CORONARY HEART DISEASE AND STROKEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701951/abstract?rss=yesP128 THE ASSOCIATION OF METABOLIC SYNDROME WITH CORONARY HEART DISEASE AND STROKEJ. Suwa10.1016/S1567-5688(10)70195-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4343P129 THE P22-PHOX C242T POLYMORPHISM IS ASSOCIATED WITH LOWER LEFT VENTRICULAR MASS IN HYPERTENSIVE PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701963/abstract?rss=yesP129 THE P22-PHOX C242T POLYMORPHISM IS ASSOCIATED WITH LOWER LEFT VENTRICULAR MASS IN HYPERTENSIVE PATIENTSR. Schreiber, M.C. Ferreira-Sae, M.L. Sales, J. Cipolli, C. Piveta, J.R. Matos-Souza, K. Franchini, W. Nadruz10.1016/S1567-5688(10)70196-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4343P130 POSTPRANDIAL BETA CELL RESPONSIVENESS – DOES IT HAVE A PROTECTIVE ROLE IN THE DEVELOPMENT OF DIABETIC COMPLICATION?http://www.atherosclerosis-supplements.com/article/PIIS1567568810701975/abstract?rss=yesP130 POSTPRANDIAL BETA CELL RESPONSIVENESS – DOES IT HAVE A PROTECTIVE ROLE IN THE DEVELOPMENT OF DIABETIC COMPLICATION?C.S. Kim, C.W. Ahn, M.H. Cho, E.J. Lee, S.W. Park, S.K. Kim, S.H. Kim, S.J. Han, S.H. Lee, S.E. Park, Y.J. Choi, S.H. Ji, K.B. Huh10.1016/S1567-5688(10)70197-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4344P131 MYELOPEROXIDASE IS ASSOCIATED WITH BLOOD PRESSURE ON A BACKGROUND OF HYPERGLYCEMIA OR OXIDATIVE STRESShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701987/abstract?rss=yesP131 MYELOPEROXIDASE IS ASSOCIATED WITH BLOOD PRESSURE ON A BACKGROUND OF HYPERGLYCEMIA OR OXIDATIVE STRESST. Teerlink, L.P. van der Zwan, J.M. Dekker, C.D.A. Stehouwer, R.J. Heine, P.G. Scheffer10.1016/S1567-5688(10)70198-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4444P132 OPTIMAL TYPE 2 DIABETES MANAGEMENT INCLUDING BENCHMARKING AND STANDARD TREATMENT. BASELINE EUROPEAN RESULTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810701999/abstract?rss=yesP132 OPTIMAL TYPE 2 DIABETES MANAGEMENT INCLUDING BENCHMARKING AND STANDARD TREATMENT. BASELINE EUROPEAN RESULTSM. Hermans, E. Muls, G. Michel, M. Elisaf, C. Brotons, A. Matthys10.1016/S1567-5688(10)70199-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4444P133 LOW BODY MASS INDEX BOOSTS THE NEGATIVE IMPACT OF HYPERGLYCEMIA ON SURVIVAL IN THE ELDERLYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702002/abstract?rss=yesP133 LOW BODY MASS INDEX BOOSTS THE NEGATIVE IMPACT OF HYPERGLYCEMIA ON SURVIVAL IN THE ELDERLYJ. Ohrvik, P. Hedberg, G. Nilsson10.1016/S1567-5688(10)70200-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4444P134 BODY WEIGHT AND WAIST CIRCUMFERENCE INFLUENCE OVER BLOOD PRESSURE CONTROL IN PRIMARY CARE IN SPAIN. TAPAS STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702014/abstract?rss=yesP134 BODY WEIGHT AND WAIST CIRCUMFERENCE INFLUENCE OVER BLOOD PRESSURE CONTROL IN PRIMARY CARE IN SPAIN. TAPAS STUDYT. Mantilla, C. Suarez, A. Galgo, M. Leal, J. Arana, M. Hernandez, E. Lara, M. Marco, M.L. Asensio, J. San Jose10.1016/S1567-5688(10)70201-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4444P135 PREVALENCE OF FEATURES OF THE METABOLIC SYNDROME IN HEALTHY WHITE-COLLAR EMPLOYEES WITH OR WITHOUT FATTY LIVER DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702026/abstract?rss=yesP135 PREVALENCE OF FEATURES OF THE METABOLIC SYNDROME IN HEALTHY WHITE-COLLAR EMPLOYEES WITH OR WITHOUT FATTY LIVER DISEASEJ. Haas, S. Teufel-Sies, S. Mack, E. Becker, B. Knebel, J. Kotzka, A. Frisch, A. Burchard, M. Merkel, T. Stein, D. Müller-Wieland10.1016/S1567-5688(10)70202-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4545P136 LIPID PROFILE IN JAPANESE PATIENTS WHO DEVELOPED CORONARY ARTERY DISEASE DURING STATIN THERAPYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702038/abstract?rss=yesP136 LIPID PROFILE IN JAPANESE PATIENTS WHO DEVELOPED CORONARY ARTERY DISEASE DURING STATIN THERAPYK. Kojima, A. Motoyama, M. Watanabe, H. Tanabe, H. Aoki, R. Saito, K. Fujibayashi, R. Sato, H. Akao, Y. Kawai, M. Kitayama, K. Kajinami10.1016/S1567-5688(10)70203-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4545P137 PREVALENCE OF LOW HDL-C IN STATIN-TREATED PATIENTS WITH CARDIOVASCULAR DISEASE. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)http://www.atherosclerosis-supplements.com/article/PIIS156756881070204X/abstract?rss=yesP137 PREVALENCE OF LOW HDL-C IN STATIN-TREATED PATIENTS WITH CARDIOVASCULAR DISEASE. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)J. Millan, J.R. Gonzalez-Juanatey, C. Guijarro, E. Alegria, J.V. Lozano, B. Gonzalez-Timon, G. Vitale10.1016/S1567-5688(10)70204-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4545P138 RESIDUAL RISK IN SPANISH STATIN TREATED PATIENTS WITH LDL-C AT GOAL. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)http://www.atherosclerosis-supplements.com/article/PIIS1567568810702051/abstract?rss=yesP138 RESIDUAL RISK IN SPANISH STATIN TREATED PATIENTS WITH LDL-C AT GOAL. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)J. Millan, J.R. Gonzalez-Juanatey, E. Alegria, C. Guijarro, J.V. Lozano, B. Gonzalez-Timon, G. Vitale10.1016/S1567-5688(10)70205-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4545P139 THE ASSOCIATION OF ALBUMINURIA WITH ANGIOGRAPHICALLY DETERMINED CORONARY ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702063/abstract?rss=yesP139 THE ASSOCIATION OF ALBUMINURIA WITH ANGIOGRAPHICALLY DETERMINED CORONARY ATHEROSCLEROSISP. Rein, C.H. Saely, A. Vonbank, S. Beer, S. Aczel, V. Jankovic, C. Boehnel, L. Risch, H. Drexel10.1016/S1567-5688(10)70206-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4546P140 EVALUATION OF SYSTEMIC AND TISSUE-SPECIFIC INFLAMMATION AS RISK FACTOR FOR ATHEROSCLEROSIS IN PIGS FED WITH HIGH-FAT DIEThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702075/abstract?rss=yesP140 EVALUATION OF SYSTEMIC AND TISSUE-SPECIFIC INFLAMMATION AS RISK FACTOR FOR ATHEROSCLEROSIS IN PIGS FED WITH HIGH-FAT DIETR. Giovannoni, M. Busnelli, M.G. Cerrito, A. Froio, S. Manzini, A. Vargiolu, B.E. Leone, M. Forni, M.L. Bacci, G.M. Biasi, M. Lavitrano10.1016/S1567-5688(10)70207-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4646P141 RELATION BETWEEN IRON STATUS PARAMETERS AND OTHER CARDIOVASCULAR RISK FACTORS EXTRACTED BY FACTOR ANALYSIS IN PATIENTS WITH CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702087/abstract?rss=yesP141 RELATION BETWEEN IRON STATUS PARAMETERS AND OTHER CARDIOVASCULAR RISK FACTORS EXTRACTED BY FACTOR ANALYSIS IN PATIENTS WITH CORONARY ARTERY DISEASEV. Spasojevic-Kalimanovska, N. Bogavac-Stanojevic, S. Spasic, D. Kalimanovska-Ostric, J. Kotur-Stevuljevic, Z. Jelic-Ivanovic10.1016/S1567-5688(10)70208-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4646P142 CAROTID PLAQUES FROM SYMPTOMATIC STROKE PATIENTS SHOW INDUCTION OF GENES THAT ARE RELATED TO PROLIFERATION, ANGIOGENESIS AND NEURODEGENERATIVE DISORDERShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702099/abstract?rss=yesP142 CAROTID PLAQUES FROM SYMPTOMATIC STROKE PATIENTS SHOW INDUCTION OF GENES THAT ARE RELATED TO PROLIFERATION, ANGIOGENESIS AND NEURODEGENERATIVE DISORDERSR. Vemuganti, R.J. Dempsey, K. Tureyen, S. Salamat, B. Hermann10.1016/S1567-5688(10)70209-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4646P143 IL-6 SERUM LEVELS AND PRODUCTION IN PCOS ADOLESCENTS IS RELATED TO INSULIN RESISTANCEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702105/abstract?rss=yesP143 IL-6 SERUM LEVELS AND PRODUCTION IN PCOS ADOLESCENTS IS RELATED TO INSULIN RESISTANCES. Uda, A.M. Fulghesu, F. Sanna, R. Magnini, E. Portoghese, S. Accossu, P.P. Contini, B. Batetta10.1016/S1567-5688(10)70210-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4646P144 APOLIPOPROTEIN E GENOTYPE, CARDIOVASCULAR BIOMARKERS AND STROKE RISK: SYSTEMATIC REVIEW OF 10,550 STROKE CASES AND POOLED ANALYSIS OF 74,052 INDIVIDUALShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702117/abstract?rss=yesP144 APOLIPOPROTEIN E GENOTYPE, CARDIOVASCULAR BIOMARKERS AND STROKE RISK: SYSTEMATIC REVIEW OF 10,550 STROKE CASES AND POOLED ANALYSIS OF 74,052 INDIVIDUALST. Shah, T. Khan, A. Hingorani, J. Casas10.1016/S1567-5688(10)70211-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4647P145 SOCIAL BUT NOT PHYSICAL STRESSORS RESULTS IN IL-6 RELEASE IN MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702129/abstract?rss=yesP145 SOCIAL BUT NOT PHYSICAL STRESSORS RESULTS IN IL-6 RELEASE IN MICEE. Bernberg, M.E. Johansson, G. Bergström10.1016/S1567-5688(10)70212-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4747P146 LOW ARYLESTERASE ACTIVITY AND R ALLELE (PON1 Q192R POLYMORPHISM) ARE THE PUTATIVE RISK FACTORS OF CADhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702130/abstract?rss=yesP146 LOW ARYLESTERASE ACTIVITY AND R ALLELE (PON1 Q192R POLYMORPHISM) ARE THE PUTATIVE RISK FACTORS OF CADI. Ahmad, R. Narang, A. Venkatraman, N. Das10.1016/S1567-5688(10)70213-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4747P147 THE RESTING HEART RATE STRONGLY PREDICTS ALL-CAUSE DEATH AMONG MIDDLE AGED WOMEN AND MEN FROM A GENERAL POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702142/abstract?rss=yesP147 THE RESTING HEART RATE STRONGLY PREDICTS ALL-CAUSE DEATH AMONG MIDDLE AGED WOMEN AND MEN FROM A GENERAL POPULATIONG. Nilsson, A. Rosenblad, J. Leppert10.1016/S1567-5688(10)70214-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4747P148 THE ASSOCIATION BETWEEN D-VITAMIN STATUS, GLUCOSE AND METABOLIC SYNDROM IN GENERAL POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702154/abstract?rss=yesP148 THE ASSOCIATION BETWEEN D-VITAMIN STATUS, GLUCOSE AND METABOLIC SYNDROM IN GENERAL POPULATIONO. Mayer, J. Vrzalová10.1016/S1567-5688(10)70215-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4747P149 DOES INSULIN RESISTANCE INFLUENCE ENDOTHELIAL PROGENITOR CELLS IN OBESE PATIENTS?http://www.atherosclerosis-supplements.com/article/PIIS1567568810702166/abstract?rss=yesP149 DOES INSULIN RESISTANCE INFLUENCE ENDOTHELIAL PROGENITOR CELLS IN OBESE PATIENTS?E. Miller-Kasprzak, P. Bogdanski, D. Pupek-Musialik, P.P. Jagodzinski10.1016/S1567-5688(10)70216-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4748P150 HIGH LIPOPROTEIN(a) LEVEL IS ASSOCIATED WITH POOR LONG-TERM PROGNOSIS AFTER CORONARY ARTERY BYPASS GRAFTINGhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702178/abstract?rss=yesP150 HIGH LIPOPROTEIN(a) LEVEL IS ASSOCIATED WITH POOR LONG-TERM PROGNOSIS AFTER CORONARY ARTERY BYPASS GRAFTINGM. Ezhov, O. Afanasieva, A. Lyakishev, M. Afanasieva, R. Akchurin, S. Pokrovsky10.1016/S1567-5688(10)70217-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4848P151 ASSOCIATION OF ELEVATED LIPOPROTEIN(a) LEVEL WITH PREMATURE CORONARY HEART DISEASE IN MEN AND WOMENhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070218X/abstract?rss=yesP151 ASSOCIATION OF ELEVATED LIPOPROTEIN(a) LEVEL WITH PREMATURE CORONARY HEART DISEASE IN MEN AND WOMENM. Safarova, M. Ezhov, O. Afanasieva, A. Lyakishev, S. Pokrovsky10.1016/S1567-5688(10)70218-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4848P152 AORTIC BIFURCATION ANGLE AS AN INDEPENDENT RISK FACTOR FOR AORTOILIAC OCCLUSIVE DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702191/abstract?rss=yesP152 AORTIC BIFURCATION ANGLE AS AN INDEPENDENT RISK FACTOR FOR AORTOILIAC OCCLUSIVE DISEASEA. Shakeri Bavil, R.S. Tubbs, M.M. Shoja, H. Nosratinia, W.J. Oakes, M. Nemati10.1016/S1567-5688(10)70219-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4848P153 PREVALENCE OF THE CLASSICAL CARDIOVASCULAR RISK FACTORS IN ROMA MINORITY POPULATION OF CROATIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702208/abstract?rss=yesP153 PREVALENCE OF THE CLASSICAL CARDIOVASCULAR RISK FACTORS IN ROMA MINORITY POPULATION OF CROATIAH.M. Zeljko, T. Škarić-Juric, N. Smolej Narancic, M. Pericic Salihovic, I. Martinovic Klaric, J. Milicic, M. Barbalic, M. Zajc, L. Barac Lauc, B. Janicijevic10.1016/S1567-5688(10)70220-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4848P154 PREDICTION OFR THE POPULATION AT RISK OF ATHEROTHROMBOTIC DISEASE IS INDEPENDENT OF BLOOD SUGAR LEVELhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070221X/abstract?rss=yesP154 PREDICTION OFR THE POPULATION AT RISK OF ATHEROTHROMBOTIC DISEASE IS INDEPENDENT OF BLOOD SUGAR LEVELW. Feeman10.1016/S1567-5688(10)70221-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4848P155 EFFECTS OF RAMADAN FASTING ON CARDIOVASCULAR RISK FACTORShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702221/abstract?rss=yesP155 EFFECTS OF RAMADAN FASTING ON CARDIOVASCULAR RISK FACTORSA. Norouzy, M. Nematy, M. Alinezhad-Namaghi, M. Shakhskalaee, M. Mozhdehifard, S. Sajjadi, M. Sabery10.1016/S1567-5688(10)70222-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4849P156 PLA2G2A, PLA2G5 AND PLA2G10 VARIANTS, SPLA2 ACTIVITY AND MASS AND CHD RISK: RESULTS FROM GRACE AND EPIC-NORFOLKhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702233/abstract?rss=yesP156 PLA2G2A, PLA2G5 AND PLA2G10 VARIANTS, SPLA2 ACTIVITY AND MASS AND CHD RISK: RESULTS FROM GRACE AND EPIC-NORFOLKM. Guardiola, H.J. Exeter, J. Palmen, C. Perret, K. Li, J.A. Cooper, K.-T. Khaw, M.S. Sandhu, S. Ricketts, A. Tedgui, S.E. Humphries, E. Ninio, S.-A. Karabina, S.M. Boekhold, Z. Mallat, P.J. Talmud10.1016/S1567-5688(10)70223-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4949P157 PLASMA OXIDIZED LDL AND THIOL-CONTAINING MOLECULES IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702245/abstract?rss=yesP157 PLASMA OXIDIZED LDL AND THIOL-CONTAINING MOLECULES IN PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATIONA. Ghorbanihaghjo, A. Javadzadeh, E. Bahreini, N. Rashtchizadeh, S. Alizadeh10.1016/S1567-5688(10)70224-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4949P158 VASCULAR DYSFUNCTION IN ESRD PATIENTS UNDER REPLACEMENT THERAPYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702257/abstract?rss=yesP158 VASCULAR DYSFUNCTION IN ESRD PATIENTS UNDER REPLACEMENT THERAPYS. Abdelwhab10.1016/S1567-5688(10)70225-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4949P159 CRITICAL ISCHAEMIA AND MRF SCORE OF ATHEROSCLEROTIC DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702269/abstract?rss=yesP159 CRITICAL ISCHAEMIA AND MRF SCORE OF ATHEROSCLEROTIC DISEASEM. Dilic, E. Kurtalic, A. Begic10.1016/S1567-5688(10)70226-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4949P160 THE PREVELANCE OF SUBCLINICAL HYPOTHYROIDISM AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702270/abstract?rss=yesP160 THE PREVELANCE OF SUBCLINICAL HYPOTHYROIDISM AMONG PATIENTS WITH ACUTE MYOCARDIAL INFARCTIONE. Okuyan, A. Uslu, O. Levent10.1016/S1567-5688(10)70227-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations4950P161 PLASMA INFLAMMATORY MARKERS AND SUBCLINICAL ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702282/abstract?rss=yesP161 PLASMA INFLAMMATORY MARKERS AND SUBCLINICAL ATHEROSCLEROSISA. Panayiotou, M. Griffin, N. Georgiou, D. Bond, D. Hoppensteadt, J. Fareed, A. Nicolaides10.1016/S1567-5688(10)70228-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5050P162 PREVALENCE OF LOW HDL-C IN STATIN TREATED PATIENTS – THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)http://www.atherosclerosis-supplements.com/article/PIIS1567568810702294/abstract?rss=yesP162 PREVALENCE OF LOW HDL-C IN STATIN TREATED PATIENTS – THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)J. Millan, J.R. Gonzalez-Juanatey, E. Alegria, C. Guijarro, B. Gonzalez-Timon, G. Vitale10.1016/S1567-5688(10)70229-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5050P163 ASSOCIATION BETWEEN STRESS-HORMONES AND HEALTH IN MOSCOW POPULATION SAMPLE AGED 55 YEARS AND OLDERhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702300/abstract?rss=yesP163 ASSOCIATION BETWEEN STRESS-HORMONES AND HEALTH IN MOSCOW POPULATION SAMPLE AGED 55 YEARS AND OLDERV. Metelskaya, N. Gumanova, A. Deev, S. Shalnova, M. Shkolnikova, V. Shkolnikov10.1016/S1567-5688(10)70230-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5050P164 PROTECTION AGAINST NEPHROPATHY IN TYPE 2 DIABETES WITH ATORVASTATIN: RELATIONSHIP BETWEEN LIPOPROTEIN PHOSPHOLIPASE A2 AND ADIPONECTIN AND RENAL FUNCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702312/abstract?rss=yesP164 PROTECTION AGAINST NEPHROPATHY IN TYPE 2 DIABETES WITH ATORVASTATIN: RELATIONSHIP BETWEEN LIPOPROTEIN PHOSPHOLIPASE A2 AND ADIPONECTIN AND RENAL FUNCTIONV. Charlton-Menys, M. Rutter, P. Durrington10.1016/S1567-5688(10)70231-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5050P165 ASYMMETRIC DIMETHYLARGININE (ADMA) PREDICTS SKIN BLOOD FLOW DURING HEMODIALYSIS (HD)http://www.atherosclerosis-supplements.com/article/PIIS1567568810702324/abstract?rss=yesP165 ASYMMETRIC DIMETHYLARGININE (ADMA) PREDICTS SKIN BLOOD FLOW DURING HEMODIALYSIS (HD)E. Mistrik, V. Blaha, S. Dusilova-Sulkova, R. Safranek, L. Sobotka10.1016/S1567-5688(10)70232-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5051P166 FAT MASS WAS INVERSELY ASSOCIATED TO ANTIOXIDANT DEFENSE SYSTEM IN OBESE MALE ADOLESCENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702336/abstract?rss=yesP166 FAT MASS WAS INVERSELY ASSOCIATED TO ANTIOXIDANT DEFENSE SYSTEM IN OBESE MALE ADOLESCENTSI. Rosety, M.A. Rosety, M. Rosety-Rodriguez, A. Camacho, F.J. Ordonez, G. Fornieles, M. Rosety10.1016/S1567-5688(10)70233-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5151P167 ASSOCIATION OF VARIOUS POLYMORPHISMS WITH CAD IN NORTH INDIAN POPULATION: REPLICATION OF SNPS IDENTIFIED THROUGH GENOME WIDE ASSOCIATION STUDIEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702348/abstract?rss=yesP167 ASSOCIATION OF VARIOUS POLYMORPHISMS WITH CAD IN NORTH INDIAN POPULATION: REPLICATION OF SNPS IDENTIFIED THROUGH GENOME WIDE ASSOCIATION STUDIESJ. Kumar, S. Yumnam, T. Basu, A. Ghosh, G. Garg, G. Karthikeyan, S. Sengupta10.1016/S1567-5688(10)70234-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5151P168 PLANT AND ANIMAL PROTEIN CONSUMPTION ARE ASSOCIATED WITH LIKELIHOOD OF DEVELOPING LEFT VENTRICULAR SYSTOLIC DYSFUNCTION, IN ACUTE CORONARY SYNDROME PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070235X/abstract?rss=yesP168 PLANT AND ANIMAL PROTEIN CONSUMPTION ARE ASSOCIATED WITH LIKELIHOOD OF DEVELOPING LEFT VENTRICULAR SYSTOLIC DYSFUNCTION, IN ACUTE CORONARY SYNDROME PATIENTSC.-M. Kastorini, C. Chrysohoou, D.B. Panagiotakos, P. Aggelopoulos, C. Pitsavos, C. Stefanadis10.1016/S1567-5688(10)70235-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5151P169 MODERATE COFFEE CONSUMPTION LOWERS THE LIKELIHOOD OF DEVELOPING LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN POST-ACUTE CORONARY SYNDROME NORMOTENSIVE PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702361/abstract?rss=yesP169 MODERATE COFFEE CONSUMPTION LOWERS THE LIKELIHOOD OF DEVELOPING LEFT VENTRICULAR SYSTOLIC DYSFUNCTION IN POST-ACUTE CORONARY SYNDROME NORMOTENSIVE PATIENTSC.-M. Kastorini, C. Chrysohoou, D.B. Panagiotakos, P. Aggelopoulos, C. Liontou, C. Pitsavos, C. Stefanadis10.1016/S1567-5688(10)70236-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5151P170 COMPARATIVE MAPPING OF LINKAGE AND ASSOCIATION SIGNALS IN MYOCARDIAL INFARCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702373/abstract?rss=yesP170 COMPARATIVE MAPPING OF LINKAGE AND ASSOCIATION SIGNALS IN MYOCARDIAL INFARCTIONA. Medack, C. Loley, J. Nahrstaedt, I.R. König, B. Mayer, C. Hengstenberg, K. Stark, H.-E. Wichmann, S. Schreiber, T. Meitinger, H. Schunkert, J. Erdmann10.1016/S1567-5688(10)70237-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5152P171 ASSIMILATED ANALYSIS OF FIRST WAVE HITS FROM GENOME WIDE ASSOCIATION STUDIES WITH BLOOD BIOMARKERS AND CORONARY EVENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702385/abstract?rss=yesP171 ASSIMILATED ANALYSIS OF FIRST WAVE HITS FROM GENOME WIDE ASSOCIATION STUDIES WITH BLOOD BIOMARKERS AND CORONARY EVENTSA. Angelakopoulou10.1016/S1567-5688(10)70238-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5252P172 UNIVARIATE ANTHROPOMETRIC MEASURES FOR PREDICTING MAJOR CARDIOVASCULAR EVENTS MAY BE MISLEADINGhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702397/abstract?rss=yesP172 UNIVARIATE ANTHROPOMETRIC MEASURES FOR PREDICTING MAJOR CARDIOVASCULAR EVENTS MAY BE MISLEADINGA. Rosenblad, G. Nilsson, J. Leppert10.1016/S1567-5688(10)70239-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5252P173 THE CONNECTIONS OF ADAM8S (A DISINTEGRIN AND METALLOPROTEASE) GENETIC POLYMORPHISMS TO CORONARY ARTERY DISEASE AND MYOCARDIAL INFARCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702403/abstract?rss=yesP173 THE CONNECTIONS OF ADAM8S (A DISINTEGRIN AND METALLOPROTEASE) GENETIC POLYMORPHISMS TO CORONARY ARTERY DISEASE AND MYOCARDIAL INFARCTIONE. Raitoharju, M. Levula, P. Kuukasjärvi, J. Laurikka, K. Nikus, A.-P.J. Huovila, R. Laaksonen, P.J. Karhunen, J. Viik, M. Tarkka, M. Kähönen, T. Lehtimäki10.1016/S1567-5688(10)70240-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5252P174 ADMA (ASYMMETRIC DIMETHYLARGININE) PREDICTS ALL-CAUSE MORTALITY AND CARDIOVASCULAR EVENTS IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE: THE GETABI STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702415/abstract?rss=yesP174 ADMA (ASYMMETRIC DIMETHYLARGININE) PREDICTS ALL-CAUSE MORTALITY AND CARDIOVASCULAR EVENTS IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE: THE GETABI STUDYM. Anderssohn, R.H. Böger, H.G. Endres, E. Schwedhelm, H. Darius, D. Atzler, N. Lüneburg, B. von Stritzky, R. Maas, U. Thiem, R.A. Benndorf, C. Diehm10.1016/S1567-5688(10)70241-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5253P175 CARDIOVASCULAR RISK SCORES IN THE PREDICTION OF SUBCLINICAL ATHEROSCLEROSIS IN YOUNG ADULTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702427/abstract?rss=yesP175 CARDIOVASCULAR RISK SCORES IN THE PREDICTION OF SUBCLINICAL ATHEROSCLEROSIS IN YOUNG ADULTSJ. Raiko, C. Magnussen, M. Kivimäki, L. Taittonen, T. Laitinen, M. Kähönen, N. Hutri-Kähönen, A. Jula, B.-M. Loo, R. Thomson, T. Lehtimäki, J. Viikari, O. Raitakari, M. Juonala10.1016/S1567-5688(10)70242-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5353P176 IMPACT OF CARDIOVASCULAR MULTI-MORBIDITY ON PERSISTENT DYSLIPIDEMIA IN PATIENTS TREATED WITH STATINS IN GERMANY: LESSONS LEARNED FROM DYSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702439/abstract?rss=yesP176 IMPACT OF CARDIOVASCULAR MULTI-MORBIDITY ON PERSISTENT DYSLIPIDEMIA IN PATIENTS TREATED WITH STATINS IN GERMANY: LESSONS LEARNED FROM DYSISW. Smolka, C. Juenger, K. Bestehorn, A.K. Gitt10.1016/S1567-5688(10)70243-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5353P177 PRE-CLINICAL EFFICACY OF DRL-17822: A POTENT ORALLY ACTIVE CETP INHIBITORhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702440/abstract?rss=yesP177 PRE-CLINICAL EFFICACY OF DRL-17822: A POTENT ORALLY ACTIVE CETP INHIBITORA. Shanavas, K. Ramesh, S. Akhila, K. Ranjan, K. Rajesh, S.N. Hasham, B. Anima, I. Khanna, R. Pillarisetti, R. Kumar10.1016/S1567-5688(10)70244-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5353P178 CORONARY PATIENTS REACHING LDL-CHOLESTEROL < 2.0 mmol/L HAVE THE LOWEST RISK OF CARDIOVASCULAR EVENTS DURING STATIN TREATMENT: THE IDEAL STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702452/abstract?rss=yesP178 CORONARY PATIENTS REACHING LDL-CHOLESTEROL < 2.0 mmol/L HAVE THE LOWEST RISK OF CARDIOVASCULAR EVENTS DURING STATIN TREATMENT: THE IDEAL STUDYA. Olsson, C. Lindahl, I. Holme, R. Fayyad, O. Faergeman, J. Kastelein, M. Tikkanen, M. Lytken Larsen, T. Pedersen10.1016/S1567-5688(10)70245-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5353P179 PEDIATRIC METABOLIC SYNDROME IN PREDICTING METABOLIC SYNDROME, HIGH CAROTID INTIMA-MEDIA THICKNESS, AND TYPE II DIABETES MELLITUS IN ADULTHOODhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702464/abstract?rss=yesP179 PEDIATRIC METABOLIC SYNDROME IN PREDICTING METABOLIC SYNDROME, HIGH CAROTID INTIMA-MEDIA THICKNESS, AND TYPE II DIABETES MELLITUS IN ADULTHOODC.G. Magnussen, J. Koskinen, M. Juonala, S.R. Srinivasan, J.S.A. Viikari, G.S. Berenson, O.T. Raitakari10.1016/S1567-5688(10)70246-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5454P180 ESTIMATION OF OXIDATIVE STRESS MARKERS AND THEIR CONNECTION WITH ATHEROSCLEROSIS RISK FACTORS IN CHRONIC KIDNEY DISEASE PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702476/abstract?rss=yesP180 ESTIMATION OF OXIDATIVE STRESS MARKERS AND THEIR CONNECTION WITH ATHEROSCLEROSIS RISK FACTORS IN CHRONIC KIDNEY DISEASE PATIENTSA. Stencel, A. Pacanis, B. Kortas-Stempak, A. Ćwiklińska, M. Wróblewska, B. Rutkowski, M. Ziętkiewicz, M. Renke10.1016/S1567-5688(10)70247-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5454P181 ELEVATED TRIGLYCERIDE/HDL CHOLESTEROL RATIO IS A PREDICTOR OF POOR RENAL FUNCTION IN A LARGE TERTIARY REFERRAL LIPID CLINIChttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702488/abstract?rss=yesP181 ELEVATED TRIGLYCERIDE/HDL CHOLESTEROL RATIO IS A PREDICTOR OF POOR RENAL FUNCTION IN A LARGE TERTIARY REFERRAL LIPID CLINICJ. Davies, D. Goldsmith, M. Crook, A. Wierzbicki10.1016/S1567-5688(10)70248-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5454P182 HUMAN T-LYMPHOTROPIC VIRUS TYPE 1 INFECTION AS A RISK FACTOR FOR ATHEROSCLESOSIShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070249X/abstract?rss=yesP182 HUMAN T-LYMPHOTROPIC VIRUS TYPE 1 INFECTION AS A RISK FACTOR FOR ATHEROSCLESOSISH. Takeoka, N. Furusyo, K. Toyoda, M. Murata, H. Ohnishi, S. Maeda, Y. Sawayama, Y. Sagara, S. Kashiwagi, J. Hayashi10.1016/S1567-5688(10)70249-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5454P183 GENETIC SCREENING AND ASSOCIATION STUDY OF SERUM AMYLOID A1 (SAA1), AN ACUTE PHASE PROTEIN WITH A POSSIBLE ROLE IN ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702506/abstract?rss=yesP183 GENETIC SCREENING AND ASSOCIATION STUDY OF SERUM AMYLOID A1 (SAA1), AN ACUTE PHASE PROTEIN WITH A POSSIBLE ROLE IN ATHEROSCLEROSISK.Y. Leow10.1016/S1567-5688(10)70250-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5454P184 CHRONIC KIDNEY DISEASE IS COMMON IN THE SETTING OF A LARGE TERTIARY REFERRAL LIPID CLINIChttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702518/abstract?rss=yesP184 CHRONIC KIDNEY DISEASE IS COMMON IN THE SETTING OF A LARGE TERTIARY REFERRAL LIPID CLINICJ. Davies, D. Goldsmith, M. Crook, A. Wierzbicki10.1016/S1567-5688(10)70251-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5555P185 IMPACT OF PLANT STEROLS, FISH OIL OMEGA-3S AND THEIR COMBINATION ON LDL-C AND LDL PARTICLE-SIZE IN INDIAN ADULTShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070252X/abstract?rss=yesP185 IMPACT OF PLANT STEROLS, FISH OIL OMEGA-3S AND THEIR COMBINATION ON LDL-C AND LDL PARTICLE-SIZE IN INDIAN ADULTSS. Khandelwal, I. Demonty, P. Jeemon, R. Lakshmy, R. Mukherjee, R. Gupta, Y. Singh, S.J. Passi, D. Prabhakaran, S. Reddy10.1016/S1567-5688(10)70252-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5555P186 ECCENTRIC ENDURANCE EXERCISE SIGNIFICANTLY LOWERS CRP AND POSTPRANDIAL TRIGLYCERIDEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702531/abstract?rss=yesP186 ECCENTRIC ENDURANCE EXERCISE SIGNIFICANTLY LOWERS CRP AND POSTPRANDIAL TRIGLYCERIDESP. Rein, A. Vonbank, C.H. Saely, S. Aczel, S. Beer, V. Kiene, T. Bochdansky, H. Drexel10.1016/S1567-5688(10)70253-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5555P187 COMMON CAROTID INTIMA-MEDIA THICKNESS IN HIGH-RISK PATIENTS IN RUSSIA AND EUROPEAN POPULATIONShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702543/abstract?rss=yesP187 COMMON CAROTID INTIMA-MEDIA THICKNESS IN HIGH-RISK PATIENTS IN RUSSIA AND EUROPEAN POPULATIONSI. Sobenin, V. Myasoedova, T. Kirichenko, E. Anisimova, S. Castelnuovo, M. Amato, B. Frigerio, A. Ravani, A. Orekhov, E. Tremoli, D. Baldassarre10.1016/S1567-5688(10)70254-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5555P188 ASSOCIATION BETWEEN ATHEROSCLEROSIS AND LUNG FUNCTION – RESULTS FROM INTERNATIONAL TWIN STUDY 2009http://www.atherosclerosis-supplements.com/article/PIIS1567568810702555/abstract?rss=yesP188 ASSOCIATION BETWEEN ATHEROSCLEROSIS AND LUNG FUNCTION – RESULTS FROM INTERNATIONAL TWIN STUDY 2009D.L. Tarnoki, A.D. Tarnoki, A. Stazi, E. Medda, R. Cotichini, C. Baracchini, G. Meneghetti, F. Fanelli, L. Littvay, J. Metneki, A.A. Molnar, Z. Garami, V. Berczi, Z. Lazar, I. Horvath10.1016/S1567-5688(10)70255-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5556P189 IS HIGH ANKLE-BRACHIAL INDEX PREDICTOR OF INCREASED CARDIOVASCULAR RISK? THE CZECH POST-MONICA STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702567/abstract?rss=yesP189 IS HIGH ANKLE-BRACHIAL INDEX PREDICTOR OF INCREASED CARDIOVASCULAR RISK? THE CZECH POST-MONICA STUDYP. Wohlfahrt, D. Palous, M. Ingrischova, A. Krajcoviechova, J. Seidlerova, J. Bruthans, M. Galovcova, V. Adamkova, J. Filipovsky, R. Cifkova10.1016/S1567-5688(10)70256-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5656P190 PREMATURE TREATMENT EFECTS OF METABOLIC SYNDROME AS THE PREDICTOR OF DIABETES MELLITUS TYPE 2http://www.atherosclerosis-supplements.com/article/PIIS1567568810702579/abstract?rss=yesP190 PREMATURE TREATMENT EFECTS OF METABOLIC SYNDROME AS THE PREDICTOR OF DIABETES MELLITUS TYPE 2T. Gamezardashvili, N. Kipshidze10.1016/S1567-5688(10)70257-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5656P191 PROGNOSTIC VALUE OF ENDOTHELIUM-DEPENDENT VASODILATATION AND PULSE WAVE VELOCITY IN YOUNG HYPERTENSIVE PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702580/abstract?rss=yesP191 PROGNOSTIC VALUE OF ENDOTHELIUM-DEPENDENT VASODILATATION AND PULSE WAVE VELOCITY IN YOUNG HYPERTENSIVE PATIENTST. Pronko10.1016/S1567-5688(10)70258-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5656P192 SERUM URIC ACID, BUT NOT RS7442295 POLYMORPHISM OF SCL2A9 GENE, PREDICTS TOTAL AND CARDIOVASCULAR MORTALITY IN SEVERE CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702592/abstract?rss=yesP192 SERUM URIC ACID, BUT NOT RS7442295 POLYMORPHISM OF SCL2A9 GENE, PREDICTS TOTAL AND CARDIOVASCULAR MORTALITY IN SEVERE CORONARY ARTERY DISEASEN. Martinelli, L. Annarumma, D. Girelli, G. Malerba, F. Pizzolo, S. Friso, L. Consoli, T. Illig, P.F. Pignatti, R. Corrocher, O. Olivieri10.1016/S1567-5688(10)70259-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5656P193 SMOKING BEHAVIORS AFTER ACUTE CORONARY SYNDROMES (ACS) IN ADULT MALE SMOKERShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702609/abstract?rss=yesP193 SMOKING BEHAVIORS AFTER ACUTE CORONARY SYNDROMES (ACS) IN ADULT MALE SMOKERSI. Tzanogiorgis, E. Nikolaou, I. Kogias10.1016/S1567-5688(10)70260-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5657P194 “PARAOXONASE (PON1) GLN, ARG 192 POLYMORPHISM” AN INDEPENDENT RISK FACTOR FOR CORONARY ARTERY DISEASE IN NORTH-WEST INDIAN POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702610/abstract?rss=yesP194 “PARAOXONASE (PON1) GLN, ARG 192 POLYMORPHISM” AN INDEPENDENT RISK FACTOR FOR CORONARY ARTERY DISEASE IN NORTH-WEST INDIAN POPULATIONN. Gupta, S. Singh, K.D. Gill10.1016/S1567-5688(10)70261-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5757P195 GAMMA-GLUTAMYL-TRANSFERASE, GLUTAMATE-PYRUVATE TRANSAMINASE, AND THE GLUTAMATE-PYRUVATETRANSAMINASE/GLUTAMATE-OXALACETATE TRANSAMINASE RATIO ARE SIGNIFICANTLY REDUCED BY EIGHT WEEKS OF ECCENTRIC ENDURANCE EXERCISEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702622/abstract?rss=yesP195 GAMMA-GLUTAMYL-TRANSFERASE, GLUTAMATE-PYRUVATE TRANSAMINASE, AND THE GLUTAMATE-PYRUVATETRANSAMINASE/GLUTAMATE-OXALACETATE TRANSAMINASE RATIO ARE SIGNIFICANTLY REDUCED BY EIGHT WEEKS OF ECCENTRIC ENDURANCE EXERCISEC.H. Saely, P. Rein, A. Vonbank, S. Beer, V. Kiene, S. Aczel, T. Bochdansky, H. Drexel10.1016/S1567-5688(10)70262-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5757P196 ATRIAL FIBRILATION AS CONTRIBUTING FACTOR TO STROKE – EPIDEMIOLOGIC STUDY IN THE GREEK POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702634/abstract?rss=yesP196 ATRIAL FIBRILATION AS CONTRIBUTING FACTOR TO STROKE – EPIDEMIOLOGIC STUDY IN THE GREEK POPULATIONI. Kanonidis, K. Martiadou, G. Rompolas, N. Sailer, S. Tzotzis, C. Kagiadaki, D. Eclisiarhos, G. Sakantamis10.1016/S1567-5688(10)70263-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5757P197 SUBCLINICAL ATHEROSCLEROSIS DETERMINED BY PULSE WAVE VELOCITY IN OVERWEIGHT AND OBESE RURAL FILIPINO SUBJECTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702646/abstract?rss=yesP197 SUBCLINICAL ATHEROSCLEROSIS DETERMINED BY PULSE WAVE VELOCITY IN OVERWEIGHT AND OBESE RURAL FILIPINO SUBJECTSH. Marcoyannopoulou Fojas, E.B. Barrios10.1016/S1567-5688(10)70264-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5757P198 THE ASSOCIATION BETWEEN VARIATION IN NEGR1 GENE AND BODY-WEIGHT IS MODULATED BY PHYSICAL ACTIVITY IN A HIGH–RISK MEDITERRANEAN POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702658/abstract?rss=yesP198 THE ASSOCIATION BETWEEN VARIATION IN NEGR1 GENE AND BODY-WEIGHT IS MODULATED BY PHYSICAL ACTIVITY IN A HIGH–RISK MEDITERRANEAN POPULATIONM. Sotos-Prieto, C. Ortega-Azorín, P. Carrasco, J.V. Sorli, P. Guillem-Saiz, J.I. Gonzalez, D. Corella10.1016/S1567-5688(10)70265-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5758P199 DAILY INTAKE OF A DAIRY DRINK ENRICHED WITH OMEGA-3 (EPA+DHA) AND OLEIC ACID IMPROVES CARDIOVASCULAR MARKERS IN HEALTHY POSTMENOPAUSAL WOMENhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070266X/abstract?rss=yesP199 DAILY INTAKE OF A DAIRY DRINK ENRICHED WITH OMEGA-3 (EPA+DHA) AND OLEIC ACID IMPROVES CARDIOVASCULAR MARKERS IN HEALTHY POSTMENOPAUSAL WOMENJ. Fonolla, M. Diaz-Ropero, A. Geerlings, J. Marti, E. Lopez-Huertas10.1016/S1567-5688(10)70266-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5858P200 EVEN SMALL DECREASE IN WEIGHT TROUGH LIFE STYLE MODIFICATIONS CAN IMPROVE RISK FACTORS ASSOCIATED TO ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702671/abstract?rss=yesP200 EVEN SMALL DECREASE IN WEIGHT TROUGH LIFE STYLE MODIFICATIONS CAN IMPROVE RISK FACTORS ASSOCIATED TO ATHEROSCLEROSISR. Santos, J. Freitas, M. Macedo, I. Rebelo10.1016/S1567-5688(10)70267-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5858P201 MODERATE PHYSICAL ACTIVITY IS ASSOCIATED WITH LOWER apoB/apoA-I RATIOS INDEPENDENTLY OF OTHER RISK FACTORS IN HEALTHY MIDDLE-AGED MENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702683/abstract?rss=yesP201 MODERATE PHYSICAL ACTIVITY IS ASSOCIATED WITH LOWER apoB/apoA-I RATIOS INDEPENDENTLY OF OTHER RISK FACTORS IN HEALTHY MIDDLE-AGED MENC. Schmidt, C.J. Behre, G. Bergström10.1016/S1567-5688(10)70268-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5858P202 PERSISTENT LIPID ABNORMALITIES IN STATIN TREATED PATIENTS IN SPAIN. THE DYSLIPIDEMIA INTERNATIONAL SURVEY STUDY (DYSIS-SPAIN)http://www.atherosclerosis-supplements.com/article/PIIS1567568810702695/abstract?rss=yesP202 PERSISTENT LIPID ABNORMALITIES IN STATIN TREATED PATIENTS IN SPAIN. THE DYSLIPIDEMIA INTERNATIONAL SURVEY STUDY (DYSIS-SPAIN)J. Millan, J.R. Gonzalez-Juanatey, C. Guijarro, E. Alegria, J.V. Lozano, B. Gonzalez-Timon, G. Vitale10.1016/S1567-5688(10)70269-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5859P203 RELATIONSHIP BETWEEN ALCOHOL INTAKE, HDL-CHOLESTEROL AND CARDIOVASCULAR RISK-FACTORS IN THE URBAN PARIS-ILE-DE-FRANCE COHORT: IS THE CARDIOPROTECTIVE ACTION OF ALCOHOL A MYTH?http://www.atherosclerosis-supplements.com/article/PIIS1567568810702701/abstract?rss=yesP203 RELATIONSHIP BETWEEN ALCOHOL INTAKE, HDL-CHOLESTEROL AND CARDIOVASCULAR RISK-FACTORS IN THE URBAN PARIS-ILE-DE-FRANCE COHORT: IS THE CARDIOPROTECTIVE ACTION OF ALCOHOL A MYTH?B. Hansel, F. Thomas-Jean, B. Panier, K. Bean, A. Kontush, M.J. Chapman, L. Guize, E. Bruckert10.1016/S1567-5688(10)70270-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5959P204 ADHERENCE TO THE MEDITERRANEAN DIETARY PATTERN IS INVERSELY ASSOCIATED WITH SMALL DENSE LOW-DENSITY LIPOPROTEIN (SDLDL) PHENOTYPE B: THE ATTICA STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702713/abstract?rss=yesP204 ADHERENCE TO THE MEDITERRANEAN DIETARY PATTERN IS INVERSELY ASSOCIATED WITH SMALL DENSE LOW-DENSITY LIPOPROTEIN (SDLDL) PHENOTYPE B: THE ATTICA STUDYC.-M. Kastorini, D.B. Panagiotakos, C. Chrysohoou, C. Pitsavos, J. Skoumas, S. Vellas, M. Kambaxis, C. Stefanadis10.1016/S1567-5688(10)70271-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5959P205 ATHEROSCLEROSIS AND BODY COMPOSITION. FINDINGS OF INTERNATIONAL TWIN STUDY 2009http://www.atherosclerosis-supplements.com/article/PIIS1567568810702725/abstract?rss=yesP205 ATHEROSCLEROSIS AND BODY COMPOSITION. FINDINGS OF INTERNATIONAL TWIN STUDY 2009A. Tarnoki, D.L. Tarnoki, A. Stazi, E. Medda, R. Cotichini, C. Fagnani, L. Nisticò, P. Lucatelli, E. Boatta, C. Zini, G. Meneghetti, C. Baracchini, J. Osztovits, G. Jermendy, L. Littvay, J. Metneki, K. Karlinger, A.A. Molnar, F. Fanelli, Z. Garami, V. Berczi10.1016/S1567-5688(10)70272-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5959P206 A DESCRIPTIVE STUDY OF CARDIOVASCULAR RISK MANAGEMENT AND STATIN THERAPY IN BELGIAN AND NORWEGIAN GENERAL PRACTICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702737/abstract?rss=yesP206 A DESCRIPTIVE STUDY OF CARDIOVASCULAR RISK MANAGEMENT AND STATIN THERAPY IN BELGIAN AND NORWEGIAN GENERAL PRACTICEA. Svilaas, C. McGrath, H. van Campenhout, M. Grönsleth, X. Fournie, P. Kramarz, G. de Backer10.1016/S1567-5688(10)70273-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations5960P207 ADIPOKINES IN MIDDLE-AGED WOMEN'S RISK PROFILEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702749/abstract?rss=yesP207 ADIPOKINES IN MIDDLE-AGED WOMEN'S RISK PROFILES. Bergmann, K. Assig, F. Richter10.1016/S1567-5688(10)70274-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6060P208 ROLE OF THE ADAPTOR PROTEIN PID1 IN LRP1 MEDIATED ENDOCYTOSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702750/abstract?rss=yesP208 ROLE OF THE ADAPTOR PROTEIN PID1 IN LRP1 MEDIATED ENDOCYTOSISB. Hoffzimmer, P. Gordts, H. Schmale, J. Heeren10.1016/S1567-5688(10)70275-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6060P209 GLYCATED LDL STIMULATE FOAM CELL FORMATION IN VITRO AND LDL GLYCATION IS OPPOSED BY PARAOXONASE-RICH HDLhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702762/abstract?rss=yesP209 GLYCATED LDL STIMULATE FOAM CELL FORMATION IN VITRO AND LDL GLYCATION IS OPPOSED BY PARAOXONASE-RICH HDLN. Younis, H. Soran, R. Sharma, P. Pemberton, V. Charlton-Menys, M. Elseweidy, P. Durrington10.1016/S1567-5688(10)70276-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6060P210 ROLE OF FARNESOID X RECEPTOR AGONISTS IN THE IN VIVO AND IN VITRO EXPRESSION OF APOLIPOPROTEIN(a)http://www.atherosclerosis-supplements.com/article/PIIS1567568810702774/abstract?rss=yesP210 ROLE OF FARNESOID X RECEPTOR AGONISTS IN THE IN VIVO AND IN VITRO EXPRESSION OF APOLIPOPROTEIN(a)I. Chennamsetty, G. Kostner10.1016/S1567-5688(10)70277-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6060P211 ADIPOSE TRIGLYCERIDE LIPASE DEFICIENCY RESULTS IN MACROPHAGE APOPTOSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702786/abstract?rss=yesP211 ADIPOSE TRIGLYCERIDE LIPASE DEFICIENCY RESULTS IN MACROPHAGE APOPTOSISE. Aflaki, R. Malli, B. Radovic, T. Eisenberg, J. Ring, P.G. Chandak, W. Graier, F. Madeo, D. Kratky10.1016/S1567-5688(10)70278-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6060P212 SAA ACTIVATES PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ THROUGH EXTRACELLULAR-REGULATED KINASE 1/2 AND COX-2 EXPRESSION IN HEPATOCYTEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702798/abstract?rss=yesP212 SAA ACTIVATES PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ THROUGH EXTRACELLULAR-REGULATED KINASE 1/2 AND COX-2 EXPRESSION IN HEPATOCYTESH. Li, Y. Zhao, S. Zhou, C.-K. Heng10.1016/S1567-5688(10)70279-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6161P213 ENDOGENOUS APOLIPOPROTEIN E REGULATES ADIPOGENIC DIFFERENTIATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702804/abstract?rss=yesP213 ENDOGENOUS APOLIPOPROTEIN E REGULATES ADIPOGENIC DIFFERENTIATIOND. Lasrich, A. Bartelt, A. Laatsch, U. Beisiegel, J. Heeren10.1016/S1567-5688(10)70280-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6161P214 PROTEIN KINASES ARE KEY REGULATOR OF OX-LDL INDUCED IL-1β SECRETIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702816/abstract?rss=yesP214 PROTEIN KINASES ARE KEY REGULATOR OF OX-LDL INDUCED IL-1β SECRETIONR. Tiwari, V. Singh, A. Verma, M. Dikshit, M. Barthwal10.1016/S1567-5688(10)70281-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6161P215 ACTIVATION OF UNFOLDED PROTEIN RESPONSE SIGNALING MEDIATES APOLIPOPROTEIN E-DEFICIENT LIPOPROTEIN-INDUCED FOAM CELL FORMATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702828/abstract?rss=yesP215 ACTIVATION OF UNFOLDED PROTEIN RESPONSE SIGNALING MEDIATES APOLIPOPROTEIN E-DEFICIENT LIPOPROTEIN-INDUCED FOAM CELL FORMATIONH. Yang, Y. Zhao, Z. Guo10.1016/S1567-5688(10)70282-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6161P216 CARRIERS OF LCAT GENE MUTATIONS HAVE INCREASED ATHEROSCLEROSIS: A 3.0 TESLA MRI STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070283X/abstract?rss=yesP216 CARRIERS OF LCAT GENE MUTATIONS HAVE INCREASED ATHEROSCLEROSIS: A 3.0 TESLA MRI STUDYA.G. Holleboom, R. Duivenvoorden, B. van den Bogaard, E. de Groot, A.J. Nederveen, J.S. Lameris, J.J.P. Kastelein, E.S.G. Stroes, J.A. Kuivenhoven10.1016/S1567-5688(10)70283-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6161P217 MOUSE GENE EXPRESSION NETWORKS INDICATE MITOCHONDRIAL DYSFUNCTION CAUSES METABOLIC INFLAMMATION IN OBESITY: VALIDATION BY HUMAN GENE EXPRESSION AND SNP ANALYSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702841/abstract?rss=yesP217 MOUSE GENE EXPRESSION NETWORKS INDICATE MITOCHONDRIAL DYSFUNCTION CAUSES METABOLIC INFLAMMATION IN OBESITY: VALIDATION BY HUMAN GENE EXPRESSION AND SNP ANALYSISJ. Scott, X. Li10.1016/S1567-5688(10)70284-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6162P218 TWO NOVEL GENETIC LOCI FOR HIGH AND LOW PLASMA HDL-C LEVELS IN 2 LARGE FAMILIES FROM DUTCH ANCESTRYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702853/abstract?rss=yesP218 TWO NOVEL GENETIC LOCI FOR HIGH AND LOW PLASMA HDL-C LEVELS IN 2 LARGE FAMILIES FROM DUTCH ANCESTRYMo. Mahdi Motazacker, I. Tietjen, M. Hayden, J.P.P. Kastelein, E.S.G. Stroes, G.K. Hovingh, J.A. Kuivenhoven10.1016/S1567-5688(10)70285-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6161P219 CARRIERS OF LCAT GENE MUTATIONS HAVE HIGH DENSITY LIPOPROTEIN WITH DECREASED ANTI-OXIDATIVE CAPACITYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702865/abstract?rss=yesP219 CARRIERS OF LCAT GENE MUTATIONS HAVE HIGH DENSITY LIPOPROTEIN WITH DECREASED ANTI-OXIDATIVE CAPACITYA.G. Holleboom, G. Daniel, G.K. Hovingh, A.W. Schimmel, J.N. van Miert, J.J.P. Kastelein, E.S.G. Stroes, J.A. Kuivenhoven, A. Chroni10.1016/S1567-5688(10)70286-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6262P220 THE LEPTIN RECEPTOR GLN223ARG POLYMORPHISM MEDIATES THE POSTPRANDIAL LIPAEMIC RESPONSE IN ADULT MALEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702877/abstract?rss=yesP220 THE LEPTIN RECEPTOR GLN223ARG POLYMORPHISM MEDIATES THE POSTPRANDIAL LIPAEMIC RESPONSE IN ADULT MALESK. Jackson, E. Olano-Martin, E. Abraham, R. Gill, A. Valdes, F. Tang, J. Lovegrove, C. Williams, A. Minihane10.1016/S1567-5688(10)70287-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6262P221 LIPID DROPLETS IN HUMAN MACROPHAGES RECRUIT CYTOSOLIC PHOSPHOLIPASE A2 AND PROMOTE SECRETION OF INFLAMMATORY MEDIATORShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702889/abstract?rss=yesP221 LIPID DROPLETS IN HUMAN MACROPHAGES RECRUIT CYTOSOLIC PHOSPHOLIPASE A2 AND PROMOTE SECRETION OF INFLAMMATORY MEDIATORSC. De Pascale, P. Bostrom, Y. Wickström, C. Mogensen, L. MattssonHultén, R. Perkins, M. Ståhlman, O. Wiklund, S.-O. Olofsson, J. Borén10.1016/S1567-5688(10)70288-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6262P222 COMPOSITE DEFICIENCY OF THE LIPOLYTIC COMPLEX IN PREGNANCY-INDUCED MAJOR HYPERTRIGLYCERIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702890/abstract?rss=yesP222 COMPOSITE DEFICIENCY OF THE LIPOLYTIC COMPLEX IN PREGNANCY-INDUCED MAJOR HYPERTRIGLYCERIDEMIAP. Benlian, B. Donadille, C. Bouché, C. Vincent Dejean, R. Valero, F. Dufernez, V. Sapin, F. Paye, P. Bouchard10.1016/S1567-5688(10)70289-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6263P223 INTERACTION OF PARAOXONASE 1 WITH LIPID RAFT MICRO-DOMAINS FOR THE ENHANCEMENT OF CHOLESTEROL EFFLUXhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702907/abstract?rss=yesP223 INTERACTION OF PARAOXONASE 1 WITH LIPID RAFT MICRO-DOMAINS FOR THE ENHANCEMENT OF CHOLESTEROL EFFLUXH. Berrougui, O. Helal, T. Said, A. Khalil10.1016/S1567-5688(10)70290-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6363P224 OXLDL STIMULATES LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 EXPRESSION IN THP-1 MONOCYTES VIA PI3K AND P38 MAPK PATHWAYShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702919/abstract?rss=yesP224 OXLDL STIMULATES LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 EXPRESSION IN THP-1 MONOCYTES VIA PI3K AND P38 MAPK PATHWAYSY. Wang, W. Wang, Y. Leng, J. Shen10.1016/S1567-5688(10)70291-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6363P225 SCAVENGER RECEPTOR CD36 MEDIATES HDL SELECTIVE CHOLESTERYL ESTER UPTAKE AND HDL PARTICLE INTERNALISATION IN VITROhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702920/abstract?rss=yesP225 SCAVENGER RECEPTOR CD36 MEDIATES HDL SELECTIVE CHOLESTERYL ESTER UPTAKE AND HDL PARTICLE INTERNALISATION IN VITROM. Brundert, P. Groitl, J. Heeren, T. Dobner, F. Rinninger10.1016/S1567-5688(10)70292-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6363P226 TIP47 AFFECTS TRIGLYCERIDE CONTENT IN MACROPHAGE FOAM CELLShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702932/abstract?rss=yesP226 TIP47 AFFECTS TRIGLYCERIDE CONTENT IN MACROPHAGE FOAM CELLSI. Buers, O. Hofnagel, H. Robenek10.1016/S1567-5688(10)70293-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6363P227 NON-CHOLESTEROL STEROLS IN COMMON HYPERCHOLESTEROLEMIA AND FAMILIAL COMBINED HYPERLIPEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702944/abstract?rss=yesP227 NON-CHOLESTEROL STEROLS IN COMMON HYPERCHOLESTEROLEMIA AND FAMILIAL COMBINED HYPERLIPEMIAG. Lupattelli, M. Pirro, D. Siepi, M.R. Mannarino, A.R. Roscini, G. Vaudo, G. Schillaci, E. Mannarino10.1016/S1567-5688(10)70294-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6364P228 POTENTIAL ATHEROGENICITY OF POSTPRANDIAL LIPEMIA IN MIXED DYSLIPIDEMIA: THERAPEUTIC TARGET FOR CETP INHIBITIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702956/abstract?rss=yesP228 POTENTIAL ATHEROGENICITY OF POSTPRANDIAL LIPEMIA IN MIXED DYSLIPIDEMIA: THERAPEUTIC TARGET FOR CETP INHIBITIONZ. Julia, E. Duchene, N. Fournier, N. Bellanger, M.J. Chapman, W. Le Goff, M. Guerin10.1016/S1567-5688(10)70295-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6464P229 EFFECTS OF HIGH DOSE STATIN ON THE HUMAN HEPATIC EXPRESSION OF GENES INVOLVED IN CARBOHYDRATE AND TRIGLYCERIDE METABOLISMhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702968/abstract?rss=yesP229 EFFECTS OF HIGH DOSE STATIN ON THE HUMAN HEPATIC EXPRESSION OF GENES INVOLVED IN CARBOHYDRATE AND TRIGLYCERIDE METABOLISMC. Pramfalk, P. Parini, U. Gustafsson, S. Sahlin, M. Eriksson10.1016/S1567-5688(10)70296-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6464P230 ABC TRANSPORTERS-MEDIATED CHOLESTEROL EFFLUX FROM HUMAN MACROPHAGE FOAM CELLS IS IMPAIRED IN AN ACIDIC EXTRACELLULAR ENVIRONMENThttp://www.atherosclerosis-supplements.com/article/PIIS156756881070297X/abstract?rss=yesP230 ABC TRANSPORTERS-MEDIATED CHOLESTEROL EFFLUX FROM HUMAN MACROPHAGE FOAM CELLS IS IMPAIRED IN AN ACIDIC EXTRACELLULAR ENVIRONMENTM. Lee-Rueckert, J. Lappalainen, H. Leinonen, M. Jauhiainen, P. Kovanen10.1016/S1567-5688(10)70297-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6464P231 IDENTIFICATION OF COMPOUND HETEROZYGOUS DEFICIENCY WITH A NOVEL LARGE DELETION AND Y61X OF THE LIPOPROTEIN LIPASE GENE IN JAPANESE SUBJECThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702981/abstract?rss=yesP231 IDENTIFICATION OF COMPOUND HETEROZYGOUS DEFICIENCY WITH A NOVEL LARGE DELETION AND Y61X OF THE LIPOPROTEIN LIPASE GENE IN JAPANESE SUBJECTA. Takagi, M. Nagano, T. Iwanaga, N. Ito, H. Hattori, T. Egashira, Y. Ikeda10.1016/S1567-5688(10)70298-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6464P232 LDL RECEPTOR RELATED PROTEIN 1 (LRP1) IS NECESSARY FOR APOLIPOPROTEIN A5 (APOA5) MEDIATED TRIGLYCERIDE REDUCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810702993/abstract?rss=yesP232 LDL RECEPTOR RELATED PROTEIN 1 (LRP1) IS NECESSARY FOR APOLIPOPROTEIN A5 (APOA5) MEDIATED TRIGLYCERIDE REDUCTIONK. Brügelmann, D. Teupser, A. Bartelt, P. Gordts, J. Heeren, M. Merkel10.1016/S1567-5688(10)70299-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6465P233 ACTIVE PHOSPHOLIPID TRANSFER PROTEIN (PLTP) REDUCES PROTHROMBIN ACTIVATION AND ATTENUATES BLOOD COAGULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703007/abstract?rss=yesP233 ACTIVE PHOSPHOLIPID TRANSFER PROTEIN (PLTP) REDUCES PROTHROMBIN ACTIVATION AND ATTENUATES BLOOD COAGULATIONC. Oslakovic, M. Jauhiainen, C. Ehnholm, B. Dahlback10.1016/S1567-5688(10)70300-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6565P234 SUPPRESSION OF NUCLEAR FACTOR-kappaB ACTIVITY IN MACROPHAGES BY CHYLOMICRON REMNANTS: MODULATION BY THE FATTY ACID COMPOSITION OF THE PARTICLEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703019/abstract?rss=yesP234 SUPPRESSION OF NUCLEAR FACTOR-kappaB ACTIVITY IN MACROPHAGES BY CHYLOMICRON REMNANTS: MODULATION BY THE FATTY ACID COMPOSITION OF THE PARTICLESC. de Pascale, V. Graham, R.C. Fowkes, C.P. Wheeler-Jones, K.M. Botham10.1016/S1567-5688(10)70301-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6565P235 NOVEL FORM OF SEVERE COMBINED HYPOLIPIDEMIA EXHIBITS A MUTATION IN THE MASTER REGULATOR OF LIPID METABOLISM SREBP-1http://www.atherosclerosis-supplements.com/article/PIIS1567568810703020/abstract?rss=yesP235 NOVEL FORM OF SEVERE COMBINED HYPOLIPIDEMIA EXHIBITS A MUTATION IN THE MASTER REGULATOR OF LIPID METABOLISM SREBP-1J. Kotzka, B. Knebel, O. Janssen, J. Schaefer, S. Mack, J. Haas, H. Avci, D. Müller-Wieland10.1016/S1567-5688(10)70302-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6565P236 THE ROLE OF DYSLIPOPROTEINEMIA IN THE TREATMENT OF ISOLATED SYSTOLIC ARTERIAL HYPERTENSION (ISAH) IN GERIATRIC PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703032/abstract?rss=yesP236 THE ROLE OF DYSLIPOPROTEINEMIA IN THE TREATMENT OF ISOLATED SYSTOLIC ARTERIAL HYPERTENSION (ISAH) IN GERIATRIC PATIENTST. Zubiashvili, N. Kipshidze10.1016/S1567-5688(10)70303-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6565P237 HYPERCHOLESTEROLEMIA (HC) ABROGATES THE BIPHASIC EFFECT OF ANGIOTENSIN II (ANG II) ON ENDOGENOUS CHOLESTEROL SYNTHESIS IN HUMAN MONOCYTEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703044/abstract?rss=yesP237 HYPERCHOLESTEROLEMIA (HC) ABROGATES THE BIPHASIC EFFECT OF ANGIOTENSIN II (ANG II) ON ENDOGENOUS CHOLESTEROL SYNTHESIS IN HUMAN MONOCYTESG. Fóris, Z. Sarang, I. Seres, G. Paragh10.1016/S1567-5688(10)70304-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6566P238 ONSET OF CORONARY ARTERY DISEASE IN PATIENTS WITH AND WITHOUT FAMILIAL HYPERCHOLESTEROLEMIA IN JAPANhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703056/abstract?rss=yesP238 ONSET OF CORONARY ARTERY DISEASE IN PATIENTS WITH AND WITHOUT FAMILIAL HYPERCHOLESTEROLEMIA IN JAPANA. Nohara, J. Kobayashi, T. Noguchi, H. Tada, C. Nakanishi, M.-A. Kawashiri, A. Inazu, M. Yamagishi, H. Mabuchi10.1016/S1567-5688(10)70305-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6666P239 METABOLIC BENEFITS OF LIFESTYLE MODIFICATIONS IN PATIENTS WITH METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703068/abstract?rss=yesP239 METABOLIC BENEFITS OF LIFESTYLE MODIFICATIONS IN PATIENTS WITH METABOLIC SYNDROMEK. Gkogkos, C. Miggos, O. Siarkou, O. Nikitidou, E. Panara, T. Plougarlis, G. Pavlidis10.1016/S1567-5688(10)70306-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6666P240 UNFOLDED PROTEIN RESPONSE IN NONALCOHOLIC FATTY LIVER INDUCED BY HIGH FRUCTOSE DIET IN RATShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070307X/abstract?rss=yesP240 UNFOLDED PROTEIN RESPONSE IN NONALCOHOLIC FATTY LIVER INDUCED BY HIGH FRUCTOSE DIET IN RATSH. Osamah, I. Shams, M. Shenkman, K. Abu Gabal, S. Svalb, A. Apotovski, G. Lederkremer10.1016/S1567-5688(10)70307-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6666P241 SERUM PARAOXONASE ACTIVITY AND ADIPOKINES IN RENAL TRANSPLANTED PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703081/abstract?rss=yesP241 SERUM PARAOXONASE ACTIVITY AND ADIPOKINES IN RENAL TRANSPLANTED PATIENTSI. Seres, L. Lőcsey, L. Szabó, F. Sztanek, L. Asztalos, J. Padra, G. Paragh10.1016/S1567-5688(10)70308-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6666P242 INCREASED PLASMA RESISTIN CONCENTRATIONS ARE ASSOCIATED WITH ATHEROGENIC SMALL, DENSE LOW-DENSITY LIPOPROTEINS IN PATIENTS WITH TYPE-2 DIABETEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703093/abstract?rss=yesP242 INCREASED PLASMA RESISTIN CONCENTRATIONS ARE ASSOCIATED WITH ATHEROGENIC SMALL, DENSE LOW-DENSITY LIPOPROTEINS IN PATIENTS WITH TYPE-2 DIABETESM. Rizzo, B. Amann-Vesti, C. Zwimpfer, G. Spinas, K. Berneis10.1016/S1567-5688(10)70309-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6667P243 MUTANT apo A-I (L178P) IDENTIFIED IN HDL FROM HETEROZYGOTES OF A FAMILY WITH ENDOTHELIAL DYSFUNCTION AND INCREASED ARTERIAL WALL THICKNESShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070310X/abstract?rss=yesP243 MUTANT apo A-I (L178P) IDENTIFIED IN HDL FROM HETEROZYGOTES OF A FAMILY WITH ENDOTHELIAL DYSFUNCTION AND INCREASED ARTERIAL WALL THICKNESSH. Karlsson, S. Sundberg, J.H.M. Levels, M. Turkina, G. Daniel, A. Chroni, J.A. Kuivenhoven, G.K. Hovingh, A.G. Holleboom, M. Lindahl10.1016/S1567-5688(10)70310-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6767P244 MORPHOLOGICAL AND FUNCTIONAL CHANGES IN LIVER MITOCHONDRIA OF RATS TREATED WITH HIGH ATORVASTATIN DOSES AND HYPERCHOLESTEROLEMIC DIEThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703111/abstract?rss=yesP244 MORPHOLOGICAL AND FUNCTIONAL CHANGES IN LIVER MITOCHONDRIA OF RATS TREATED WITH HIGH ATORVASTATIN DOSES AND HYPERCHOLESTEROLEMIC DIETJ. Díaz-Zagoya, I. Juárez-Rojop, A.M. Zetina, J. Ble-Castillo, T. Ramón-Frias, A. Rodriguez-Hernández10.1016/S1567-5688(10)70311-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6767P245 VERY HIGH INTAKE OF PLANT STANOL ESTERS. TIME FOR REVISION OF EFFICACY AND SAFETY?http://www.atherosclerosis-supplements.com/article/PIIS1567568810703123/abstract?rss=yesP245 VERY HIGH INTAKE OF PLANT STANOL ESTERS. TIME FOR REVISION OF EFFICACY AND SAFETY?P. Simonen, M. Hallikainen, M. Nissinen, T. Miettinen, H. Gylling10.1016/S1567-5688(10)70312-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6767P246 IS CHOLESTEROL TEST STRIP A GOOD TOOL FOR CVD RISK SCREENING ?http://www.atherosclerosis-supplements.com/article/PIIS1567568810703135/abstract?rss=yesP246 IS CHOLESTEROL TEST STRIP A GOOD TOOL FOR CVD RISK SCREENING ?S. Mabille, J.F. Cambier, A. De Meester, O. Marcovitch, O. Descamps10.1016/S1567-5688(10)70313-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6767P247 ROSUVASTATIN PROMOTES ANTIOXIDANT EFFECT THROUGH NITRIC OXIDE PATHWAY AND REDUCES SERUM LEVELS OF OXIDIZED-LDL/β2GPI COMPLEXES IN PATIENTS WITH DIABETES MELLITUShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703147/abstract?rss=yesP247 ROSUVASTATIN PROMOTES ANTIOXIDANT EFFECT THROUGH NITRIC OXIDE PATHWAY AND REDUCES SERUM LEVELS OF OXIDIZED-LDL/β2GPI COMPLEXES IN PATIENTS WITH DIABETES MELLITUSL. Lopez, P. Ames, J. Batuca, I. Garcia De La Torre, K. Kojima, E. Matsuura10.1016/S1567-5688(10)70314-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6868P248 INFLUENCE OF FENOFIBRATE, SIMVASTATIN AND/OR EZETIMIBE ON CORRELATION OF LDL AND NON-HDL CHOLESTEROL WITH APOLIPOPROTEIN B IN MIXED DYSLIPIDEMIC PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703159/abstract?rss=yesP248 INFLUENCE OF FENOFIBRATE, SIMVASTATIN AND/OR EZETIMIBE ON CORRELATION OF LDL AND NON-HDL CHOLESTEROL WITH APOLIPOPROTEIN B IN MIXED DYSLIPIDEMIC PATIENTSM. Farnier, W. Taggart, Q. Dong, A. Shah, P. Brudi10.1016/S1567-5688(10)70315-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6868P249 EFFECT OF PUFA n-3 ON LDL SUBFRACTIONS AND SOME NOVEL RISK FACTORS FOR ISCHEMIC HEART DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703160/abstract?rss=yesP249 EFFECT OF PUFA n-3 ON LDL SUBFRACTIONS AND SOME NOVEL RISK FACTORS FOR ISCHEMIC HEART DISEASEM. Dušejovska, M. Vecka, M. Zeman, E. Tvrzicka, J. Kodydkova, L. Vavrova, A. Zak10.1016/S1567-5688(10)70316-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6868P250 LOW HDL-apoAI CLEARANCE ASSOCIATED TO INCREASED HDL3A AND HDL3B CHOLESTEROL PLASMA CONCENTRATIONS IN NEW ZEALAND RABBITS WITH PARTIAL NEPHRECTOMYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703172/abstract?rss=yesP250 LOW HDL-apoAI CLEARANCE ASSOCIATED TO INCREASED HDL3A AND HDL3B CHOLESTEROL PLASMA CONCENTRATIONS IN NEW ZEALAND RABBITS WITH PARTIAL NEPHRECTOMYO. Perez-Mendez, P. Toledo-Ibelles, M. Franco10.1016/S1567-5688(10)70317-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6868P251 EZETIMIBE WITH OR WITHOUT SIMVASTATIN INCREASES SMALL DENSE LOW-DENSITY LIPOPROTEINS IN HEALTHY MEN – A RANDOMIZED TRIALhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703184/abstract?rss=yesP251 EZETIMIBE WITH OR WITHOUT SIMVASTATIN INCREASES SMALL DENSE LOW-DENSITY LIPOPROTEINS IN HEALTHY MEN – A RANDOMIZED TRIALI. Gouni-Berthold, M. Rizzo, H.K. Berthold, G. Spinas, W. Krone, K. Berneis10.1016/S1567-5688(10)70318-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6869P252 A RANDOMIZED COMPARISON OF ROSUVASTATIN PLUS EZETIMIBE VERSUS SIMVASTATIN PLUS EZETIMIBE: RESULTS OF THE GRAVITY STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703196/abstract?rss=yesP252 A RANDOMIZED COMPARISON OF ROSUVASTATIN PLUS EZETIMIBE VERSUS SIMVASTATIN PLUS EZETIMIBE: RESULTS OF THE GRAVITY STUDYC.M. Ballantyne, R. Schiebinger, V. Cain10.1016/S1567-5688(10)70319-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6969P253 SUBGROUP ANALYSES FROM UK INPRACTICE STUDY: ACHIEVEMENT OF LDL-C LEVELS WITH THREE DIFFERENT DRUG STRATEGIES AFTER FAILURE OF SIMVASTATIN 40 mghttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703202/abstract?rss=yesP253 SUBGROUP ANALYSES FROM UK INPRACTICE STUDY: ACHIEVEMENT OF LDL-C LEVELS WITH THREE DIFFERENT DRUG STRATEGIES AFTER FAILURE OF SIMVASTATIN 40 mgP. Harvey, T. Mccormack, R. Gaunt, A. Ahmad, S. Griffiths, P. Robinson10.1016/S1567-5688(10)70320-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6969P254 INVERSE RELATIONSHIP BETWEEN HDL-C RAISING AND HSCRP REDUCTION IN OLDER PATIENTS TREATED WITH LIPID-LOWERING THERAPY IN THE VYTELD STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703214/abstract?rss=yesP254 INVERSE RELATIONSHIP BETWEEN HDL-C RAISING AND HSCRP REDUCTION IN OLDER PATIENTS TREATED WITH LIPID-LOWERING THERAPY IN THE VYTELD STUDYW. Brown, J. Foody, F. Zieve, C. Jones-Burton, Q. Dong, J. Tomassini, A. Shah, A. Tershakovec10.1016/S1567-5688(10)70321-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations6970P255 HDL CHOLESTEROL RESPONSE TO GROWTH HORMONE REPLACEMENT IS ASSOCIATED WITH COMMON CETP GENE VARIATION (−629C>A) AND MODIFIED BY GLUCOCORTICOID TREATMENThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703226/abstract?rss=yesP255 HDL CHOLESTEROL RESPONSE TO GROWTH HORMONE REPLACEMENT IS ASSOCIATED WITH COMMON CETP GENE VARIATION (−629C>A) AND MODIFIED BY GLUCOCORTICOID TREATMENTR. Dullaart, G. van den Berg, A. van der Knaap, J. Dijck-Brouwer, G. Dallinga-Thie, P. Zelissen, W. Sluiter, A. van Beek10.1016/S1567-5688(10)70322-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7070P256 HIGH DENSITY LIPOPROTEIN AND CHOLESTEROL EFFLUX IN PATIENTS WITH TYPE 2 DIABETEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703238/abstract?rss=yesP256 HIGH DENSITY LIPOPROTEIN AND CHOLESTEROL EFFLUX IN PATIENTS WITH TYPE 2 DIABETESH.C. Tan, E.S. Tai, D. Sviridov, P. Nestel, C.L.W. Ng, Y.H.L. Teo, M. Lu, E. Chan, D.C.H. Wai10.1016/S1567-5688(10)70323-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7070P257 OPTIMIZED ASPIRIN DOSING REGIMEN FOR REDUCTION OF NIACIN-INDUCED FLUSHINGhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070324X/abstract?rss=yesP257 OPTIMIZED ASPIRIN DOSING REGIMEN FOR REDUCTION OF NIACIN-INDUCED FLUSHINGC. Sundell, C. Keyserling, H. Klepp, R. Goldwater, R. Scott10.1016/S1567-5688(10)70324-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7070P258 THE EFFECTS OF OMEGA-3-POLYUNSATURATED FATTY ACIDS AND ATORVASTATIN ON FATTY ACID STATUS OF BLOOD IN PATIENTS WITH DYSLIPIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703251/abstract?rss=yesP258 THE EFFECTS OF OMEGA-3-POLYUNSATURATED FATTY ACIDS AND ATORVASTATIN ON FATTY ACID STATUS OF BLOOD IN PATIENTS WITH DYSLIPIDEMIAA. Galyavich, L. Salakhova10.1016/S1567-5688(10)70325-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7071P259 CHOLESTERYL ESTER TRANSFER PROTEIN AND MORTALITY IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703263/abstract?rss=yesP259 CHOLESTERYL ESTER TRANSFER PROTEIN AND MORTALITY IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHYP. Eller, A. Ritsch, H. Scharnagl, I. Tancevski, K. Duwensee, E. Demetz, A. Sandhofer, B. Boehm, B. Winkelmann, J. Patsch, W. März10.1016/S1567-5688(10)70326-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7171P260 CETP EXPRESSION REVERSES THE RECONSTITUTED HDL-INDUCED INCREASE IN VLDLhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703275/abstract?rss=yesP260 CETP EXPRESSION REVERSES THE RECONSTITUTED HDL-INDUCED INCREASE IN VLDLY. Wang, J.F.P. Berbée, J.A. Kuivenhoven, J.W.A. Smit, L.M. Havekes, J.A. Romijn, P.C.N. Rensen10.1016/S1567-5688(10)70327-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7171P261 HEPATIC LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1 (LRP1) INCREASES CHYLOMICRON REMNANT UPTAKE BY TWO MECHANISMShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703287/abstract?rss=yesP261 HEPATIC LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 1 (LRP1) INCREASES CHYLOMICRON REMNANT UPTAKE BY TWO MECHANISMSA. Laatsch, U. Beisiegel, J. Heeren10.1016/S1567-5688(10)70328-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7171P262 DEFECTIVE TG CATABOLISM AND SUBSTRATE OXIDATION IN MICE LACKING CGI-58 IN OXIDATIVE TISSUEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703299/abstract?rss=yesP262 DEFECTIVE TG CATABOLISM AND SUBSTRATE OXIDATION IN MICE LACKING CGI-58 IN OXIDATIVE TISSUESK.A. Zierler, D. Jaeger, N.M. Pollak, R. Zechner, G. Haemmerle10.1016/S1567-5688(10)70329-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7171P263 REVERSE CHOLESTEROL TRANSPORT IS NOT INFLUENCED BY HDL COMPOSITION OR THE REDUCED MACROPHAGE ABCG-1 EXPRESSION IN CHRONIC KIDNEY DISEASE RATShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703305/abstract?rss=yesP263 REVERSE CHOLESTEROL TRANSPORT IS NOT INFLUENCED BY HDL COMPOSITION OR THE REDUCED MACROPHAGE ABCG-1 EXPRESSION IN CHRONIC KIDNEY DISEASE RATSJ.T. Machado, R.S. Pinto, G. Castilho, A. Machado-Lima, L.S. Okuda, R.T. Iborra, J.C. Rocha, A.B. Carreiro, E.R. Nakandakare, S. Catanozi, M. Passarelli10.1016/S1567-5688(10)70330-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7172P264 DIETARY MILK PHOSPHOLIPID IMPROVES DIET-INDUCED HEPATIC STEATOSIS IN MICE BY REDUCING INTESTINAL CHOLESTEROL ABSORPTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703317/abstract?rss=yesP264 DIETARY MILK PHOSPHOLIPID IMPROVES DIET-INDUCED HEPATIC STEATOSIS IN MICE BY REDUCING INTESTINAL CHOLESTEROL ABSORPTIONA. Kamili, E. Wat, S. Tandy, W.S.R. Chung, A. Brown, M. Rowney, J.S. Cohn10.1016/S1567-5688(10)70331-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7272P265 LIPOPROTEIN(a) ACCELERATES ATHEROSCLEROSIS IN UREMIC MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703329/abstract?rss=yesP265 LIPOPROTEIN(a) ACCELERATES ATHEROSCLEROSIS IN UREMIC MICET.X. Pedersen, S.P. McCormick, S. Tsimikas, S. Bro, L.B. Nielsen10.1016/S1567-5688(10)70332-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7272P266 FENOFIBRATE TREATMENT MODULATES GENE EXPRESSION ACTIVITY IN PERIPHERAL BLOOD MONOCYTES OF HEALTHY VOLUNTEERShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703330/abstract?rss=yesP266 FENOFIBRATE TREATMENT MODULATES GENE EXPRESSION ACTIVITY IN PERIPHERAL BLOOD MONOCYTES OF HEALTHY VOLUNTEERSC. Foucher, A. Menicacci, S. Vachenc, B. Gerstmayer, G. Henrion, U. Janssen, D. Wilbraham, K. Le Malicot, J.-C. Ansquer10.1016/S1567-5688(10)70333-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7272P267 NON HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IS BETTER PREDICTOR FOR CORONARY RISK, AND IS USEFUL TO EVALUATE THE EFFICACY OF STATIN THERAPYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703342/abstract?rss=yesP267 NON HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IS BETTER PREDICTOR FOR CORONARY RISK, AND IS USEFUL TO EVALUATE THE EFFICACY OF STATIN THERAPYK. Mizuno, H. Nakamura10.1016/S1567-5688(10)70334-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7272P268 THE “BEYOND CHOLESTEROL-LOWERING ACTIVITY” OF PRAVASTATIN. ANALYSIS OF THREE OVERLAPPING DOSE GROUPShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703354/abstract?rss=yesP268 THE “BEYOND CHOLESTEROL-LOWERING ACTIVITY” OF PRAVASTATIN. ANALYSIS OF THREE OVERLAPPING DOSE GROUPSH. Nakamura, K. Mizuno10.1016/S1567-5688(10)70335-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7273P269 EFFICACY OF EZETIMIBE ADDED TO ATORVASTATIN VS. UPTITRATION OF ATORVASTATIN IN SUBGROUPS OF PATIENTS 65–74 YEARS AND ≥ 75 YEARS OLDhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703366/abstract?rss=yesP269 EFFICACY OF EZETIMIBE ADDED TO ATORVASTATIN VS. UPTITRATION OF ATORVASTATIN IN SUBGROUPS OF PATIENTS 65–74 YEARS AND ≥ 75 YEARS OLDO. Ben-Yehuda, N. Wenger, C. Constance, F. Zieve, J. Lin, M. Hanson, A. Shah, C. Jones-Burton, A. Tershakovec10.1016/S1567-5688(10)70336-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7272P270 LONG-TERM STATIN THERAPY IS ASSOCIATED WITH BETTER EPISODIC MEMORY IN AGED FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS IN COMPARISON WITH POPULATION CONTROLShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703378/abstract?rss=yesP270 LONG-TERM STATIN THERAPY IS ASSOCIATED WITH BETTER EPISODIC MEMORY IN AGED FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS IN COMPARISON WITH POPULATION CONTROLSL. Hyttinen, A. Tuulio-Henriksson, A.F. Vuorio, N. Kuosmanen, T. Härkänen, S. Koskinen, T.E. Strandberg10.1016/S1567-5688(10)70337-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7373P271 ACTIVATION OF LYSOSOMES BY INTRACELLULAR TRIACYLGLYCEROL ACCUMULATION CONTRIBUTES TO THE DEVELOPMENT OF HEPATIC INSULIN RESISTANCE AND OXIDATIVE STRESShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070338X/abstract?rss=yesP271 ACTIVATION OF LYSOSOMES BY INTRACELLULAR TRIACYLGLYCEROL ACCUMULATION CONTRIBUTES TO THE DEVELOPMENT OF HEPATIC INSULIN RESISTANCE AND OXIDATIVE STRESSM. Cahova, Z. Drahota, H. Dankova, O. Oliyarnyk, E. Palenickova, Z. Papackova, I. Markova, L. Kazdova10.1016/S1567-5688(10)70338-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7374P272 ARE POST-TREATMENT LOW DENSITY LIPOPROTEIN SUBCLASS PATTERN ANALYSES POTENTIALLY MISLEADING?http://www.atherosclerosis-supplements.com/article/PIIS1567568810703391/abstract?rss=yesP272 ARE POST-TREATMENT LOW DENSITY LIPOPROTEIN SUBCLASS PATTERN ANALYSES POTENTIALLY MISLEADING?H. Bays, S. Conard, L.A. Leiter, E. Jensen, S. Bird, M.E. Hanson, A.M. Tershakovec10.1016/S1567-5688(10)70339-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7474P273 EZETIMIBE/SIMVASTATIN 10/20 mg VERSUS ROSUVASTATIN 10 mg IN HIGH RISK HYPERCHOLESTEROLEMIC PATIENTS STRATIFIED BY PRIOR STATIN TREATMENT POTENCYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703408/abstract?rss=yesP273 EZETIMIBE/SIMVASTATIN 10/20 mg VERSUS ROSUVASTATIN 10 mg IN HIGH RISK HYPERCHOLESTEROLEMIC PATIENTS STRATIFIED BY PRIOR STATIN TREATMENT POTENCYM. Viigimaa, H. Vaverkova, M. Farnier, M. Averna, L. Missault, Q. Dong, A. Shah, M. Hanson, P. Brudi10.1016/S1567-5688(10)70340-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7474P274 PIOGLITAZONE SUPPRESSES ONLY PLASMA SMALL, DENSE LDL BUT NOT LARGE LDL IN TYPE 2 DIABETIC PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070341X/abstract?rss=yesP274 PIOGLITAZONE SUPPRESSES ONLY PLASMA SMALL, DENSE LDL BUT NOT LARGE LDL IN TYPE 2 DIABETIC PATIENTSM. Miyagi, K. Kuboki, T. Matsumoto, R. Iga, N. Masai, K. Iso, E. Murakami, S. Kodate, T. Hirano, G. Yoshino10.1016/S1567-5688(10)70341-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7575P275 DOES GENDER IMPACT ON STATIN DOSE RESPONSE? RESULTS FROM THE VOYAGER INDIVIDUAL PATIENT DATA META-ANALYSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703421/abstract?rss=yesP275 DOES GENDER IMPACT ON STATIN DOSE RESPONSE? RESULTS FROM THE VOYAGER INDIVIDUAL PATIENT DATA META-ANALYSISP. Lundman, S.J. Nicholls, G. Brandrup-Wognsen, M. Palmer, P.J. Barter10.1016/S1567-5688(10)70342-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7575P276 THE EFFECTS OF EZETIMIBE, ALONE OR COMBINED WITH ORLISTAT, ON TRIGLYCERIDE-RICH LIPOPROTEIN METABOLISM IN OVERWEIGHT AND OBESE PATIENTS WITH HYPERLIPIDAEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703433/abstract?rss=yesP276 THE EFFECTS OF EZETIMIBE, ALONE OR COMBINED WITH ORLISTAT, ON TRIGLYCERIDE-RICH LIPOPROTEIN METABOLISM IN OVERWEIGHT AND OBESE PATIENTS WITH HYPERLIPIDAEMIAE. Nakou, T. Filippatos, C. Kostara, A. Agouridis, E. Bairaktari, M. Elisaf10.1016/S1567-5688(10)70343-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7575P277 SAFETY AND EFFICACY OF EZETIMIBE/SIMVASTATIN COMBINATION VERSUS ATORVASTATIN IN PATIENTS 65 YEARS OF AGE AND OLDERhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703445/abstract?rss=yesP277 SAFETY AND EFFICACY OF EZETIMIBE/SIMVASTATIN COMBINATION VERSUS ATORVASTATIN IN PATIENTS 65 YEARS OF AGE AND OLDERJ.M. Foody, W.V. Brown, F. Zieve, A.J. Adewale, D. Flaim, R.S. Lowe, C. Jones-Burton, A.M. Tershakovec10.1016/S1567-5688(10)70344-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7576P278 THE RELATIONSHIP BETWEEN FIBRINOLYSIS, LIPID PROFILE AND GLUCOSE METABOLISM CHARACTERISTICS IN RANDOMLY SELECTED MOSCOW RESIDENTS AGED 55 AND OVERhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703457/abstract?rss=yesP278 THE RELATIONSHIP BETWEEN FIBRINOLYSIS, LIPID PROFILE AND GLUCOSE METABOLISM CHARACTERISTICS IN RANDOMLY SELECTED MOSCOW RESIDENTS AGED 55 AND OVERV. Metelskaya, L. Ratnikova, S. Shalnova, M. Shkolnikova, A. Deev, V. Shkolnikov10.1016/S1567-5688(10)70345-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7676P279 INFLUENCE OF NOVEL SELECTIVE CYCLOOXYGENASE-2 (COX-2) INHIBITORS ON COPPER-MEDIATED OXIDATION OF HUMAN LDLhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703469/abstract?rss=yesP279 INFLUENCE OF NOVEL SELECTIVE CYCLOOXYGENASE-2 (COX-2) INHIBITORS ON COPPER-MEDIATED OXIDATION OF HUMAN LDLJ. Pietzsch, F.-J. Pietzsch, M. Laube, R. Bergmann, F. Wuest, J. Steinbach, T. Kniess10.1016/S1567-5688(10)70346-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7676P280 LDL-APHERESIS SELECTIVELY INDUCES CHANGES IN THE LIPIDOME AND PROTEOME OF APO-AI-CONTAINING LIPOPROTEIN PARTICLES IN FAMILIAL HYPERCHOLESTEROLEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703470/abstract?rss=yesP280 LDL-APHERESIS SELECTIVELY INDUCES CHANGES IN THE LIPIDOME AND PROTEOME OF APO-AI-CONTAINING LIPOPROTEIN PARTICLES IN FAMILIAL HYPERCHOLESTEROLEMIAA. Orsoni, M. Guérin, M. Couturier, G.M. Dallinga-Thie, J.H.M. Levels, S. Saheb, M. Atassi-Dumont, D. Bonnefont-Rousselot, A. Kontush, A. Carrié, E. Bruckert, M.J. Chapman10.1016/S1567-5688(10)70347-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7676P281 CIRCULATING PCSK9 LEVELS ARE ASSOCIATED WITH FRUCTOSE-INDUCED HYPERTRIGLYCERIDAEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703482/abstract?rss=yesP281 CIRCULATING PCSK9 LEVELS ARE ASSOCIATED WITH FRUCTOSE-INDUCED HYPERTRIGLYCERIDAEMIAB. Cariou, M. LeBras, C. Langhi, M. Bortolotti, K.-A. Lê, C. LeMay, R. Kreis, C. Boesch, M. Krempf, L. Tappy, P. Costet10.1016/S1567-5688(10)70348-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7676P282 ABCG5/G8 DEFICIENCY INCREASES TRIGLYCERIDE LEVELS BY AFFECTING MULTIPLE METABOLIC PATHWAYShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703494/abstract?rss=yesP282 ABCG5/G8 DEFICIENCY INCREASES TRIGLYCERIDE LEVELS BY AFFECTING MULTIPLE METABOLIC PATHWAYSJ. Méndez-González, J. Julve, N. Rotllan, F. Blanco-Vaca, J.C. Escolà-Gil10.1016/S1567-5688(10)70349-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7777P283 THE ROLE OF SNARE PROTEINS IN HUMAN INSULIN RESISTANCEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703500/abstract?rss=yesP283 THE ROLE OF SNARE PROTEINS IN HUMAN INSULIN RESISTANCEP. Bostrom, L. Andersson, B. Vind, L. Haversen, Y. Wickstrom, E. Larsson, P.-A. Jansson, M. Svensson, R. Branemark, C. Ling, H. Beck-Nielsen, J. Boren, K. Hojlund, S.-O. Olofsson10.1016/S1567-5688(10)70350-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7777P284 ROLE OF ABCA1 TRANSPORTER IN HUMANS AND RELATIONSHIP TO ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703512/abstract?rss=yesP284 ROLE OF ABCA1 TRANSPORTER IN HUMANS AND RELATIONSHIP TO ATHEROSCLEROSISE. Demina, V. Miroshnikova, A. Denisenko, A. Schwarzman10.1016/S1567-5688(10)70351-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7777P285 FIRST DEMONSTRATION OF THE LOCALIZATION OF HEPATIC apoB100- AND INTESTINAL apoB48-CONTAINING LIPOPROTEIN PARTICLES IN HUMAN ATHEROSCLEROTIC PLAQUES USING DUAL-STAINING IMMUNOFLUORESCENCEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703524/abstract?rss=yesP285 FIRST DEMONSTRATION OF THE LOCALIZATION OF HEPATIC apoB100- AND INTESTINAL apoB48-CONTAINING LIPOPROTEIN PARTICLES IN HUMAN ATHEROSCLEROTIC PLAQUES USING DUAL-STAINING IMMUNOFLUORESCENCEJ.G. Vazquez Figueroa, P. Battey, M. Kinoshita, I. Marvasty, B. Blackman, A. Pryor, T. Matsushima, T. Teramoto, S. Rinehart, S. Voros10.1016/S1567-5688(10)70352-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7777P286 DIFFERENTIAL LIPID/LIPOPROTEIN RESPONSE IN WOMEN VS MEN IN PRIMARY AND SECONDARY PREVENTION TREATED WITH STATINShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703536/abstract?rss=yesP286 DIFFERENTIAL LIPID/LIPOPROTEIN RESPONSE IN WOMEN VS MEN IN PRIMARY AND SECONDARY PREVENTION TREATED WITH STATINSG. Mombelli, N. Fabbri, S. Frasson, C. Baldo, V. De Vergori, M. Triolo, C.R. Sirtori10.1016/S1567-5688(10)70353-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7777P287 LONGITUDINAL ASSESSMENT OF DYSLIPIDEMIA AMONG PATIENTS TREATED WITH LIPID MODIFYING THERAPY IN UK CLINICAL PRACTICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703548/abstract?rss=yesP287 LONGITUDINAL ASSESSMENT OF DYSLIPIDEMIA AMONG PATIENTS TREATED WITH LIPID MODIFYING THERAPY IN UK CLINICAL PRACTICEB. Ambegaonkar, S. Eaton, K. Jameson, V. Amber, P. Durrington10.1016/S1567-5688(10)70354-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7878P288 STRUCTURE–FUNCTION RELATIONSHIPS OF APOLIPOPROTEIN A-I MIMETIC PEPTIDES: IMPLICATIONS FOR ANTI-ATHEROGENIC ACTIVITIES OF HIGH DENSITY LIPOPROTEINhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070355X/abstract?rss=yesP288 STRUCTURE–FUNCTION RELATIONSHIPS OF APOLIPOPROTEIN A-I MIMETIC PEPTIDES: IMPLICATIONS FOR ANTI-ATHEROGENIC ACTIVITIES OF HIGH DENSITY LIPOPROTEIND. Sviridov, W. D'Souza, J.A. Stonik, A. Murphy, S.J. Demosky, A.A. Sethi, J. Chin-Dusting, A.T. Remaley10.1016/S1567-5688(10)70355-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7878P289 LOVASTATIN ENHANCES PARAOXONASE ENZYME ACTIVITY AND PROLONGS LOW DENSITIY LIPOPROTEIN PEROXIDATION LAG PHASE IN TYPE II DIABETIC NEPHROPATHYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703561/abstract?rss=yesP289 LOVASTATIN ENHANCES PARAOXONASE ENZYME ACTIVITY AND PROLONGS LOW DENSITIY LIPOPROTEIN PEROXIDATION LAG PHASE IN TYPE II DIABETIC NEPHROPATHYN. Nezami, A. Ghorbanihaghjo, H. Argani, J. Safa, N. Rashtchizadeh10.1016/S1567-5688(10)70356-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7878P290 FAT OVERLOAD INFLUENCES LIPOGENIC FACTORS IN THE METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703573/abstract?rss=yesP290 FAT OVERLOAD INFLUENCES LIPOGENIC FACTORS IN THE METABOLIC SYNDROMEM. Queipo-Ortuño, M.D. Mayas, M. Clemente-Postigo, R. El Bakay, M. Macias, F.J. Tinahones, F. Cardona10.1016/S1567-5688(10)70357-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7878P291 SIMULTANEOUS DETERMINATION OF TRIGLYCERIDE AND GLUCOSE TOLERANCE BY A NOVEL SEQUENTIAL TEST PROTOCOL IN 511 PATIENTS WITH CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703585/abstract?rss=yesP291 SIMULTANEOUS DETERMINATION OF TRIGLYCERIDE AND GLUCOSE TOLERANCE BY A NOVEL SEQUENTIAL TEST PROTOCOL IN 511 PATIENTS WITH CORONARY ARTERY DISEASEC. Werner, A. Filmer, S. Groenewold, M. Fritsch, M. Böhm, U. Laufs10.1016/S1567-5688(10)70358-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7879P292 PARAMETERS OF THE LIPID PROFILE AND ASSOCIATION WITH THE DEVELOPMENT OF RE-OBSTRUCTION AFTER STENT IMPLANTATION IN THE SFA IN PAD-PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703597/abstract?rss=yesP292 PARAMETERS OF THE LIPID PROFILE AND ASSOCIATION WITH THE DEVELOPMENT OF RE-OBSTRUCTION AFTER STENT IMPLANTATION IN THE SFA IN PAD-PATIENTST. Gary, P. Rief, T. Stojakovic, H. Froehlich, H. Scharnagl, F. Hafner, E. Pilger, M. Brodmann10.1016/S1567-5688(10)70359-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7979P293 DISCOVERY OF A NOVEL AND POTENT CHOLESTEROL ABSORPTION INHIBITOR AS PROMISING ORALLY ACTIVE LIPID LOWERING DRUGhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703603/abstract?rss=yesP293 DISCOVERY OF A NOVEL AND POTENT CHOLESTEROL ABSORPTION INHIBITOR AS PROMISING ORALLY ACTIVE LIPID LOWERING DRUGM. Kanou, Y. Nishiwaki, A. Nakano, Y. Yamanaka10.1016/S1567-5688(10)70360-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7979P294 ADIPONECTIN ENHANCES DE NOVO HEPATIC HDL SYNTHESIS THROUGH LXR ALPHA- AND COUP-TFII-DEPENDENT PATHWAYShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703615/abstract?rss=yesP294 ADIPONECTIN ENHANCES DE NOVO HEPATIC HDL SYNTHESIS THROUGH LXR ALPHA- AND COUP-TFII-DEPENDENT PATHWAYSK. Tsubakio-Yamamoto, T. Ohama, D. Masuda, J.C. Sandoval, M. Inagaki, K. Nakatani, M. Yuasa-Kawase, R. Kawase, H. Nakaoka, Y. Nakagawa-Toyama, M. Nishida, M. Ishigami, S. Kihara, I. Shimomura, I. Komuro, S. Yamashita10.1016/S1567-5688(10)70361-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7979P295 COMPARISON OF METHODS FOR MEASURING LDL-CHOLESTEROL IN THE FASTING AND NONFASTING STATE IN PATIENTS WITH TYPE-2 DIABETES MELLITUShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703627/abstract?rss=yesP295 COMPARISON OF METHODS FOR MEASURING LDL-CHOLESTEROL IN THE FASTING AND NONFASTING STATE IN PATIENTS WITH TYPE-2 DIABETES MELLITUSS. Lund, M. Petersen, M. Frandsen, U. Smidt, H.-H. Parving, A. Vaag, T. Jensen10.1016/S1567-5688(10)70362-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7979P296 EFFECTS OF FENOFIBRIC ACID IN COMBINATION WITH STATIN THERAPY ON LOW-DENSITY LIPOPROTEIN PARTICLE SIZE IN PATIENTS WITH MIXED DYSLIPIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703639/abstract?rss=yesP296 EFFECTS OF FENOFIBRIC ACID IN COMBINATION WITH STATIN THERAPY ON LOW-DENSITY LIPOPROTEIN PARTICLE SIZE IN PATIENTS WITH MIXED DYSLIPIDEMIAD.J. Sleep, I.S. Mandair, C.M. Setze, M.T. Kelly10.1016/S1567-5688(10)70363-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations7980P297 SUSTAINED RELEASE NICOTINIC ACID VERSUS INOSITOL HEXANICOTINATE FOR THE TREATMENT OF DYSLIPIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703640/abstract?rss=yesP297 SUSTAINED RELEASE NICOTINIC ACID VERSUS INOSITOL HEXANICOTINATE FOR THE TREATMENT OF DYSLIPIDEMIAJ. Keenan10.1016/S1567-5688(10)70364-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8080P298 DISTINCT PLASMA FATTY ACIDS ASSOCIATE WITH COMPONENTS OF THE METABOLIC SYNDROME IN HEALTHY OFFSPRING OF TYPE 2 DIABETES PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703652/abstract?rss=yesP298 DISTINCT PLASMA FATTY ACIDS ASSOCIATE WITH COMPONENTS OF THE METABOLIC SYNDROME IN HEALTHY OFFSPRING OF TYPE 2 DIABETES PATIENTSL. Scheja, M. Vossen, K. Toedter, U. Beisiegel10.1016/S1567-5688(10)70365-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8080P299 RELATIVE RESPONSIVENESS TO LDL-LOWERING AGENTS THAT BLOCK CHOLESTEROL ABSORPTION (EZETIMIBE) AND INHIBIT CHOLESTEROL SYNTHESIS (SIMVASTATIN)http://www.atherosclerosis-supplements.com/article/PIIS1567568810703664/abstract?rss=yesP299 RELATIVE RESPONSIVENESS TO LDL-LOWERING AGENTS THAT BLOCK CHOLESTEROL ABSORPTION (EZETIMIBE) AND INHIBIT CHOLESTEROL SYNTHESIS (SIMVASTATIN)S.G. Lakoski, G.L. Vega, S.M. Grundy, M. Chandalia, C. Lam, R.S. Lowe, M.E. Stepanavage, T.A. Musliner, J.C. Cohen, H.H. Hobbs10.1016/S1567-5688(10)70366-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8080P300 EFFECT OF PROBUCOL ON AN ANTIOXIDANT PROPERTY OF HDL IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703676/abstract?rss=yesP300 EFFECT OF PROBUCOL ON AN ANTIOXIDANT PROPERTY OF HDL IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIAM. Inagaki, Y. Nakagawa-Toyama, R. Kawase, H. Nakaoka, K. Nakatani, M. Yuasa-Kawase, K. Tsubakio-Yamamoto, J.C. Sandoval, D. Masuda, T. Ohama, M. Nishida, M. Ishigami, S. Yamashita10.1016/S1567-5688(10)70367-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8081P301 ENVIRONMENTAL RISK FACTORS LEADING TO HYPERTRIGLYCERIDEMIA ON HETEROZYGOUS LIPOPROTEIN LIPASE (LPL) DEFICIENCY IDENTIFIED IN THE GENERAL POPULATION OF JAPANESEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703688/abstract?rss=yesP301 ENVIRONMENTAL RISK FACTORS LEADING TO HYPERTRIGLYCERIDEMIA ON HETEROZYGOUS LIPOPROTEIN LIPASE (LPL) DEFICIENCY IDENTIFIED IN THE GENERAL POPULATION OF JAPANESEY. Ikeda, A. Takagi, N. Iwai, Y. Kokubo, H. Tomoike10.1016/S1567-5688(10)70368-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8181P302 TRANS ELAIDIC BUT NOT VACCENIC ACID IMPAIRS ABCA1-DEPENDENT CHOLESTEROL EFFLUX FROM J774 MACROPHAGEShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070369X/abstract?rss=yesP302 TRANS ELAIDIC BUT NOT VACCENIC ACID IMPAIRS ABCA1-DEPENDENT CHOLESTEROL EFFLUX FROM J774 MACROPHAGESN. Fournier, N. Attia, D. Rousseau, B. Vedie, F. Destaillats, A. Grynberg, J.-L. Paul10.1016/S1567-5688(10)70369-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8181P303 THE DIAGNOSTIC ALGORITHM FOR apoB DYSLIPOPROTEINEMIAS APPLIED TO THE DUTCH POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703706/abstract?rss=yesP303 THE DIAGNOSTIC ALGORITHM FOR apoB DYSLIPOPROTEINEMIAS APPLIED TO THE DUTCH POPULATIONS. Holewijn, A. Sniderman, M. den Heijer, D. Swinkels, A. Stalenhoef, J. de Graaf10.1016/S1567-5688(10)70370-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8181P304 CIRCADIAN BLOOD PRESSURE VARIABILITY, AMBULATORY ARTERIAL STIFFNESS INDEX AND ERYTHROCYTE ELECTRON TRANSFER IN SIBLINGS OF TYPE 1 DIABETES FAMILIEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703718/abstract?rss=yesP304 CIRCADIAN BLOOD PRESSURE VARIABILITY, AMBULATORY ARTERIAL STIFFNESS INDEX AND ERYTHROCYTE ELECTRON TRANSFER IN SIBLINGS OF TYPE 1 DIABETES FAMILIESE. Matteucci, C. Consani, M.C. Masoni, O. Giampietro10.1016/S1567-5688(10)70371-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8181P305 IMPACT OF RENAL INSUFFICIENCY ON DYSLIPIDEMIA IN A TRANSGENIC MOUSE MODELhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070372X/abstract?rss=yesP305 IMPACT OF RENAL INSUFFICIENCY ON DYSLIPIDEMIA IN A TRANSGENIC MOUSE MODELM. Chabert, X. Rousset, M. Lacasa, F. Châtelet, A. Kalopissis10.1016/S1567-5688(10)70372-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8282P306 LYSOSOMAL DYSFUNCTION IN ATHEROSCLEROTIC HEART DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703731/abstract?rss=yesP306 LYSOSOMAL DYSFUNCTION IN ATHEROSCLEROTIC HEART DISEASEM. Greeve, G. MacIntosh, P. Meikle10.1016/S1567-5688(10)70373-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8282P307 GLUT 4 AND THE ATGL AND HSL LIPASES ARE DOWN-REGULATED IN SUBCUTANEOUS ADIPOSE TISSUE OF PATIENTS WITH FCHLhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703743/abstract?rss=yesP307 GLUT 4 AND THE ATGL AND HSL LIPASES ARE DOWN-REGULATED IN SUBCUTANEOUS ADIPOSE TISSUE OF PATIENTS WITH FCHLJ. Ribalta, J. Salazar, J.C. Vallvé, M. Gonzàlez, A. Horra, R. Rosales, N. Plana, R. Ferré, L. Masana10.1016/S1567-5688(10)70374-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8282P308 EFFICACY AND SAFETY OF A FIXED COMBINATION OF FENOFIBRATE AND METFORMIN IN CO-ADMINISTRATION WITH STATIN THERAPY. THE FAME METFO STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703755/abstract?rss=yesP308 EFFICACY AND SAFETY OF A FIXED COMBINATION OF FENOFIBRATE AND METFORMIN IN CO-ADMINISTRATION WITH STATIN THERAPY. THE FAME METFO STUDYP. Valensi, I. Gottlieb, S. Le-Mouhaer, M. Conte10.1016/S1567-5688(10)70375-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8282P309 HDL-C RELATES TO MARKERS OF ABSORPTION BUT NOT OF SYNTHESIS OF CHOLESTEROL: STUDY IN SUBJECTS WITH LOW VS. HIGH HDL-Chttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703767/abstract?rss=yesP309 HDL-C RELATES TO MARKERS OF ABSORPTION BUT NOT OF SYNTHESIS OF CHOLESTEROL: STUDY IN SUBJECTS WITH LOW VS. HIGH HDL-CV. Sutti Nunes, C.C. Leança, N.B. Pnazoldo, D.F. Correa, E.R. Nakandakare, E.C. de Faria, E.C.R. Quintão10.1016/S1567-5688(10)70376-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8283P310 CHOLESTEROL- AND FATTY-ACID-PROFILES IN SUBJECTS WITH IRON OVERLOAD AND IRON DEFICIENCY ANEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703779/abstract?rss=yesP310 CHOLESTEROL- AND FATTY-ACID-PROFILES IN SUBJECTS WITH IRON OVERLOAD AND IRON DEFICIENCY ANEMIAN. Sauer, K. Tödter, U. Beisiegel, P. Nielsen10.1016/S1567-5688(10)70377-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8383P311 LIPID TRANSFER FROM AN ARTIFICIAL LIPIDIC NANOEMULSION TO HIGH DENSITY LIPOPROTEIN IN RESISTANCE EXERCISEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703780/abstract?rss=yesP311 LIPID TRANSFER FROM AN ARTIFICIAL LIPIDIC NANOEMULSION TO HIGH DENSITY LIPOPROTEIN IN RESISTANCE EXERCISEJ.L. Da Silva, R.C. Maranhão, V.M. Silva, C.G.C.M. Vinagre10.1016/S1567-5688(10)70378-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8383P312 OXIDATION OF CYANIDE TO CYANATE BY MYELOPEROXIDASE: A NEW ROUTE FOR APOLIPOPROTEIN CARBAMYLATION?http://www.atherosclerosis-supplements.com/article/PIIS1567568810703792/abstract?rss=yesP312 OXIDATION OF CYANIDE TO CYANATE BY MYELOPEROXIDASE: A NEW ROUTE FOR APOLIPOPROTEIN CARBAMYLATION?P. Van Antwerpen, K. Zouaoui Boudjeltia, P. Furmueller, M. Dieu, C. Delporte, M. Raes, N. Moguilevsky, M. Vanhaeverbeek, J. Ducobu, J. Nève, C. Obinger10.1016/S1567-5688(10)70379-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8383P313 INVESTIGATION OF THE SUBSTRATE- AND STEREOSELECTIVITY OF ADIPOSE TRIGLYCERIDE LIPASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703809/abstract?rss=yesP313 INVESTIGATION OF THE SUBSTRATE- AND STEREOSELECTIVITY OF ADIPOSE TRIGLYCERIDE LIPASET.O. Eichmann, A. Lass, R. Zimmermann, R. Zechner10.1016/S1567-5688(10)70380-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8383P314 IDENTIFICATION AND CLONING OF NOVEL SOLUBLE AND MEMBRANE BOUND FORMS OF HUMAN ATP-BINDING CASSETTE TRANSPORTER G4http://www.atherosclerosis-supplements.com/article/PIIS1567568810703810/abstract?rss=yesP314 IDENTIFICATION AND CLONING OF NOVEL SOLUBLE AND MEMBRANE BOUND FORMS OF HUMAN ATP-BINDING CASSETTE TRANSPORTER G4Y. Uehara, S. Abe, E. Yahiro, A. Kawamura, T. Iwamoto, S.-I. Miura, K. Saku10.1016/S1567-5688(10)70381-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8384P315 GENETIC VARIATION IN THE ABCA1-GENE ABROGATES THE PROTECTIVE EFFECT OF ADIPONECTIN ON CAROTID IMThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703822/abstract?rss=yesP315 GENETIC VARIATION IN THE ABCA1-GENE ABROGATES THE PROTECTIVE EFFECT OF ADIPONECTIN ON CAROTID IMTC. Ciardi, A. Sandhofer, B. Iglseder, B. Paulweber, J. Patsch10.1016/S1567-5688(10)70382-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8484P316 NEW SPLICING MUTATIONS OF MTP LEADING TO SEVERE ABETALIPOPROTEINEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703834/abstract?rss=yesP316 NEW SPLICING MUTATIONS OF MTP LEADING TO SEVERE ABETALIPOPROTEINEMIAE. Mas, V. Pons, C. Rolland, M. Nauze, M. Danjoux, G. Gaibelet, A. Sassolas, E. Lévy, F. Tercé, X. Collet10.1016/S1567-5688(10)70383-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8484P317 FUNCTION OF HDL MODIFYING PROTEINS IN THE HUMAN PLACENTAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703846/abstract?rss=yesP317 FUNCTION OF HDL MODIFYING PROTEINS IN THE HUMAN PLACENTAJ. Saarela, J. Metso, R. Kaaja, W.J. Schneider, M. Jauhiainen10.1016/S1567-5688(10)70384-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8484P318 EZETIMIBE EFFECT ON SERUM apoB48 LEVELS IN FAMILIAL HYPERCHOLESTEROLEMIA AND TYPE 2 DIABETEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703858/abstract?rss=yesP318 EZETIMIBE EFFECT ON SERUM apoB48 LEVELS IN FAMILIAL HYPERCHOLESTEROLEMIA AND TYPE 2 DIABETESM. Sudo, S. Takemitsu, Y. Sato, M. Nagao, T. Harada, Y. Nakajima, K. Tanimura, F. Okajima, S. Oikawa10.1016/S1567-5688(10)70385-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8484P319 RESEQUENCING THE LPL GENE IN PATIENTS WITH VARIOUS HYPERTRIGLYCERIDEMIAS TO DETERMINE THE RELATIVE IMPORTANCE OF RARE ALLELES AND COMMON VARIANTShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070386X/abstract?rss=yesP319 RESEQUENCING THE LPL GENE IN PATIENTS WITH VARIOUS HYPERTRIGLYCERIDEMIAS TO DETERMINE THE RELATIVE IMPORTANCE OF RARE ALLELES AND COMMON VARIANTSD. Evans, J. Azar, F. Beil10.1016/S1567-5688(10)70386-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8485P320 HYPOGLYCEMIC POTENTIAL OF Cucurbita pepo L. IN ALLOXAN-INDUCED DIABETIC RATShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703871/abstract?rss=yesP320 HYPOGLYCEMIC POTENTIAL OF Cucurbita pepo L. IN ALLOXAN-INDUCED DIABETIC RATSS. Asgary, A. Adelnia, S. Kazemi, F. Shamsi, M. Rafieian-Kopaei10.1016/S1567-5688(10)70387-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8585P321 CLASSIFICATION OF DYSLIPIDEMIAS BASED ON APOLIPOPROTEIN B AND TRIGLYCERIDES. ASSOCIATION OF DYSLIPIDEMIC PHENOTYPES WITH MARKERS OF INSULIN RESISTANCE AND INFLAMMATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703883/abstract?rss=yesP321 CLASSIFICATION OF DYSLIPIDEMIAS BASED ON APOLIPOPROTEIN B AND TRIGLYCERIDES. ASSOCIATION OF DYSLIPIDEMIC PHENOTYPES WITH MARKERS OF INSULIN RESISTANCE AND INFLAMMATIONH. Vaverkova, D. Karasek, D. Jackuliakova, D. Novotny, M. Halenka, J. Lukes, L. Slavik10.1016/S1567-5688(10)70388-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8585P322 ASPIRIN'S EFFECT ON OXIDATIVE STRESS IN PATIENTS WITH TYPE II DIABETES MELLITUShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703895/abstract?rss=yesP322 ASPIRIN'S EFFECT ON OXIDATIVE STRESS IN PATIENTS WITH TYPE II DIABETES MELLITUSJ. Geske, K. Guyer, I. Muncy, M. Boisen, I. Garcia De La Torre, L. Lopez10.1016/S1567-5688(10)70389-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8585P323 ABCG5 POLYMORPHISMS MODULATE PLASMA LIPID LEVELS: INSIGHT FROM THE SPANISH FAMILIAL HYPERCHOLESTEROLEMIA COHORT STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703901/abstract?rss=yesP323 ABCG5 POLYMORPHISMS MODULATE PLASMA LIPID LEVELS: INSIGHT FROM THE SPANISH FAMILIAL HYPERCHOLESTEROLEMIA COHORT STUDYA. Garcia Rios, P. Perez Martinez, P. Mata Lopez, F. Fuentes Jimenez, R. Alonso Karlezi, J. Caballero, N. Mata, J.M. Ordovas, F. Perez Jimenez, J. Lopez Miranda10.1016/S1567-5688(10)70390-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8585P324 PERTURBED CELLULAR LRP1 LOCALIZATION LEADS TO INCREASED HEPATIC LDLR EXPRESSION WITH ATHEROPROTECTIVE CONSEQUENCEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703913/abstract?rss=yesP324 PERTURBED CELLULAR LRP1 LOCALIZATION LEADS TO INCREASED HEPATIC LDLR EXPRESSION WITH ATHEROPROTECTIVE CONSEQUENCESP. Gordts, A. Bartelt, S. Nilsson, W. Annaert, J. Heeren, A. Roebroek10.1016/S1567-5688(10)70391-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8586P325 THE EFFECTS OF HYPOLIPIDEMIC TREATMENT ON LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN PATIENTS WITH MIXED HYPERLIPIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703925/abstract?rss=yesP325 THE EFFECTS OF HYPOLIPIDEMIC TREATMENT ON LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN PATIENTS WITH MIXED HYPERLIPIDEMIAA.P. Agouridis, P.S. Kazakou, T.D. Filippatos, C.C. Tellis, M.S. Elisaf, A.D. Tselepis10.1016/S1567-5688(10)70392-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8686P326 DETERMINATION OF VLDL CHOLESTEROL: IS THERE ANYTHING BETTER THAN THE FRIEDEWALD TERM?http://www.atherosclerosis-supplements.com/article/PIIS1567568810703937/abstract?rss=yesP326 DETERMINATION OF VLDL CHOLESTEROL: IS THERE ANYTHING BETTER THAN THE FRIEDEWALD TERM?M. Vossen, E. Vettorazzi, K. Wegscheider, A. Laatsch10.1016/S1567-5688(10)70393-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8686P327 THE INHIBITION OF UBIQUITIN-PROTEASOME-DEPENDENT DEGRADATION OF ABCA1 AND ABCG1 ENHANCES REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VITRO AND IN VIVOhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703949/abstract?rss=yesP327 THE INHIBITION OF UBIQUITIN-PROTEASOME-DEPENDENT DEGRADATION OF ABCA1 AND ABCG1 ENHANCES REVERSE CHOLESTEROL TRANSPORT FROM MACROPHAGES IN VITRO AND IN VIVOM. Ogura, M. Ayaori, H. Kondo, K. Ikewaki10.1016/S1567-5688(10)70394-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8686P328 APOE*3LEIDEN.CETP TRANSGENIC MICE AS MODEL FOR THE METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703950/abstract?rss=yesP328 APOE*3LEIDEN.CETP TRANSGENIC MICE AS MODEL FOR THE METABOLIC SYNDROMEJ.W.A. van der Hoorn, A.M. van den Hoek, A.C. Maas, R.M. van den Hoogen, A. van Nieuwkoop, E.O. Offerman, L.M. Havekes, H.M. Princen10.1016/S1567-5688(10)70395-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8686P329 HIGH SERUM LIPOPROTEIN(a) IS MORE STRONGLY ASSOCIATED WITH PERIPHERAL ARTERIAL DISEASE THAN WITH STABLE CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703962/abstract?rss=yesP329 HIGH SERUM LIPOPROTEIN(a) IS MORE STRONGLY ASSOCIATED WITH PERIPHERAL ARTERIAL DISEASE THAN WITH STABLE CORONARY ARTERY DISEASEA. Vonbank, C.H. Saely, P. Rein, S. Beer, H. Drexel10.1016/S1567-5688(10)70396-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8787P330 AN apoJ DECAPEPTIDE REGULATES MONOCYTE ADHESION TO ENDOTHELIAL CELL MONOLAYERShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703974/abstract?rss=yesP330 AN apoJ DECAPEPTIDE REGULATES MONOCYTE ADHESION TO ENDOTHELIAL CELL MONOLAYERSK. Navab, L. Vakili, S. Safarpoor, N. Kamranpour, O. Elboudwarej, M. Garife, S. Hama, G. Hough10.1016/S1567-5688(10)70397-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8787P331 ANGIOPOIETIN-LIKE PROTEIN 4 (Angptl4) SERUM LEVELS ARE INVERSELY CORRELATED WITH OBESITY IN YOUNG ADULTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703986/abstract?rss=yesP331 ANGIOPOIETIN-LIKE PROTEIN 4 (Angptl4) SERUM LEVELS ARE INVERSELY CORRELATED WITH OBESITY IN YOUNG ADULTSM.R. Robciuc, K.H. Pietiläinen, N. Lundbom, A. Hakkarainen, J. Kaprio, A. Rissanen, M. Jauhiainen, C. Ehnholm10.1016/S1567-5688(10)70398-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8787P332 LESS ATHEROGENIC PROFILE OF TRIGLYCERIDES-RICH LIPOPROTEINS AFTER EZETIMIBE IN TYPE 2 DIABETIC PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810703998/abstract?rss=yesP332 LESS ATHEROGENIC PROFILE OF TRIGLYCERIDES-RICH LIPOPROTEINS AFTER EZETIMIBE IN TYPE 2 DIABETIC PATIENTSL. Bozzetto, G. Annuzzi, G. Della Corte, L. Patti, P. Cipriano, A. Strazzullo, L. Di Capua, G. Riccardi, A.A. Rivellese10.1016/S1567-5688(10)70399-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8787P333 DIETARY FATTY ACIDS INFLUENCE ENDOTHELIAL FUNCTION DURING ACUTE NEFA ELEVATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704001/abstract?rss=yesP333 DIETARY FATTY ACIDS INFLUENCE ENDOTHELIAL FUNCTION DURING ACUTE NEFA ELEVATIONA. Thompson, K. Newens, K. Jackson, C. Williams10.1016/S1567-5688(10)70400-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8787P334 HIV INFECTION INDUCES MAJOR CHANGES IN HDL PARTICLE SIZE DISTRIBUTION AND COMPOSITION: THE EFFECT OF ANTIRETROVIRAL TREATMENT AND DISEASE SEVERITYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704013/abstract?rss=yesP334 HIV INFECTION INDUCES MAJOR CHANGES IN HDL PARTICLE SIZE DISTRIBUTION AND COMPOSITION: THE EFFECT OF ANTIRETROVIRAL TREATMENT AND DISEASE SEVERITYG. Aragones, R. Beltrán-Debón, A. Rull, L. Fernández-Sender, J. Camps, J. Joven, C. Alonso-Villaverde10.1016/S1567-5688(10)70401-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8788P335 SMALL-DENSE LDL IS A BETTER DETERMINANT OF PLASMA GLYCATED APOLIPOPROTEIN B THAN GLYCAEMIA IN METABOLIC SYNDROME AND TYPE 2 DIABETIC PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704025/abstract?rss=yesP335 SMALL-DENSE LDL IS A BETTER DETERMINANT OF PLASMA GLYCATED APOLIPOPROTEIN B THAN GLYCAEMIA IN METABOLIC SYNDROME AND TYPE 2 DIABETIC PATIENTSN. Younis, R. Sharma, H. Soran, V. Charlton-Menys, M. Elseweidy, P. Durrington10.1016/S1567-5688(10)70402-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8888P336 ABNORMAL LPL RELEASE LEADS TO CHYLOMICRONEMIA IN THE PRESENCE OF GPIHBP1 DEFECTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704037/abstract?rss=yesP336 ABNORMAL LPL RELEASE LEADS TO CHYLOMICRONEMIA IN THE PRESENCE OF GPIHBP1 DEFECTSB.J. Arsenault, A.P. Beigneux, F. Peelman, R. Franssen, J. Hertecant, S.G. Young, G.M. Dallinga-Thie10.1016/S1567-5688(10)70403-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8888P337 FEATURES OF THE INTIMAL-MEDIAL THICKNESS AND ENDOTHELIAL FUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE & THE METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704049/abstract?rss=yesP337 FEATURES OF THE INTIMAL-MEDIAL THICKNESS AND ENDOTHELIAL FUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE & THE METABOLIC SYNDROMEK. Yanovska10.1016/S1567-5688(10)70404-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8888P338 INTERACTIONS OF APOLIPOPROTEIN A-I MUTANTS WITH ENDOTHELIAL CELLShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704050/abstract?rss=yesP338 INTERACTIONS OF APOLIPOPROTEIN A-I MUTANTS WITH ENDOTHELIAL CELLSP. Ohnsorg, L. Rohrer, A. Chroni, V. Zannis, A. von Eckardstein10.1016/S1567-5688(10)70405-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8888P339 USEFULNESS OF INTIMA MEDIA THICKNESS, apoB AND NON-HDL-C IN PRIMARY DISLIPIDEMIC CHILDRENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704062/abstract?rss=yesP339 USEFULNESS OF INTIMA MEDIA THICKNESS, apoB AND NON-HDL-C IN PRIMARY DISLIPIDEMIC CHILDRENV. Baracco, F. Abello, O. Guardamagna10.1016/S1567-5688(10)70406-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8889P340 INFLUENCE OF BODY FAT DISTRIBUTION, DIET AND EXERCISE ON THE FORMATION OF NITROTYROSINE IN THE HEART OF RATShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704074/abstract?rss=yesP340 INFLUENCE OF BODY FAT DISTRIBUTION, DIET AND EXERCISE ON THE FORMATION OF NITROTYROSINE IN THE HEART OF RATSC. Rodrigues Fernandes, K.M.A. Mata, F.M. Mauad, F.T.T. Frajacomo, A.P. Farnesi, V.K. Cardoso, T. Marini, J.E. Junior, S.A. Uyemura, S.G. Ramos, S.B. Garcia10.1016/S1567-5688(10)70407-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8989P341 EFFECT OF APOCIII SSTI POLYMORPHISM IN POSTPRANDIAL RESPONSE TO A FAT OVERLOAD IN METABOLIC SYNDROME PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704086/abstract?rss=yesP341 EFFECT OF APOCIII SSTI POLYMORPHISM IN POSTPRANDIAL RESPONSE TO A FAT OVERLOAD IN METABOLIC SYNDROME PATIENTSM. Clemente-Postigo, M. Queipo-Ortuño, F.J. Tinahones, F. Cardona10.1016/S1567-5688(10)70408-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8989P342 COMMON GENETIC VARIATION IN APOA5, LEVELS OF TRIGLYCERIDES AND RISK OF MYOCARDIAL INFARCTION IN THE GENERAL POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704098/abstract?rss=yesP342 COMMON GENETIC VARIATION IN APOA5, LEVELS OF TRIGLYCERIDES AND RISK OF MYOCARDIAL INFARCTION IN THE GENERAL POPULATIONA. Berg Jørgensen, R. Frikke-Schmidt, P. Grande, B.G. Nordestgaard, A. Tybjærg-Hansen10.1016/S1567-5688(10)70409-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8989P343 FATTY ACIDS DERIVATIVES BY LIPID PEROXIDATION ARE SIGNIFICANTLY INCREASED IN PATIENTS WITH HIGH APOLIPOPROTEIN B-48 LEVELS, INDEPENDENT OF TRIGLYCERIDE CONCENTRATIONShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704104/abstract?rss=yesP343 FATTY ACIDS DERIVATIVES BY LIPID PEROXIDATION ARE SIGNIFICANTLY INCREASED IN PATIENTS WITH HIGH APOLIPOPROTEIN B-48 LEVELS, INDEPENDENT OF TRIGLYCERIDE CONCENTRATIONSD. Masuda, H. Nakaoka, R. Kawase, M. Inagaki, M. Yuasa-Kawase, K. Nakatani, K. Tsubakio-Yamamoto, J.C. Sandocal, T. Ohama, Y. Nakagawa-Toyama, M. Nishida, M. Ishigami, N. Ishida, M. Shichiri, Y. Yoshida, I. Komuro, S. Yamashita10.1016/S1567-5688(10)70410-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations8989P344 COMMON GENETIC VARIATION IN APOA1 CONTRIBUTES TO ELEVATED HDL CHOLESTEROL IN THE GENERAL POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704116/abstract?rss=yesP344 COMMON GENETIC VARIATION IN APOA1 CONTRIBUTES TO ELEVATED HDL CHOLESTEROL IN THE GENERAL POPULATIONC.L. Haase, R. Frikke-Schmidt, B.G. Nordestgaard, G. Jensen, A. Tybjærg-Hansen10.1016/S1567-5688(10)70411-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9090P345 THE VALUE OF THE apoB/apoA1 RATIO FOR THE DIAGNOSIS OF INSULIN RESISTANCEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704128/abstract?rss=yesP345 THE VALUE OF THE apoB/apoA1 RATIO FOR THE DIAGNOSIS OF INSULIN RESISTANCEL. Lopez-Rios, J.C. Wiebe, A.M. Wägner, Y. Brito-Casillas, M. Lorenzo-Media, J.A. Aguilar-Doreste, N. Pérez-Martín, R. Chirino, J. Nóvoa, M. Boronat10.1016/S1567-5688(10)70412-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9090P346 APOB48/TG RATIO IS A NOVEL AND USEFUL MARKER FOR THE DETECTION OF TYPE III HYPERLIPIDEMIA AFTER ANTIHYPERLIPIDEMIC INTERVENTIONShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070413X/abstract?rss=yesP346 APOB48/TG RATIO IS A NOVEL AND USEFUL MARKER FOR THE DETECTION OF TYPE III HYPERLIPIDEMIA AFTER ANTIHYPERLIPIDEMIC INTERVENTIONSH. Nakaoka, M. Yuasa-Kawase, D. Masuda, R. Kawase, K. Nakatani, M. Inagaki, J.C. Sandoval, K. Tsubakio-Yamamoto, T. Ohama, Y. Nakagawa-Toyama, M. Nishida, M. Ishigami, I. Komuro, S. Yamashita10.1016/S1567-5688(10)70413-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9090P347 THE GENERATION OF NEW PRE-BETA HDL LIKE PARTICLES – A KEY MECHANISM OF THE ANTI-ATHEROGENIC ACTION OF LIPOSOMES?http://www.atherosclerosis-supplements.com/article/PIIS1567568810704141/abstract?rss=yesP347 THE GENERATION OF NEW PRE-BETA HDL LIKE PARTICLES – A KEY MECHANISM OF THE ANTI-ATHEROGENIC ACTION OF LIPOSOMES?A. Wolska, M. Czyzewska, A. Szutowicz, A. Ćwiklińska, M. Wróblewska10.1016/S1567-5688(10)70414-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9090P348 MOLECULAR DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA (FH) IN GREECE. KNOWN AND NOVEL MUTATIONS IN THE LOW DENSITY LIPOPROTEIN RECEPTOR (LDLR) GENEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704153/abstract?rss=yesP348 MOLECULAR DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA (FH) IN GREECE. KNOWN AND NOVEL MUTATIONS IN THE LOW DENSITY LIPOPROTEIN RECEPTOR (LDLR) GENEV. Mollaki, P. Progias, A. Skouma, E. Drogari10.1016/S1567-5688(10)70415-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9091P349 INCREASED ATHEROSCLEROSIS MARKERS ARE ASSOCIATED WITH HIGHER ACTIVITIES OF PHOSPHOLIPID OR CHOLESTERYL ESTER TRANSFER PROTEINS IN ADULTS WITH HIGH HDL-CHOLESTEROLhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704165/abstract?rss=yesP349 INCREASED ATHEROSCLEROSIS MARKERS ARE ASSOCIATED WITH HIGHER ACTIVITIES OF PHOSPHOLIPID OR CHOLESTERYL ESTER TRANSFER PROTEINS IN ADULTS WITH HIGH HDL-CHOLESTEROLI.F. Espirito Santo, F.D. Santiago, R.T. Nakamura, M. Gidlund, P.M. Cazita, E. Cotta de Faria10.1016/S1567-5688(10)70416-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9191P350 ATHEROSCLEROTIC AND METABOLIC REPERCUSSIONS OF INCREASED PLASMA LEVELS OF OXIDIZED LDL AND ANTIBODIES AGAINST OXIDIZED LDL IN ASYMPTOMATIC ADULTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704177/abstract?rss=yesP350 ATHEROSCLEROTIC AND METABOLIC REPERCUSSIONS OF INCREASED PLASMA LEVELS OF OXIDIZED LDL AND ANTIBODIES AGAINST OXIDIZED LDL IN ASYMPTOMATIC ADULTSF.D. Santiago, P. Moriel, R.O. Correa, R.T. Nakamura, M. Gidlund, R. Schreiber, S. Barros-Mazon, E. Cotta de Faria10.1016/S1567-5688(10)70417-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9191P351 THE SUPPLEMENTATION OF COENZYME Q10 TO A MEDITERRANEAN DIET IMPROVES ANTIOXIDANT SYSTEMS AND REDUCES CELLULAR OXIDATION IN ELDERLY SUBJECTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704189/abstract?rss=yesP351 THE SUPPLEMENTATION OF COENZYME Q10 TO A MEDITERRANEAN DIET IMPROVES ANTIOXIDANT SYSTEMS AND REDUCES CELLULAR OXIDATION IN ELDERLY SUBJECTSN. Delgado-Casado, E.M. Yubero-Serrano, P. Pérez-Martínez, I. Tasset-Cuevas, M. Santos-González, J. Delgado-Lista, A. García-Ríos, C. Marín, F. Fuentes, J.M. Villalba, I. Túnez, F. Pérez-Jiménez, J. López-Miranda10.1016/S1567-5688(10)70418-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9191P352 EFFECTS OF IRON OVERLOAD-INDUCED OXIDATIVE STRESShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704190/abstract?rss=yesP352 EFFECTS OF IRON OVERLOAD-INDUCED OXIDATIVE STRESSH. Arnold, K. Gerken, P. Nielsen, U. Wenzel, R. Böger, E. Schwedhelm10.1016/S1567-5688(10)70419-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9191P353 SPECIFIC OXIDATION OF APOLIPOPROTEIN-B-100 BY MYELOPEROXIDASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704207/abstract?rss=yesP353 SPECIFIC OXIDATION OF APOLIPOPROTEIN-B-100 BY MYELOPEROXIDASEC. Delporte, P. Van Antwerpen, K. Zouaoui Boudjeltia, C. Noyon, D. Calay, F. Reyé, A. Rousseau, M. Raes, M. Vanhaeverbeek, J. Ducobu, J. Nève10.1016/S1567-5688(10)70420-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9192P354 A NOVEL HDL-ASSOCIATED PROTEIN, PROGRANULIN, IS INVOLVED IN LIPID METABOLISM AND MACROPHAGE RECRUITMENT INTO ADIPOSE TISSUEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704219/abstract?rss=yesP354 A NOVEL HDL-ASSOCIATED PROTEIN, PROGRANULIN, IS INVOLVED IN LIPID METABOLISM AND MACROPHAGE RECRUITMENT INTO ADIPOSE TISSUESR. Kawase, T. Ohama, A. Matsuyama, H. Okura, T. Matsuwaki, M. Yuasa-Kawase, K. Nakatani, M. Inagaki, J.C. Sandoval, K. Tsubakio-Yamamoto, D. Masuda, Y. Nakagawa-Toyama, M. Nishida, M. Ishigami, Y. Ohmoto, M. Nishihara, I. Komuro, S. Yamashita10.1016/S1567-5688(10)70421-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9292P355 THE EFFECTIVENESS OF EZETIMIBE PLUS PRAVASTATIN FOR HYPERCHOLESTEROLEMIC PATIENTS WITH POSTPRANDIAL HYPERLIPIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704220/abstract?rss=yesP355 THE EFFECTIVENESS OF EZETIMIBE PLUS PRAVASTATIN FOR HYPERCHOLESTEROLEMIC PATIENTS WITH POSTPRANDIAL HYPERLIPIDEMIAY. Sawayama, H. Ohnishi, T. Koga, M. Kainuma, N. Furusyo, J. Hayashi10.1016/S1567-5688(10)70422-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9292P356 CHOLESTEROL LOADING INDUCES SMOOTH MUSCLE CELLS TRANSDIFFERENTIATION TO MACROPHAGE-LIKE CELLShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704232/abstract?rss=yesP356 CHOLESTEROL LOADING INDUCES SMOOTH MUSCLE CELLS TRANSDIFFERENTIATION TO MACROPHAGE-LIKE CELLSA. Bonomo, M. Canavesi, I. Giunzioni, C. Anelli, A. Corsini, S. Bellosta10.1016/S1567-5688(10)70423-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9292P357 LOW LEVELS OF CIRCULATING SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS IN PATIENTS WITH DEGENERATIVE AORTIC VALVE STENOSIS AND CARDIOVASCULAR CALCIFICATIONShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704244/abstract?rss=yesP357 LOW LEVELS OF CIRCULATING SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END-PRODUCTS IN PATIENTS WITH DEGENERATIVE AORTIC VALVE STENOSIS AND CARDIOVASCULAR CALCIFICATIONSA. Mazzone, A.I. Corciu, A. Vianello, S. Del Turco, I. Foffa, T. Navarra, D. Chiappino, S. Berti, G. Basta10.1016/S1567-5688(10)70424-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9292P358 CHANGES IN PROTEASOMAL ACTIVITY AT MODELING OF CHOLESTEROL-INDUCED ATHEROSCLEROSIS: QUERCETIN INFLUENCEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704256/abstract?rss=yesP358 CHANGES IN PROTEASOMAL ACTIVITY AT MODELING OF CHOLESTEROL-INDUCED ATHEROSCLEROSIS: QUERCETIN INFLUENCED. Pashevin, L. Tumanovskaya, V. Dosenko, A. Moibenko10.1016/S1567-5688(10)70425-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9393P359 LENTIVIRAL OVEREXPRESSION OF HYALURONIC ACID SYNTHASES 1 AND 2 RESTORES ESTRADIOL-MEDIATED INHIBITION OF PDGF-INDUCED PROLIFERATION IN VASCULAR SMOOTH MUSCLE CELLShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704268/abstract?rss=yesP359 LENTIVIRAL OVEREXPRESSION OF HYALURONIC ACID SYNTHASES 1 AND 2 RESTORES ESTRADIOL-MEDIATED INHIBITION OF PDGF-INDUCED PROLIFERATION IN VASCULAR SMOOTH MUSCLE CELLST. Freudenberger, G. Dai, P. Mayer, H.-K. Heim, J.W. Fischer10.1016/S1567-5688(10)70426-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9393P360 THE EFFECTS OF MYOCYTE ENHANCER FACTOR 2A GENE ON PROLIFERATION, MIGRATION AND PHENOTYPE OF VASCULAR SMOOTH MUSCLE CELLShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070427X/abstract?rss=yesP360 THE EFFECTS OF MYOCYTE ENHANCER FACTOR 2A GENE ON PROLIFERATION, MIGRATION AND PHENOTYPE OF VASCULAR SMOOTH MUSCLE CELLSW. Zhao, S.-P. Zhao, P.-C. Wu, D.-Q. Peng10.1016/S1567-5688(10)70427-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9393P361 THE CELLULAR THIOL REDOX STATE DETERMINES MONOCYTE RESPONSIVENESS TO CHEMOATTRACTANTS AND REGULATES MACROPHAGE RECRUITMENT INTO ATHEROSCLEROTIC LESIONShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704281/abstract?rss=yesP361 THE CELLULAR THIOL REDOX STATE DETERMINES MONOCYTE RESPONSIVENESS TO CHEMOATTRACTANTS AND REGULATES MACROPHAGE RECRUITMENT INTO ATHEROSCLEROTIC LESIONSQ. Zhao, S. Ullevig, R. Asmis10.1016/S1567-5688(10)70428-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9393P362 HYPOXIA UP-REGULATES FIBULIN-5 IN ENDOTHELIAL CELLS THROUGH A HIF-1 DEPENDENT MECHANISMhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704293/abstract?rss=yesP362 HYPOXIA UP-REGULATES FIBULIN-5 IN ENDOTHELIAL CELLS THROUGH A HIF-1 DEPENDENT MECHANISMA. Guadall, R. Rodríguez-Calvo, R. Aledo, O. Calvayrac, J. Martínez-González, C. Rodríguez10.1016/S1567-5688(10)70429-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9394P363 LDL UP-REGULATES CCL20 IN HUMAN VASCULAR SMOOTH MUSCLE CELLS THROUGH A NF-úB DEPENDENT MECHANISMhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070430X/abstract?rss=yesP363 LDL UP-REGULATES CCL20 IN HUMAN VASCULAR SMOOTH MUSCLE CELLS THROUGH A NF-úB DEPENDENT MECHANISMO. Calvayrac, R. Rodríguez-Calvo, M. Gentile, A. Guadall, C. Rodríguez, J. Martínez-González10.1016/S1567-5688(10)70430-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9494P364 OXIDIZED LDL EXPOSURE DECREASES KR ÜPPEL-LIKE FACTOR 2 EXPRESSION AND INCREASES PRO-INFLAMMATORY CAPACITY OF M2 MACROPHAGEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704311/abstract?rss=yesP364 OXIDIZED LDL EXPOSURE DECREASES KR ÜPPEL-LIKE FACTOR 2 EXPRESSION AND INCREASES PRO-INFLAMMATORY CAPACITY OF M2 MACROPHAGESB. van Tits, R. Stienstra, M. Netea, L. Joosten, A. Stalenhoef10.1016/S1567-5688(10)70431-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9494P365 NPY RECEPTORS ON T-REGULATORY CELLS DERIVED FROM CAROTID PLAQUES OF SYMPTOMATIC AND ASYMPTOMATIC PATIENTS WITH CAROTID STENOSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704323/abstract?rss=yesP365 NPY RECEPTORS ON T-REGULATORY CELLS DERIVED FROM CAROTID PLAQUES OF SYMPTOMATIC AND ASYMPTOMATIC PATIENTS WITH CAROTID STENOSISD. Agrawal, D. Pankajakshan, G. Jia, Z. Shao, I. Pipinos10.1016/S1567-5688(10)70432-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9494P366 RhoA AND TCTA – A “BACK-TO-BACK” PROMOTER SYSTEMhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704335/abstract?rss=yesP366 RhoA AND TCTA – A “BACK-TO-BACK” PROMOTER SYSTEMB. Schröer, R.-G. Telgmann, F. Bruns, E. Brand, S.-M. Brand-Herrmann10.1016/S1567-5688(10)70433-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9494P367 LDL INCREASES VASCULAR ETB2 RECEPTOR EXPRESSION VIA ACTIVATION OF ERK1/2 AND P38 MAPK PATHWAYShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704347/abstract?rss=yesP367 LDL INCREASES VASCULAR ETB2 RECEPTOR EXPRESSION VIA ACTIVATION OF ERK1/2 AND P38 MAPK PATHWAYSY. Zhang, J.-P. Zheng, W. Zhang, L. Edvinsson, C.-B. Xu10.1016/S1567-5688(10)70434-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9495P368 PROFILING OF MICRORNAS FOLLOWING VASCULAR INJURY IN ApoE−/− MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704359/abstract?rss=yesP368 PROFILING OF MICRORNAS FOLLOWING VASCULAR INJURY IN ApoE−/− MICEM. Nazari Jahantigh, C. Weber, A. Schober10.1016/S1567-5688(10)70435-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9595P369 HYPERCHOLESTEROLEMIA (HC) ABROGATES THE CONCENTRATION-DEPENDENT BIPHASIC EFFECT OF ANGIOTENSIN (ANG II) ON ENDOGENOUS CHOLESTEROL SYNTHESIS IN HUMAN MONOCYTEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704360/abstract?rss=yesP369 HYPERCHOLESTEROLEMIA (HC) ABROGATES THE CONCENTRATION-DEPENDENT BIPHASIC EFFECT OF ANGIOTENSIN (ANG II) ON ENDOGENOUS CHOLESTEROL SYNTHESIS IN HUMAN MONOCYTESG. Fóris, Z. Sarang, I. Seres, G. Kónya, G. Paragh10.1016/S1567-5688(10)70436-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9595P370 EVIDENCE FOR INFILTRATION OF NEUTROPHIL GRANULOCYTES IN PLAQUES OF UNSTABLE CAROTID ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704372/abstract?rss=yesP370 EVIDENCE FOR INFILTRATION OF NEUTROPHIL GRANULOCYTES IN PLAQUES OF UNSTABLE CAROTID ARTERY DISEASEB. Dorweiler, M. Torzewski, M. Dahm, C. Kirkpatrick, K. Lackner, C. Vahl10.1016/S1567-5688(10)70437-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9595P371 RELATIONSHIP BETWEEN CD59 POSITIVE PERIPHERAL MONONUCLEAR CELLS AND HDL-CHOLESTEROL LEVELS IN PATIENTS WITH PROGRESSING ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704384/abstract?rss=yesP371 RELATIONSHIP BETWEEN CD59 POSITIVE PERIPHERAL MONONUCLEAR CELLS AND HDL-CHOLESTEROL LEVELS IN PATIENTS WITH PROGRESSING ATHEROSCLEROSISV. Gurevich, L. Vasina, A. Lugovaya, N. Petrischev10.1016/S1567-5688(10)70438-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9595P372 PROTEOMIC ANALYSIS OF HUMAN ATHEROSCLEROTIC CORONARY INTIMA REVEALS NOVEL POTENTIAL BIOMARKERS IN HUMAN ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704396/abstract?rss=yesP372 PROTEOMIC ANALYSIS OF HUMAN ATHEROSCLEROTIC CORONARY INTIMA REVEALS NOVEL POTENTIAL BIOMARKERS IN HUMAN ATHEROSCLEROSISF. de la Cuesta, G. Alvarez-Llamas, I. Zubiri, A.S. Maroto, A. Donado, L.R. Padial, A.G. Pinto, M.G. Barderas, F. Vivanco10.1016/S1567-5688(10)70439-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9595P373 PROTEOMIC CHARACTERIZATION OF EXTRACELLULAR ENVIRONMENT COMPONENTS REVEALS NOVEL PROTEINS IN THE HUMAN AORTAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704402/abstract?rss=yesP373 PROTEOMIC CHARACTERIZATION OF EXTRACELLULAR ENVIRONMENT COMPONENTS REVEALS NOVEL PROTEINS IN THE HUMAN AORTAA. Didangelos, K. Mandall, M. Jahangiri, M. Mayr10.1016/S1567-5688(10)70440-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9696P374 EPIGENETIC MODIFICATIONS IN HUMAN CAROTID ATHEROMATOUS PLAQUEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704414/abstract?rss=yesP374 EPIGENETIC MODIFICATIONS IN HUMAN CAROTID ATHEROMATOUS PLAQUESC. Kroupis, S. Georgopoulos, N. Poumpouridou, S.C. Oliveira, I. Chatziioannidou, A. Dionyssiou-Asteriou10.1016/S1567-5688(10)70441-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9696P375 MONOCYTIC NOX4, A NOVEL SOURCE OF INTRACELLULAR ROS, LOCALIZES TO REDOX SIGNALING COMPLEXES AND IS REQUIRED FOR OxLDL-INDUCED MACROPHAGE DEATHhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704426/abstract?rss=yesP375 MONOCYTIC NOX4, A NOVEL SOURCE OF INTRACELLULAR ROS, LOCALIZES TO REDOX SIGNALING COMPLEXES AND IS REQUIRED FOR OxLDL-INDUCED MACROPHAGE DEATHC.F. Lee, R. Asmis10.1016/S1567-5688(10)70442-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9696P376 VASCULAR ENDOTHELIAL GROWTH FACTOR INDUCES EXPRESSION OF POLY(ADP-RIBOSE)-POLYMERASE AND INHIBITOR OF CASPASE-ACTIVATED DEOXYRIBONUCLEASE IN ENDOTHELIAL CELLS: A NOVEL ANTI-APOPTOTIC MECHANISMhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704438/abstract?rss=yesP376 VASCULAR ENDOTHELIAL GROWTH FACTOR INDUCES EXPRESSION OF POLY(ADP-RIBOSE)-POLYMERASE AND INHIBITOR OF CASPASE-ACTIVATED DEOXYRIBONUCLEASE IN ENDOTHELIAL CELLS: A NOVEL ANTI-APOPTOTIC MECHANISMN. Al-Fakhri, M. Hörmann, L. Mey, Z. Kharip, K. Nemeth, H. Renz, M. Heidt10.1016/S1567-5688(10)70443-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9696P377 ROLE OF GROWTH-DIFFERENTIATION FACTOR 15 (GDF-15) IN A MOUSE-MODEL OF ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070444X/abstract?rss=yesP377 ROLE OF GROWTH-DIFFERENTIATION FACTOR 15 (GDF-15) IN A MOUSE-MODEL OF ATHEROSCLEROSISG.A. Bonaterra, J. Thogersen, S. Zügel, G. Bendner, S. Vorwald, J. Fey, U. Traut, J. Strelau, R. Kinscherf10.1016/S1567-5688(10)70444-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9697P378 RESVERATROL REVERSES eNOS UNCOUPLING: IMPLICATION OF SIRT1http://www.atherosclerosis-supplements.com/article/PIIS1567568810704451/abstract?rss=yesP378 RESVERATROL REVERSES eNOS UNCOUPLING: IMPLICATION OF SIRT1H. Li, N. Xia, A. Daiber, A. Habermeier, G. Spanier, Q. Lu, M. Oelze, E. Closs, T. Münzel, U. Förstermann10.1016/S1567-5688(10)70445-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9797P379 SHORT-TERM INGESTION OF PURPLE GRAPE EXTRACT IMPROVES ARTERIAL ELASTICITY INDEXES IN PATIENTS WITH POSTINFARCTION CHRONIC HEART FAILUREhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704463/abstract?rss=yesP379 SHORT-TERM INGESTION OF PURPLE GRAPE EXTRACT IMPROVES ARTERIAL ELASTICITY INDEXES IN PATIENTS WITH POSTINFARCTION CHRONIC HEART FAILUREE. Vataman, N. Ciobanu, A. Grivenco, N. Ostapciuc10.1016/S1567-5688(10)70446-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9797P380 PENTRAXIN 3 (PTX3), A NOVEL CARDIOVASCULAR BIOMARKER, IS EXPRESSED IN VASCULAR SPECIMENS OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD)http://www.atherosclerosis-supplements.com/article/PIIS1567568810704475/abstract?rss=yesP380 PENTRAXIN 3 (PTX3), A NOVEL CARDIOVASCULAR BIOMARKER, IS EXPRESSED IN VASCULAR SPECIMENS OF PATIENTS WITH CORONARY ARTERY DISEASE (CAD)I. Hollan, M. Nebuloni, B. Bottazzi, K. Mikkelsen, Ø. Førre, P.L. Meroni10.1016/S1567-5688(10)70447-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9797P381 DIRECT INVESTIGATION OF BIVALENT MANGANESE IN ATHEROSCLEROTIC PLAQUE BY MEANS OF HIGH-FREQUENCY ELECTRON PARAMAGNETIC RESONANCE SPECTROSCOPYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704487/abstract?rss=yesP381 DIRECT INVESTIGATION OF BIVALENT MANGANESE IN ATHEROSCLEROTIC PLAQUE BY MEANS OF HIGH-FREQUENCY ELECTRON PARAMAGNETIC RESONANCE SPECTROSCOPYA. Galyavich, G. Mamin, E. Kovaleva, S. Orlinskii, V. Putliaev, M. Salakhov, N. Silkin, R. Khairullin, Y. Chelyshev10.1016/S1567-5688(10)70448-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9797P382 THE IMPACT OF CIGARETTE SMOKE ON THE ADHESION PROPERTIES OF HUMAN MONOCYTES TO ENDOTHELIAL CELLS IN VITROhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704499/abstract?rss=yesP382 THE IMPACT OF CIGARETTE SMOKE ON THE ADHESION PROPERTIES OF HUMAN MONOCYTES TO ENDOTHELIAL CELLS IN VITROM. Lietz, C. Berger, H.-P. Lammerich, Y. Steffen, K. Stolle, S. Lebrun, J. Schueller, T. Wallerath10.1016/S1567-5688(10)70449-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9798P383 RAPID INCREASE OF THE NOS INHIBITOR ASYMMETRIC DIMETHYLARGININE (ADMA) IN ERYTHROCYTE LYSATES DUE TO PROTEOLYSIS OF ADMA-CONTAINING PROTEINShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704505/abstract?rss=yesP383 RAPID INCREASE OF THE NOS INHIBITOR ASYMMETRIC DIMETHYLARGININE (ADMA) IN ERYTHROCYTE LYSATES DUE TO PROTEOLYSIS OF ADMA-CONTAINING PROTEINSM. Davids, A. van Hell, T. Teerlink10.1016/S1567-5688(10)70450-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9898P384 THE AROMATASE GENE EXPRESSION IN STROMAL VASCULAR FRACTION CELLS (SVF) OF HUMAN SUBCUTANEOUS VERSUS ABDOMINAL ADIPOSE TISSUEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704517/abstract?rss=yesP384 THE AROMATASE GENE EXPRESSION IN STROMAL VASCULAR FRACTION CELLS (SVF) OF HUMAN SUBCUTANEOUS VERSUS ABDOMINAL ADIPOSE TISSUEA. Dembinska-Kiec, B. Kiec-Wilk, B. Nowak-Zapala, W. Dudek, U. Czech, U. Razny10.1016/S1567-5688(10)70451-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9898P385 CHLOROGENIC ACID ATTENUATES ADHESION MOLECULES UPREGULATION IN IL-1βTREATED HUVECShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704529/abstract?rss=yesP385 CHLOROGENIC ACID ATTENUATES ADHESION MOLECULES UPREGULATION IN IL-1βTREATED HUVECSW.-C. Chang, C.-H. Chen, Y.-M. Yu10.1016/S1567-5688(10)70452-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9898P386 CARTILAGE OLIGOMERIC MATRIX PROTEIN (COMP) PREVENTS VASCULAR SMOOTH MUSCLE CELL CALCIFICATION IN VITRO AND IN VIVOhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704530/abstract?rss=yesP386 CARTILAGE OLIGOMERIC MATRIX PROTEIN (COMP) PREVENTS VASCULAR SMOOTH MUSCLE CELL CALCIFICATION IN VITRO AND IN VIVOW. Kong, Y. Du, Y. Wang, L. Wang, C. Tang, X. Wang10.1016/S1567-5688(10)70453-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9898P387 MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) IS A BIOLOGICAL MARKER FOR VASCULAR INFLAMMATION INDUCED BY ENVIRONMENTAL TOXICANTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704542/abstract?rss=yesP387 MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) IS A BIOLOGICAL MARKER FOR VASCULAR INFLAMMATION INDUCED BY ENVIRONMENTAL TOXICANTSB. Hennig, Z. Majkova, M. Toborek10.1016/S1567-5688(10)70454-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9899P388 EXPRESSION OF VARIOUS ISOFORMS OF GLUTATHIONE PEROXIDASE IN THE AORTA OF GPX-1−/− ApoE−/− MICE DURING ATHEROSCLEROTIC LESION DEVELOPMENThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704554/abstract?rss=yesP388 EXPRESSION OF VARIOUS ISOFORMS OF GLUTATHIONE PEROXIDASE IN THE AORTA OF GPX-1−/− ApoE−/− MICE DURING ATHEROSCLEROTIC LESION DEVELOPMENTF. Cheng, M. Torzewski, A. Degreif, J. Almering, F. Haeuser, H. Rossmann, K.J. Lackner10.1016/S1567-5688(10)70455-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9999P389 ANALYSIS OF ARACHIDONIC ACID METABOLITES AFTER INFLAMMATORIC ACTIVATION OF PRIMARY HUMAN MONOCYTES BY HYBRID QTRAP MASS SPECTROMETRYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704566/abstract?rss=yesP389 ANALYSIS OF ARACHIDONIC ACID METABOLITES AFTER INFLAMMATORIC ACTIVATION OF PRIMARY HUMAN MONOCYTES BY HYBRID QTRAP MASS SPECTROMETRYM. Brügel, L. Kortz, S. Hausschildt, G.M. Fiedler, J. Thiery, U. Ceglarek10.1016/S1567-5688(10)70456-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9999P390 MITOCHONDRIAL INDEPENDENT APOPTOSIS IS STIMULATED IN MONONUCLEAR CELLS FROM HYPERTRIGLYCERIDEMIC MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704578/abstract?rss=yesP390 MITOCHONDRIAL INDEPENDENT APOPTOSIS IS STIMULATED IN MONONUCLEAR CELLS FROM HYPERTRIGLYCERIDEMIC MICEH. Oliveira, L. Alberici, K. Zecchin, B. Paim, S. Mirandola, R. Castilho, A. Vercesi10.1016/S1567-5688(10)70457-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9999P391 OSTEOPONTIN GENE VARIATION AND CARDIO/CEREBROVASCULAR DISEASE PHENOTYPEShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070458X/abstract?rss=yesP391 OSTEOPONTIN GENE VARIATION AND CARDIO/CEREBROVASCULAR DISEASE PHENOTYPESB. Schmitz, K. Schmidt-Petersen, E. Brand, R. Telgmann, V. Nicaud, C. Hagedorn, J. Labreuche, C. Dördelmann, A. Elbaz, M. Gautier-Bertrand, J. Fischer, A. Evans, C. Morrison, D. Arveiler, M. Stoll, P. Amarenco, F. Cambien, M. Paul, S.-M. Brand-Herrmann10.1016/S1567-5688(10)70458-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations9999P392 INTERACTION OF PLATELET-DERIVED MICROPARTICLES WITH PLASMA LIPOPROTEINS. EFFECT ON PLATELET ACTIVATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704591/abstract?rss=yesP392 INTERACTION OF PLATELET-DERIVED MICROPARTICLES WITH PLASMA LIPOPROTEINS. EFFECT ON PLATELET ACTIVATIONA. Dimitriou, J. Mitsios, A. Tselepis10.1016/S1567-5688(10)70459-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations99100P393 EFFECT OF ACUTE INFLAMMATION ON RESPONSE OF BETA-2 ADRENOCEPTORS OF RAT KNEE JOINT VESSELS DECREASED IN PRESENCE OF DIABETEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704608/abstract?rss=yesP393 EFFECT OF ACUTE INFLAMMATION ON RESPONSE OF BETA-2 ADRENOCEPTORS OF RAT KNEE JOINT VESSELS DECREASED IN PRESENCE OF DIABETESS. Hajizadeh10.1016/S1567-5688(10)70460-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations100100P394 REACTIVE OXYGEN SPECIES, VIA MITOCHONDRIAL KATP CHANNELS, ACTIVATE PRO-SURVIVAL PATHWAY IN PRAVASTATIN-INDUCED CARDIOPROTECTIONhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070461X/abstract?rss=yesP394 REACTIVE OXYGEN SPECIES, VIA MITOCHONDRIAL KATP CHANNELS, ACTIVATE PRO-SURVIVAL PATHWAY IN PRAVASTATIN-INDUCED CARDIOPROTECTIONT. Saikawa, L. Cong Thuc, Y. Teshima, N. Takahashi, Y. Nagano-Torigoe, K. Ezaki, K. Yufu, M. Nakagawa, M. Hara10.1016/S1567-5688(10)70461-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations100100P395 AUGMENTED ANGIOGENESIS IN ADVENTITIA PROMOTES PLAQUE FORMATION IN ABDOMINAL AORTA OF APOLIPOPROTEIN E-DEFICIENT MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704621/abstract?rss=yesP395 AUGMENTED ANGIOGENESIS IN ADVENTITIA PROMOTES PLAQUE FORMATION IN ABDOMINAL AORTA OF APOLIPOPROTEIN E-DEFICIENT MICEK. Tanaka, D. Nagata, Y. Hirata, Y. Tabata, R. Nagai, M. Sata10.1016/S1567-5688(10)70462-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations100100P396 ATHEROPROTECTIVE EFFECTS OF SIMVASTATIN, TELMISARTAN AND RESVERATROL: INHIBITION OF MONOCYTE ADHESION TO ENDOTHELIUM EXPOSED TO NON-UNIFORM SHEAR-STRESS AND TNF-αhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704633/abstract?rss=yesP396 ATHEROPROTECTIVE EFFECTS OF SIMVASTATIN, TELMISARTAN AND RESVERATROL: INHIBITION OF MONOCYTE ADHESION TO ENDOTHELIUM EXPOSED TO NON-UNIFORM SHEAR-STRESS AND TNF-αK. Urschel, I. Cicha, W.G. Daniel, C.D. Garlichs10.1016/S1567-5688(10)70463-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations100100P397 NEUTROPHIL IL-1R AND CHEMOKINE EXPRESSION FOLLOWING IN VIVO EXTRAVASATION IN PATIENTS WITH CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704645/abstract?rss=yesP397 NEUTROPHIL IL-1R AND CHEMOKINE EXPRESSION FOLLOWING IN VIVO EXTRAVASATION IN PATIENTS WITH CORONARY ARTERY DISEASEJ. Paulsson, A. Moshfegh, E. Dadfar, A. Bygdén-Nylander, C. Held, S. Jacobson, J. Lundahl10.1016/S1567-5688(10)70464-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations100101P398 EXPRESSION OF INFLAMMATION-RELATED GENES IN HUMAN ATHEROSCLEROTIC PLAQUEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704657/abstract?rss=yesP398 EXPRESSION OF INFLAMMATION-RELATED GENES IN HUMAN ATHEROSCLEROTIC PLAQUESM.D. Di Taranto, A. Morgante, U.M. Bracale, L. Del Guercio, F. Carbone, F.P. D'Armiento, M. Porcellini, G. Bracale, F. Salvatore, G. Fortunato10.1016/S1567-5688(10)70465-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations101101P399 LONG-TERM ENDURANCE EXERCISE ATTENUATES THE AGING PROCESS IN CIRCULATING LEUKOCYTEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704669/abstract?rss=yesP399 LONG-TERM ENDURANCE EXERCISE ATTENUATES THE AGING PROCESS IN CIRCULATING LEUKOCYTESC. Werner, T. Fürster, J. Scharhag, M. Böhm, U. Laufs10.1016/S1567-5688(10)70466-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations101101P400 CYTOPROTECTIVE AND ANTIOXIDANT PATHWAYS IN PERIPHERAL BLOOD MONONUCLEAR CELLS ARE REGULATED BY LDL CHOLESTEROL LEVELS IN FAMILIAL HYPERCHOLESTEROLEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704670/abstract?rss=yesP400 CYTOPROTECTIVE AND ANTIOXIDANT PATHWAYS IN PERIPHERAL BLOOD MONONUCLEAR CELLS ARE REGULATED BY LDL CHOLESTEROL LEVELS IN FAMILIAL HYPERCHOLESTEROLEMIAM. Puntoni, F. Bigazzi, F. Sbrana, B. Pennato, T. Sampietro10.1016/S1567-5688(10)70467-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations101101P401 DISTINCT DEFECTS IN COLLAGEN MICRO-ARCHITECTURE UNDERLIE VESSEL WALL FAILURE IN GROWING AORTIC ABDOMINAL ANEURYSMS AND ANEURYSMS IN MARFAN SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704682/abstract?rss=yesP401 DISTINCT DEFECTS IN COLLAGEN MICRO-ARCHITECTURE UNDERLIE VESSEL WALL FAILURE IN GROWING AORTIC ABDOMINAL ANEURYSMS AND ANEURYSMS IN MARFAN SYNDROMEJ.-W.M. Beenakker, J.H.N. Lindeman, B.A. Ashcroft, M. vanEs, N.B.R. Koekkoek, F.A. Prins, J.F. Tielemans, H. Abdul-Hussien, R.A. Bank, T.H. Oosterkamp10.1016/S1567-5688(10)70468-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations101101P402 THE CX3C CHEMOKINE FRACTALKINE AND GPIbα MEDIATE PLATELET TRANSLOCATION ON VON WILLEBRAND FACTOR UNDER PHYSIOLOGIC FLOW CONDITIONShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704694/abstract?rss=yesP402 THE CX3C CHEMOKINE FRACTALKINE AND GPIbα MEDIATE PLATELET TRANSLOCATION ON VON WILLEBRAND FACTOR UNDER PHYSIOLOGIC FLOW CONDITIONSS. Meyer dos Santos, U. Klinkhardt, K. Scholich, K. Kuczka, S. Harder10.1016/S1567-5688(10)70469-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations101102P403 FIBROUS CAP THINNING AND PLAQUE VULNERABILITY AT THE PROXIMAL REGION ARE ASSOCIATED WITH INCREASED LEVELS OF CATHEPSIN Lhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704700/abstract?rss=yesP403 FIBROUS CAP THINNING AND PLAQUE VULNERABILITY AT THE PROXIMAL REGION ARE ASSOCIATED WITH INCREASED LEVELS OF CATHEPSIN LI. Cicha, A. Wörner, K. Urschel, M. Klein, D. Raithel, W.G. Daniel, C.D. Garlichs10.1016/S1567-5688(10)70470-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations102102P404 ENDOTHELIAL PROGENITOR CELLS (EPCS) IN PATIENTS WITH MIXED HYPERLIPIDAEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704712/abstract?rss=yesP404 ENDOTHELIAL PROGENITOR CELLS (EPCS) IN PATIENTS WITH MIXED HYPERLIPIDAEMIAV. Chantzichristos, A. Agouridis, M. Elisaf, A. Tselepis10.1016/S1567-5688(10)70471-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations102102P405 HETEROGENEITY OF HUMAN CULTURED MACROPHAGES IS GROWTH FACTOR-DEPENDENT AND AFFECTS THE EXPRESSION OF GENES RELATED TO CHOLESTEROL EFFLUX AND METABOLISMhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704724/abstract?rss=yesP405 HETEROGENEITY OF HUMAN CULTURED MACROPHAGES IS GROWTH FACTOR-DEPENDENT AND AFFECTS THE EXPRESSION OF GENES RELATED TO CHOLESTEROL EFFLUX AND METABOLISMJ. Lappalainen, N. Yeung, M. Jauhiainen, P.T. Kovanen, M. Lee-Rueckert10.1016/S1567-5688(10)70472-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations102102P406 INCREASED TIMP3 EXPRESSION IN MONOCYTE/MACROPHAGE CELLS PROTECTS FROM ATHEROSCLEROSIS IN MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704736/abstract?rss=yesP406 INCREASED TIMP3 EXPRESSION IN MONOCYTE/MACROPHAGE CELLS PROTECTS FROM ATHEROSCLEROSIS IN MICEV. Casagrande, R. Menghini, M. Cavalera, S. Menini, G. Pugliese, R. Lauro, M. Federici10.1016/S1567-5688(10)70473-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations102102P407 ENDOGLIN EXPRESSION IN ATHEROGENESIS IS NOT RELATED TO EITHER CHOLESTEROL LEVELS OR PLAQUE SIZE IN ApoE/LDLR DOUBLE KNOCKOUT MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704748/abstract?rss=yesP407 ENDOGLIN EXPRESSION IN ATHEROGENESIS IS NOT RELATED TO EITHER CHOLESTEROL LEVELS OR PLAQUE SIZE IN ApoE/LDLR DOUBLE KNOCKOUT MICEL. Vecerova, Z. Strasky, J. Rathouska, M. Slanarova, E. Brcakova, S. Micuda, P. Nachtigal10.1016/S1567-5688(10)70474-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations103103P408 LIVER-SPECIFIC IKK-β ACTIVATION SEVERELY AGGRAVATES ATHEROSCLEROSIS DEVELOPMENT IN APOE*3-LEIDEN MICEhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070475X/abstract?rss=yesP408 LIVER-SPECIFIC IKK-β ACTIVATION SEVERELY AGGRAVATES ATHEROSCLEROSIS DEVELOPMENT IN APOE*3-LEIDEN MICEM.-C. Wong, J.A. van Diepen, L. Hu, B. Guigas, H.C. de Boer, J.A. Romijn, L.M. Havekes, S.E. Shoelson, P.J. Voshol, J.T. Tamsma, P.C.N. Rensen, P.S. Hiemstra, J.F.P. Berbée10.1016/S1567-5688(10)70475-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations103103P409 TWO-PHOTON MICROSCOPIC IMAGING OF PLAQUE-ASSOCIATED NEO-VASCULATURE IN MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704761/abstract?rss=yesP409 TWO-PHOTON MICROSCOPIC IMAGING OF PLAQUE-ASSOCIATED NEO-VASCULATURE IN MICET. Rademakers, K. Douma, T.M. Hackeng, E.A.L. Biessen, M.J. Post, S. Heeneman, M.A.M.J. van Zandvoort10.1016/S1567-5688(10)70476-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations103103P410 DEFICIENCY OF INTERLEUKIN-1 RECEPTOR TYPE I IN NON BONE MARROW-DERIVED CELLS INHIBITS ATHEROSCLEROSIS IN apoE-KNOCKOUT MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704773/abstract?rss=yesP410 DEFICIENCY OF INTERLEUKIN-1 RECEPTOR TYPE I IN NON BONE MARROW-DERIVED CELLS INHIBITS ATHEROSCLEROSIS IN apoE-KNOCKOUT MICES. Shemesh, Y. Kamari, A. Shaish, S. Olteanu, N. Relvy, H. Levkovitz, O. Fingrut, S. Dotan, M. White, E. Voronov, R. Apte, D. Harats10.1016/S1567-5688(10)70477-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations103103P411 GENOMIC DIFFERENCES BETWEEN MOUSE FOAMY AND NON-FOAMY MACROPHAGEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704785/abstract?rss=yesP411 GENOMIC DIFFERENCES BETWEEN MOUSE FOAMY AND NON-FOAMY MACROPHAGESA. Thomas, W. Eijgelaar, M. Daemen, A. Newby10.1016/S1567-5688(10)70478-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations103104P412 PLEIOTROPIC EFFECTS OF ATORVASTATIN AND TGF-β/ENDOGLIN CASCADE IN THE VESSEL WALL OF ApoE/LDLR DOUBLE KNOCKOUT MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704797/abstract?rss=yesP412 PLEIOTROPIC EFFECTS OF ATORVASTATIN AND TGF-β/ENDOGLIN CASCADE IN THE VESSEL WALL OF ApoE/LDLR DOUBLE KNOCKOUT MICEZ. Strasky, L. Vecerova, M. Slanarova, J. Rathouska, E. Brcakova, S. Micuda, P. Nachtigal10.1016/S1567-5688(10)70479-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations104104P413 OXIDIZED-HEMOGLOBIN INDUCES INNATE IMMUNE CELL CHEMOTAXIS, MONOCYTE ARREST AND THEIR SUBINTIMAL MIGRATION INTO EARLY ATHEROSCLEROTIC TISSUEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704803/abstract?rss=yesP413 OXIDIZED-HEMOGLOBIN INDUCES INNATE IMMUNE CELL CHEMOTAXIS, MONOCYTE ARREST AND THEIR SUBINTIMAL MIGRATION INTO EARLY ATHEROSCLEROTIC TISSUEB. Buttari, E. Profumo, G. Domenici, M. Leopizzi, C. Di Cristofano, R. Businaro, G. Di Giammarco, R. Riganò10.1016/S1567-5688(10)70480-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations104104P414 EXPRESSION OF GENES AND PROTEINS IN ASCENDING THORACIC AORTIC ANEURYSMS AND SMOOTH MUSCLE CELLS ISOLATED FROM ANEURYSMAL SAMPLEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704815/abstract?rss=yesP414 EXPRESSION OF GENES AND PROTEINS IN ASCENDING THORACIC AORTIC ANEURYSMS AND SMOOTH MUSCLE CELLS ISOLATED FROM ANEURYSMAL SAMPLESZ. Adigüzel, M. Serhatli, O. Kaçar, A. Tuncer, E. Tuncer, K. Baysal10.1016/S1567-5688(10)70481-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations104104P415 ROLE OF THE COP9 SIGNALOSOME IN NF-úB SIGNALING IN ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704827/abstract?rss=yesP415 ROLE OF THE COP9 SIGNALOSOME IN NF-úB SIGNALING IN ATHEROSCLEROSISY. Asare, H. Noels, H. Lue, A. Zernecke, C. Weber, M. deWinther, J. Bernhagen10.1016/S1567-5688(10)70482-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations104104P416 INFLAMMATORY MARKERS IN PATIENTS UNDERGOING IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IMPLANTATION FOR LIFE THREATENING VENTRICULAR ARRHYTHMIAShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704839/abstract?rss=yesP416 INFLAMMATORY MARKERS IN PATIENTS UNDERGOING IMPLANTABLE CARDIOVERTER DEFIBRILLATOR IMPLANTATION FOR LIFE THREATENING VENTRICULAR ARRHYTHMIAST. Papadopoulos, N. Katsiki, G. Dadous, I. Kanonidis, G. Sakadamis10.1016/S1567-5688(10)70483-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations104105P417 ATHEROGENIC NON-UNIFORM SHEAR STRESS INDUCES ENDOTHELIAL DYSFUNCTION AND INCREASED LEUKOCYTE RECRUITMENT IN RESPONSE TO TNF-αhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704840/abstract?rss=yesP417 ATHEROGENIC NON-UNIFORM SHEAR STRESS INDUCES ENDOTHELIAL DYSFUNCTION AND INCREASED LEUKOCYTE RECRUITMENT IN RESPONSE TO TNF-αK. Urschel, A. Wörner, K. Beronov, W.G. Daniel, C.D. Garlichs, I. Cicha10.1016/S1567-5688(10)70484-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations105105P418 CREATION OF A RAT EXPERIMENTAL MODEL OF ABDOMINAL AORTIC ANEURYSMShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704852/abstract?rss=yesP418 CREATION OF A RAT EXPERIMENTAL MODEL OF ABDOMINAL AORTIC ANEURYSMSK.M. Mata, F.S. Rocha, P.S. Prudente, C.M. Prado, E.M. Floriano, J. Elias, E. Rizzi, R.F. Gerlach, M.A. Rossi, S.G. Ramos10.1016/S1567-5688(10)70485-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations105105P419 FENOFIBRATE ATTENUATES NICOTINE-INDUCED VASCULAR ENDOTHELIAL DYSFUNCTION IN THE RAThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704864/abstract?rss=yesP419 FENOFIBRATE ATTENUATES NICOTINE-INDUCED VASCULAR ENDOTHELIAL DYSFUNCTION IN THE RATV. Chakkarwar, M. Singh10.1016/S1567-5688(10)70486-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations105105P420 PEROXYNITRITE ACTIVATES THE TRANSCRIPTION FACTOR NRF2 IN HUMAN ENDOTHELIAL CELLShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704876/abstract?rss=yesP420 PEROXYNITRITE ACTIVATES THE TRANSCRIPTION FACTOR NRF2 IN HUMAN ENDOTHELIAL CELLSL. Mattart, D. Simon, D. Calay, V. Tevel, M. Van Steenbrugge, M. Raes10.1016/S1567-5688(10)70487-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations105105P421 EARLY EFFECTS OF ATORVASTATIN AND CLOPIDOGREL ALONE OR COMBINED ON ENDOTHELIAL PROGENITOR CELLS AND MICROPARTICLES IN SUBJECTS WITH CORONARY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704888/abstract?rss=yesP421 EARLY EFFECTS OF ATORVASTATIN AND CLOPIDOGREL ALONE OR COMBINED ON ENDOTHELIAL PROGENITOR CELLS AND MICROPARTICLES IN SUBJECTS WITH CORONARY DISEASEC. França, L. Pinheiro, M. Izar, M. Brunialti, R. Salomão, F. Fonseca10.1016/S1567-5688(10)70488-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations105106P422 PROFILING OF BIGLYCAN MOLECULAR PROMOTER HAPLOTYPEShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070489X/abstract?rss=yesP422 PROFILING OF BIGLYCAN MOLECULAR PROMOTER HAPLOTYPESB. Schmitz, R. Telgmann, E. Brand, C. Rüßmann, J. Fischer, M. Paul, S.-M. Brand-Herrmann10.1016/S1567-5688(10)70489-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations106106P423 RESPONSE OF ENDOTHELIAL CELLS TO SIMVASTATIN UNDER STATIC CULTURE, STEADY FLOW, NON-REVERSING PULSATILE FLOW AND OSCILLATING FLOWhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704906/abstract?rss=yesP423 RESPONSE OF ENDOTHELIAL CELLS TO SIMVASTATIN UNDER STATIC CULTURE, STEADY FLOW, NON-REVERSING PULSATILE FLOW AND OSCILLATING FLOWJ. Rossi, L. Rouleau, J.-C. Tardif, R.L. Leask10.1016/S1567-5688(10)70490-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations106106P424 ENDOGLIN (TYPE III TGF-β1 RECEPTOR), BAD OR GOOD IN ATHEROSCLEROSIS?http://www.atherosclerosis-supplements.com/article/PIIS1567568810704918/abstract?rss=yesP424 ENDOGLIN (TYPE III TGF-β1 RECEPTOR), BAD OR GOOD IN ATHEROSCLEROSIS?P. Nachtigal, Z. Strasky, L. Vecerova, E. Brcakova, M. Slanarova, J. Rathouska, S. Micuda10.1016/S1567-5688(10)70491-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations106106P425 EXPRESSION OF MATRIX METALLOPROTEINASES AND MECHANISM OF EXTRACELLULAR MATRIX REMODELING IN TAKAYASU'S ARTERITIShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070492X/abstract?rss=yesP425 EXPRESSION OF MATRIX METALLOPROTEINASES AND MECHANISM OF EXTRACELLULAR MATRIX REMODELING IN TAKAYASU'S ARTERITISN. Mahajan, S. Malik, S. Jain, V. Dhawan10.1016/S1567-5688(10)70492-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations106106P426 Bcl-xL INACTIVATION IN MACROPHAGES IS ASSOCIATED WITH ACCELERATED PROGRESSION IN ADVANCED ATHEROSCLEROTIC LESIONS OF apoE−/− MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704931/abstract?rss=yesP426 Bcl-xL INACTIVATION IN MACROPHAGES IS ASSOCIATED WITH ACCELERATED PROGRESSION IN ADVANCED ATHEROSCLEROTIC LESIONS OF apoE−/− MICEA. Shearn, V. Deswaerte, J. Pirault, F. Saint Charles, M.J. Chapman, E.L. Gautier, T. Huby, P. Lesnik10.1016/S1567-5688(10)70493-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations106107P427 ROLE OF DIFFERENT FORMS OF HDL (Ox-HDL AND nHDL) ON Ox-LDL INDUCED APOPTOSIS IN DIFFERENTIATED MONOCYTEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704943/abstract?rss=yesP427 ROLE OF DIFFERENT FORMS OF HDL (Ox-HDL AND nHDL) ON Ox-LDL INDUCED APOPTOSIS IN DIFFERENTIATED MONOCYTESN. Kaur, S. Kumari, S. Jain, S. Majumdar, S. Ghosh10.1016/S1567-5688(10)70494-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations107107P428 SEX PARTICULARITIES IN NITRIC OXIDE AVAILABILITY IN HEALTHY AND HYPERTENSIVE RATS UNDER NORMAL AND STRESS CONDITIONShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704955/abstract?rss=yesP428 SEX PARTICULARITIES IN NITRIC OXIDE AVAILABILITY IN HEALTHY AND HYPERTENSIVE RATS UNDER NORMAL AND STRESS CONDITIONSA. Kuznetsova, O. Semychkina-Glushkovskaya, T. Sindyakova, I. Semyachkin-Glushkovskij, Y. Kuznetsova10.1016/S1567-5688(10)70495-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations107107P429 A NOVEL APPROACH THROUGH THE EFFECTS OF TURBULENT FLOW ON THE ENDOTHELIAL CELL SHAPEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704967/abstract?rss=yesP429 A NOVEL APPROACH THROUGH THE EFFECTS OF TURBULENT FLOW ON THE ENDOTHELIAL CELL SHAPER. Paeizi, E. Barzanouni, M. Bokaiyan10.1016/S1567-5688(10)70496-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations107107P430 THE BENEFICIAL EFFECT OF MEDITERRANEAN DIET ON METABOLIC SYNDROME: A META-ANALYSIS OF 49 STUDIES AND 175,529 INDIVIDUALShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704979/abstract?rss=yesP430 THE BENEFICIAL EFFECT OF MEDITERRANEAN DIET ON METABOLIC SYNDROME: A META-ANALYSIS OF 49 STUDIES AND 175,529 INDIVIDUALSC.-M. Kastorini, H. Milionis, K. Esposito, D. Giugliano, J. Goudevenos, D.B. Panagiotakos10.1016/S1567-5688(10)70497-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations107107P431 MIPOMERSEN, AN apo B SYNTHESIS INHIBITOR, PREFERENTIALLY REDUCES SMALL LDL PARTICLE NUMBER AND INCREASES LDL PARTICLE SIZE IN HoFH PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704980/abstract?rss=yesP431 MIPOMERSEN, AN apo B SYNTHESIS INHIBITOR, PREFERENTIALLY REDUCES SMALL LDL PARTICLE NUMBER AND INCREASES LDL PARTICLE SIZE IN HoFH PATIENTSW. Cromwell, R. Santos, D. Blom, A.D. Marais, M.-J. Charng, R. Lachmann, D. Gaudet, J.-L. Tan, D. Tribble, J. Flaim, S. Chasan-Taber, J. Donovan, F. Raal10.1016/S1567-5688(10)70498-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations107108P432 ANTIOXIDATIVE ACTIVITY OF SMALL DENSE HDL3 IS ENHANCED IN HETEROZYGOUS CETP DEFICIENCY: A CASE REPORT FROM A DUTCH FAMILYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810704992/abstract?rss=yesP432 ANTIOXIDATIVE ACTIVITY OF SMALL DENSE HDL3 IS ENHANCED IN HETEROZYGOUS CETP DEFICIENCY: A CASE REPORT FROM A DUTCH FAMILYS. Chantepie, A. Klerkx, J.A. Kuivenhoven, G.K. Hovingh, M.J. Chapman, A. Kontush10.1016/S1567-5688(10)70499-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations108108P433 IS LYSOPHOSPHATIDYLCHOLINE INVOLVED IN APOPTOSIS AND IN DEFECTIVE EFFEROCYTOSIS IN ADVANCED ATHEROSCLEROTIC PLAQUES?http://www.atherosclerosis-supplements.com/article/PIIS1567568810705006/abstract?rss=yesP433 IS LYSOPHOSPHATIDYLCHOLINE INVOLVED IN APOPTOSIS AND IN DEFECTIVE EFFEROCYTOSIS IN ADVANCED ATHEROSCLEROTIC PLAQUES?U. Garbin, E. Baggio, C. Stranieri, G. Lipari, S. Manfro, A. Pasini, C. Mozzini, A. Fratta Pasini, L. Cominacini10.1016/S1567-5688(10)70500-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations108108P434 NEW INSIGHTS IN FOAM CELL FORMATION. THE ANTIOXIDANT KEY REGULATORY FACTOR Nrf2 DIRECTLY MODULATES FABP4 EXPRESSIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705018/abstract?rss=yesP434 NEW INSIGHTS IN FOAM CELL FORMATION. THE ANTIOXIDANT KEY REGULATORY FACTOR Nrf2 DIRECTLY MODULATES FABP4 EXPRESSIONI. Lazaro, A. Cabre, J. Girona, L. Masana10.1016/S1567-5688(10)70501-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Poster Presentations108108MS1 REGULAR EXERCISE IMPROVED ENDOTHELIAL DYSFUNCTION IN YOUNG MALE ADULTS WITH METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070502X/abstract?rss=yesMS1 REGULAR EXERCISE IMPROVED ENDOTHELIAL DYSFUNCTION IN YOUNG MALE ADULTS WITH METABOLIC SYNDROMEG. Fornieles-Gonzalez, M.A. Rosety-Rodriguez, I. Rosety-Rodriguez, F.J. Ordoñez, N. Garcia-Gomez, A. Camacho, M. Rosety-Rodriguez10.1016/S1567-5688(10)70502-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations109109MS2 EFFECTS OF SIBUTRAMINE PLUS L-CARNITINE COMPARED TO SIBUTRAMINE OR PLACEBO ON INFLAMMATORY PARAMETERShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705031/abstract?rss=yesMS2 EFFECTS OF SIBUTRAMINE PLUS L-CARNITINE COMPARED TO SIBUTRAMINE OR PLACEBO ON INFLAMMATORY PARAMETERSG. Derosa, I. Ferrari, P. Maffioli, S. Salvadeo, A. Gravina, R. Mereu, A. D'Angelo, I. Palumbo, S. Randazzo, A. Cicero10.1016/S1567-5688(10)70503-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations109109MS3 BLOOD PRESSURE-LOWERING RESPONSE TO AMLODIPINE AS A DETERMINANT OF THE ANTIOXIDATIVE ACTIVITY OF SMALL, DENSE HDL3 IN HYPERTENSIVE SUBJECTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705043/abstract?rss=yesMS3 BLOOD PRESSURE-LOWERING RESPONSE TO AMLODIPINE AS A DETERMINANT OF THE ANTIOXIDATIVE ACTIVITY OF SMALL, DENSE HDL3 IN HYPERTENSIVE SUBJECTSB. Hansel, X. Girerd, D. Bonnefont-Rousselot, R. Bittar, S. Chantepie, A. Orsoni, E. Bruckert, M.J. Chapman, A. Kontush10.1016/S1567-5688(10)70504-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations109109MS4 CHRONIC INFLAMMATORY STATE PRESENT IN FAMILIAL HYPERCHOLESTEROLEMIA IS REDUCED AFTER A FAT OVERLOAD RICH IN UNSATURATED FATTY ACIDShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705055/abstract?rss=yesMS4 CHRONIC INFLAMMATORY STATE PRESENT IN FAMILIAL HYPERCHOLESTEROLEMIA IS REDUCED AFTER A FAT OVERLOAD RICH IN UNSATURATED FATTY ACIDSS. Martinez-Hervas, C. Ivorra, T. Pedro, V. Gonzalez-Albert, R. Hilario, J.F. Ascaso, R. Carmena, J.T. Real, F.J. Chaves10.1016/S1567-5688(10)70505-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations109110MS5 THE HAMBURG STUDY – A PROSPECTIVE OBSERVATION OF 2000 HEALTHY WORKERS TO STUDY THE DEVELOPMENT OF THE METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705067/abstract?rss=yesMS5 THE HAMBURG STUDY – A PROSPECTIVE OBSERVATION OF 2000 HEALTHY WORKERS TO STUDY THE DEVELOPMENT OF THE METABOLIC SYNDROMEU. Beisiegel, K. Wegscheider, B. Löwe, C. Altenburg, B. Sawitzky-Rose, I. Zorn, L. Scheja, J. Gebhard, D. Müller-Wieland10.1016/S1567-5688(10)70506-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations110110MS6 ROLE OF BUTYROPHILIN IN LIPID DROPLET SECRETIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705079/abstract?rss=yesMS6 ROLE OF BUTYROPHILIN IN LIPID DROPLET SECRETIONA. Ruebel, I. Buers, H. Robenek10.1016/S1567-5688(10)70507-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations110110MS7 SERUM APOLIPOPROTEIN B48 LEVELS UNDER FASTING AND POSTPRANDIAL CONDITIONS IN WOMEN WITH AND WITHOUT POLYCYSTIC OVARIAN SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705080/abstract?rss=yesMS7 SERUM APOLIPOPROTEIN B48 LEVELS UNDER FASTING AND POSTPRANDIAL CONDITIONS IN WOMEN WITH AND WITHOUT POLYCYSTIC OVARIAN SYNDROMEA. McGowan, T. KyawTun, N. Correia, N. Phelan, H. Roche, G. Boran, J. Gibney10.1016/S1567-5688(10)70508-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations110110MS8 DETERMINATION OF APOLIPOPROTEIN (apo)B48 CONCENTRATIONS USING A NOVEL HUMAN ELISA TECHNIQUEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705092/abstract?rss=yesMS8 DETERMINATION OF APOLIPOPROTEIN (apo)B48 CONCENTRATIONS USING A NOVEL HUMAN ELISA TECHNIQUEA. McGowan, W. Widdowson, J. Gibney10.1016/S1567-5688(10)70509-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations110110MS9 EFFECTIVENESS OF OMACOR MONOTHERAPY IN SEVERE HYPERTRIGLYCERIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705109/abstract?rss=yesMS9 EFFECTIVENESS OF OMACOR MONOTHERAPY IN SEVERE HYPERTRIGLYCERIDEMIAD. Agapakis, M. Papagianni, N. Katsiki, K. Tziomalos, C. Savopoulos, A. Satsoglou, A. Hatzitolios10.1016/S1567-5688(10)70510-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations110111MS10 A CORRELATION BETWEEN HYPERLIPIDEMIA, HYPERGLYCEMIA AND TESTICULAR FUNCTIONS IN ALBINO RATS: A TESTICULAR POPULATION DYNAMICShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705110/abstract?rss=yesMS10 A CORRELATION BETWEEN HYPERLIPIDEMIA, HYPERGLYCEMIA AND TESTICULAR FUNCTIONS IN ALBINO RATS: A TESTICULAR POPULATION DYNAMICSA. Purohit10.1016/S1567-5688(10)70511-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations111111MS11 THE WHEY FERMENTATION PRODUCT MALLEABLE PROTEIN MATRIX-SL0905 DECREASES TRIGLYCERIDE CONCENTRATIONS IN PATIENTS WITH HYPERCHOLESTEROLEMIA: A RANDOMIZED PLACEBO-CONTROLLED TRIALhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705122/abstract?rss=yesMS11 THE WHEY FERMENTATION PRODUCT MALLEABLE PROTEIN MATRIX-SL0905 DECREASES TRIGLYCERIDE CONCENTRATIONS IN PATIENTS WITH HYPERCHOLESTEROLEMIA: A RANDOMIZED PLACEBO-CONTROLLED TRIALI. Gouni-Berthold, D.M. Schulte, W. Krone, H.K. Berthold10.1016/S1567-5688(10)70512-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations111111MS12 INFLUENCE OF SIMVASTATIN ON apoB-100 SECRETION IN NON-OBESE SUBJECTS WITH MODERATE HYPERCHOLESTEROLEMIA: A STABLE ISOTOPE STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705134/abstract?rss=yesMS12 INFLUENCE OF SIMVASTATIN ON apoB-100 SECRETION IN NON-OBESE SUBJECTS WITH MODERATE HYPERCHOLESTEROLEMIA: A STABLE ISOTOPE STUDYH.K. Berthold, P.H.R. Barrett, I. Gouni-Berthold10.1016/S1567-5688(10)70513-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations111111MS13 SERUM ALBUMIN ISOLATED FROM DIABETIC OR UREMIC RATS ENHANCES THE MOUSE PERITONEAL MACROPHAGES LDL UPTAKEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705146/abstract?rss=yesMS13 SERUM ALBUMIN ISOLATED FROM DIABETIC OR UREMIC RATS ENHANCES THE MOUSE PERITONEAL MACROPHAGES LDL UPTAKEA.B. Carreiro, A. Machado-Lima, R.T. Iborra, R.S. Pinto, G. Castilho, J.C. Rocha, J.T. Machado, E.R. Nakandakare, S. Catanozi, M. Passarelli10.1016/S1567-5688(10)70514-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations111111MS14 SEX DIFFERENCES IN EFFECTS OF NPC1L1 GENE POLYMORPHISM ON CHOLESTEROL ABSORPTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705158/abstract?rss=yesMS14 SEX DIFFERENCES IN EFFECTS OF NPC1L1 GENE POLYMORPHISM ON CHOLESTEROL ABSORPTIONT. Maeda, A. Honda, Y. Mashimo, Y. Takeoka, D. Yasuda, N. Yoshimura, J. Kusano, K. Tsukamoto, T. Ishikawa, M. Kinoshita, Y. Matsuzaki, T. Teramoto10.1016/S1567-5688(10)70515-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations111112MS15 FUNCTIONALITY OF PLA2G2A PROMOTER VARIANTS ASSOCIATED WITH SPLA2-IIA LEVELShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070516X/abstract?rss=yesMS15 FUNCTIONALITY OF PLA2G2A PROMOTER VARIANTS ASSOCIATED WITH SPLA2-IIA LEVELSH. Exeter, J. Palmen, P.J. Talmud10.1016/S1567-5688(10)70516-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations112112MS16 RELATIONSHIPS BETWEEN LDL-C, ApoB AND NON-HDL-C WITH hsCRP IN HYPERCHOLESTEROLEMIC PATIENTS AT RISK FOR CARDIOVASCULAR DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705171/abstract?rss=yesMS16 RELATIONSHIPS BETWEEN LDL-C, ApoB AND NON-HDL-C WITH hsCRP IN HYPERCHOLESTEROLEMIC PATIENTS AT RISK FOR CARDIOVASCULAR DISEASEJ. O'Keefe, M. Abuannadi, J. Lin, A. Shah, D. Neff, J.E. Tomassini, A. Tershakovec10.1016/S1567-5688(10)70517-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations112112MS17 THE ROLE OF ACYLATION STIMULATING PROTEIN IN GENESIS OF DYSLIPIDEMIAS AND IN REGULATION OF TRIACYLGLYCEROL SYNTHESIS: CLINICAL AND EXPERIMENTAL DATAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705183/abstract?rss=yesMS17 THE ROLE OF ACYLATION STIMULATING PROTEIN IN GENESIS OF DYSLIPIDEMIAS AND IN REGULATION OF TRIACYLGLYCEROL SYNTHESIS: CLINICAL AND EXPERIMENTAL DATAE. Ageeva, Y. Frolova, E. Dizhe, A. Vinogradov, A. Denisenko10.1016/S1567-5688(10)70518-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations112113MS18 C-REACTIVE PROTEIN LEVEL AND CAROTID ARTERIES ATHEROSCLEROSIS IN ABDOMINAL OBESITY PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705195/abstract?rss=yesMS18 C-REACTIVE PROTEIN LEVEL AND CAROTID ARTERIES ATHEROSCLEROSIS IN ABDOMINAL OBESITY PATIENTSO. Belyaeva, T. Karonova, E. Bazhenova, E. Baranova, O. Berkovich, A. Berezina, N. Ananieva, V. Mandal, E. Shlyakhto10.1016/S1567-5688(10)70519-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations113113MS19 FUNCTIONAL ANALYSIS OF LDLR PROMOTER MUTATIONS ASSOCIATED WITH FAMILIAL HYPERCHOLESTEROLEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705201/abstract?rss=yesMS19 FUNCTIONAL ANALYSIS OF LDLR PROMOTER MUTATIONS ASSOCIATED WITH FAMILIAL HYPERCHOLESTEROLEMIAI. De Castro-Orós, L. Palacios, S. Pampín, N. Plana, L. Masana, M. Stef, F. Civeira, J.C. Ródriguez-Rey, M. Pocoví10.1016/S1567-5688(10)70520-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations113113MS20 NATIVE AND GLYCOXIDIZED HIGH DENSITY LIPOPROTEIN (HDL) MODULATE ADRENAL STEROIDOGENESIS VIA SCAVENGER RECEPTOR CLASS B, TYPE I (SR-BI)http://www.atherosclerosis-supplements.com/article/PIIS1567568810705213/abstract?rss=yesMS20 NATIVE AND GLYCOXIDIZED HIGH DENSITY LIPOPROTEIN (HDL) MODULATE ADRENAL STEROIDOGENESIS VIA SCAVENGER RECEPTOR CLASS B, TYPE I (SR-BI)S. Kopprasch, S. Saha, J. Graessler, J. Pietzsch, S.R. Bornstein10.1016/S1567-5688(10)70521-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations113113MS21 COPPER AND MYELOPEROXIDASE-MODIFIED LDLS ACTIVATE NRF2 THROUGH DIFFERENT PATHWAYS OF ROS PRODUCTION IN MACROPHAGEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705225/abstract?rss=yesMS21 COPPER AND MYELOPEROXIDASE-MODIFIED LDLS ACTIVATE NRF2 THROUGH DIFFERENT PATHWAYS OF ROS PRODUCTION IN MACROPHAGESD. Calay, A. Rousseau, L. Mattart, V. Nuyens, P. Van Antwerpen, N. Moguilevsky, K. Zouaoui Boudjeltia, M. Raes10.1016/S1567-5688(10)70522-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations113113MS22 VOLUNTARY WHEEL RUNNING BENEFICIALLY AFFECTS CHOLESTEROL TURNOVER AND ATHEROSCLEROSIS IN HYPERCHOLESTEROLEMIC MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705237/abstract?rss=yesMS22 VOLUNTARY WHEEL RUNNING BENEFICIALLY AFFECTS CHOLESTEROL TURNOVER AND ATHEROSCLEROSIS IN HYPERCHOLESTEROLEMIC MICEM. Meissner, E. Lombardo, T.H. van Dijk, R. Havinga, U.J.F. Tietge, R. Boverhof, T. Boer, K. Bijsterveld, F. Kuipers, A.K. Groen10.1016/S1567-5688(10)70523-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations114114MS23 TARGETING ONLY HIGH LDL-CHOLESTEROL DOES NOT ELIMINATE RESIDUAL CARDIOVASCULAR RISKhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705249/abstract?rss=yesMS23 TARGETING ONLY HIGH LDL-CHOLESTEROL DOES NOT ELIMINATE RESIDUAL CARDIOVASCULAR RISKM. Granér, O. Rimpiläinen, H. Tikkanen, M.-L. Lokki, M.S. Nieminen, M.-R. Taskinen, J. Sinisalo10.1016/S1567-5688(10)70524-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations114114MS24 EFFICACY AND TOLERABILITY OF SUSTAINED RELEASE FORMULATION OF SIMVASTATIN; IS THERE ANY DIFFERENCE BETWEEN MORNING TIME OR NIGHTTIME INTAKE GROUP?http://www.atherosclerosis-supplements.com/article/PIIS1567568810705250/abstract?rss=yesMS24 EFFICACY AND TOLERABILITY OF SUSTAINED RELEASE FORMULATION OF SIMVASTATIN; IS THERE ANY DIFFERENCE BETWEEN MORNING TIME OR NIGHTTIME INTAKE GROUP?S.-H. Kim, M.S. Hyeon, G.R. Han, S.W. Cho, Y.G. Kim, H.S. Seo, S.H. Park10.1016/S1567-5688(10)70525-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations114114MS25 LDL-ASSOCIATED LYSOZYME AND apoJ-SPECIFIC DISTRIBUTION IN INDIVIDUALS WITH TYPE 2 DIABETES AND THE METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705262/abstract?rss=yesMS25 LDL-ASSOCIATED LYSOZYME AND apoJ-SPECIFIC DISTRIBUTION IN INDIVIDUALS WITH TYPE 2 DIABETES AND THE METABOLIC SYNDROMEC. Pettersson, H. Karlsson, B. Fagerberg, M. Ståhlman, T. Larsson, M. Lindahl, J. Borén, O. Wiklund, L. Fogelstrand10.1016/S1567-5688(10)70526-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations114114MS26 CHOLESTERYL ESTER STORAGE DISEASE (ACID LIPASE DEFICIENCY): ANOTHER FACTOR FOR EARLY ATHEROSCLEROSIS DISEASE. EXPERIENCE FROM THE GREEK POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705274/abstract?rss=yesMS26 CHOLESTERYL ESTER STORAGE DISEASE (ACID LIPASE DEFICIENCY): ANOTHER FACTOR FOR EARLY ATHEROSCLEROSIS DISEASE. EXPERIENCE FROM THE GREEK POPULATIONE. Drogari, P. Progias, E. Koniari, N. Manolaki, H. Christomanou10.1016/S1567-5688(10)70527-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations114115MS27 PROTHROMBOTIC MARKERS IN DYSLIPIDEMIC PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705286/abstract?rss=yesMS27 PROTHROMBOTIC MARKERS IN DYSLIPIDEMIC PATIENTSD. Karasek, H. Vaverkova, M. Halenka, D. Jackuliakova, Z. Frysak, L. Slavik, D. Novotny10.1016/S1567-5688(10)70528-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations115115MS28 INCREASED INSULIN RESISTANCE, INSULIN SECRETION, THROMBOTIC AND INFLAMMATORY FACTORS IN CHILDREN, ADOLESCENTS AND YOUTH WITH METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705298/abstract?rss=yesMS28 INCREASED INSULIN RESISTANCE, INSULIN SECRETION, THROMBOTIC AND INFLAMMATORY FACTORS IN CHILDREN, ADOLESCENTS AND YOUTH WITH METABOLIC SYNDROMEV. Dimitrijevic-Sreckovic, P. Djordjevic, S. Damjanovic, B. Sreckovic, E. Colak, I. Soldatovic, A. Stamenkovic10.1016/S1567-5688(10)70529-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations115115MS29 USEFULNESS OF DNA ANALYSIS FOR THE DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA (FH) AND EXTRAORDINARILY HIGH FREQUENCY OF FH IN JAPANhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705304/abstract?rss=yesMS29 USEFULNESS OF DNA ANALYSIS FOR THE DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLEMIA (FH) AND EXTRAORDINARILY HIGH FREQUENCY OF FH IN JAPANH. Mabuchi, A. Nohara, T. Noguchi, J. Kobayashi, M.-A. Kawashiri, H. Tada, M. Yamagishi, A. Inazu, J. Koizumi10.1016/S1567-5688(10)70530-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations115115MS30 LEVELS OF PLASMA LIPIDS, LIPOPROTEINS AND APOLIPOPROTEINS IN OVERWEIGHT HYPERTENSIVE CHILDRENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705316/abstract?rss=yesMS30 LEVELS OF PLASMA LIPIDS, LIPOPROTEINS AND APOLIPOPROTEINS IN OVERWEIGHT HYPERTENSIVE CHILDRENZ. Jelic-Ivanovic, S. Spasic, V. Spasojevic-Kalimanovska10.1016/S1567-5688(10)70531-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations115115MS31 CIRCULATING OXIDIZED LOW-DENSITY LIPOPROTEIN LEVELS MAY SERVE AS A RISK MARKER FOR CAROTID STENOSIS DURING STATIN THERAPYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705328/abstract?rss=yesMS31 CIRCULATING OXIDIZED LOW-DENSITY LIPOPROTEIN LEVELS MAY SERVE AS A RISK MARKER FOR CAROTID STENOSIS DURING STATIN THERAPYS. Kougialis, D. Levisianou, E. Skopelitis, S. Nikolaou, A. Kroustalis, T. Gogalis, G. Groumas, A. Zervou, N. Kosmas, N. Iliopoulos, C. Mpilinis10.1016/S1567-5688(10)70532-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations115116MS32 BIOCHEMICAL CHARACTERIZATION OF LDL SUBFRACTIONS AND VERIFICATION OF SPECIFICITY OF A NEW HOMOGENEOUS ASSAY FOR SMALL, DENSE LDL-CHOLESTEROLhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070533X/abstract?rss=yesMS32 BIOCHEMICAL CHARACTERIZATION OF LDL SUBFRACTIONS AND VERIFICATION OF SPECIFICITY OF A NEW HOMOGENEOUS ASSAY FOR SMALL, DENSE LDL-CHOLESTEROLM. Fujimura, M. Ohta, Y. Ito10.1016/S1567-5688(10)70533-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations116116MS33 APOLIPOPROTEIN B BOUND TO ERYTHROCYTES: A NOVEL ANTI-ATHEROGENIC MECHANISMhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705341/abstract?rss=yesMS33 APOLIPOPROTEIN B BOUND TO ERYTHROCYTES: A NOVEL ANTI-ATHEROGENIC MECHANISMS.A. Bovenberg, A. Westzaan, S. Martinez-Hervas, G.-J. van de Geijn, H. Janssen, T. Njo, E. Birnie, A. Rietveld, J.W.F. Elte, M. Castro Cabezas10.1016/S1567-5688(10)70534-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations116116MS34 HNE-INDUCED 5-LOX EXPRESSION IS TRANSCRIPTIONAL REGULATED BY NF-kB/ERK AND SP1/P38 MAPK PATHWAYS VIA EGF RECEPTOR IN MURINE MACROPHAGEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705353/abstract?rss=yesMS34 HNE-INDUCED 5-LOX EXPRESSION IS TRANSCRIPTIONAL REGULATED BY NF-kB/ERK AND SP1/P38 MAPK PATHWAYS VIA EGF RECEPTOR IN MURINE MACROPHAGESS.-J. Lee, C.-E. Kim, K.-W. Seo, C.-D. Kim10.1016/S1567-5688(10)70535-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations116116MS35 SMALL, DENSE HDL3 PARTICLES EXHIBIT DEFECTIVE ANTIOXIDATIVE AND ANTIINFLAMMATORY FUNCTION IN FAMILIAL HYPERCHOLESTEROLEMIA: PARTIAL CORRECTION BY LDL-APHERESIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705365/abstract?rss=yesMS35 SMALL, DENSE HDL3 PARTICLES EXHIBIT DEFECTIVE ANTIOXIDATIVE AND ANTIINFLAMMATORY FUNCTION IN FAMILIAL HYPERCHOLESTEROLEMIA: PARTIAL CORRECTION BY LDL-APHERESISH. Hussein, S. Saheb, M. Couturier, M. Atassi, A. Orsoni, A. Carrié, P. Therond, S. Chantepie, P. Robillard, E. Bruckert, M.J. Chapman, A. Kontush10.1016/S1567-5688(10)70536-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations116116MS36 ATORVASTATIN EFFECT ON THE DISTRIBUTION OF HDL SUBFRACTIONS AND HUMAN PARAOXONASE ACTIVITYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705377/abstract?rss=yesMS36 ATORVASTATIN EFFECT ON THE DISTRIBUTION OF HDL SUBFRACTIONS AND HUMAN PARAOXONASE ACTIVITYG. Paragh, M. Harangi, H.Z. Mirdamadi, A. Kassai, Z. Derdák, I. Seres10.1016/S1567-5688(10)70537-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations117117MS37 ATHEROGENIC POTENTIAL OF SUBCLINICAL HYPOTHYROIDISM AND WAYS OF HIS CORRECTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705389/abstract?rss=yesMS37 ATHEROGENIC POTENTIAL OF SUBCLINICAL HYPOTHYROIDISM AND WAYS OF HIS CORRECTIONA. Logvinenko, V. Romanov, O. Mitchenko, I. Chulaevskaya10.1016/S1567-5688(10)70538-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations117117MS38 ATORVASTATIN EFFECTS ON LIPID PROFILE IN ApoE/LDLR-DEFICIENT MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705390/abstract?rss=yesMS38 ATORVASTATIN EFFECTS ON LIPID PROFILE IN ApoE/LDLR-DEFICIENT MICEM. Slanařová, L. Večeřová, Z. Stráský, A. Tichá, R. Hyšpler, P. Nachtigal10.1016/S1567-5688(10)70539-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations117117MS39 MOLECULAR STUDY OF FAMILIAL HYPERCHOLESTEROLEMIA IN BELGIUMhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705407/abstract?rss=yesMS39 MOLECULAR STUDY OF FAMILIAL HYPERCHOLESTEROLEMIA IN BELGIUME. Tarantino, S. Mabille, M. Bruniaux, O. Descamps10.1016/S1567-5688(10)70540-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations117117MS40 THE INFLUENCE OF GENES ON LIPID METABOLISM IN WEST SIBERIA CAUCASIAN POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705419/abstract?rss=yesMS40 THE INFLUENCE OF GENES ON LIPID METABOLISM IN WEST SIBERIA CAUCASIAN POPULATIONE. Shakhtshneider, A. Allakhverdyan, I. Kulikov, V. Maksimov, A. Romashchenko, Y. Nikitin, S. Malyutina, M. Voevoda10.1016/S1567-5688(10)70541-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations117117MS41 PITAVASTATIN REDUCES HIGH-SENSITIVITY C-REACTIVE PROTEIN AND IMPROVES LIPID PROFILES IRRESPECTIVELY OF BODY MASS INDICES – SUBANALYSIS OF KISHIMEN MULTI-CENTER PROSPECTIVE STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705420/abstract?rss=yesMS41 PITAVASTATIN REDUCES HIGH-SENSITIVITY C-REACTIVE PROTEIN AND IMPROVES LIPID PROFILES IRRESPECTIVELY OF BODY MASS INDICES – SUBANALYSIS OF KISHIMEN MULTI-CENTER PROSPECTIVE STUDYN. Kume, Y. Fujioka, A. Taniguchi, K. Tanaka, S. Kagimoto, K. Hirata, Y. Nakamura, T. Yamamoto, S. Fujimoto, Y. Hamamoto, K. Tsuda, N. Inagaki, Y. Seino, H. Koshiyama10.1016/S1567-5688(10)70542-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations118118MS42 IMPROVED LIPID REDUCTION AND TARGET ATTAINMENT WITH EZETIMIBE/SIMVASTATIN VERSUS ROSUVASTATIN IN HIGH-RISK PATIENTS FAILING PRIOR STATIN THERAPY: AGE FACTORhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705432/abstract?rss=yesMS42 IMPROVED LIPID REDUCTION AND TARGET ATTAINMENT WITH EZETIMIBE/SIMVASTATIN VERSUS ROSUVASTATIN IN HIGH-RISK PATIENTS FAILING PRIOR STATIN THERAPY: AGE FACTORL. Missault, H. Vaverkova, M. Farnier, M. Averna, M. Viigimaa, Q. Dong, A. Shah, W. Taggart, P. Brudi10.1016/S1567-5688(10)70543-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations118118MS43 COPPER BINDING TO S100A12: SUGGESTED ROLE IN OXIDATIVE MODIFICATION OF HUMAN LDLhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705444/abstract?rss=yesMS43 COPPER BINDING TO S100A12: SUGGESTED ROLE IN OXIDATIVE MODIFICATION OF HUMAN LDLJ. Pietzsch, M. Walther, R. Bergmann, S. Hoppmann10.1016/S1567-5688(10)70544-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations118118MS44 A DECREASE OF PLASMA TRIACYLGLYCEROL AFTER ORAL GLUCOSE LOAD PREDICTS LOWER METABOLIC RISKhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705456/abstract?rss=yesMS44 A DECREASE OF PLASMA TRIACYLGLYCEROL AFTER ORAL GLUCOSE LOAD PREDICTS LOWER METABOLIC RISKM. Vossen, K. Toedter, U. Beisiegel, R. Müller, L. Scheja10.1016/S1567-5688(10)70545-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations118118MS45 IMPACT OF SWITCHING TO SIMVASTATIN ON LOW DENSITY LIPOPROTEIN CHOLESTEROL GOAL ATTAINMENThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705468/abstract?rss=yesMS45 IMPACT OF SWITCHING TO SIMVASTATIN ON LOW DENSITY LIPOPROTEIN CHOLESTEROL GOAL ATTAINMENTK. Tunceli, S. Sajjan, D. Ramey, D. Neff, A. Tershakovec, H. Hu, J. Foody10.1016/S1567-5688(10)70546-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations118119MS46 THE EFFECTS OF HYPOLIPIDEMIC REGIMEN ON LOW DENSITY LIPOPROTEIN (LDL) PHENOTYPE IN PATIENTS WITH MIXED HYPERLIPIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070547X/abstract?rss=yesMS46 THE EFFECTS OF HYPOLIPIDEMIC REGIMEN ON LOW DENSITY LIPOPROTEIN (LDL) PHENOTYPE IN PATIENTS WITH MIXED HYPERLIPIDEMIAA.P. Agouridis, T.D. Filippatos, E.O. Moutzouri, A.A. Kei, A.D. Tselepis, M.S. Elisaf10.1016/S1567-5688(10)70547-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations119119MS47 COMMON GENETIC VARIATION IN THE ATP-BINDING CASSETTE TRANSPORTER A1, LIPIDS PROFILE AND RISK OF CORONARY STENOSIS IN A TUNISIAN POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705481/abstract?rss=yesMS47 COMMON GENETIC VARIATION IN THE ATP-BINDING CASSETTE TRANSPORTER A1, LIPIDS PROFILE AND RISK OF CORONARY STENOSIS IN A TUNISIAN POPULATIONJ. Rejeb, A. Omezzine, I. Boumaiza, L. Rebhi, K. Kchock, R. Belkahla, N. Ben Rejeb, N. Nabli, A. Ben Abdelaziz, E. Boughzala, A. Bouslama10.1016/S1567-5688(10)70548-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations119119MS48 EFFECTS OF AGE AND STATIN DOSE ON LIPID LEVELS: RESULTS FROM THE VOYAGER INDIVIDUAL PATIENT DATA META-ANALYSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705493/abstract?rss=yesMS48 EFFECTS OF AGE AND STATIN DOSE ON LIPID LEVELS: RESULTS FROM THE VOYAGER INDIVIDUAL PATIENT DATA META-ANALYSISS.J. Nicholls, P. Lundman, G. Brandrup-Wognsen, M. Palmer, P.J. Barter10.1016/S1567-5688(10)70549-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations119120MS49 THE HELSINKI FIELD SUBSTUDY: EFFECTS OF FENOFIBRATE AND HOMOCYSTEINE ON IN VITRO CHOLESTEROL EFFLUX POTENTIAL OF HDL AND PLASMAhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070550X/abstract?rss=yesMS49 THE HELSINKI FIELD SUBSTUDY: EFFECTS OF FENOFIBRATE AND HOMOCYSTEINE ON IN VITRO CHOLESTEROL EFFLUX POTENTIAL OF HDL AND PLASMAM. Maranghi, A. Hiukka, R.M. Badeau, M. Robciuc, R. Vikstedt, R. Pahlman, M. Jauhiainen, M.-R. Taskinen10.1016/S1567-5688(10)70550-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations120120MS50 EFFECTS OF EZETIMIBE ADDED TO ON-GOING LOW-DOSE PRAVASTATIN ON SERUM LIPOPROTEIN, CHOLESTEROL SYNTHESIS AND ABSORPTION IN HYPERCHOLESTEROLEMIC JAPANESE PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705511/abstract?rss=yesMS50 EFFECTS OF EZETIMIBE ADDED TO ON-GOING LOW-DOSE PRAVASTATIN ON SERUM LIPOPROTEIN, CHOLESTEROL SYNTHESIS AND ABSORPTION IN HYPERCHOLESTEROLEMIC JAPANESE PATIENTSJ. Sasaki, S. Biro, T. Saikawa, S. Kono10.1016/S1567-5688(10)70551-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations120120MS51 COMPARATIVE EFFECT OF APHERESIS VS ATORVASTATIN/APHERESIS ON MARKERS OF INFLAMMATION IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705523/abstract?rss=yesMS51 COMPARATIVE EFFECT OF APHERESIS VS ATORVASTATIN/APHERESIS ON MARKERS OF INFLAMMATION IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIAM. Puntoni, F. Bigazzi, F. Sbrana, B. Pennato, F. Minichilli, T. Sampietro10.1016/S1567-5688(10)70552-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations120120MS52 HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (FH) IN GREECEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705535/abstract?rss=yesMS52 HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (FH) IN GREECEE. Drogari, P. Progias, A. Skouma, M. Elisaf, V. Mollaki10.1016/S1567-5688(10)70553-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations120120MS53 LOW HDL-HIGH INFLAMMATORY MARKERS IN HEART FAILURE INDUCED BY HIGH FREQUENCY PACING IN MINIPIGShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705547/abstract?rss=yesMS53 LOW HDL-HIGH INFLAMMATORY MARKERS IN HEART FAILURE INDUCED BY HIGH FREQUENCY PACING IN MINIPIGSB. Pennato, V. Lionetti, F. Bigazzi, M. Puntoni, A. Simioniuc, M. Campan, F. Recchia, T. Sampietro10.1016/S1567-5688(10)70554-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations120121MS54 SERUM APOLIPOPROTEIN B-48 LEVEL IS CORRELATED WITH CAROTID INTIMA-MEDIA THICKNESS (IMT) IN SUBJECTS WITH NORMAL SERUM TRIGLYCERIDE LEVELhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705559/abstract?rss=yesMS54 SERUM APOLIPOPROTEIN B-48 LEVEL IS CORRELATED WITH CAROTID INTIMA-MEDIA THICKNESS (IMT) IN SUBJECTS WITH NORMAL SERUM TRIGLYCERIDE LEVELK. Nakatani, T. Sugimoto, R. Kawase, H. Nakaoka, M. Inagaki, M. Yuasa-Kawase, K. Tsubakio-Yamamoto, J.C. Sandoval, D. Masuda, T. Ohama, Y. Nakagawa-Toyama, M. Nishida, M. Ishigami, I. Komuro, S. Yamashita10.1016/S1567-5688(10)70555-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations121121MS55 TRANSFER OF LIPIDS TO HDL IN PATIENTS WITH PRECOCIOUS ISCHEMIC HEART DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705560/abstract?rss=yesMS55 TRANSFER OF LIPIDS TO HDL IN PATIENTS WITH PRECOCIOUS ISCHEMIC HEART DISEASER. Maranhão, F.R.S. Freitas, A.P. Mansur, C. Strunz, A.T. Yamada, A.J. Mansur10.1016/S1567-5688(10)70556-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations121121MS56 APOLIPOPROTEINS IN THE DISCRIMINATION OF ATHEROSCLEROTIC BURDEN AND CARDIAC FUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705572/abstract?rss=yesMS56 APOLIPOPROTEINS IN THE DISCRIMINATION OF ATHEROSCLEROTIC BURDEN AND CARDIAC FUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASEA. Abraheem, P. Jeetesh, M. Gunning, J. Creamer, E. Hughs, G. Lip, M. Elhassan10.1016/S1567-5688(10)70557-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations121121MS57 IN VITRO AND IN VIVO POLYPHENOL BINDING TO LIPOPROTEINS: A PROTECTIVE MECHANISM FOR ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705584/abstract?rss=yesMS57 IN VITRO AND IN VIVO POLYPHENOL BINDING TO LIPOPROTEINS: A PROTECTIVE MECHANISM FOR ATHEROSCLEROSISJ. Vinson10.1016/S1567-5688(10)70558-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations121121MS58 EFFECTS ON CVD RISK FACTORS OF ADDING GROUND, SLICED AND WHOLE HAZELNUTS TO CUSTOMARY DIETS OF HYPERCHOLESTEROLAEMIC MEN AND WOMENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705596/abstract?rss=yesMS58 EFFECTS ON CVD RISK FACTORS OF ADDING GROUND, SLICED AND WHOLE HAZELNUTS TO CUSTOMARY DIETS OF HYPERCHOLESTEROLAEMIC MEN AND WOMENA. Chisholm, S. Tey, R. Brown, A. Gray, C. Delahunty10.1016/S1567-5688(10)70559-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations122122MS59 AN 8-WEEK TRIAL INVESTIGATING THE EFFICACY AND TOLERABILITY OF ATORVASTATIN IN CHILDREN AND ADOLESCENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HeFH)http://www.atherosclerosis-supplements.com/article/PIIS1567568810705602/abstract?rss=yesMS59 AN 8-WEEK TRIAL INVESTIGATING THE EFFICACY AND TOLERABILITY OF ATORVASTATIN IN CHILDREN AND ADOLESCENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HeFH)K. Gandelman, P. Glue, R. Laskey, J. Jones, R. Labadie, L. Ose10.1016/S1567-5688(10)70560-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations122122MS60 DEFICIENT ANTIOXIDATIVE FUNCTION OF HDL PARTICLES IN LOW HDL-CHOLESTEROL DYSLIPIDEMIAS: IMPACT OF THE DEGREE OF TRIGLYCERIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705614/abstract?rss=yesMS60 DEFICIENT ANTIOXIDATIVE FUNCTION OF HDL PARTICLES IN LOW HDL-CHOLESTEROL DYSLIPIDEMIAS: IMPACT OF THE DEGREE OF TRIGLYCERIDEMIAH. Hussein, L. Tokgözoğlu, S. Chantepie, P. Giral, B. Hansel, M. Alikasifoglu, M. Ercan, M.J. Chapman, A. Kontush10.1016/S1567-5688(10)70561-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations122122MS61 WHEN IS THE DYSLIPIDEMIA BEGINNING IN FACT? THE IMPAIRED LIPID METABOLISM (ILM)http://www.atherosclerosis-supplements.com/article/PIIS1567568810705626/abstract?rss=yesMS61 WHEN IS THE DYSLIPIDEMIA BEGINNING IN FACT? THE IMPAIRED LIPID METABOLISM (ILM)I. Reiber, I. Mező10.1016/S1567-5688(10)70562-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations122122MS62 PRELIMINARY BIOCHEMICAL AND MOLECULAR RESULTS OF PORTUGUESE FAMILIAL COMBINED HYPERLIPIDAEMIA PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705638/abstract?rss=yesMS62 PRELIMINARY BIOCHEMICAL AND MOLECULAR RESULTS OF PORTUGUESE FAMILIAL COMBINED HYPERLIPIDAEMIA PATIENTST. Santos, Q. Rato, A. Guerra, I.M. Gaspar, M. Bourbon10.1016/S1567-5688(10)70563-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations122122MS63 PARADOXICAL DECREASE IN HIGH DENSITY LIPOPROTEIN CHOLESTEROL WITH FENOFIBRATE: A QUITE RARE PHENOMENON INDEEDhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070564X/abstract?rss=yesMS63 PARADOXICAL DECREASE IN HIGH DENSITY LIPOPROTEIN CHOLESTEROL WITH FENOFIBRATE: A QUITE RARE PHENOMENON INDEEDG. Mombelli, F. Pazzucconi, A. Bondioli, A. Zanaboni, S. Gaito, L. Calabresi, C.R. Sirtori10.1016/S1567-5688(10)70564-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations123123MS64 CAPILLARY ISOTACHOPHORESIS AS AN OVERALL TOOL TO REVEAL ATHEROGENIC LIPOPROTEIN PHENOTYPEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705651/abstract?rss=yesMS64 CAPILLARY ISOTACHOPHORESIS AS AN OVERALL TOOL TO REVEAL ATHEROGENIC LIPOPROTEIN PHENOTYPEA. Dergunov, S. Visvikis-Siest, G. Siest10.1016/S1567-5688(10)70565-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations123123MS65 WOMEN'S HEALTH: ESTROGEN, PROGESTINS AND BLOOD PRESSUREhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705663/abstract?rss=yesMS65 WOMEN'S HEALTH: ESTROGEN, PROGESTINS AND BLOOD PRESSURER.-M. Korth10.1016/S1567-5688(10)70566-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations123123MS66 MODIFIED, EXTRACTED BARLEY BETA GLUCAN (BBG) EFFECTIVELY LOWERS LDL CHOLESTEROL DESPITE REDUCED VISCOSITYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705675/abstract?rss=yesMS66 MODIFIED, EXTRACTED BARLEY BETA GLUCAN (BBG) EFFECTIVELY LOWERS LDL CHOLESTEROL DESPITE REDUCED VISCOSITYJ. Keenan10.1016/S1567-5688(10)70567-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations123123MS67 INTERRELATION BETWEEN OBSTRUCTIVE SLEEP APNEA AND LIPID SPECTRUM AMONG CARDIOVASCULAR PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705687/abstract?rss=yesMS67 INTERRELATION BETWEEN OBSTRUCTIVE SLEEP APNEA AND LIPID SPECTRUM AMONG CARDIOVASCULAR PATIENTSN. Belinskaya, L. Yashina10.1016/S1567-5688(10)70568-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations123123MS68 ATHEROGENIC DISLIPIDEMIA IN METABOLIC SYNDROME: ROLE OF INSULIN RESISTANCE, NONESTERIFIED FATTY ACIDS AND ADIPOKINEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705699/abstract?rss=yesMS68 ATHEROGENIC DISLIPIDEMIA IN METABOLIC SYNDROME: ROLE OF INSULIN RESISTANCE, NONESTERIFIED FATTY ACIDS AND ADIPOKINESD. Tanyanskiy, E. Firova, L. Shatilina, A. Denisenko10.1016/S1567-5688(10)70569-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations123124MS69 THE FATE OF apo A-I AND apo A-II DURING LIPOSOME–HDL INTERACTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705705/abstract?rss=yesMS69 THE FATE OF apo A-I AND apo A-II DURING LIPOSOME–HDL INTERACTIONM. Czyżewska, A. Wolska, A. Szutowicz, B. Kortas-Stempak, M. Wróblewska10.1016/S1567-5688(10)70570-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations124124MS70 STUDY ON THE MOLECULAR BASIS OF FAMILIAL HYPERCHOLESTEROLEMIA IN MEXICO. ADVANCES OF PROJECThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705717/abstract?rss=yesMS70 STUDY ON THE MOLECULAR BASIS OF FAMILIAL HYPERCHOLESTEROLEMIA IN MEXICO. ADVANCES OF PROJECTG. Vaca, A. Vázquez, M.T. Magaña, M.L. Ramírez, I.P. Dávalos, B. Marín, E. Martínez, G. Carrillo10.1016/S1567-5688(10)70571-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations124124MS71 CRP, LIPIDS AND LIPOPROTEINS AFTER HORMONAL CONTRACEPTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705729/abstract?rss=yesMS71 CRP, LIPIDS AND LIPOPROTEINS AFTER HORMONAL CONTRACEPTIONV. Soska, J. Fiala, D. Hruba, K. Nebeska10.1016/S1567-5688(10)70572-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations124124MS72 CHOLESTEROL EFFLUX CAPACITY OF MOUSE PERITONEAL MACROPHAGES IS INDEPENDENT OF HUMAN apo A-II EXPRESSION LEVEL AND DIETARY FAT CONTENThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705730/abstract?rss=yesMS72 CHOLESTEROL EFFLUX CAPACITY OF MOUSE PERITONEAL MACROPHAGES IS INDEPENDENT OF HUMAN apo A-II EXPRESSION LEVEL AND DIETARY FAT CONTENTS. Maïga, A. Gaaya, L. Fourchaud, N. Fournier, M. Chabert, A. Kalopissis10.1016/S1567-5688(10)70573-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations124124MS73 DECREASE OF PLASMA LEVELS OF LIPOPROTEIN A [Lp(a)] AFTER ADMINISTRATION OF L-CARNITINEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705742/abstract?rss=yesMS73 DECREASE OF PLASMA LEVELS OF LIPOPROTEIN A [Lp(a)] AFTER ADMINISTRATION OF L-CARNITINEK. Gkogkos, O. Nikitidou, E. Panara, O. Siarkou, C. Miggos, T. Plougarlis, G. Pavlidis10.1016/S1567-5688(10)70574-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations124125MS74 THE IMPACT OF EZETIMIBE ADMINISTRATION ON THE LIPID PROFILE OF PATIENTS WITH PRIMARY DYSLIPIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705754/abstract?rss=yesMS74 THE IMPACT OF EZETIMIBE ADMINISTRATION ON THE LIPID PROFILE OF PATIENTS WITH PRIMARY DYSLIPIDEMIAK. Gkogkos, O. Siarkou, O. Nikitidou, E. Panara, C. Miggos, T. Plougarlis, G. Pavlidis10.1016/S1567-5688(10)70575-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations125125MS75 RELM-α REDUCES ATHEROSCLEROSIS VIA REGULATION OF LIPID METABOLISMhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705766/abstract?rss=yesMS75 RELM-α REDUCES ATHEROSCLEROSIS VIA REGULATION OF LIPID METABOLISMY.-H. Lee, M.-R. Lee, M. Cho, G.T. Oh10.1016/S1567-5688(10)70576-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations125125MS76 SINGLE DOSES OF 2 FORMULATIONS OF PITAVASTATIN SHOW EQUIVALENT PHARMACOKINETICS IN HEALTHY EUROPID AND JAPANESE MENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705778/abstract?rss=yesMS76 SINGLE DOSES OF 2 FORMULATIONS OF PITAVASTATIN SHOW EQUIVALENT PHARMACOKINETICS IN HEALTHY EUROPID AND JAPANESE MENN. Hounslow, S. Nakagawa, S. Warrington10.1016/S1567-5688(10)70577-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations125125MS77 HORMONOTHERAPY AND LIPIDS IN POSTMENOPAUSAL WOMEN WITH BREAST CANCERhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070578X/abstract?rss=yesMS77 HORMONOTHERAPY AND LIPIDS IN POSTMENOPAUSAL WOMEN WITH BREAST CANCERC. Kypridemos, K. Rossios, K. Traianou, C. Dontas, F. Lagra, X. Krokidis, S. Papantoniou, P. Papadopoulou-Zekeridou10.1016/S1567-5688(10)70578-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations125125MS78 MONITORING OF PLATELET FUNCTION AND EICOSANOID RELEASE USING LC-MS/MS IN PATIENTS WITH PHENYLKETONURIA (PKU)http://www.atherosclerosis-supplements.com/article/PIIS1567568810705791/abstract?rss=yesMS78 MONITORING OF PLATELET FUNCTION AND EICOSANOID RELEASE USING LC-MS/MS IN PATIENTS WITH PHENYLKETONURIA (PKU)U. Mütze, S. Beblo, U. Ceglarek, M. Brügel, L. Kortz, G.M. Fiedler, A. Leichtle, J. Thiery, W. Kiess10.1016/S1567-5688(10)70579-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations125125MS79 MOLECULAR STUDY OF LPL, APOAIV, APOAV, APOCII AND APOCIII GENES IN PATIENTS WITH HYPERTRIGLYCERIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705808/abstract?rss=yesMS79 MOLECULAR STUDY OF LPL, APOAIV, APOAV, APOCII AND APOCIII GENES IN PATIENTS WITH HYPERTRIGLYCERIDEMIAT. Santos, A. Gaspar, I.M. Gaspar, Q. Rato, M. Bourbon10.1016/S1567-5688(10)70580-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations125126MS80 LIPOPROTEIN FILTRATION BY MONET: FIRST CLINICAL APPLICATION IN LDL REMOVALhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070581X/abstract?rss=yesMS80 LIPOPROTEIN FILTRATION BY MONET: FIRST CLINICAL APPLICATION IN LDL REMOVALJ. Ringel10.1016/S1567-5688(10)70581-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations126126MS81 LIVER-SPECIFIC LIPOPLEXES FOR THE KNOCKDOWN OF SCAVENGER RECEPTOR CLASS B TYPE Ihttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705821/abstract?rss=yesMS81 LIVER-SPECIFIC LIPOPLEXES FOR THE KNOCKDOWN OF SCAVENGER RECEPTOR CLASS B TYPE IK. Duwensee, I. Tancevski, E. Demetz, P. Eller, C. Heim, E. Huber, A. Schroll, A. Ritsch, J. Patsch10.1016/S1567-5688(10)70582-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations126126MS82 A NEW METHOD TO FIND OUT THE HYDROPHILITY OF SERUM-LIPOPROTEINShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705833/abstract?rss=yesMS82 A NEW METHOD TO FIND OUT THE HYDROPHILITY OF SERUM-LIPOPROTEINSG. Schrot10.1016/S1567-5688(10)70583-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations126126MS83 LIPID PROFILE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ATTENDED IN OUR HOSPITALhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705845/abstract?rss=yesMS83 LIPID PROFILE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION ATTENDED IN OUR HOSPITALA. Gavarró, R. Tomas, G. Celma, M. Martinez, Y. Sanchez10.1016/S1567-5688(10)70584-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations126126MS84 DIFFERENTIAL SORTING OF apoER2 AND VLDL RECEPTOR AND IMPLICATIONS TO THE REELIN SIGNALING PATHWAYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705857/abstract?rss=yesMS84 DIFFERENTIAL SORTING OF apoER2 AND VLDL RECEPTOR AND IMPLICATIONS TO THE REELIN SIGNALING PATHWAYJ. Nimpf10.1016/S1567-5688(10)70585-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations126126MS85 LIPID PEROXIDATION WAS REDUCED BY AEROBIC TRAINING IN WOMEN WITH METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705869/abstract?rss=yesMS85 LIPID PEROXIDATION WAS REDUCED BY AEROBIC TRAINING IN WOMEN WITH METABOLIC SYNDROMEM. Rosety-Rodriguez, G. Fornieles-Gonzalez, I. Rosety, M.A. Rosety, N. Garcia-Gomez, A. Camacho, F.J. Ordoñez10.1016/S1567-5688(10)70586-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations127127MS86 HORMONAL-METABOLIC ASPECTS OF HYPERLIPIDAEMIAS IN NON-OBESE TYPE II DIABETIC PATIENTS WITH ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705870/abstract?rss=yesMS86 HORMONAL-METABOLIC ASPECTS OF HYPERLIPIDAEMIAS IN NON-OBESE TYPE II DIABETIC PATIENTS WITH ATHEROSCLEROSISV. Anestiadi, V. Anestiadis, Z. Anestiadi10.1016/S1567-5688(10)70587-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations127127MS87 AGE-RELATED ELEVATED LEVEL OF C-TERMINAL TRUNCATED APOLIPOPROTEIN A-I IN HIGH-DENSITY LIPOPROTEIN WITH AN INCREASE OF CHOLESTERYL ESTER TRANSFER ACTIVITYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705882/abstract?rss=yesMS87 AGE-RELATED ELEVATED LEVEL OF C-TERMINAL TRUNCATED APOLIPOPROTEIN A-I IN HIGH-DENSITY LIPOPROTEIN WITH AN INCREASE OF CHOLESTERYL ESTER TRANSFER ACTIVITYK.-H. Park, W. Jang, D.-G. Shin, J.-R. Kim, K.-H. Cho10.1016/S1567-5688(10)70588-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations127127MS88 FEMALES WITH ANGINA PECTORIS HAVE ALTERED LIPOPROTEIN METABOLISM WITH IMPAIRED HDL-ASSOCIATED ANTIOXIDANT ENZYMEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705894/abstract?rss=yesMS88 FEMALES WITH ANGINA PECTORIS HAVE ALTERED LIPOPROTEIN METABOLISM WITH IMPAIRED HDL-ASSOCIATED ANTIOXIDANT ENZYMESJ.-H. Lee, S.-M. Kim, K.-H. Cho10.1016/S1567-5688(10)70589-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations127127MS89 MECHANISM OF HYPERCHOLESTEROLEMIA IN PRAGUE HEREDITARY HYPERCHOLESTEROLEMIC (PHHC) RAThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705900/abstract?rss=yesMS89 MECHANISM OF HYPERCHOLESTEROLEMIA IN PRAGUE HEREDITARY HYPERCHOLESTEROLEMIC (PHHC) RATM. Zimolova, M. Coufalikova, M. Heczkova, R. Bohuslavova, V. Stranecky, R. Ivanek, M. Jirsa, R. Poledne, J. Kovar10.1016/S1567-5688(10)70590-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations127127MS90 ADIPOCYTE FACTORS, hsCRP AND MALONDIALDEHYDE LEVELS IN OVERWEIGHT POSTMENOPAUSAL WOMEN WITH NORMAL AND IMPAIRED OGTThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705912/abstract?rss=yesMS90 ADIPOCYTE FACTORS, hsCRP AND MALONDIALDEHYDE LEVELS IN OVERWEIGHT POSTMENOPAUSAL WOMEN WITH NORMAL AND IMPAIRED OGTTE. Kassi, G. Hroussalas, M. Dalamaga, K. Kazanis, G. Merantzi, A. Zachari, E.J. Giamarellos-Bourboulis, A. Dionyssiou-Asteriou10.1016/S1567-5688(10)70591-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations127128MS91 PCSK9: FROM GENE AND VARIANTS TO PROTEIN AND PLASMA LEVELShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705924/abstract?rss=yesMS91 PCSK9: FROM GENE AND VARIANTS TO PROTEIN AND PLASMA LEVELSM. AbiFadel, J.-P. Rabès, M. Varret, M.-E. Samson-Bouma, E. Bruckert, M. Devillers, V. Carreau, L. Tosolini, M. Marduel, A. Marques, P. Couvert, D. Bonnefont-Rousselot, M. Guérin, A. Carrié, A. Prat, N. Seidah, C. Boileau10.1016/S1567-5688(10)70592-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations128128MS92 ANTI OX-LDL ANTIBODIES CORRELATE WITH SOLUBLE INTERLEUKIN 2 RECEPTOR IN PATIENTS WITH CLINICALLY DIAGNOSED FAMILIAL HYPERCHOLESTEROLEMIA (FH)http://www.atherosclerosis-supplements.com/article/PIIS1567568810705936/abstract?rss=yesMS92 ANTI OX-LDL ANTIBODIES CORRELATE WITH SOLUBLE INTERLEUKIN 2 RECEPTOR IN PATIENTS WITH CLINICALLY DIAGNOSED FAMILIAL HYPERCHOLESTEROLEMIA (FH)M. Walus-Miarka, A. Hubalewska-Dydejczyk, D. Fedak, M. Opalinska, T. Stompor, P. Miarka, D. Czarnecka, B. Idzior-Walus10.1016/S1567-5688(10)70593-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations128128MS93 HYPOLIPIDEMIC EFFECTS OF Salvia officinalis L. LEAVES IN NORMAL AND STREPTOZOTOCIN-INDUCED DIABETIC RATShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705948/abstract?rss=yesMS93 HYPOLIPIDEMIC EFFECTS OF Salvia officinalis L. LEAVES IN NORMAL AND STREPTOZOTOCIN-INDUCED DIABETIC RATSA. Eidi, M. Eidi10.1016/S1567-5688(10)70594-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations128128MS94 CHANGES IN PRESCRIPTION PATTERNS FOR EZETIMIBE/SIMVASTATIN, EZETIMIBE + STATIN AND STATIN THERAPIES AND EXPECTED EFFECTS ON LDL-C REDUCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070595X/abstract?rss=yesMS94 CHANGES IN PRESCRIPTION PATTERNS FOR EZETIMIBE/SIMVASTATIN, EZETIMIBE + STATIN AND STATIN THERAPIES AND EXPECTED EFFECTS ON LDL-C REDUCTIONP. Toth, C. Ballantyne, M. Davidson, D. Ramey, D. Neff, A. Tershakovec, H. Hu, J. Tomassini, K. Tunceli10.1016/S1567-5688(10)70595-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations128129MS95 LIPIDAEMIC PROFILE IN PATIENTS WITH ACUTE CORONARY SYNDROME IN A GREEK URBAN POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705961/abstract?rss=yesMS95 LIPIDAEMIC PROFILE IN PATIENTS WITH ACUTE CORONARY SYNDROME IN A GREEK URBAN POPULATIONI. Kanonidis, K. Martiadou, G. Rompolas, C. Kagiadaki, D. Eclisiarhos, G. Dadoush, G. Sakantamis10.1016/S1567-5688(10)70596-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations129129MS96 THE METABOLIC SYNDROME CANDIDATE GENE POLYMORPHISMS AND POSTPRANDIAL CHANGES IN LDL DENSITY. THE EU LIPGENE STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705973/abstract?rss=yesMS96 THE METABOLIC SYNDROME CANDIDATE GENE POLYMORPHISMS AND POSTPRANDIAL CHANGES IN LDL DENSITY. THE EU LIPGENE STUDYA. Dembinska-Kiec, M. Malczewska-Malec, J. Hartwich, D. Siedlecka, I. Wybranska, B. Kiec-Wilk, P. Perez-Martinez, C. Marin, J. Lopez-Miranda, A. Tierney, J. Mc Monagle, H. Roche, C. Defoort, P. Wolkow10.1016/S1567-5688(10)70597-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations129129MS97 THE EFFECT OF THE n-3/n-6 PUFA RATIO ON THE TRANSFORMATION OF POSTPRANDIAL STATE PROATHEROGENIC LDL PHENOTYPE AND OXIDATIVE STRESS PARAMETERShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705985/abstract?rss=yesMS97 THE EFFECT OF THE n-3/n-6 PUFA RATIO ON THE TRANSFORMATION OF POSTPRANDIAL STATE PROATHEROGENIC LDL PHENOTYPE AND OXIDATIVE STRESS PARAMETERSA. Dembinska-Kiec, M. Malczewska-Malec, H. Roche, I. Leszczynska-Golabek, J. Hartwich, I. Wybranska, B. Kiec-Wilk, P. Perez-Martinez, C. Defort, P. Wolkow, J. Lopez-Miranda10.1016/S1567-5688(10)70598-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations129130MS98 CHOLESTEROL-LOWERING EFFECT OF FORMALDEHYDE INJECTIONS IN SUPER-LOW DOSEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810705997/abstract?rss=yesMS98 CHOLESTEROL-LOWERING EFFECT OF FORMALDEHYDE INJECTIONS IN SUPER-LOW DOSESE. Tereshina, S. Ivanenko10.1016/S1567-5688(10)70599-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations130130MS99 SEASONAL DIFFERENCES IN TRANS-SIALIDASES ACTIVITYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706000/abstract?rss=yesMS99 SEASONAL DIFFERENCES IN TRANS-SIALIDASES ACTIVITYE. Orekhova, V. Myasoedova, I. Sobenin, A. Orekhov10.1016/S1567-5688(10)70600-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations130130MS100 CORRELATION BETWEEN LAG TIME OF LDL TO IN VITRO OXIDATION AND IN VIVO OX-LDL IN THE PATIENTS WITH CADhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706012/abstract?rss=yesMS100 CORRELATION BETWEEN LAG TIME OF LDL TO IN VITRO OXIDATION AND IN VIVO OX-LDL IN THE PATIENTS WITH CADH. Nayeri, G.A. Naderi, S. Asgary, F. Pakmehr, M. Sadeghi, E. Javadi10.1016/S1567-5688(10)70601-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations130130MS101 EVIDENCE OF INCREASED SDLDL PARTICLES DURING ACUTE INFECTION WITH EPSTEIN–BARR VIRUShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706024/abstract?rss=yesMS101 EVIDENCE OF INCREASED SDLDL PARTICLES DURING ACUTE INFECTION WITH EPSTEIN–BARR VIRUSF. Apostolou, I. Gazi, V. Saougos, A. Tselepis, M. Elisaf, E. Liberopoulos10.1016/S1567-5688(10)70602-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations130130MS102 LIPIDS-INDEPENDENT EFFECTS ON BRAIN ISCHEMIC STROKEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706036/abstract?rss=yesMS102 LIPIDS-INDEPENDENT EFFECTS ON BRAIN ISCHEMIC STROKESM. Talebi, V. Ehsasat, S.A. Sadredini, A. Taheragdam10.1016/S1567-5688(10)70603-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations130130MS103 AN 8-WEEK AEROBIC TRAINING PROGRAM INCREASED ADIPONECTIN LEVELS IN YOUNG MALE ADULTS WITH METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706048/abstract?rss=yesMS103 AN 8-WEEK AEROBIC TRAINING PROGRAM INCREASED ADIPONECTIN LEVELS IN YOUNG MALE ADULTS WITH METABOLIC SYNDROMEM.A. Rosety, G. Fornieles-Gonzalez, I. Rosety, M. Rosety-Rodriguez, F.J. Ordoñez10.1016/S1567-5688(10)70604-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations131131MS104 THE RELATIONSHIP BETWEEN LEPTIN SERUM CONCENTRATIONS AND PRODUCTION OF SMALL, DENSE LDL PARTICLEShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070605X/abstract?rss=yesMS104 THE RELATIONSHIP BETWEEN LEPTIN SERUM CONCENTRATIONS AND PRODUCTION OF SMALL, DENSE LDL PARTICLESZ. Vogrinc, M. Trbojevic-Cepe, J. Sertic, Z. Reiner10.1016/S1567-5688(10)70605-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations131131MS105 ARYLESTERASE ACTIVITY IN NEONATES FROM THE MERIDA'S COHORThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706061/abstract?rss=yesMS105 ARYLESTERASE ACTIVITY IN NEONATES FROM THE MERIDA'S COHORTF. Sanchez-Muniz, E. Gesteiro, M. Vázquez-Velasco, R. Lucas, S. Bastida10.1016/S1567-5688(10)70606-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations131131MS106 PORTUGUESE FAMILIAL HYPERCHOLESTEROLAEMIA STUDY: FINDING THE GENETIC DEFECT TO PREVENT PREMATURE CARDIOVASCULAR DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706073/abstract?rss=yesMS106 PORTUGUESE FAMILIAL HYPERCHOLESTEROLAEMIA STUDY: FINDING THE GENETIC DEFECT TO PREVENT PREMATURE CARDIOVASCULAR DISEASEA.M. Medeiros, A.C. Alves, S. Silva, V. Francisco, M. Bourbon10.1016/S1567-5688(10)70607-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations131131MS107 TO EVALUATE THE FUNCTIONS OF FOODS OR FORMULA THAT CAN REDUCE RISK PARAMETERS OF METABOLIC SYNDROME BY AN ANIMAL MODELhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706085/abstract?rss=yesMS107 TO EVALUATE THE FUNCTIONS OF FOODS OR FORMULA THAT CAN REDUCE RISK PARAMETERS OF METABOLIC SYNDROME BY AN ANIMAL MODELC.C. Yu, J. Tsai10.1016/S1567-5688(10)70608-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations131131MS108 LIPID LEVELS IN 4 COHORTS OF HYPERTENSIVE PATIENTS AND THEIR RELATIONSHIP WITH BLOOD PRESSURE IN PRIMARY CARE SPAIN. TAPAS STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706097/abstract?rss=yesMS108 LIPID LEVELS IN 4 COHORTS OF HYPERTENSIVE PATIENTS AND THEIR RELATIONSHIP WITH BLOOD PRESSURE IN PRIMARY CARE SPAIN. TAPAS STUDYT. Mantilla, A. Galgo, C. Suarez, A. Modrego, J.M. Mateo, B. Fernandez, R. Sendino, R. Dominguez, J. Gallardo, M. Leal10.1016/S1567-5688(10)70609-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations132132MS109 HIGH SERUM CHOLESTEROL AND ELECTRICAL INSTABILITY IN PATIENTS WITH AN OLD MYOCARDIAL INFARCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706103/abstract?rss=yesMS109 HIGH SERUM CHOLESTEROL AND ELECTRICAL INSTABILITY IN PATIENTS WITH AN OLD MYOCARDIAL INFARCTIONI. Mozos, M. Hancu10.1016/S1567-5688(10)70610-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations132132MS110 PLASMA PLANT STEROLS AND THE RISK OF CORONARY HEART DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706115/abstract?rss=yesMS110 PLASMA PLANT STEROLS AND THE RISK OF CORONARY HEART DISEASEG. Fauler, G. Silbernagel, B. Winkelmann, B. Boehm, W. März10.1016/S1567-5688(10)70611-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations132132MS111 SERUM CHOLESTEROL, TRIGLYCERIDES AND THE QT INTERVAL IN HYPERTENSIVE PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706127/abstract?rss=yesMS111 SERUM CHOLESTEROL, TRIGLYCERIDES AND THE QT INTERVAL IN HYPERTENSIVE PATIENTSI. Mozos, C. Costea10.1016/S1567-5688(10)70612-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations132132MS112 CORRELATION OF THE LIPIDEMIC PROFILE IN THE GENERAL POPULATION WITH AGE AND GENDER IN THE RURAL OF KASTORIA OF GREECEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706139/abstract?rss=yesMS112 CORRELATION OF THE LIPIDEMIC PROFILE IN THE GENERAL POPULATION WITH AGE AND GENDER IN THE RURAL OF KASTORIA OF GREECEC. Charalampous, S. Patiakas10.1016/S1567-5688(10)70613-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations132132MS113 EFFECTS OF ALCOHOLIC EXTRACT OF Olea europea L. LEAVES ON SERUM LIPIDS AND ACTIVITIES OF AMINOTRANSFERASE ENZYMEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706140/abstract?rss=yesMS113 EFFECTS OF ALCOHOLIC EXTRACT OF Olea europea L. LEAVES ON SERUM LIPIDS AND ACTIVITIES OF AMINOTRANSFERASE ENZYMESR. Hajikhani, J. Solati10.1016/S1567-5688(10)70614-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations132133MS114 HDL-CHOLESTEROL: ONE OF THE PRIME TARGETS IN THE TREATMENT OF CORONARY HEART DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706152/abstract?rss=yesMS114 HDL-CHOLESTEROL: ONE OF THE PRIME TARGETS IN THE TREATMENT OF CORONARY HEART DISEASEL.M. Srivastava, S. Das, A. Manocha, S. Bhargava, M. Kankra10.1016/S1567-5688(10)70615-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations133133MS115 LIPOPROTEIN(a) AND LIPID STATUS IN END STAGE RENAL DISEASE PATIENTS ON HEMODIALYSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706164/abstract?rss=yesMS115 LIPOPROTEIN(a) AND LIPID STATUS IN END STAGE RENAL DISEASE PATIENTS ON HEMODIALYSISD. Labudovik, K. Tosheska Trajkovska, S. Alabakovska10.1016/S1567-5688(10)70616-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations133133MS116 POST OPERATIVE PATTERNS OF SEX HORMONES LEVEL CHANGES IN THE MALE PATIENTS UNDERGOING CABGhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706176/abstract?rss=yesMS116 POST OPERATIVE PATTERNS OF SEX HORMONES LEVEL CHANGES IN THE MALE PATIENTS UNDERGOING CABGT. Emami Meybodi, S.K. Foruzannia, M.H. Abdollahi, S. Zare, H.R. Dehghan10.1016/S1567-5688(10)70617-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations133133MS117 THERE IS NO CORRELATION BETWEEN SERUM DEHYDROEPIANDROSTERONE SULPHATE AND SERUM HIGH DENSITY LIPOPROTEIN LEVELS IN TURKISH POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706188/abstract?rss=yesMS117 THERE IS NO CORRELATION BETWEEN SERUM DEHYDROEPIANDROSTERONE SULPHATE AND SERUM HIGH DENSITY LIPOPROTEIN LEVELS IN TURKISH POPULATIONH. Kilic, M.G. Vural, A.G. Ertem, R. Akdemir10.1016/S1567-5688(10)70618-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations133133MS118 CONCENTRATED ORANGE JUICE CONSUMPTION EFFECTS ON PLASMA LIPIDS, apo B AND HDL LIPID TRANSFER IN HYPERCHOLESTEROLEMIC SUBJECTShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070619X/abstract?rss=yesMS118 CONCENTRATED ORANGE JUICE CONSUMPTION EFFECTS ON PLASMA LIPIDS, apo B AND HDL LIPID TRANSFER IN HYPERCHOLESTEROLEMIC SUBJECTSN. Aptekmann, T. Cesar, M. Araújo, C. Vinagre, R. Maranhão10.1016/S1567-5688(10)70619-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations133133MS119 HYPOLIPIDEMIC EFFECT OF ETHANOLIC EXTRACT OF Allium ampeloprasum L. LEAVES IN HEALTHY AND DIABETIC NMARI MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706206/abstract?rss=yesMS119 HYPOLIPIDEMIC EFFECT OF ETHANOLIC EXTRACT OF Allium ampeloprasum L. LEAVES IN HEALTHY AND DIABETIC NMARI MICEM. Eidi, A. Eidi, P. Shahmohammadi, S. Khalaji10.1016/S1567-5688(10)70620-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations133134MS120 HYPERCHOLESTEROLEMIC INFANT WITH A POSSIBLE LPL DEFICIENCY – A CASE REPORThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706218/abstract?rss=yesMS120 HYPERCHOLESTEROLEMIC INFANT WITH A POSSIBLE LPL DEFICIENCY – A CASE REPORTA. Manocha, S. Bhargava, M. Kankra, S. Das, L.M. Srivastava10.1016/S1567-5688(10)70621-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations134134MS121 LIPID LEVEL OF PLASMA IN RATS AND THEIR BEHAVIOR AFTER SHOCKhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070622X/abstract?rss=yesMS121 LIPID LEVEL OF PLASMA IN RATS AND THEIR BEHAVIOR AFTER SHOCKN. Klyueva, S. Tsikunov, A. Denisenko, A. Pshenichnaya10.1016/S1567-5688(10)70622-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations134134MS122 LEPTIN CONTENT IN BLOOD SERUM OF WOMEN WITH ISCHEMIC HEART DISEASE AND OBESITYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706231/abstract?rss=yesMS122 LEPTIN CONTENT IN BLOOD SERUM OF WOMEN WITH ISCHEMIC HEART DISEASE AND OBESITYT. Suslova, O. Ogurkova, I. Kologrivova, O. Koshelskaya10.1016/S1567-5688(10)70623-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations134134MS123 INFLUENCE OF ATORVASTATIN ON OXIDATIVE LOW DENSITY LIPOPROTEINS MODIFICATION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706243/abstract?rss=yesMS123 INFLUENCE OF ATORVASTATIN ON OXIDATIVE LOW DENSITY LIPOPROTEINS MODIFICATION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSIONO. Ogurkova, T. Suslova, I. Kologrivova, O. Koshelskaya10.1016/S1567-5688(10)70624-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations134134MS124 SERUM CHOLESTEROL, TRIGLYCERIDES AND RENAL FUNCTION IN HYPERTENSIVE PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706255/abstract?rss=yesMS124 SERUM CHOLESTEROL, TRIGLYCERIDES AND RENAL FUNCTION IN HYPERTENSIVE PATIENTSI. Mozos, C. Costea, C. Serban, L. Susan10.1016/S1567-5688(10)70625-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations134134MS125 STRATEGIES FOR RAISING HDL AND REDUCING CHDhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706267/abstract?rss=yesMS125 STRATEGIES FOR RAISING HDL AND REDUCING CHDE. Schaefer10.1016/S1567-5688(10)70626-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations135135MS126 FATTY ACIDS AND FATTY ALDEHYDES IN MEMBRANE PATHOLOGY OF ERYTHROCYTES IN CASE OF ANGIOPATHY STATES OF VARIOUS GENESIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706279/abstract?rss=yesMS126 FATTY ACIDS AND FATTY ALDEHYDES IN MEMBRANE PATHOLOGY OF ERYTHROCYTES IN CASE OF ANGIOPATHY STATES OF VARIOUS GENESISA. Osipenko, N. Kruchinsky10.1016/S1567-5688(10)70627-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations135135MS127 EXPRESSIONS OF MACROPHAGE METALLOELASTASE (MMP-12) IN EXTRACELLULAR MATRIX OF ATHEROSCLEROTIC TISSUES FOLLOWING DISRUPTION OF THE VASCULAR ENDOTHELIAL SURFACEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706280/abstract?rss=yesMS127 EXPRESSIONS OF MACROPHAGE METALLOELASTASE (MMP-12) IN EXTRACELLULAR MATRIX OF ATHEROSCLEROTIC TISSUES FOLLOWING DISRUPTION OF THE VASCULAR ENDOTHELIAL SURFACEM. Mustakim, G.A. Froemming, M.S. Abdul Rahman, H. Nawawi, N. Ismail, E. Omar, M.S. Mohamed Said10.1016/S1567-5688(10)70628-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations135135MS128 ENDOTHELIAL ephrinB2 STIMULATES DIAPEDESIS AND PRO-INFLAMMATORY ACTIVATION OF MONOCYTES AT ATHEROSCLEROSIS-PRONE SITEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706292/abstract?rss=yesMS128 ENDOTHELIAL ephrinB2 STIMULATES DIAPEDESIS AND PRO-INFLAMMATORY ACTIVATION OF MONOCYTES AT ATHEROSCLEROSIS-PRONE SITESJ. Braun, S. Hoffmann, A. Feldner, M. Hecker, T. Korff10.1016/S1567-5688(10)70629-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations135135MS129 WNT5A EXPRESSION IN HUMAN ATHEROSCLEROTIC PLAQUES IS ELEVATED IN MACROPHAGE-RICH AND COMPLICATED PLAQUEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706309/abstract?rss=yesMS129 WNT5A EXPRESSION IN HUMAN ATHEROSCLEROTIC PLAQUES IS ELEVATED IN MACROPHAGE-RICH AND COMPLICATED PLAQUESR. Malgor, C.J. Lewis, C. Keller, L. Kohn, M.J. Silver, D.J. Goetz10.1016/S1567-5688(10)70630-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations135135MS130 EXPRESSION PATTERN OF LONG PENTRAXIN 3 (PTX3) IN HUMAN ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706310/abstract?rss=yesMS130 EXPRESSION PATTERN OF LONG PENTRAXIN 3 (PTX3) IN HUMAN ATHEROSCLEROSISA. Savchenko, A. Inoue, R. Ohashi, K. Inoue, S. Jiang, G. Hasegawa, M. Naito10.1016/S1567-5688(10)70631-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations135136MS131 THE EXPRESSION OF CYTOKINE GENES IN THE AORTA INFLUENCED BY DIET: THE EFFECT OF MCP-1 DEFICIENCYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706322/abstract?rss=yesMS131 THE EXPRESSION OF CYTOKINE GENES IN THE AORTA INFLUENCED BY DIET: THE EFFECT OF MCP-1 DEFICIENCYA. Rull, R. Beltrán-Debón, G. Aragonès, F. Rodríguez, C. Alonso-Villaverde, J. Camps, J. Joven10.1016/S1567-5688(10)70632-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations136136MS132 QUANTITATIVE PROTEOMIC APPROACH TO IDENTIFY PROTEINS INVOLVED IN ACUTE CORONARY SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706334/abstract?rss=yesMS132 QUANTITATIVE PROTEOMIC APPROACH TO IDENTIFY PROTEINS INVOLVED IN ACUTE CORONARY SYNDROMEF. Gil-Dones, C.M. Laborde, S. Alonso-Orgaz, J. Moreu, F. Vivanco, L.R. Padial, M.G. Barderas10.1016/S1567-5688(10)70633-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations136136MS133 ENDOPLASMIC RETICULUM STRESS INHIBITION PREVENTS THE ABCA-1 REDUCTION IN GLYCATED ALBUMIN-TREATED MACROPHAGEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706346/abstract?rss=yesMS133 ENDOPLASMIC RETICULUM STRESS INHIBITION PREVENTS THE ABCA-1 REDUCTION IN GLYCATED ALBUMIN-TREATED MACROPHAGESG. Castilho, C.H. Sartori, A. Machado-Lima, E.R. Nakandakare, C.X.d.C. Santos, F.R. Laurindo, M. Passarelli10.1016/S1567-5688(10)70634-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations136136MS134 HISTONE ACETYLATION MODIFIERS BUTYRATE AND TRICHOSTATIN A MODULATE EXPRESSION OF HISTONE DEACETYLASES (HDACS) IN VASCULAR SMOOTH MUSCLE CELLS (VSMC)http://www.atherosclerosis-supplements.com/article/PIIS1567568810706358/abstract?rss=yesMS134 HISTONE ACETYLATION MODIFIERS BUTYRATE AND TRICHOSTATIN A MODULATE EXPRESSION OF HISTONE DEACETYLASES (HDACS) IN VASCULAR SMOOTH MUSCLE CELLS (VSMC)K. Ranganna, F. Yatsu, O. Mathew10.1016/S1567-5688(10)70635-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations136136MS135 ADIPOPHILIN LOW EXPRESSION REDUCE CELLULAR LIPIDhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070636X/abstract?rss=yesMS135 ADIPOPHILIN LOW EXPRESSION REDUCE CELLULAR LIPIDZ. Yuan, X. Liu, Q. Liu, Z. Liu, C. Tang, Z. Wang, G. Yi, L. Liu, Z. Jiang, Y. Yang10.1016/S1567-5688(10)70636-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations136137MS136 CELL PROLIFERATION IN DIFFERENT ATHEROSCLEROTIC LESIONS OF HUMAN ARTERIEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706371/abstract?rss=yesMS136 CELL PROLIFERATION IN DIFFERENT ATHEROSCLEROTIC LESIONS OF HUMAN ARTERIESA. Orekhov, E. Andreeva, I. Adrianova, J. Kzhyshkowska, A. Gratchev10.1016/S1567-5688(10)70637-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations137137MS137 COMPARISON OF 1.5 AND 3 TESLA MRI IN SCREENING FOR ATHEROSCLEROTIC PLAQUES IN THE ABDOMINAL AORTA IN HIGH-RISK PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706383/abstract?rss=yesMS137 COMPARISON OF 1.5 AND 3 TESLA MRI IN SCREENING FOR ATHEROSCLEROTIC PLAQUES IN THE ABDOMINAL AORTA IN HIGH-RISK PATIENTSJ.-H. Buhk, P. Bannas, A.-K. Finck-Wedel, R. Buchert, B. Schnackenburg, F.U. Beil, G. Adam, C. Weber10.1016/S1567-5688(10)70638-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations137137MS138 Origanum majorana L. PREVENTS CARDIOVASCULAR DISEASE CAUSED BY OBESITY: SUPPRESSION OF LEPTIN-INDUCED PROLIFERATION IN VASCULAR SMOOTH MUSCLE CELLShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706395/abstract?rss=yesMS138 Origanum majorana L. PREVENTS CARDIOVASCULAR DISEASE CAUSED BY OBESITY: SUPPRESSION OF LEPTIN-INDUCED PROLIFERATION IN VASCULAR SMOOTH MUSCLE CELLSY.-M. Yu, Y.-W. Tzeng, W.-C. Chang10.1016/S1567-5688(10)70639-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations137137MS139 IN-STENT RESTENOSIS IS ACCOMPANIED BY ELEVATION OF CIRCULATING EOSINOPHILShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706401/abstract?rss=yesMS139 IN-STENT RESTENOSIS IS ACCOMPANIED BY ELEVATION OF CIRCULATING EOSINOPHILSZ. Gabbasov, S. Kozlov, O. Saburova, A. Imaeva, O. Vasilieva, S. Domogatsky, V. Kucharchuk10.1016/S1567-5688(10)70640-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations137137MS140 EFFECTS OF COPPER AND MYELOPEROXIDASE-MODIFIED LDLS ON THE Nrf2 PATHWAY IN HUMAN ENDOTHELIAL CELLS UNDER STATIC AND SHEAR STRESS CONDITIONShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706413/abstract?rss=yesMS140 EFFECTS OF COPPER AND MYELOPEROXIDASE-MODIFIED LDLS ON THE Nrf2 PATHWAY IN HUMAN ENDOTHELIAL CELLS UNDER STATIC AND SHEAR STRESS CONDITIONSD. Calay, L. Caesens-Koenig, A. Rousseau, L. Mattart, V. Nuyens, N. Moguilevsky, K. Zouaoui Boudjeltia, M. Raes10.1016/S1567-5688(10)70641-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations137137MS141 GLUCOSE, INSULIN AND LEPTIN PROMOTE MONOCYTE SURFACE EXPRESSION OF CD36 AND PHAGOCYTOSIS OF OXIDIZED-LDL THROUGH Na+/H+ EXCHANGER-1 ACTIVATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706425/abstract?rss=yesMS141 GLUCOSE, INSULIN AND LEPTIN PROMOTE MONOCYTE SURFACE EXPRESSION OF CD36 AND PHAGOCYTOSIS OF OXIDIZED-LDL THROUGH Na+/H+ EXCHANGER-1 ACTIVATIONM. Sarigianni, K. Paletas, A. Tsapas, M. Kaloyianni, C. Befani, G. Koliakos10.1016/S1567-5688(10)70642-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations138138MS142 CIRCULATING MONOCYTE SUBSETS IN CRITICAL LIMB ISCHAEMIA (CLI)http://www.atherosclerosis-supplements.com/article/PIIS1567568810706437/abstract?rss=yesMS142 CIRCULATING MONOCYTE SUBSETS IN CRITICAL LIMB ISCHAEMIA (CLI)A. Patel, A. Smith, P. Saha, J. Humphries, K. Mattock, M. Waltham, B. Modarai10.1016/S1567-5688(10)70643-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations138138MS143 FRACTALKINE PROMOTES A PRO-INFLAMMATORY PHENOTYPE IN HUMAN SMOOTH MUSCLE CELLShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706449/abstract?rss=yesMS143 FRACTALKINE PROMOTES A PRO-INFLAMMATORY PHENOTYPE IN HUMAN SMOOTH MUSCLE CELLSA.-M. Gan, E. Butoi, D. Stan, M.-M. Pirvulescu, V. Simion, I. Manduteanu, M. Simionescu10.1016/S1567-5688(10)70644-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations138138MS144 MMP-10 UP-REGULATION IN PATIENTS WITH ENHANCED THROMBIN GENERATION: EVIDENCE IN VIVO AND IN VITRO OF A THROMBIN/CD40L MEDIATED MECHANISMhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706450/abstract?rss=yesMS144 MMP-10 UP-REGULATION IN PATIENTS WITH ENHANCED THROMBIN GENERATION: EVIDENCE IN VIVO AND IN VITRO OF A THROMBIN/CD40L MEDIATED MECHANISMS. Martínez de Lizarrondo, L. Montori, J.A. Rodríguez, C. Roncal, J.A. Páramo, J. Orbe10.1016/S1567-5688(10)70645-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations138138MS145 A NOVEL RAT EXPERIMENTAL MODEL CONFIRMS THE CRITICAL ROLE OF METALLOPROTEINASES-2 AND -9 IN THE DEVELOPMENT OF ABDOMINAL ANEURYSMShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706462/abstract?rss=yesMS145 A NOVEL RAT EXPERIMENTAL MODEL CONFIRMS THE CRITICAL ROLE OF METALLOPROTEINASES-2 AND -9 IN THE DEVELOPMENT OF ABDOMINAL ANEURYSMSK.M. Mata, P.S. Prudente, F.S. Rocha, C.M. Prado, E.M. Floriano, J. Elias, E. Rizzi, R.F. Gerlach, K. Metze, M.A. Rossi, S.G. Ramos10.1016/S1567-5688(10)70646-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations138139MS146 EFFECT OF QUINAPRIL ON MYOCARDIAL PERFUSION IN TYPE 2 DIABETES MELLITUShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706474/abstract?rss=yesMS146 EFFECT OF QUINAPRIL ON MYOCARDIAL PERFUSION IN TYPE 2 DIABETES MELLITUSN. Kipshidze, T. Davarashvili10.1016/S1567-5688(10)70647-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations139139MS147 HSP90 EXPRESSION AND RELEASE BY STRESSED HUMAN ENDOTHELIAL CELLShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706486/abstract?rss=yesMS147 HSP90 EXPRESSION AND RELEASE BY STRESSED HUMAN ENDOTHELIAL CELLSE. Profumo, D. D'Arcangelo, A. Tagliani, B. Buttari, F. Ippoliti, R. Riganò, R. Businaro10.1016/S1567-5688(10)70648-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations139139MS148 EVALUATION OF VASCULAR REACTIVITY IN A GROUP OF PATIENTS WITH GENETIC HAEMOCHROMATOSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706498/abstract?rss=yesMS148 EVALUATION OF VASCULAR REACTIVITY IN A GROUP OF PATIENTS WITH GENETIC HAEMOCHROMATOSISE. Di Giacomo, C. Donadio, G. Carlomagno, G. Albano, A. Lucariello10.1016/S1567-5688(10)70649-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations139139MS149 A CLINICAL STUDY OF AP-1 INHIBITION IN HUMAN ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706504/abstract?rss=yesMS149 A CLINICAL STUDY OF AP-1 INHIBITION IN HUMAN ATHEROSCLEROSISA. Meijer, P. le Haen, H. van Bockel, J. Lindeman10.1016/S1567-5688(10)70650-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations139139MS150 BASEMENT MEMBRANE ADAPTATIONS IN CRITICAL LIMB ISCHAEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706516/abstract?rss=yesMS150 BASEMENT MEMBRANE ADAPTATIONS IN CRITICAL LIMB ISCHAEMIAR. Aslam, K. Khan, X. Shiwen, S. Howat, J. Tsui, D. Baker10.1016/S1567-5688(10)70651-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations139140MS151 HUMAN SAPHENOUS VEIN CULTURE IN CONDITIONS OF ENDOTHELIUM DYSFUNCTION AND HYPERLIPIDEMIA: AN EX VIVO MODEL FOR EARLY DEVELOPMENT OF ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706528/abstract?rss=yesMS151 HUMAN SAPHENOUS VEIN CULTURE IN CONDITIONS OF ENDOTHELIUM DYSFUNCTION AND HYPERLIPIDEMIA: AN EX VIVO MODEL FOR EARLY DEVELOPMENT OF ATHEROSCLEROSISY. Maneerat, V. Khachansaksumeth, R. Nintasen, U. Chaisri, P. Viriyavejakul, P. Chartiburus10.1016/S1567-5688(10)70652-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations140140MS152 DEFICIENCY OF NPP1 ATTENUATES ATHEROSCLEROTIC LESION PROGRESSION IN apoE KNOCKOUT MICEhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070653X/abstract?rss=yesMS152 DEFICIENCY OF NPP1 ATTENUATES ATHEROSCLEROTIC LESION PROGRESSION IN apoE KNOCKOUT MICEY. Nitschke, G. Weissen-Plenz, R. Terkeltaub, F. Rutsch10.1016/S1567-5688(10)70653-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations140140MS153 MOLECULAR INVESTIGATION OF THE FUNCTIONAL RELEVANCE OF MISSENSE VARIANTS OF ICAM-1http://www.atherosclerosis-supplements.com/article/PIIS1567568810706541/abstract?rss=yesMS153 MOLECULAR INVESTIGATION OF THE FUNCTIONAL RELEVANCE OF MISSENSE VARIANTS OF ICAM-1B. Schmitz, P. Vischer, R. Telgmann, K. Schmidt-Petersen, K. Beining, A. Huge, M. Paul, P. Amarenco, F. Cambien, E. Brand, S.-M. Brand-Herrmann10.1016/S1567-5688(10)70654-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations140140MS154 PLATELET ACTIVATION INDUCES PHENOTYPIC AND FUNCTIONAL CHANGES IN CIRCULATING MONOCYTES AS A CONSEQUENCE OF MONOCYTE–PLATELET AGGREGATE FORMATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706553/abstract?rss=yesMS154 PLATELET ACTIVATION INDUCES PHENOTYPIC AND FUNCTIONAL CHANGES IN CIRCULATING MONOCYTES AS A CONSEQUENCE OF MONOCYTE–PLATELET AGGREGATE FORMATIONG. Passacquale, V. Corrigall, C. Hamid, A. Ferro10.1016/S1567-5688(10)70655-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations140140MS155 TO DETERMINE CIRCULATING VISFATIN LEVELS IN PATIENTS WITH MYOCARDIAL INFARCTION AND ITS RELATIONSHIP WITH THE SEVERITY OF STENOSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706565/abstract?rss=yesMS155 TO DETERMINE CIRCULATING VISFATIN LEVELS IN PATIENTS WITH MYOCARDIAL INFARCTION AND ITS RELATIONSHIP WITH THE SEVERITY OF STENOSISM.J. Hosseinzadeh Attar, M. Mazaherioun, B. Golestan, A. Vasheghany Farahany, A. Hosseinnezhad10.1016/S1567-5688(10)70656-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations140141MS156 ENDOTHELIAL COLONY-FORMING CELL OUTGROWTH IS CORRELATED WITH INTIMA MEDIA THICKNESS AND CARDIOVASCULAR RISK FACTORS IN TYPE 2 DIABETIC PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706577/abstract?rss=yesMS156 ENDOTHELIAL COLONY-FORMING CELL OUTGROWTH IS CORRELATED WITH INTIMA MEDIA THICKNESS AND CARDIOVASCULAR RISK FACTORS IN TYPE 2 DIABETIC PATIENTSH. Sourij, N.A. Hofmann, N. Tripolt, A. Reinisch, M. Eder, T.R. Pieber, D. Strunk10.1016/S1567-5688(10)70657-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations141141MS157 INVESTIGATION OF THE FUNCTIONAL RELEVANCE OF VCAM-1 MISSENSE VARIANTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706589/abstract?rss=yesMS157 INVESTIGATION OF THE FUNCTIONAL RELEVANCE OF VCAM-1 MISSENSE VARIANTSB. Schmitz, P. Vischer, E. Brand, C. Fabritius, F. Cambien, R. Telgmann, S.-M. Brand-Herrmann10.1016/S1567-5688(10)70658-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations141141MS158 INFLAMMATION MARKERS AND ENDOTHELIUM FUNCTION IN THE PATIENTS WITH ATHEROSCLEROSIS, ARTERIAL HYPERTENSION AND CHRONICAL CEREBROVASCULAR PATHOLOGYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706590/abstract?rss=yesMS158 INFLAMMATION MARKERS AND ENDOTHELIUM FUNCTION IN THE PATIENTS WITH ATHEROSCLEROSIS, ARTERIAL HYPERTENSION AND CHRONICAL CEREBROVASCULAR PATHOLOGYA. Shabalina, M.V. Kostyreva, A.A. Shabalina, M.A. Kravchenko, A.O. Chechetkin, V.G. Ionova, Y.Y. Varakin, Z.A. Suslina10.1016/S1567-5688(10)70659-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations141141MS159 ATORVASTATIN INHIBITS OXIDIZED LOW-DENSITY LIPOPROTEIN INDUCED DIFFERENTIATION OF RAW264.7 MURINE MACROPAHGES INTO DENDRITIC LIKEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706607/abstract?rss=yesMS159 ATORVASTATIN INHIBITS OXIDIZED LOW-DENSITY LIPOPROTEIN INDUCED DIFFERENTIATION OF RAW264.7 MURINE MACROPAHGES INTO DENDRITIC LIKEH. Liuhua, S. Linghong, B. He, S. Qing, J. Shuxuan10.1016/S1567-5688(10)70660-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations141141MS160 THE ANTI-INFLAMMATORY AND ANTIAPOPTOTIC ACTION OF HUMANIN – A NEWLY DISCOVERED 24-AMINO ACID PEPTIDEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706619/abstract?rss=yesMS160 THE ANTI-INFLAMMATORY AND ANTIAPOPTOTIC ACTION OF HUMANIN – A NEWLY DISCOVERED 24-AMINO ACID PEPTIDEB. Zapala, A. Sliwa, J. Goralska, L. Kaczynski, I. Wybranska10.1016/S1567-5688(10)70661-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations141142MS161 PLASMA NITRIC OXIDE CONCENTRATIONS AND NITRIC OXIDE SYNTHASE GENE POLYMORPHISMS IN CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706620/abstract?rss=yesMS161 PLASMA NITRIC OXIDE CONCENTRATIONS AND NITRIC OXIDE SYNTHASE GENE POLYMORPHISMS IN CORONARY ARTERY DISEASES. Salimi, M. Firoozrai, A. Naghavi, S.M. Shafiee, A. Mohebbi10.1016/S1567-5688(10)70662-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations142142MS162 THE ROLE OF FIBRINOGEN Bβ-CHAIN N-TERMINUS IN PLATELET-FIBRINOGEN INTERACTIONShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706632/abstract?rss=yesMS162 THE ROLE OF FIBRINOGEN Bβ-CHAIN N-TERMINUS IN PLATELET-FIBRINOGEN INTERACTIONSV. Chernyshenko, T. Platonova10.1016/S1567-5688(10)70663-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations142142MS163 IMPACT OF CIGARETTE SMOKE ON NO BIOAVAILABILITY IN ENDOTHELIAL CELLS: ROLE OF VASCULAR NADPH OXIDASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706644/abstract?rss=yesMS163 IMPACT OF CIGARETTE SMOKE ON NO BIOAVAILABILITY IN ENDOTHELIAL CELLS: ROLE OF VASCULAR NADPH OXIDASEY. Steffen10.1016/S1567-5688(10)70664-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations142142MS164 PML NUCLEAR BODY COMPONENTS PLAY A ROLE IN ADIPOCYTOKINE REGULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706656/abstract?rss=yesMS164 PML NUCLEAR BODY COMPONENTS PLAY A ROLE IN ADIPOCYTOKINE REGULATIONL. Eissing, A. Bartelt, H. Sirma, J. Heeren10.1016/S1567-5688(10)70665-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations142142MS165 DECREASED EXPRESSION OF CD39 IN SYMPTOMATIC CAROTID ARTERY PLAQUEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706668/abstract?rss=yesMS165 DECREASED EXPRESSION OF CD39 IN SYMPTOMATIC CAROTID ARTERY PLAQUESY. Sato, S. Moriguchi-Goto, K. Hatakeyama, K. Marutsuka, Y. Asada10.1016/S1567-5688(10)70666-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations142143MS166 IMPACT OF ANDROGENS ON VASCULAR CELL PHYSIOLOGYhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070667X/abstract?rss=yesMS166 IMPACT OF ANDROGENS ON VASCULAR CELL PHYSIOLOGYS. Ling, L. Nazareth, L. Nheu, P. Komesaroff10.1016/S1567-5688(10)70667-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations143143MS167 KLF2 INDUCES SPECIFIC ACTIN SHEAR FIBRES ESSENTIAL FOR FLOW-ALIGNMENT AND PHENOTYPE OF VASCULAR ENDOTHELIUMhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706681/abstract?rss=yesMS167 KLF2 INDUCES SPECIFIC ACTIN SHEAR FIBRES ESSENTIAL FOR FLOW-ALIGNMENT AND PHENOTYPE OF VASCULAR ENDOTHELIUMT.A. Leyen, R.A. Boon, R.D. Fontijn, G.P. van Nieuw Amerongen, A.J.G. Horrevoets10.1016/S1567-5688(10)70668-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations143143MS168 UROKINASE PLASMINOGEN ACTIVATOR (UPA) PROVOKES MACROPHAGE ATHEROGENICITY AND APOPTOSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706693/abstract?rss=yesMS168 UROKINASE PLASMINOGEN ACTIVATOR (UPA) PROVOKES MACROPHAGE ATHEROGENICITY AND APOPTOSISB. Fuhrman, J. Khateeb, A. Gantman, M. Aviram10.1016/S1567-5688(10)70669-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations143143MS169 RESISTIN AND HIGH GLUCOSE MODULATE THE EXPRESSION OF FRACTALKINE RECEPTOR (CX3CR1) IN HUMAN MONOCYTEShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070670X/abstract?rss=yesMS169 RESISTIN AND HIGH GLUCOSE MODULATE THE EXPRESSION OF FRACTALKINE RECEPTOR (CX3CR1) IN HUMAN MONOCYTESD. Stan, M. Calin, E. Butoi, A.-M. Gan, M.M. Pirvulescu, V. Simion, I. Manduteanu, M. Simionescu10.1016/S1567-5688(10)70670-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations143143MS170 LOW-FLUENCE PDT IMPAIRS PHAGOCYTIC ACTIVITY OF HUMAN MACROPHAGEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706711/abstract?rss=yesMS170 LOW-FLUENCE PDT IMPAIRS PHAGOCYTIC ACTIVITY OF HUMAN MACROPHAGESO. Udartseva, E. Andreeva, L. Buravkova, I. Andrianova, E. Tararak10.1016/S1567-5688(10)70671-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations143144MS171 REGULATORY MECHANISMS IN CHEMOTAXIS OF DENDRITIC CELLS FROM HEALTHY BLOOD DONORS AND FROM PATIENTS WITH ACUTE MYOCARDIAL INFARCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706723/abstract?rss=yesMS171 REGULATORY MECHANISMS IN CHEMOTAXIS OF DENDRITIC CELLS FROM HEALTHY BLOOD DONORS AND FROM PATIENTS WITH ACUTE MYOCARDIAL INFARCTIONP. Wolkow, A. Gebska, J. Godlewski, J. Jawien, R. Olszanecki, M. Jawien, K. Zmudka, R. Korbut10.1016/S1567-5688(10)70672-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations144144MS172 SOME ALTERNATIVE DETERMINANTS OF VASCULAR STIFFNESS IN YOUNG INDIVIDUALS AT LOW CARDIOVASCULAR RISKhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706735/abstract?rss=yesMS172 SOME ALTERNATIVE DETERMINANTS OF VASCULAR STIFFNESS IN YOUNG INDIVIDUALS AT LOW CARDIOVASCULAR RISKO. Drokina, A. Semyonkin, G. Nechaeva, A. Zhenatov, L. Zhivilova, E. Lalyukova, I. Druk, A. Bogdalova, T. Miller10.1016/S1567-5688(10)70673-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations144144MS173 EFFECTS OF TUMOR NECROSIS FACTOR (TNF)-ALPHA AND 17-BETA ESTRADIOL (E2) ON PATHOLOGICAL CHANGES OF INTIMAL HYPERPLASIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706747/abstract?rss=yesMS173 EFFECTS OF TUMOR NECROSIS FACTOR (TNF)-ALPHA AND 17-BETA ESTRADIOL (E2) ON PATHOLOGICAL CHANGES OF INTIMAL HYPERPLASIAR. Nintasen, Y. Maneerat, P. Chartiburus, C. Punsawad, V. Khachansaksumeth, P. Viriyavejakul, U. Chaisri10.1016/S1567-5688(10)70674-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations144144MS174 CAN NEUROECTODERMAL ORIGIN OF SMOOTH MUSCLE CELLS IN AORTIC ATHEROSCLEROSIS BE A PREDISPOSING FACTOR FOR THE ACCUMULATION OF LIPIDS?http://www.atherosclerosis-supplements.com/article/PIIS1567568810706759/abstract?rss=yesMS174 CAN NEUROECTODERMAL ORIGIN OF SMOOTH MUSCLE CELLS IN AORTIC ATHEROSCLEROSIS BE A PREDISPOSING FACTOR FOR THE ACCUMULATION OF LIPIDS?I. Tanaskovic10.1016/S1567-5688(10)70675-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations144144MS175 PROTECTIVE EFFECT OF DIPHENYL DISELENIDE AGAINST PEROXYNITRITE-MEDIATED ENDOTHELIAL CELL TOXICITY: A COMPARISON WITH EBSELENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706760/abstract?rss=yesMS175 PROTECTIVE EFFECT OF DIPHENYL DISELENIDE AGAINST PEROXYNITRITE-MEDIATED ENDOTHELIAL CELL TOXICITY: A COMPARISON WITH EBSELENA. Bem, P. Brito, P. Calcerrada, G. Pellufo, T. Dinis, M. Trijillo, J.B. Rocha, R. Radi, L. Almeida10.1016/S1567-5688(10)70676-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations145145MS176 CAN THE VASCULAR SMOOTH MUSCLE CELLS PLAY A ROLE OF ANTIGEN-PRESENTING CELLS IN CORONARY ATHEROSCLEROSIS?http://www.atherosclerosis-supplements.com/article/PIIS1567568810706772/abstract?rss=yesMS176 CAN THE VASCULAR SMOOTH MUSCLE CELLS PLAY A ROLE OF ANTIGEN-PRESENTING CELLS IN CORONARY ATHEROSCLEROSIS?I. Tanaskovic10.1016/S1567-5688(10)70677-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations145145MS177 Citrus limon Burm f. CAN CHANGE AFFINITY OF LDL AND OX-LDL TO THEIR RECEPTORS IN RABBITS WITH ATHEROGENIC DIEThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706784/abstract?rss=yesMS177 Citrus limon Burm f. CAN CHANGE AFFINITY OF LDL AND OX-LDL TO THEIR RECEPTORS IN RABBITS WITH ATHEROGENIC DIETM. Boshtam, J. Moshtaghian, G. Naderi, S. Asgary10.1016/S1567-5688(10)70678-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations145145MS178 DOXYCYCLINE DOES NOT INTERFERE WITH THE POST-THROMBOTIC NEOINTIMA DEVELOPED IN AN EXPERIMENTAL MODEL SIMULATING AN AORTIC ECCENTRIC ATHEROSCLEROTIC PLAQUEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706796/abstract?rss=yesMS178 DOXYCYCLINE DOES NOT INTERFERE WITH THE POST-THROMBOTIC NEOINTIMA DEVELOPED IN AN EXPERIMENTAL MODEL SIMULATING AN AORTIC ECCENTRIC ATHEROSCLEROTIC PLAQUES.G. Ramos, C. Tefé-Silva, E.M. Floriano, J. Elias, M.R. Celes, M.A. Cortez, C.T. Beneli10.1016/S1567-5688(10)70679-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations145145MS179 THE ROLE OF HYPOXIA IN ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706802/abstract?rss=yesMS179 THE ROLE OF HYPOXIA IN ATHEROSCLEROSISL. Mattsson Hultén, M. Levin10.1016/S1567-5688(10)70680-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations145145MS180 SYSTEM INFLAMMATION MARKERS AND MARKERS OF ENDOTHELIAL FUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE (UNSTABLE AND STABLE ANGINA)http://www.atherosclerosis-supplements.com/article/PIIS1567568810706814/abstract?rss=yesMS180 SYSTEM INFLAMMATION MARKERS AND MARKERS OF ENDOTHELIAL FUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE (UNSTABLE AND STABLE ANGINA)I. Golikova10.1016/S1567-5688(10)70681-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations146146MS181 THE HAPTOGLOBIN 2–2 GENOTYPE IS ASSOCIATED WITH CAROTID ATHEROSCLEROSIS IN 64-YEAR OLD WOMEN WITH ESTABLISHED DIABETEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706826/abstract?rss=yesMS181 THE HAPTOGLOBIN 2–2 GENOTYPE IS ASSOCIATED WITH CAROTID ATHEROSCLEROSIS IN 64-YEAR OLD WOMEN WITH ESTABLISHED DIABETESM. Ryndel, C.J. Behre, G. Brohall, U. Prahl, C. Schmidt, G. Bergström, B. Fagerberg, F.J. Olson10.1016/S1567-5688(10)70682-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations146146MS182 NO EVIDENCE OF IMPAIRED ENDOTHELIAL FUNCTION OR ALTERED INFLAMMATORY STATE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA USING STATINShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706838/abstract?rss=yesMS182 NO EVIDENCE OF IMPAIRED ENDOTHELIAL FUNCTION OR ALTERED INFLAMMATORY STATE IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA USING STATINSI. Aagnes, A. Hovland, J.H. Flage, O.-L. Brekke, K.T. Lappegård10.1016/S1567-5688(10)70683-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations146146MS183 LONG-TERM EFFECT OF STATINS ON THE RISK OF NEW-ONSET DIABETES – A RETROSPECTIVE COHORT STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070684X/abstract?rss=yesMS183 LONG-TERM EFFECT OF STATINS ON THE RISK OF NEW-ONSET DIABETES – A RETROSPECTIVE COHORT STUDYG.-P. Jong, L. Tien, T. Ma10.1016/S1567-5688(10)70684-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations146146MS184 ADULTHOOD TELEVISION VIEWING RELATES INDEPENDENTLY TO CARDIOMETABOLIC RISK PROFILE IN EARLY MIDDLE AGEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706851/abstract?rss=yesMS184 ADULTHOOD TELEVISION VIEWING RELATES INDEPENDENTLY TO CARDIOMETABOLIC RISK PROFILE IN EARLY MIDDLE AGEE. Stamatakis, M. Hamer, G. Mishra10.1016/S1567-5688(10)70685-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations146146MS185 TF AND TFPI POLYMORPHISMS IN CORONARY HEART DISEASE AND DIABETES TYPE 2http://www.atherosclerosis-supplements.com/article/PIIS1567568810706863/abstract?rss=yesMS185 TF AND TFPI POLYMORPHISMS IN CORONARY HEART DISEASE AND DIABETES TYPE 2T. Opstad, A.Å. Pettersen, S. Åkra, T. Weiss, H. Arnesen, I. Seljeflot10.1016/S1567-5688(10)70686-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations146147MS186 BIOMARKERS OF ATHEROGENESIS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND THEIR CORRELATION WITH DISEASE ACTIVITYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706875/abstract?rss=yesMS186 BIOMARKERS OF ATHEROGENESIS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND THEIR CORRELATION WITH DISEASE ACTIVITYN. Bhowmik10.1016/S1567-5688(10)70687-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations147147MS187 THE VITAMIN E BINDING PROTEIN AFAMIN IS ASSOCIATED WITH THE METABOLIC SYNDROME AND INFERTILITYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706887/abstract?rss=yesMS187 THE VITAMIN E BINDING PROTEIN AFAMIN IS ASSOCIATED WITH THE METABOLIC SYNDROME AND INFERTILITYH. Dieplinger, G. Wietzorrek, S. Olscher, S. Kiechl, J. Willeit, G. Wakonigg, W. Engel, F. Kronenberg10.1016/S1567-5688(10)70688-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations147147MS188 SYSTEMIC LEVELS OF METALLOPROTEINASE-2/ITS INHIBITOR SYSTEM ARE ASSOCIATED WITH QUINOLINIC ACID LEVELS IN PATIENTS WITH CARDIOVASCULAR DISEASE ON PERITONEAL DIALYSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706899/abstract?rss=yesMS188 SYSTEMIC LEVELS OF METALLOPROTEINASE-2/ITS INHIBITOR SYSTEM ARE ASSOCIATED WITH QUINOLINIC ACID LEVELS IN PATIENTS WITH CARDIOVASCULAR DISEASE ON PERITONEAL DIALYSISK. Pawlak, J. Tankiewicz, M. Mysliwiec, D. Pawlak10.1016/S1567-5688(10)70689-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations147147MS189 ASSOCIATION OF TOLL-LIKE RECEPTOR-6 Pro249Ser POLYMORPHISM WITH DECREASED CYTOKINE PRODUCTION AND LOWER LEFT VENTRICULAR WALL THICKNESS IN HYPERTENSIVE WOMENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706905/abstract?rss=yesMS189 ASSOCIATION OF TOLL-LIKE RECEPTOR-6 Pro249Ser POLYMORPHISM WITH DECREASED CYTOKINE PRODUCTION AND LOWER LEFT VENTRICULAR WALL THICKNESS IN HYPERTENSIVE WOMENR. Schreiber, M.L. Sales, M.N. Fernandes, M.C. Ferreira-Sae, J.A. Cipolli, C. Piveta, J.R. Matos-Souza, A. Calixto, B. Geloneze, K.G. Franchini, W. Nadruz10.1016/S1567-5688(10)70690-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations147147MS190 PARENTAL PREDICTORS OF METABOLIC SYNDROME (JOINT INTERIM STATEMENT 2009 CRITERIA) IN ADULT CHILDREN OF PATIENTS WITH PREMATURE CORONARY HEART DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706917/abstract?rss=yesMS190 PARENTAL PREDICTORS OF METABOLIC SYNDROME (JOINT INTERIM STATEMENT 2009 CRITERIA) IN ADULT CHILDREN OF PATIENTS WITH PREMATURE CORONARY HEART DISEASEM. Konnov, L. Dobordzhginidze, A. Deev, N. Gratsiansky10.1016/S1567-5688(10)70691-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations148148MS191 BODY FAT RELATED TO RISK FACTORS FOR CVD IN YOUNGER CHILDRENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706929/abstract?rss=yesMS191 BODY FAT RELATED TO RISK FACTORS FOR CVD IN YOUNGER CHILDRENM. Dencker, O. Thorsson, M.K. Karlsson, C. Lindén, P. Wollmer, L.B. Andersen10.1016/S1567-5688(10)70692-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations148148MS192 COMPARISON OF RISK FACTOR GRAPH VERSUS FRAMINGHAM RISK SCORE IN PREDICTING THE POPULATION AT RISK OF ATHEROTHROMBOTIC DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706930/abstract?rss=yesMS192 COMPARISON OF RISK FACTOR GRAPH VERSUS FRAMINGHAM RISK SCORE IN PREDICTING THE POPULATION AT RISK OF ATHEROTHROMBOTIC DISEASEW. Feeman10.1016/S1567-5688(10)70693-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations148148MS193 THE RELATION BETWEEN ARTERIAL STIFFNESS AND AUTONOMIC NERVOUS FUNCTION CLASSICAL TESTS IN TYPE 2 DIABETIC PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706942/abstract?rss=yesMS193 THE RELATION BETWEEN ARTERIAL STIFFNESS AND AUTONOMIC NERVOUS FUNCTION CLASSICAL TESTS IN TYPE 2 DIABETIC PATIENTSD. Levisianou, A. Melidonis, S. Foussas, E. Adamopoulou, A. Koutsovasilis, T. Xenopoulou, G. Koukoulis, I. Skoularigis, F. Triposkiadis10.1016/S1567-5688(10)70694-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations148148MS194 THE INFLUENCE OF APOLIPOPROTEIN E GENETIC VARIANTS ON SERUM LIPIDS AND INSULIN RESISTANCE IN TARF STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706954/abstract?rss=yesMS194 THE INFLUENCE OF APOLIPOPROTEIN E GENETIC VARIANTS ON SERUM LIPIDS AND INSULIN RESISTANCE IN TARF STUDYE. Komurcu Bayrak, A. Onat, B. Yuzbasiogullari, N. Mononen, R. Laaksonen, G. Hergenc, S.E. Humphries, T. Lehtimäki, N. Erginel-Unaltuna10.1016/S1567-5688(10)70695-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations148149MS195 LOW BONE MINERAL DENSITY IS NOT ASSOCIATED WITH ANGIOGRAPHICALLY DETERMINED CORONARY ATHEROSCLEROSIS IN MENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706966/abstract?rss=yesMS195 LOW BONE MINERAL DENSITY IS NOT ASSOCIATED WITH ANGIOGRAPHICALLY DETERMINED CORONARY ATHEROSCLEROSIS IN MENS. Beer, C.H. Saely, G. Hoefle, P. Rein, A. Vonbank, J. Breuss, B. Gaensbacher, A. Muendlein10.1016/S1567-5688(10)70696-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations149149MS196 ARTERIAL STIFFNESS IS ASSOCIATED WITH LEFT VENTRICULAR FUNCTION IN PATIENTS WITH HYPERTENSION ARTERIAL AND DYSLIPIDAEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706978/abstract?rss=yesMS196 ARTERIAL STIFFNESS IS ASSOCIATED WITH LEFT VENTRICULAR FUNCTION IN PATIENTS WITH HYPERTENSION ARTERIAL AND DYSLIPIDAEMIAL. Agoston-Coldea, T. Mocan10.1016/S1567-5688(10)70697-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations149149MS197 GENETIC VARIANT RS4355801 A>G IS ASSOCIATED WITH BOTH ANGIOGRAPHICALLY DETERMINED CORONARY ATHEROSCLEROSIS AND BONE MINERAL DENSITYhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070698X/abstract?rss=yesMS197 GENETIC VARIANT RS4355801 A>G IS ASSOCIATED WITH BOTH ANGIOGRAPHICALLY DETERMINED CORONARY ATHEROSCLEROSIS AND BONE MINERAL DENSITYC.H. Saely, S. Beer, A. Muendlein, A. Vonbank, P. Rein, J. Breuss, B. Gaensbacher, H. Drexel10.1016/S1567-5688(10)70698-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations149149MS198 GENETIC VARIANT RS1051730 C>T IN THE NICOTINIC ACETYLCHOLINE RECEPTOR GENE CLUSTER ON CHROMOSOME 15Q24 SIGNIFICANTLY PREDICTS SMOKING SEVERITY IN CORONARYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810706991/abstract?rss=yesMS198 GENETIC VARIANT RS1051730 C>T IN THE NICOTINIC ACETYLCHOLINE RECEPTOR GENE CLUSTER ON CHROMOSOME 15Q24 SIGNIFICANTLY PREDICTS SMOKING SEVERITY IN CORONARYC.H. Saely, A. Muendlein, A. Vonbank, P. Rein, S. Beer, J. Breuss, B. Gaensbacher, H. Drexel10.1016/S1567-5688(10)70699-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations149149MS199 IMPACT OF MATERNAL AND PATERNAL HISTORY OF PREMATURE MYOCARDIAL INFARCTION ON THE AGE OF MANIFESTATION OF ACUTE CORONARY SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707005/abstract?rss=yesMS199 IMPACT OF MATERNAL AND PATERNAL HISTORY OF PREMATURE MYOCARDIAL INFARCTION ON THE AGE OF MANIFESTATION OF ACUTE CORONARY SYNDROMEJ. Pitha, V. Stanek, R. Poledne, M. Gebauerova, M. Aschermann, H. Skalicka, J. Matouskova, A. Kruger, M. Penicka, H. Hrabakova, J. Veselka, P. Hajek10.1016/S1567-5688(10)70700-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations149150MS200 PERCEPTION OF THE RELEVANCE OF LIPID PARAMETERS AND TARGET VALUES ESTIMATED BY PHYSICIANS IN EUROPE/CANADA: LESSONS LEARNED FROM DYSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707017/abstract?rss=yesMS200 PERCEPTION OF THE RELEVANCE OF LIPID PARAMETERS AND TARGET VALUES ESTIMATED BY PHYSICIANS IN EUROPE/CANADA: LESSONS LEARNED FROM DYSISW. Smolka, C. Juenger, K. Bestehorn, A.K. Gitt10.1016/S1567-5688(10)70701-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations150150MS201 LUPINE KERNEL FIBRE CAN HELP TO MANAGE RISK FACTORS FOR ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707029/abstract?rss=yesMS201 LUPINE KERNEL FIBRE CAN HELP TO MANAGE RISK FACTORS FOR ATHEROSCLEROSISA. Fechner, G. Jahreis10.1016/S1567-5688(10)70702-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations150150MS202 INCIDENCE OF ACUTE, SUBACUTE, LATE AND VERY LATE IN-STENT THROMBOSIS IN PATIENTS WITH ACS AFTER DES AND BMS IMPLANTINGhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707030/abstract?rss=yesMS202 INCIDENCE OF ACUTE, SUBACUTE, LATE AND VERY LATE IN-STENT THROMBOSIS IN PATIENTS WITH ACS AFTER DES AND BMS IMPLANTINGA.L. Romano, A. Azzano, G. Zampi, F. Fini, V. Paravati, C. Gaudio10.1016/S1567-5688(10)70703-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations150150MS203 WHY WE ARE UNABLE TO FIND CHD GENE – apoE AN EXAMPLEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707042/abstract?rss=yesMS203 WHY WE ARE UNABLE TO FIND CHD GENE – apoE AN EXAMPLER. Poledne, J. Pitha, J. Hubacek, P. Stavek, R. Cifkova, V. Lanska10.1016/S1567-5688(10)70704-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations150150MS204 ECCENTRIC ENDURANCE EXERCISE SIGNIFICANTLY IMPROVES FASTING GLUCOSE AND GLUCOSE TOLERANCE IN NON-DIABETIC SUBJECTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707054/abstract?rss=yesMS204 ECCENTRIC ENDURANCE EXERCISE SIGNIFICANTLY IMPROVES FASTING GLUCOSE AND GLUCOSE TOLERANCE IN NON-DIABETIC SUBJECTSA. Vonbank, C.H. Saely, P. Rein, S. Aczel, S. Beer, V. Kiene, T. Bochdansky10.1016/S1567-5688(10)70705-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations150151MS205 A RANDOMIZED OPEN TRIAL OF VARENICLINE VERSUS NICOTINE PATCH IN ADULT SMOKERS: EFFICACY, SAFETY AND WITHDRAWAL SYMPTOMS (THE VN-SEESAW STUDY)http://www.atherosclerosis-supplements.com/article/PIIS1567568810707066/abstract?rss=yesMS205 A RANDOMIZED OPEN TRIAL OF VARENICLINE VERSUS NICOTINE PATCH IN ADULT SMOKERS: EFFICACY, SAFETY AND WITHDRAWAL SYMPTOMS (THE VN-SEESAW STUDY)H. Tsukahara, K. Noda, Y. Uehara, K. Saku10.1016/S1567-5688(10)70706-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations151151MS206 IMPAIRED GLUCOSE TOLERANCE, INFLAMMATION AND MALNUTRITION SYNDROME IN OLDER PATIENTS WITH A SUBCLINICAL FORM OF PRIMARY HYPOTHYREOIDISMhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707078/abstract?rss=yesMS206 IMPAIRED GLUCOSE TOLERANCE, INFLAMMATION AND MALNUTRITION SYNDROME IN OLDER PATIENTS WITH A SUBCLINICAL FORM OF PRIMARY HYPOTHYREOIDISML. Majnaric, B. Vitale10.1016/S1567-5688(10)70707-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations151151MS207 IMPORTANCE OF INSULIN RESISTANCE AND GLUCOSE INTOLERANCE IN PREMENOPAUSAL WOMEN WITH POLYCYSTIC OVARIES AND POLYCYSTIC OVARIAN SYNDROME (PCOS)http://www.atherosclerosis-supplements.com/article/PIIS156756881070708X/abstract?rss=yesMS207 IMPORTANCE OF INSULIN RESISTANCE AND GLUCOSE INTOLERANCE IN PREMENOPAUSAL WOMEN WITH POLYCYSTIC OVARIES AND POLYCYSTIC OVARIAN SYNDROME (PCOS)D. Paul, I. Pantea, L. Nedelcu, A. Stoicescu, C. Scarneciu10.1016/S1567-5688(10)70708-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations151151MS208 URIC ACID, ENDOTHELIAL FUNCTION AND CARDIOVASCULAR RISKhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707091/abstract?rss=yesMS208 URIC ACID, ENDOTHELIAL FUNCTION AND CARDIOVASCULAR RISKE.E. Babes, V.V. Babes, A. Ardelean, M.I. Popescu10.1016/S1567-5688(10)70709-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations151151MS209 NEW EVENT OF MYOCARDIAL INFARCTION (MI) IN PATIENTS WITH PAST MI: AGE, SEX AND TREATMENT DIFFERENCEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707108/abstract?rss=yesMS209 NEW EVENT OF MYOCARDIAL INFARCTION (MI) IN PATIENTS WITH PAST MI: AGE, SEX AND TREATMENT DIFFERENCESA. Ioannidis, K. Oikonomou, M. Ntalapascha, E. Karapatsoudi, I. Karantoumanis, K. Karali, P. Makridis10.1016/S1567-5688(10)70710-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations151152MS210 ASSOCIATIONS BETWEEN SERUM ALANINE AMINOTRANSFERASE LEVELS AND CARDIOVASCULAR RISK FACTORS IN JAPANESE MENhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070711X/abstract?rss=yesMS210 ASSOCIATIONS BETWEEN SERUM ALANINE AMINOTRANSFERASE LEVELS AND CARDIOVASCULAR RISK FACTORS IN JAPANESE MENY. Ikeda, Y. Kumon, T. Ohguro, N. Hisakawa, A. Ishibashi, H. Takata, M. Inoue, Y. Terada10.1016/S1567-5688(10)70711-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations152152MS211 OBESITY AND CARDIOVASCULAR RISK IN NORTHERN GREECE. ATHOS CARDIO GREECE STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707121/abstract?rss=yesMS211 OBESITY AND CARDIOVASCULAR RISK IN NORTHERN GREECE. ATHOS CARDIO GREECE STUDYA. Efthimiadis, I. Kanonidis, G. Sakantamis, C. Manes, E. Paschalidou, I. Efthimiadis, S. Pavlidou, A. Tavridou10.1016/S1567-5688(10)70712-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations152152MS212 ADELINA: EFFECTS OF HIGH-DOSE ATORVASTATIN ON ESTIMATED CARDIOVASCULAR RISK AND ADIPOKINE PRODUCTION IN DYSLIPAEMIC NON-DIABETIC PATIENTS WITH METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707133/abstract?rss=yesMS212 ADELINA: EFFECTS OF HIGH-DOSE ATORVASTATIN ON ESTIMATED CARDIOVASCULAR RISK AND ADIPOKINE PRODUCTION IN DYSLIPAEMIC NON-DIABETIC PATIENTS WITH METABOLIC SYNDROMEF. Martinez-Martin, P. Soriano Perera10.1016/S1567-5688(10)70713-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations152152MS213 CORONARY HEART DISEASE IN PATIENTS WITH STROKE – PATHOPHYSIOLOGIC CORRELATIONS EPIDEMIOLOGIC STUDY IN THE GREEK POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707145/abstract?rss=yesMS213 CORONARY HEART DISEASE IN PATIENTS WITH STROKE – PATHOPHYSIOLOGIC CORRELATIONS EPIDEMIOLOGIC STUDY IN THE GREEK POPULATIONI. Kanonidis, K. Martiadou, G. Rompolas, N. Sailer, S. Tzotzis, C. Kagiadaki, D. Eclisiarhos, G. Sakantamis10.1016/S1567-5688(10)70714-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations152152MS214 ASSOCIATION BETWEEN LOW HDL-C AND FAMILY HISTORY OF PREMATURE CORONARY HEART DISEASE IN SPANISH STATIN-TREATED PATIENTS. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)http://www.atherosclerosis-supplements.com/article/PIIS1567568810707157/abstract?rss=yesMS214 ASSOCIATION BETWEEN LOW HDL-C AND FAMILY HISTORY OF PREMATURE CORONARY HEART DISEASE IN SPANISH STATIN-TREATED PATIENTS. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)J. Millan, J.R. Gonzalez-Juanatey, C. Guijarro, E. Alegria, J.V. Lozano, B. Gonzalez-Timon, G. Vitale10.1016/S1567-5688(10)70715-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations153153MS215 IDENTIFICATION OF GENES ASSOCIATED WITH QT INTERVAL USING THE 50K CARDIO-METABOLIC SNP CHIP: RESULTS FROM THE WHITEHALL II STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707169/abstract?rss=yesMS215 IDENTIFICATION OF GENES ASSOCIATED WITH QT INTERVAL USING THE 50K CARDIO-METABOLIC SNP CHIP: RESULTS FROM THE WHITEHALL II STUDYS. Shah, F. Drenos, T. Shah, J. Palmen, R. Sofat, M. Kumari, J. Pallas, P. MacFarlane, J. Whittaker, P. Talmud, S. Humphries, A. Hingorani10.1016/S1567-5688(10)70716-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations153153MS216 IL6 AND IL10 GENES ARE ASSOCIATED WITH UNFAVOURABLE OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707170/abstract?rss=yesMS216 IL6 AND IL10 GENES ARE ASSOCIATED WITH UNFAVOURABLE OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROMEK. Blagodatskikh, J. Agapkina, A. Nikitin, M. Evdokimova, V. Osmolovskaya, V. Nosikov, D. Zateyshchikov10.1016/S1567-5688(10)70717-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations153153MS217 ASSOCIATION OF THE CHOLESTEROL ESTER TRANSFER PROTEIN GENE (CETP) WITH CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707182/abstract?rss=yesMS217 ASSOCIATION OF THE CHOLESTEROL ESTER TRANSFER PROTEIN GENE (CETP) WITH CORONARY ARTERY DISEASEA. Brovkin, E. Dankovtseva, A. Nikitin, L. Minushkina, D. Zateyshchikov, V. Nosikov10.1016/S1567-5688(10)70718-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations153153MS218 ANTI-PHOSHOLIPID ANTIBODIES IN ACUTE CORONARY ATHEROTHROMBOSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707194/abstract?rss=yesMS218 ANTI-PHOSHOLIPID ANTIBODIES IN ACUTE CORONARY ATHEROTHROMBOSISI. Burazor, A. Vojdani, M. Burazor10.1016/S1567-5688(10)70719-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations153153MS219 ACUTE CHANGES IN SERUM HEAT SHOCK PROTEIN 27 ANTIGEN AND IGM CONCENTRATIONS IN PATIENTS WITH ACUTE CORONARY SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707200/abstract?rss=yesMS219 ACUTE CHANGES IN SERUM HEAT SHOCK PROTEIN 27 ANTIGEN AND IGM CONCENTRATIONS IN PATIENTS WITH ACUTE CORONARY SYNDROMED.F. Pengiran Burut, S. Shafi, G. Ferns10.1016/S1567-5688(10)70720-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations154154MS220 INTIMA-MEDIA THICKNESS, BODY MASS INDEX AND GLUCOSE METABOLISM IN ADOLESCENT GIRLS AND YOUNG WOMENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707212/abstract?rss=yesMS220 INTIMA-MEDIA THICKNESS, BODY MASS INDEX AND GLUCOSE METABOLISM IN ADOLESCENT GIRLS AND YOUNG WOMENA. Starodubova, O. Kisliak, D. Sargaeva, G. Storozhakov, V. Sergienko, V. Govorun, A. Kopelev10.1016/S1567-5688(10)70721-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations154154MS221 PREVALENCE OF ABDOMINAL OBESITY AND ITS ASSOCIATION WITH BLOOD PRESSUREhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707224/abstract?rss=yesMS221 PREVALENCE OF ABDOMINAL OBESITY AND ITS ASSOCIATION WITH BLOOD PRESSUREG. Simonyi, L. Halmy, T. Csatay, M. Medvegy, R.J. Bedros10.1016/S1567-5688(10)70722-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations154154MS222 RELATIONSHIP BETWEEN PLASMA ADMA AND HOMOCYSTEINE LEVELS AND CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707236/abstract?rss=yesMS222 RELATIONSHIP BETWEEN PLASMA ADMA AND HOMOCYSTEINE LEVELS AND CORONARY ARTERY DISEASES. Isbilir10.1016/S1567-5688(10)70723-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations154154MS223 INFLUENCE OF VITAMIN STATUS AND GENETIC POLYMORPHISM ON PLASMA HOMOCYSTEINE LEVEL IN RUSSIAN PATIENTS WITH STABLE CADhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707248/abstract?rss=yesMS223 INFLUENCE OF VITAMIN STATUS AND GENETIC POLYMORPHISM ON PLASMA HOMOCYSTEINE LEVEL IN RUSSIAN PATIENTS WITH STABLE CADO. Shakhmatova, A. Komarov, D. Rebrikov, I. Kofiadi, T. Kotkina, E. Panchenko10.1016/S1567-5688(10)70724-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations154154MS224 AGE, SEX AND SOCIOECONOMIC STATUS LARGELY DETERMINE SMOKING-RISK AWARENESShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070725X/abstract?rss=yesMS224 AGE, SEX AND SOCIOECONOMIC STATUS LARGELY DETERMINE SMOKING-RISK AWARENESST. Chimonas, P. Petrikos, E. Kostopoulos, E. Fanouraki, D. Panagiotakos, E. Chimonas, M. Elisaf10.1016/S1567-5688(10)70725-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations155155MS225 ACCEPTANCE OF MEASURES TO CURTAIL TOBACCO USE AMONG THE GREEK POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707261/abstract?rss=yesMS225 ACCEPTANCE OF MEASURES TO CURTAIL TOBACCO USE AMONG THE GREEK POPULATIONT. Chimonas, P. Petrikos, P. Papasavvas, C. Karkadaris, D. Panagiotakos, E. Chimonas, M. Elisaf10.1016/S1567-5688(10)70726-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations155155MS226 TOBACCO USE AND RISK AWARENESS AMONG A MOSTLY YOUNG ADULT POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707273/abstract?rss=yesMS226 TOBACCO USE AND RISK AWARENESS AMONG A MOSTLY YOUNG ADULT POPULATIONT. Chimonas, P. Petrikos, E. Kostopoulos, E. Fanouraki, D. Panagiotakos, E. Chimonas, M. Elisaf10.1016/S1567-5688(10)70727-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations155155MS227 BLOOD PRESSURE LEVELS CONSTITUTE THE MOST IMPORTANT DETERMINANT OF THE METABOLIC SYNDROME, IN A GREEK SAMPLEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707285/abstract?rss=yesMS227 BLOOD PRESSURE LEVELS CONSTITUTE THE MOST IMPORTANT DETERMINANT OF THE METABOLIC SYNDROME, IN A GREEK SAMPLET. Chimonas, V. Athyros, A. Karagiannis, A. Achimastos, C. Pitsavos, M. Elisaf, D. Panagiotakos10.1016/S1567-5688(10)70728-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations155155MS228 TYPE 2 DIABETES AND THE CORONARY ANGIOGRAPHIC STATE ARE MUTUALLY INDEPENDENT PREDICTORS OF FUTURE VASCULAR EVENTS AMONG ANGIOGRAPHIED CORONARY PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707297/abstract?rss=yesMS228 TYPE 2 DIABETES AND THE CORONARY ANGIOGRAPHIC STATE ARE MUTUALLY INDEPENDENT PREDICTORS OF FUTURE VASCULAR EVENTS AMONG ANGIOGRAPHIED CORONARY PATIENTSC.H. Saely, T. Gansch, S. Greber, P. Rein, A. Vonbank, S. Beer, F. Schmid, T. Marte, H. Drexel10.1016/S1567-5688(10)70729-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations155155MS229 CORRELATION BETWEEN CAROTID ATHEROSCLEROTID DISEASE AND MULTI-VESSELS CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707303/abstract?rss=yesMS229 CORRELATION BETWEEN CAROTID ATHEROSCLEROTID DISEASE AND MULTI-VESSELS CORONARY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROMEA. Azzano, F. Fini, A.L. Romano, G. Zampi, V. Paravati, C. Gaudio10.1016/S1567-5688(10)70730-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations156156MS230 INSULIN RESISTANCE IS ASSOCIATED WITH METABOLIC SYNDROME BUT NOT WITH ANGIOGRAPHICALLY DETERMINED CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707315/abstract?rss=yesMS230 INSULIN RESISTANCE IS ASSOCIATED WITH METABOLIC SYNDROME BUT NOT WITH ANGIOGRAPHICALLY DETERMINED CORONARY ARTERY DISEASEA. Vonbank, C.H. Saely, P. Rein, S. Beer, M. Woess, J. Breuss, B. Gaensbacher, H. Drexel10.1016/S1567-5688(10)70731-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations156156MS231 ENDOTHELIAL PROGENITORS CELLS AND MICROPARTICLES IN HIV-INFECTED PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707327/abstract?rss=yesMS231 ENDOTHELIAL PROGENITORS CELLS AND MICROPARTICLES IN HIV-INFECTED PATIENTSE. Ferrari Rafael Silva, F.A.H. Fonseca, C.N. França, P.R.A. Ferreira, C.M. Monteiro, L.M. Camargo, R. Salomão, S.B. Tenore, D.S. Lewi10.1016/S1567-5688(10)70732-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations156156MS232 B2-MICROGLOBULIN, A NOVEL BIOMARKER OF PERIPHERAL ARTERIAL DISEASE, IS INDEPENDENTLY ASSOCIATED WITH AORTIC STIFFNESS IN THESE PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707339/abstract?rss=yesMS232 B2-MICROGLOBULIN, A NOVEL BIOMARKER OF PERIPHERAL ARTERIAL DISEASE, IS INDEPENDENTLY ASSOCIATED WITH AORTIC STIFFNESS IN THESE PATIENTSJ. Kals, M. Zagura, M. Serg, P. Kampus, K. Zilmer, E. Unt, J. Lieberg, J. Eha, A. Peetsalu, M. Zilmer10.1016/S1567-5688(10)70733-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations156156MS233 DYSLIPIDEMIA AND CARDIOVASCULAR RISK IN NORTHERN GREECE. ATHOS CARDIO GREECE STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707340/abstract?rss=yesMS233 DYSLIPIDEMIA AND CARDIOVASCULAR RISK IN NORTHERN GREECE. ATHOS CARDIO GREECE STUDYA. Efthimiadis, I. Kanonidis, G. Sakantamis, I. Efthimiadis, E. Paschalidou, S. Pavlidou, A. Tavridou10.1016/S1567-5688(10)70734-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations156156MS234 SMOKING AND CARDIOVASCULAR RISK IN NORTHERN GREECE. ATHOS CARDIO GREECE STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707352/abstract?rss=yesMS234 SMOKING AND CARDIOVASCULAR RISK IN NORTHERN GREECE. ATHOS CARDIO GREECE STUDYA. Efthimiadis, A. Tavridou, I. Kanonidis, I. Efthimiadis, E. Paschalidou, S. Pavlidou, G. Sakantamis10.1016/S1567-5688(10)70735-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations157157MS235 EFFECTS OF FOOD ON POSTPRANDIAL BLOOD PRESSURE AND ARTERIAL STIFFNESS MEASUREMENThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707364/abstract?rss=yesMS235 EFFECTS OF FOOD ON POSTPRANDIAL BLOOD PRESSURE AND ARTERIAL STIFFNESS MEASUREMENTM. Ball, I. Robertson, K. Ahuja10.1016/S1567-5688(10)70736-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations157157MS236 PREVALENCE OF THE CAROTID-INTIMA-MEDIA THICKNESS AND CAROTID PLAQUES IN HYPERTENSIVE PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707376/abstract?rss=yesMS236 PREVALENCE OF THE CAROTID-INTIMA-MEDIA THICKNESS AND CAROTID PLAQUES IN HYPERTENSIVE PATIENTSJ. Ble-Castillo, L. Cantera-Rangel, A. Garcia-Magaña, F. Aguilar-Balcazar, H. Ble-Castillo, S. Aguilar-Barojas, I. Juarez-Rojop, A. Rodriguez-Hernández, H. Aguilar-Mariscal, J. Díaz-Zagoya10.1016/S1567-5688(10)70737-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations157157MS237 SERUM ATHEROGENIC LIPID MARKERS IN SUBJECTS FROM THREE ISLANDS OF THE AZORES' ARCHIPELAGO (PORTUGAL) – A COMPARISON STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707388/abstract?rss=yesMS237 SERUM ATHEROGENIC LIPID MARKERS IN SUBJECTS FROM THREE ISLANDS OF THE AZORES' ARCHIPELAGO (PORTUGAL) – A COMPARISON STUDYR. Ferin, C. Correia, M. Raposo, A.R. Castro, C. Reis, T. Vieira, B. Gonçalves, M.L. Pavão10.1016/S1567-5688(10)70738-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations157157MS238 RISK FACTORS PREVALENCE AND CONTROL IN SECONDARY PREVENTION AFTER MYOCARDIAL INFARCTION AND ISCHEMIC STROKE IN UKRAINIAN URBAN AREAhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070739X/abstract?rss=yesMS238 RISK FACTORS PREVALENCE AND CONTROL IN SECONDARY PREVENTION AFTER MYOCARDIAL INFARCTION AND ISCHEMIC STROKE IN UKRAINIAN URBAN AREAA. Yagensky, I. Sichkaruk, N. Sydor, J. Kyyak, E. Zaremba, L. Dukhnevych10.1016/S1567-5688(10)70739-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations157157MS239 ADIPOSE TISSUE INFLAMMATORY ACTIVITY IS ASSOCIATED WITH CARDIOVASCULAR DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707406/abstract?rss=yesMS239 ADIPOSE TISSUE INFLAMMATORY ACTIVITY IS ASSOCIATED WITH CARDIOVASCULAR DISEASET. Weiss, I. Seljeflot, E. Hjerkinn, H. Arnesen10.1016/S1567-5688(10)70740-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations157158MS240 INTERRELATIONSHIP BETWEEN PULSE WAVE VELOCITY AND RISK FACTORS OF ATHEROSCLEROSIS IN YOUNG HEALTHY PERSONShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707418/abstract?rss=yesMS240 INTERRELATIONSHIP BETWEEN PULSE WAVE VELOCITY AND RISK FACTORS OF ATHEROSCLEROSIS IN YOUNG HEALTHY PERSONST. Pronko10.1016/S1567-5688(10)70741-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations158158MS241 FASTING BLOOD GLUCOSE LEVELS CORRELATE WITH SEVERITY OF CAROTID STENOSIS IN NON-DIABETIC HYPERLIPIDEMIC PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070742X/abstract?rss=yesMS241 FASTING BLOOD GLUCOSE LEVELS CORRELATE WITH SEVERITY OF CAROTID STENOSIS IN NON-DIABETIC HYPERLIPIDEMIC PATIENTSE. Skopelitis, D. Levisianou, S. Kougialis, N. Iliopoulos, T. Gogalis, A. Kroustalis, G. Groumas, E. Katsadorou, P. Terlis, A. Destounis, C. Drakoulis, C. Mpilinis10.1016/S1567-5688(10)70742-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations158158MS242 THE STUDY OF HEREDITARY FACTORS, PREDISPOSING TO THE DEVELOPMENT OF ANTIATHEROGENIC PHENOTYPE IN IV PATIENTS, ON EXAMPLE OF APOE-GENE POLYMORPHISMhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707431/abstract?rss=yesMS242 THE STUDY OF HEREDITARY FACTORS, PREDISPOSING TO THE DEVELOPMENT OF ANTIATHEROGENIC PHENOTYPE IN IV PATIENTS, ON EXAMPLE OF APOE-GENE POLYMORPHISMA. Allahverdyan, J. Maksimova, E. Schakhtschneider, S. Malyutina, V. Maksimov10.1016/S1567-5688(10)70743-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations158158MS243 FOOD, QUALITY OF LIFE AND ABDOMINAL OBESITYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707443/abstract?rss=yesMS243 FOOD, QUALITY OF LIFE AND ABDOMINAL OBESITYO. Bragina, L. Shcherbakova, G. Simonova10.1016/S1567-5688(10)70744-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations158158MS244 THE PREVALENCE OF MASKED HYPERTENSION IN TREATED TYPE 2 DIABETIC PATIENTS AND ITS ASSOCIATION WITH CARDIOVASCULAR TARGET ORGAN DAMAGEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707455/abstract?rss=yesMS244 THE PREVALENCE OF MASKED HYPERTENSION IN TREATED TYPE 2 DIABETIC PATIENTS AND ITS ASSOCIATION WITH CARDIOVASCULAR TARGET ORGAN DAMAGEJ. Charvat, J. Chlumský, M. Szabó, V. Zamrazil10.1016/S1567-5688(10)70745-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations158159MS245 FTO POLYMORPHISM IS ASSOCIATED WITH MYOCARDIAL INFARCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707467/abstract?rss=yesMS245 FTO POLYMORPHISM IS ASSOCIATED WITH MYOCARDIAL INFARCTIONJ. Hubacek10.1016/S1567-5688(10)70746-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations159159MS246 LIPID PROFILE OF SPANISH PATIENTS WITH CORONARY HEART DISEASE TREATED WITH STATINS. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)http://www.atherosclerosis-supplements.com/article/PIIS1567568810707479/abstract?rss=yesMS246 LIPID PROFILE OF SPANISH PATIENTS WITH CORONARY HEART DISEASE TREATED WITH STATINS. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)J. Millan, J.R. Gonzalez-Juanatey, C. Guijarro, E. Alegria, J.V. Lozano, B. Gonzalez-Timon, G. Vitale10.1016/S1567-5688(10)70747-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations159159MS247 LEPTIN, ADIPONECTIN AND LEPTIN TO ADIPONECTIN RATIO IN DEPRESSIVE WOMENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707480/abstract?rss=yesMS247 LEPTIN, ADIPONECTIN AND LEPTIN TO ADIPONECTIN RATIO IN DEPRESSIVE WOMENM. Zeman, R. Jirák, M. Vecka, A. Žák, J. Macášek, E. Tvrzická, T. Vařeka, L. Vávrová, J. Kodydková, B. Staňková10.1016/S1567-5688(10)70748-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations159159MS248 WAIST CIRCUMFERENCE NEGATIVE CORRELATION WITH TESTOSTERONE AND SHBG IN YOUTH WITH PRE-METABOLIC AND METABOLIC SYNDROMEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707492/abstract?rss=yesMS248 WAIST CIRCUMFERENCE NEGATIVE CORRELATION WITH TESTOSTERONE AND SHBG IN YOUTH WITH PRE-METABOLIC AND METABOLIC SYNDROMESV. Dimitrijevic-Sreckovic, P. Djordjevic, S. Damjanovic, B. Sreckovic, V. Barac, I. Soldatovic, M. Cvetkovic10.1016/S1567-5688(10)70749-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations159159MS249 ASSOCIATION OF THE Q223R POLYMORPHISM IN THE LEPTIN RECEPTOR GENE WITH AGE AT MENARCHEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707509/abstract?rss=yesMS249 ASSOCIATION OF THE Q223R POLYMORPHISM IN THE LEPTIN RECEPTOR GENE WITH AGE AT MENARCHEA. García Anguita, P. Riestra, C. Garcés10.1016/S1567-5688(10)70750-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations159160MS250 NEGATIVE PSYCHOSOCIAL RISK FACTORS AND OBESITY. THE RESULTS FROM NATIONAL HEALTH SURVEY (WOBASZ)http://www.atherosclerosis-supplements.com/article/PIIS1567568810707510/abstract?rss=yesMS250 NEGATIVE PSYCHOSOCIAL RISK FACTORS AND OBESITY. THE RESULTS FROM NATIONAL HEALTH SURVEY (WOBASZ)J. Piwonski, E. Sygnowska, A. Piwonska10.1016/S1567-5688(10)70751-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations160160MS251 EFFECTS OF NIACIN ON THE INCIDENCE OF NEW ONSET DIABETES AND CARDIOVASCULAR EVENTS IN PATIENTS WITH NORMAL AND IMPAIRED GLUCOSEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707522/abstract?rss=yesMS251 EFFECTS OF NIACIN ON THE INCIDENCE OF NEW ONSET DIABETES AND CARDIOVASCULAR EVENTS IN PATIENTS WITH NORMAL AND IMPAIRED GLUCOSED. Maccubbin, V. Sazonov, C. Mccrary Sisk, P. Canner10.1016/S1567-5688(10)70752-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations160160MS252 ASSOCIATION OF USF1-S2 POLYMORPHISM WITH T2DM RISK IN THE TURKISH ADULT MALE POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707534/abstract?rss=yesMS252 ASSOCIATION OF USF1-S2 POLYMORPHISM WITH T2DM RISK IN THE TURKISH ADULT MALE POPULATIONM. Poda, E. Hörgüşlüoğlu-Güner, S. Humphries, A. Onat, G. Hergenç, G. Can, N. Erginel-Ünaltuna10.1016/S1567-5688(10)70753-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations160160MS253 VASCULAR RISK FACTORS IN YOUNG PEOPLE: RESULTS FROM AN OBSERVATIONAL STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707546/abstract?rss=yesMS253 VASCULAR RISK FACTORS IN YOUNG PEOPLE: RESULTS FROM AN OBSERVATIONAL STUDYA. Consoli, L. Zeppilli, M.T. Di Mascio, G. Carbotta, P. Lucchetti, G. Barilaro, D. Toni, M.L. Sacchetti, S. Vidale10.1016/S1567-5688(10)70754-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations160160MS254 MONOCYTE CHEMOATTRACTANT PROTEIN 1 (MCP-1): THE LINK BETWEEN OBESITY AND ATHEROSCLEROSIS?http://www.atherosclerosis-supplements.com/article/PIIS1567568810707558/abstract?rss=yesMS254 MONOCYTE CHEMOATTRACTANT PROTEIN 1 (MCP-1): THE LINK BETWEEN OBESITY AND ATHEROSCLEROSIS?A. Abou-Raya, S. Abou-Raya, M. Helmii10.1016/S1567-5688(10)70755-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations160161MS255 C-REACTIVE PROTEIN BUT NOT SOLUBLE CD40 LIGAND IS ASSOCIATED WITH THE SEVERITY OF ANGIOGRAPHICALLY VERIFIED CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070756X/abstract?rss=yesMS255 C-REACTIVE PROTEIN BUT NOT SOLUBLE CD40 LIGAND IS ASSOCIATED WITH THE SEVERITY OF ANGIOGRAPHICALLY VERIFIED CORONARY ARTERY DISEASEV. Spasojevic-Kalimanovska, S. Veljic, J. Kotur-Stevuljevic, N. Bogavac-Stanojevic, L. Memon, D. Kalimanovska-Ostric10.1016/S1567-5688(10)70756-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations161161MS256 FEATURES OF METABOLIC SYNDROME IN DEPRESSIVE DISORDERhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707571/abstract?rss=yesMS256 FEATURES OF METABOLIC SYNDROME IN DEPRESSIVE DISORDERT. Vařeka, M. Zeman, M. Vecka, M. Dušejovská, R. Jirák, A. Žák, E. Tvrzická, J. Macášek, B. Staňková10.1016/S1567-5688(10)70757-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations161161MS257 CHARACTERISTICS OF PATIENTS WITH HIGH CLDL PLUS LOW CHDL AND/OR HIGH TG IN SPAIN. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)http://www.atherosclerosis-supplements.com/article/PIIS1567568810707583/abstract?rss=yesMS257 CHARACTERISTICS OF PATIENTS WITH HIGH CLDL PLUS LOW CHDL AND/OR HIGH TG IN SPAIN. THE DYSLIPIDEMIA INTERNATIONAL STUDY (DYSIS-SPAIN)J. Millan, J.R. Gonzalez-Juanatey, E. Alegria, C. Guijarro, J.V. Lozano, B. Gonzalez-Timon, G. Vitale10.1016/S1567-5688(10)70758-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations161161MS258 CONSENSUS ON EARLY MANAGEMENT OF FAMILIAL HYPERCHOLESTEROLEMIA IN BELGIUMhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707595/abstract?rss=yesMS258 CONSENSUS ON EARLY MANAGEMENT OF FAMILIAL HYPERCHOLESTEROLEMIA IN BELGIUMO. Descamps, S. Tenoutasse, X. Stephenne, I. Gies, V. Beauloye, M.-C. Lebrethon, C. De Beaufort, J. Ducobu, M. Langlois, K. De Waele, V. Blaton, Y. Carpentier, G. De Backer, R. Rooman, A. Scheen, L. Van Gaal, E. Sokal, F.R. Heller10.1016/S1567-5688(10)70759-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations161161MS259 RELATIONSHIP OF INFLAMMATORY MARKER C-REACTIVE PROTEIN, LIPID MARKERS AND CONVENTIONAL CARDIOVASCULAR RISK FACTORS IN SUBJECTS WITH SUSPECTED CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707601/abstract?rss=yesMS259 RELATIONSHIP OF INFLAMMATORY MARKER C-REACTIVE PROTEIN, LIPID MARKERS AND CONVENTIONAL CARDIOVASCULAR RISK FACTORS IN SUBJECTS WITH SUSPECTED CORONARY ARTERY DISEASEF. Beutner, D. Teupser, C. Tennert, M. Scholz, S. Gielen, M. Sandri, G. Schuler, J. Thiery10.1016/S1567-5688(10)70760-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations161162MS260 GENDER-DEPENDENT RISK ASSOCIATION OF UCP2-UCP3 LOCUS FOR CORONARY HEART DISEASE AND OBESITY AMONG TURKShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707613/abstract?rss=yesMS260 GENDER-DEPENDENT RISK ASSOCIATION OF UCP2-UCP3 LOCUS FOR CORONARY HEART DISEASE AND OBESITY AMONG TURKSM. Poda, S. Humphries, A. Onat, E. Bayrak, G. Can, G. Hergenç, N. Erginel-Unaltuna10.1016/S1567-5688(10)70761-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations162162MS261 FAMILIAL HYPOBETALIPOPROTEINEMIA – DETECTION BY USING PROGRAM OF PREVENTION OF CORONARY ARTERY DISEASE FROM CHILDHOOD IN THE CZECH REPUBLIChttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707625/abstract?rss=yesMS261 FAMILIAL HYPOBETALIPOPROTEINEMIA – DETECTION BY USING PROGRAM OF PREVENTION OF CORONARY ARTERY DISEASE FROM CHILDHOOD IN THE CZECH REPUBLICZ. Urbanová, M. Šamánek10.1016/S1567-5688(10)70762-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations162162MS262 RELATIONSHIP BETWEEN HISTORY OF CARDIOVASCULAR DISEASES, DIABETES MELLITUS AND LIPID PROFILE IN TURKISH POPULATION WITH ACUTE CORONARY SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707637/abstract?rss=yesMS262 RELATIONSHIP BETWEEN HISTORY OF CARDIOVASCULAR DISEASES, DIABETES MELLITUS AND LIPID PROFILE IN TURKISH POPULATION WITH ACUTE CORONARY SYNDROMEY. Dogan, Y. Doğan, K. Bayir, A. Soylu, G. Aşik, N. Yaşar, M. Taşkale, B. Kumbasar10.1016/S1567-5688(10)70763-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations162162MS263 HIGH-FAT, HIGH-FAT-PROTEIN DIETS AND EXERCISE: DISTINCT ADAPTATIONS IN THE THORACIC AORTA AND LIPID PROFILEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707649/abstract?rss=yesMS263 HIGH-FAT, HIGH-FAT-PROTEIN DIETS AND EXERCISE: DISTINCT ADAPTATIONS IN THE THORACIC AORTA AND LIPID PROFILEC. Rodrigues Fernandes, K.M.A. Mata, D.S. Leonardi, F.T.T. Frajacomo, T. Marini, V.K. Cardoso, A.P. Farnesi, P. Paião, A.A.J. Junior, S.G. Ramos, S.B. Garcia10.1016/S1567-5688(10)70764-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations162162MS264 FRAMINGHAM AND PROCAM SCORE PLUS CD44L SHOW STRONG ASSOCIATION OF PERIODONTAL DISEASE SCOREhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707650/abstract?rss=yesMS264 FRAMINGHAM AND PROCAM SCORE PLUS CD44L SHOW STRONG ASSOCIATION OF PERIODONTAL DISEASE SCOREL. Nucci da Silva, L. Timerman, J. Simone, C. Gun10.1016/S1567-5688(10)70765-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations162163MS265 MICROALBUMINURIA IN METABOLIC CENTRE OUTPATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707662/abstract?rss=yesMS265 MICROALBUMINURIA IN METABOLIC CENTRE OUTPATIENTSH. Rusnakova, H. Pittrova, D. Rajdl, J. Racek10.1016/S1567-5688(10)70766-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations163163MS266 ASSOCIATION BETWEEN CARDIOVASCULAR RISK FACTORS AND PRESENCE AND EXTENT OF CORONARY ATHEROSCLEROTIC PLAQUE AS DETECTED BY MSCT IN EGYPTIAN PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707674/abstract?rss=yesMS266 ASSOCIATION BETWEEN CARDIOVASCULAR RISK FACTORS AND PRESENCE AND EXTENT OF CORONARY ATHEROSCLEROTIC PLAQUE AS DETECTED BY MSCT IN EGYPTIAN PATIENTSF. Aboul-Enein10.1016/S1567-5688(10)70767-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations163163MS267 C-REACTIVE PROTEIN AND HEMOGLOBIN LEVELS PREDICT FUTURE ADVERSE CARDIAC EVENTS IN PATIENTS WITH CHRONIC STABLE ANGINA PECTORIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707686/abstract?rss=yesMS267 C-REACTIVE PROTEIN AND HEMOGLOBIN LEVELS PREDICT FUTURE ADVERSE CARDIAC EVENTS IN PATIENTS WITH CHRONIC STABLE ANGINA PECTORISP. Avanzas, R. Arroyo-Espliguero, A. Domínguez-Rodríguez, J.C. Kaski10.1016/S1567-5688(10)70768-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations163163MS268 GENDER DIFFERENCES IN THE PREVALENCE OF CARDIOVASCULAR DISEASE RISK FACTORS AND CORRESPONDING 10-YEAR CARDIOVASCULAR RISK, AMONG SUBJECTS WITH METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707698/abstract?rss=yesMS268 GENDER DIFFERENCES IN THE PREVALENCE OF CARDIOVASCULAR DISEASE RISK FACTORS AND CORRESPONDING 10-YEAR CARDIOVASCULAR RISK, AMONG SUBJECTS WITH METABOLIC SYNDROMET. Chimonas, V. Athyros, E. Ganotakis, V. Nicolaou, D. Panagiotakos, M. Elisaf10.1016/S1567-5688(10)70769-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations163163MS269 PLASMA AMINOTHIOLS STATUS IN THE POPULATION OF THE ISLAND OF S ÃO JORGE (THE AZORES' ARCHIPELAGO, PORTUGAL)http://www.atherosclerosis-supplements.com/article/PIIS1567568810707704/abstract?rss=yesMS269 PLASMA AMINOTHIOLS STATUS IN THE POPULATION OF THE ISLAND OF S ÃO JORGE (THE AZORES' ARCHIPELAGO, PORTUGAL)R. Ferin, C. Correia, M. Raposo, B. Gonçalves, C. Gonçalves, J. Baptista, M.L. Pavão10.1016/S1567-5688(10)70770-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations163164MS270 LABORATORY EVALUATION OF HYPERURICEMIA AND STUDY OF DISEASE'S OUTCOME IN PATIENTS OF THE NORTH GREECEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707716/abstract?rss=yesMS270 LABORATORY EVALUATION OF HYPERURICEMIA AND STUDY OF DISEASE'S OUTCOME IN PATIENTS OF THE NORTH GREECEC. Charalampous, S. Patiakas10.1016/S1567-5688(10)70771-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations164164MS271 INCIDENCE OF OBESITY OF THE YOUNG AND REGISTRATION OF THE PROGRESSION OF BMI OVER TIMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707728/abstract?rss=yesMS271 INCIDENCE OF OBESITY OF THE YOUNG AND REGISTRATION OF THE PROGRESSION OF BMI OVER TIMES. Patiakas, C. Charalampous10.1016/S1567-5688(10)70772-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations164164MS272 LIPIDEMIC PROFILE STUDY OF WOMEN AFTER LONG-TERM ADMINISTRATION OF CONTRACEPTIVE PILLShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070773X/abstract?rss=yesMS272 LIPIDEMIC PROFILE STUDY OF WOMEN AFTER LONG-TERM ADMINISTRATION OF CONTRACEPTIVE PILLSC. Charalampous, S. Patiakas, E. Pavlidou, E. Savvidou10.1016/S1567-5688(10)70773-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations164164MS273 INFLUENCE OF ATHEROSCLEROTIC DISEASE RISK FACTORS IN THE DEVELOPMENT OF ATRIAL FIBRILLATION IN THE POSTOPERATIVE PERIOD OF CARDIAC SURGERYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707741/abstract?rss=yesMS273 INFLUENCE OF ATHEROSCLEROTIC DISEASE RISK FACTORS IN THE DEVELOPMENT OF ATRIAL FIBRILLATION IN THE POSTOPERATIVE PERIOD OF CARDIAC SURGERYR.J. Alves, B.C. Andrade, R.N. Campos, K. Nakiri10.1016/S1567-5688(10)70774-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations164164MS274 RISK FACTOR DIFFERENCES PREDISPOSING TO RECURRENCE AND/OR DEATH IN YOUNG EARLY ONSET CORONARY ARTERY DISEASE PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707753/abstract?rss=yesMS274 RISK FACTOR DIFFERENCES PREDISPOSING TO RECURRENCE AND/OR DEATH IN YOUNG EARLY ONSET CORONARY ARTERY DISEASE PATIENTSA. Aggarwal, S. Dwivedi, M. Dev10.1016/S1567-5688(10)70775-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations164165MS275 POTENTIAL METABOLIC BENEFITS OF ADDING CHILLI PEPPER TO A MEALhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707765/abstract?rss=yesMS275 POTENTIAL METABOLIC BENEFITS OF ADDING CHILLI PEPPER TO A MEALM. Ball, I. Robertson, N. Harvey, K. Ahuja10.1016/S1567-5688(10)70776-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations165165MS276 DETERMINATION OF CAROTID INTIMA MEDIA THICKNESS (CIMT) IN ASYMPTOMATIC BRAZILIANShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707777/abstract?rss=yesMS276 DETERMINATION OF CAROTID INTIMA MEDIA THICKNESS (CIMT) IN ASYMPTOMATIC BRAZILIANSI.F. Espirito Santo, R.T. Nakamura, E.S. Parra, M.R.G. Danelon, E. Cotta de Faria10.1016/S1567-5688(10)70777-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations165165MS277 STUDY RISK FACTORS OF CHRONIC NON-INFECTIOUS DISEASES BY A METHOD OF THE STATISTICAL ANALYSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707789/abstract?rss=yesMS277 STUDY RISK FACTORS OF CHRONIC NON-INFECTIOUS DISEASES BY A METHOD OF THE STATISTICAL ANALYSISN. Nasonova, L. Shcherbakova10.1016/S1567-5688(10)70778-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations165165MS278 THE RELEVANCE OF ANGIOTENSIN CONVERTING ENZYME AND ENDOTHELIAL NITRIC OXIDE SYNTHASE GLU298ASP GENE POLYMORPHISMS FOR SUSCEPTIBILITY TO CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707790/abstract?rss=yesMS278 THE RELEVANCE OF ANGIOTENSIN CONVERTING ENZYME AND ENDOTHELIAL NITRIC OXIDE SYNTHASE GLU298ASP GENE POLYMORPHISMS FOR SUSCEPTIBILITY TO CORONARY ARTERY DISEASEA. Naghavi, S. Salimi, M. Firoozrai, S.M. Shafiee, A. Mohebbi10.1016/S1567-5688(10)70779-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations165165MS279 IN APPLICABILITY OF THE CARDIOVASCULAR RISK PREDICTOR “SCORE” TO PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH)http://www.atherosclerosis-supplements.com/article/PIIS1567568810707807/abstract?rss=yesMS279 IN APPLICABILITY OF THE CARDIOVASCULAR RISK PREDICTOR “SCORE” TO PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH)O. Descamps, J. Cooper, A. Neil, S. Humphries10.1016/S1567-5688(10)70780-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations165166MS280 INFLAMMATORY STATUS AND OXIDATIVE STRESS BIOMARKERS IN NON-TREATED HYPERTENSION AND DISLIPIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707819/abstract?rss=yesMS280 INFLAMMATORY STATUS AND OXIDATIVE STRESS BIOMARKERS IN NON-TREATED HYPERTENSION AND DISLIPIDEMIAC. Grigore, I. Stoian, O. Grigore, L. Dawkins, D. Isacoff, I.V. Bruckner10.1016/S1567-5688(10)70781-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations166166MS281 RISK PROFILE IN PATIENTS UNDERGOING CAROTID ENDARTERECTOMYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707820/abstract?rss=yesMS281 RISK PROFILE IN PATIENTS UNDERGOING CAROTID ENDARTERECTOMYS. Vidale, S. Bellocchi, R. Caronno, M. Arnaboldi, A. Taborelli10.1016/S1567-5688(10)70782-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations166166MS282 ROLE OF SUSCEPTIBILITY GENETIC VARIANTS AND ENVIRONMENTAL FACTORS IN OBESITY RISK IN TWO SPANISH POPULATION BASED STUDIEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707832/abstract?rss=yesMS282 ROLE OF SUSCEPTIBILITY GENETIC VARIANTS AND ENVIRONMENTAL FACTORS IN OBESITY RISK IN TWO SPANISH POPULATION BASED STUDIESF.J. Chaves, M.L. Mansego, S. Morcillo, G. Rojo, F. Martínez, J.C. Martín-Escudero, J. Redon, F. Soriguer10.1016/S1567-5688(10)70783-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations166166MS283 FEMALE VERSUS MALE RISK FACTORS FOR ATHEROTHROMBOTIC DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707844/abstract?rss=yesMS283 FEMALE VERSUS MALE RISK FACTORS FOR ATHEROTHROMBOTIC DISEASEW. Feeman10.1016/S1567-5688(10)70784-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations166166MS284 THE FREQUENCY AND PREVALENCE OF THE CORONARY HEART DISEASE IN PATIENTS WITH METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707856/abstract?rss=yesMS284 THE FREQUENCY AND PREVALENCE OF THE CORONARY HEART DISEASE IN PATIENTS WITH METABOLIC SYNDROMEH. Altug Cakmak, N. Karadag, B. Karadag, K. Cosansu, Z. Ongen, V.A. Vural10.1016/S1567-5688(10)70785-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations166167MS285 PREVALENCE AND RISK FACTORS FOR DIABETES: A TEN YEAR FOLLOW-UP STUDY OF THE YAEYAMA DISTRICT OF OKINAWAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707868/abstract?rss=yesMS285 PREVALENCE AND RISK FACTORS FOR DIABETES: A TEN YEAR FOLLOW-UP STUDY OF THE YAEYAMA DISTRICT OF OKINAWAK. Okada, N. Furusyo, Y. Sawayama, Y. Kanamoto, M. Murata, J. Hayashi10.1016/S1567-5688(10)70786-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations167167MS286 GENES POLYMORPHISMS ANTIOXIDATIVE ENZYMES AND RISK CORONARY IN-STENT RESTENOSIShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070787X/abstract?rss=yesMS286 GENES POLYMORPHISMS ANTIOXIDATIVE ENZYMES AND RISK CORONARY IN-STENT RESTENOSISA. Kaminnyi, J. Shuvalova, A. Meshkov, A. Samko, V. Kukharchuk10.1016/S1567-5688(10)70787-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations167167MS287 RISK OF CORONARY HEART DISEASE IN PATIENTS WITH CHRONIC RENAL FAILURE – EVALUATION STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707881/abstract?rss=yesMS287 RISK OF CORONARY HEART DISEASE IN PATIENTS WITH CHRONIC RENAL FAILURE – EVALUATION STUDYS. Patiakas, C. Charalampous, E. Basiliou10.1016/S1567-5688(10)70788-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations167167MS288 OBESITY AND DISLIPIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707893/abstract?rss=yesMS288 OBESITY AND DISLIPIDEMIAG. Grujic-Ilic, L. Pejcic10.1016/S1567-5688(10)70789-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations167167MS289 COMPARATIVE STUDY OF RISK FACTORS IN YOUNG AND OLDER PATIENTS OF CORONARY ARTERY DISEASE IN A TERTIARY CARE HOSPITALhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070790X/abstract?rss=yesMS289 COMPARATIVE STUDY OF RISK FACTORS IN YOUNG AND OLDER PATIENTS OF CORONARY ARTERY DISEASE IN A TERTIARY CARE HOSPITALA. Aggarwal, P. Schroff, S. Dwivedi10.1016/S1567-5688(10)70790-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations168168MS290 ARE THE SAME RISK FACTORS INVOLVED IN CAROTID PLAQUE OCCURRENCE AND SIGNIFICANT DOPPLER CAROTID STENOSIS?http://www.atherosclerosis-supplements.com/article/PIIS1567568810707911/abstract?rss=yesMS290 ARE THE SAME RISK FACTORS INVOLVED IN CAROTID PLAQUE OCCURRENCE AND SIGNIFICANT DOPPLER CAROTID STENOSIS?B. Pojskic, A. Macic Dzankovic, D. Kolenda10.1016/S1567-5688(10)70791-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations168168MS291 EFFECTS OF ApoE GENE POLYMORPHISM ON ANTHROPOMETRIC AND BIOCHEMICAL PARAMETERS IN MENhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707923/abstract?rss=yesMS291 EFFECTS OF ApoE GENE POLYMORPHISM ON ANTHROPOMETRIC AND BIOCHEMICAL PARAMETERS IN MENE. Stokic, I. Djan, M. Djan, D. Sakač10.1016/S1567-5688(10)70792-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations168168MS292 PECULIARITIES OF SYSTOLIC, DIASTOLIC, PULSE BP, HEART RATES AND FREQUENCY OF FATAL CARDIOVASCULAR DISEASE IN SIBERIAN POPULATION WITH METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707935/abstract?rss=yesMS292 PECULIARITIES OF SYSTOLIC, DIASTOLIC, PULSE BP, HEART RATES AND FREQUENCY OF FATAL CARDIOVASCULAR DISEASE IN SIBERIAN POPULATION WITH METABOLIC SYNDROMEG. Simonova, O. Glushanina, Y. Nikitin, S. Malutina, L. Scherbakova10.1016/S1567-5688(10)70793-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations168168MS293 GENDER DIFFERENCES IN ELDERLY PATIENTS WITH SUBCLINICAL ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707947/abstract?rss=yesMS293 GENDER DIFFERENCES IN ELDERLY PATIENTS WITH SUBCLINICAL ATHEROSCLEROSISO. Vittos, F. Halici, I. Teodorescu10.1016/S1567-5688(10)70794-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations168168MS294 MOST IMPORTANT CARDIOVASCULAR RISK FACTORS IN PROGNOSIS OF PATIENTS WITH MYOCARDIAL INFARCTION – 5 YEAR FOLLOW UP STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707959/abstract?rss=yesMS294 MOST IMPORTANT CARDIOVASCULAR RISK FACTORS IN PROGNOSIS OF PATIENTS WITH MYOCARDIAL INFARCTION – 5 YEAR FOLLOW UP STUDYT. Emami Meybodi, M. Emami, M. Hasan Lotfi, S. Mahdiye Namayande, S. Mahmood Sad10.1016/S1567-5688(10)70795-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations168169MS295 WEEKLY AND SEASONAL VARIATIONS IN THE ONSET OF CARDIOVASCULAR EVENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707960/abstract?rss=yesMS295 WEEKLY AND SEASONAL VARIATIONS IN THE ONSET OF CARDIOVASCULAR EVENTSS. Vidale, R. Bonatti, M. Arnaboldi, C. Campana10.1016/S1567-5688(10)70796-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations169169MS296 TO ASSESS THE ATTITUDE AND NEGLIGENCE OF HYPERTENSIVE PATIENTS TOWARDS LIFESTYLE MODIFICATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707972/abstract?rss=yesMS296 TO ASSESS THE ATTITUDE AND NEGLIGENCE OF HYPERTENSIVE PATIENTS TOWARDS LIFESTYLE MODIFICATIONS. Jawed, S. Tai, M.A. Saleem, S. Bashir, M. Majid, A. Zaki, M. Kazmi, A. Qasim10.1016/S1567-5688(10)70797-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations169169MS297 RISK FACTORS CONTROL BENEFITS IN A CARDIOVASCULAR UNIThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810707984/abstract?rss=yesMS297 RISK FACTORS CONTROL BENEFITS IN A CARDIOVASCULAR UNITR. Bagina, C. Baeta10.1016/S1567-5688(10)70798-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations169169MS298 RISK FACTORS OF IRANIAN PATIENTS WITH 3 VESSELS DISEASE CANDIDATE FOR CORONARY ARTERY BYPASS GRAFT SURGERY (CABG)http://www.atherosclerosis-supplements.com/article/PIIS1567568810707996/abstract?rss=yesMS298 RISK FACTORS OF IRANIAN PATIENTS WITH 3 VESSELS DISEASE CANDIDATE FOR CORONARY ARTERY BYPASS GRAFT SURGERY (CABG)M. Najafi Kalyani, N. Jamshidi10.1016/S1567-5688(10)70799-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations169169MS299 PLANTS ARE POPULARLY USED BY ALTERNATIVE MEDICINAL PRACTITIONERS OF KISHOREGANJ DISTRICT, BANGLADESH TO TREAT VARIOUS BODY PAINS INCLUDING RHEUMATOID ARTHRITIShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070800X/abstract?rss=yesMS299 PLANTS ARE POPULARLY USED BY ALTERNATIVE MEDICINAL PRACTITIONERS OF KISHOREGANJ DISTRICT, BANGLADESH TO TREAT VARIOUS BODY PAINS INCLUDING RHEUMATOID ARTHRITISA. Haque Mollik10.1016/S1567-5688(10)70800-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations170170MS300 ASSOCIATION OF HIGH PCR LEVELS AND DYSLIPIDEMIA IN PATIENTS WITH ATRIAL FIBRILLATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708011/abstract?rss=yesMS300 ASSOCIATION OF HIGH PCR LEVELS AND DYSLIPIDEMIA IN PATIENTS WITH ATRIAL FIBRILLATIONJ.A. Díaz-Peromingo, J. Grandes-Ibáñez, F. García-Suárez, J. Sánchez-Leira, M.D.C. Gayol-Fernández, J. Saborido-Froján, S. Molinos-Castro, P. Pesqueira-Fontán, M. Iglesias-Gallego, E. Padín-Paz, J. Naveiro-Soneira10.1016/S1567-5688(10)70801-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations170170MS301 USING BIOIMPEDANCE ANALYSIS FOR QUANTIFICATION OF BODY FAT AS RISK OF METABOLIC SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708023/abstract?rss=yesMS301 USING BIOIMPEDANCE ANALYSIS FOR QUANTIFICATION OF BODY FAT AS RISK OF METABOLIC SYNDROMEP. Hlubik, H. Stritecka, J. Hlubik10.1016/S1567-5688(10)70802-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations170170MS302 BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) Val66Met POLYMORPHISM IS NOT ASSOCIATED WITH MYOCARDIAL INFARCTION IN CZECH POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708035/abstract?rss=yesMS302 BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) Val66Met POLYMORPHISM IS NOT ASSOCIATED WITH MYOCARDIAL INFARCTION IN CZECH POPULATIONJ. Petrkova, A. Stahelova, N. Motakova, F. Mrazek, M. Petrek10.1016/S1567-5688(10)70803-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations170170MS303 ABDOMINAL CIRCUMFERENCE AS PREDICTIVE FACTOR OF UNBALANCED METABOLISM AND ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETES MELLITUS PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708047/abstract?rss=yesMS303 ABDOMINAL CIRCUMFERENCE AS PREDICTIVE FACTOR OF UNBALANCED METABOLISM AND ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETES MELLITUS PATIENTST. Alexescu, V. Negrean, N. Rednic, F. Eniu, A. Cozma10.1016/S1567-5688(10)70804-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations170170MS304 NEURO-VASCULAR ALTERATIONS IN CHRONIC HAPATITIS C PATIENTS TREATED WITH INTERFERON: A CASE CONTROL STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708059/abstract?rss=yesMS304 NEURO-VASCULAR ALTERATIONS IN CHRONIC HAPATITIS C PATIENTS TREATED WITH INTERFERON: A CASE CONTROL STUDYV. Vedovetto, V. Vedovetto, A. Rossato, F. Veronese, A. Zancan, F. Bilora10.1016/S1567-5688(10)70805-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations171171MS305 CORONARY ECTASIA: RISK MARKERS & RISK FACTORShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708060/abstract?rss=yesMS305 CORONARY ECTASIA: RISK MARKERS & RISK FACTORSM. Soliman, H. el Ezawy10.1016/S1567-5688(10)70806-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations171171MS306 THE ROLE OF UNKNOWN RISK FACTORS IN THE MYOCARDIAL INFARCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708072/abstract?rss=yesMS306 THE ROLE OF UNKNOWN RISK FACTORS IN THE MYOCARDIAL INFARCTIONA.A. Rafighdoust, A.H. Rafighdoust, M. Haghmoradi, S. Hoorzad10.1016/S1567-5688(10)70807-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations171171MS307 INFECTION OF AORTA-FEMORALE PROSTHESIS (BY-PASS) WITH PARTICIPATION OF SIGMOID COLONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708084/abstract?rss=yesMS307 INFECTION OF AORTA-FEMORALE PROSTHESIS (BY-PASS) WITH PARTICIPATION OF SIGMOID COLONA. Limuris, N. Fistas10.1016/S1567-5688(10)70808-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations171171MS308 ACUTE PULMONARY THROMBOEMBOLISM A.P.TE. EMERGENT TREATMENT WITH RT-PAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708096/abstract?rss=yesMS308 ACUTE PULMONARY THROMBOEMBOLISM A.P.TE. EMERGENT TREATMENT WITH RT-PAA. Limuris, J. Lazaridis, N. Fistas10.1016/S1567-5688(10)70809-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations171171MS309 PROTEIN C DEFICIENCY IN ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE AND DYSLIPIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708102/abstract?rss=yesMS309 PROTEIN C DEFICIENCY IN ELDERLY PATIENTS WITH ISCHEMIC HEART DISEASE AND DYSLIPIDEMIAS. Urazgildeeva, L. Eremkina, V. Gurevich10.1016/S1567-5688(10)70810-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations171172MS310 EFFECT OF DYSGLYCEMIA AND SMOKING ON SHORT TERM MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708114/abstract?rss=yesMS310 EFFECT OF DYSGLYCEMIA AND SMOKING ON SHORT TERM MORTALITY IN PATIENTS WITH ACUTE CORONARY SYNDROMES. Dwivedi, A. Aggarwal, R. Kumar10.1016/S1567-5688(10)70811-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations172172MS311 CORRELATION OF METABOLIC SYNDROME AND CEREBRAL VASCULAR STROKE IN ELDERLY PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708126/abstract?rss=yesMS311 CORRELATION OF METABOLIC SYNDROME AND CEREBRAL VASCULAR STROKE IN ELDERLY PATIENTSC. Charalampous, S. Patiakas10.1016/S1567-5688(10)70812-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations172172MS312 CHANGE IN PREVALENCE OF METABOLIC SYNDROME RISK FACTORS IN CZECH ARMY DURING LAST 10 YEARShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708138/abstract?rss=yesMS312 CHANGE IN PREVALENCE OF METABOLIC SYNDROME RISK FACTORS IN CZECH ARMY DURING LAST 10 YEARSP. Hlubik, H. Stritecka10.1016/S1567-5688(10)70813-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations172172MS313 EFFICIENCY OF SECONDARY PREVENTION IN POPULATION WITH CORONARY ARTERY DISEASE IN DNIPROPETROVSK REGION, UKRAINEhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070814X/abstract?rss=yesMS313 EFFICIENCY OF SECONDARY PREVENTION IN POPULATION WITH CORONARY ARTERY DISEASE IN DNIPROPETROVSK REGION, UKRAINEO. Kuryata, O. Soya, N. Bardachenko10.1016/S1567-5688(10)70814-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations172172MS314 3 YEAR AGGRESSIVE LIPID LOWERING THERAPY OF PATIENTS WITH CHRONIC CORONARY HEART DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708151/abstract?rss=yesMS314 3 YEAR AGGRESSIVE LIPID LOWERING THERAPY OF PATIENTS WITH CHRONIC CORONARY HEART DISEASET. Vakhtangadze, M. Akhvlediani, D. Gachechiladze, N. Gakhokidze10.1016/S1567-5688(10)70815-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations172172MS315 EFFECT OF ATORVASTATIN IN PATIENTS WITH SYSTOLIC HEART FAILURE DUE TO ISCHEMIC CARDIOMYOPATHY AFTER MYOCARDIAL INFARCThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708163/abstract?rss=yesMS315 EFFECT OF ATORVASTATIN IN PATIENTS WITH SYSTOLIC HEART FAILURE DUE TO ISCHEMIC CARDIOMYOPATHY AFTER MYOCARDIAL INFARCTT. Vakhtangadze, F. Todua, M. Razmadze, M. Akhvlediani10.1016/S1567-5688(10)70816-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations173173MS316 ADVENTITIAL CALCIFICATIONS: SURPRISE LOCATION. ATHEROSCLEROTIC AND CALCIFIED PLAQUES BEGIN AND GROW UP NOT ONLY BENEATH THE ENDOTHELIUM, BUT ALSO ON THE ADVENTITIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708175/abstract?rss=yesMS316 ADVENTITIAL CALCIFICATIONS: SURPRISE LOCATION. ATHEROSCLEROTIC AND CALCIFIED PLAQUES BEGIN AND GROW UP NOT ONLY BENEATH THE ENDOTHELIUM, BUT ALSO ON THE ADVENTITIAF. Erzengin10.1016/S1567-5688(10)70817-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations173173MS317 CORONARY ARTERY CALCIUM IS AN IMPORTANT RISK INDEX FOR ARTERIAL HYPERTENSION PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708187/abstract?rss=yesMS317 CORONARY ARTERY CALCIUM IS AN IMPORTANT RISK INDEX FOR ARTERIAL HYPERTENSION PATIENTST. Kuznetsova, D. Gavrilov, S. Madany, I. Dudanov10.1016/S1567-5688(10)70818-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations173173MS318 INFLUENCE OF ENHANCED EXTERNAL COUNTERPULSATION ON ANGIOGENESIS INDUCED FACTORShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708199/abstract?rss=yesMS318 INFLUENCE OF ENHANCED EXTERNAL COUNTERPULSATION ON ANGIOGENESIS INDUCED FACTORSI. Sergienko, S. Gabrusenko, V. Malakhov, V. Masenko, V. Kukharchuk10.1016/S1567-5688(10)70819-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations173173MS319 IDENTIFICATION OF NOVEL PROTEIN BIOMARKERS FOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708205/abstract?rss=yesMS319 IDENTIFICATION OF NOVEL PROTEIN BIOMARKERS FOR ATHEROSCLEROTIC CARDIOVASCULAR DISEASES. Decasper, D. Hof, B. Biedermann, A. von Eckardstein10.1016/S1567-5688(10)70820-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations173173MS320 DETERMINANTS OF CORONARY PLAQUE COMPOSITION BY COMPUTERIZED CORONARY TOMOGRAPHY ANGIOGRAPHY IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708217/abstract?rss=yesMS320 DETERMINANTS OF CORONARY PLAQUE COMPOSITION BY COMPUTERIZED CORONARY TOMOGRAPHY ANGIOGRAPHY IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIAM.H. Miname, M.S. Ribeiro, F. Ávila, J. Parga, C.E. Rochitte, R.D. Santos10.1016/S1567-5688(10)70821-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations173174MS321 COMBINATION OF NIGELLA SATIVA AND LOW DOSE REPAGLINADE RETARDS THE PROGRESSION OF ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708229/abstract?rss=yesMS321 COMBINATION OF NIGELLA SATIVA AND LOW DOSE REPAGLINADE RETARDS THE PROGRESSION OF ATHEROSCLEROSISB. Mohammad, N. Hadi10.1016/S1567-5688(10)70822-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations174174MS322 HS-CRP AND ANTI-PHOSPHORYLCHOLINE IgM ANTIBODIES: BIOMARKERS FOR RISK ASSESSMENT OF CVDhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708230/abstract?rss=yesMS322 HS-CRP AND ANTI-PHOSPHORYLCHOLINE IgM ANTIBODIES: BIOMARKERS FOR RISK ASSESSMENT OF CVDV. Polymerou, S. Kanakari, L. Fountas, D. Lavranos, J. Kremastinou10.1016/S1567-5688(10)70823-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations174174MS323 STUDIES ON HDL-ASSOCIATED ENZYMES AND SCAVENGER RECEPTORS UNDER EXPERIMENTAL HYPERCHOLESTEROLEMIA: POSSIBLE MODULATION ON SELENIUM SUPPLEMENTATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708242/abstract?rss=yesMS323 STUDIES ON HDL-ASSOCIATED ENZYMES AND SCAVENGER RECEPTORS UNDER EXPERIMENTAL HYPERCHOLESTEROLEMIA: POSSIBLE MODULATION ON SELENIUM SUPPLEMENTATIONH. Kaur, M.P. Bansal10.1016/S1567-5688(10)70824-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations174174MS324 EXTENDED RELEASE NIACIN/LAROPIPRANT IS PROJECTED TO REDUCE CORONARY RISK BEYOND STATINS: COST-EFFECTIVENESS ANALYSIS IN SECONDARY PREVENTION PATIENTS IN GERMANYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708254/abstract?rss=yesMS324 EXTENDED RELEASE NIACIN/LAROPIPRANT IS PROJECTED TO REDUCE CORONARY RISK BEYOND STATINS: COST-EFFECTIVENESS ANALYSIS IN SECONDARY PREVENTION PATIENTS IN GERMANYG.V. Michailov, G.M. Davies, B.M. Ambegaonkar, K.J. Krobot10.1016/S1567-5688(10)70825-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations174174MS325 INHIBITION OF ENDOTHELIAL AND MONOCYTIC CELL MIGRATION BY RESVERATROL: IMPLICATIONS FOR ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708266/abstract?rss=yesMS325 INHIBITION OF ENDOTHELIAL AND MONOCYTIC CELL MIGRATION BY RESVERATROL: IMPLICATIONS FOR ATHEROSCLEROSISI. Cicha, M. Regler, K. Urschel, W.G. Daniel, C.D. Garlichs10.1016/S1567-5688(10)70826-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations174175MS326 LXR ACTIVATION WITH TO901317 AND GW3965 IN MICE: DIFFERENTIAL EFFECTS ON LIVER AND INTESTINE, BUT NO NEGATIVE IMPACT ON BONEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708278/abstract?rss=yesMS326 LXR ACTIVATION WITH TO901317 AND GW3965 IN MICE: DIFFERENTIAL EFFECTS ON LIVER AND INTESTINE, BUT NO NEGATIVE IMPACT ON BONEJ. Prawitt, F.T. Beil, B. Staels, J. Heeren, A. Niemeier10.1016/S1567-5688(10)70827-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations175175MS327 CLUSTERING BY PLASMA LIPOPROTEIN PROFILE REVEALS LARGE FENOFIBRATE RESPONDER SUBGROUPhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070828X/abstract?rss=yesMS327 CLUSTERING BY PLASMA LIPOPROTEIN PROFILE REVEALS LARGE FENOFIBRATE RESPONDER SUBGROUPD.B. van Schalkwijk, K. van Bochove, L.D. Parnell, C.-Q. Lai, J.M. Ordovás, A.A. de Graaf, B. van Ommen, D.K. Arnett10.1016/S1567-5688(10)70828-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations175175MS328 EFFECTS OF INTENSIVE LIPID LOWERING WITH ATORVASTATIN ON PERIPHERAL ARTERIAL DISEASE IN PATIENTS WITH CORONARY HEART DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708291/abstract?rss=yesMS328 EFFECTS OF INTENSIVE LIPID LOWERING WITH ATORVASTATIN ON PERIPHERAL ARTERIAL DISEASE IN PATIENTS WITH CORONARY HEART DISEASEM. Lytken Larsen, I. Holme, M. Tikkanen, R. Fayyad, R. Laskey10.1016/S1567-5688(10)70829-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations175175MS329 SWITCHING FROM ANY STATIN BRAND TO EZETIMIBE/SIMVASTATIN 10/20 mg IS MORE EFFECTIVE AT LOWERING PLASMA LIPIDS VERSUS ROSUVASTATIN 10 mghttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708308/abstract?rss=yesMS329 SWITCHING FROM ANY STATIN BRAND TO EZETIMIBE/SIMVASTATIN 10/20 mg IS MORE EFFECTIVE AT LOWERING PLASMA LIPIDS VERSUS ROSUVASTATIN 10 mgP. Brudi, M. Averna, M. Farnier, L. Missault, H. Vaverkova, L.M. Viigimaa, Q. Dong, A. Shah, W. Taggart, A. Johnson-Levonas10.1016/S1567-5688(10)70830-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations175176MS330 ROSUVASTATIN DELAYS PROGRESSION OF AORTIC VALVE STENOSIS CAUSED BY HYPERTENSIONhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070831X/abstract?rss=yesMS330 ROSUVASTATIN DELAYS PROGRESSION OF AORTIC VALVE STENOSIS CAUSED BY HYPERTENSIONG. Giunta, E. Guevara, L. Marziali, G. Yannarelli, L. Gomez Rosso, T. Meroño, R. Favaloro, F. Brites, L. Cuniberti10.1016/S1567-5688(10)70831-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations176176MS331 ARTERIAL BAROREFLEX FUNCTION IS A NEW TARGET OF ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708321/abstract?rss=yesMS331 ARTERIAL BAROREFLEX FUNCTION IS A NEW TARGET OF ATHEROSCLEROSISG.-J. Cai10.1016/S1567-5688(10)70832-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations176176MS332 ROLE OF CARVEDILOL WITH TOCOTRIENOL TO EXTENUATE ANTHRACYCLINE INDUCED CARDIOMYOPATHY IN RATShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708333/abstract?rss=yesMS332 ROLE OF CARVEDILOL WITH TOCOTRIENOL TO EXTENUATE ANTHRACYCLINE INDUCED CARDIOMYOPATHY IN RATSM. Jainu, V. Mohan10.1016/S1567-5688(10)70833-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations176176MS333 DIABETIC CARDIOMYOPATHY IN TYPE 2 DIABETIC PATIENTS: EFFECTS OF ADMINISTERED ω-3 POLYUNSATURATED FATTY ACIDS AND SIMVASTATIN ON THE METABOLIC DISTURBANCEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708345/abstract?rss=yesMS333 DIABETIC CARDIOMYOPATHY IN TYPE 2 DIABETIC PATIENTS: EFFECTS OF ADMINISTERED ω-3 POLYUNSATURATED FATTY ACIDS AND SIMVASTATIN ON THE METABOLIC DISTURBANCESV. Serhiyenko, O. Serhiyenko, L. Serhiyenko10.1016/S1567-5688(10)70834-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations177177MS334 THE EFFECTS OF COMBINED ATORVASTATIN AND EXERCISE TREATMENT ON THE DEVELOPMENT AND STABILITY OF THE ATHEROSCLEROTIC PLAQUES – EXPERIMENTAL STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708357/abstract?rss=yesMS334 THE EFFECTS OF COMBINED ATORVASTATIN AND EXERCISE TREATMENT ON THE DEVELOPMENT AND STABILITY OF THE ATHEROSCLEROTIC PLAQUES – EXPERIMENTAL STUDYP. Moustardas, N. Kadoglou, M. Katsimpoulas, A. Kapelouzou, N. Kostomitsopoulos, P. Karayannakos, C. Liapis10.1016/S1567-5688(10)70835-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations177177MS335 EFFECTS OF DALCETRAPIB IN COMBINATION WITH PRAVASTATIN ON LIPOPROTEIN PROFILE IN PATIENTS WITH TYPE II DYSLIPIDAEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708369/abstract?rss=yesMS335 EFFECTS OF DALCETRAPIB IN COMBINATION WITH PRAVASTATIN ON LIPOPROTEIN PROFILE IN PATIENTS WITH TYPE II DYSLIPIDAEMIAM. Miller, C.M. Ballantyne, E.J. Niesor, T. Burgess, D. Kallend, E.A. Stein10.1016/S1567-5688(10)70836-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations177177MS336 REDUCTION OF EXISTING ATHEROSCLEROTIC PLAQUES: LIPID-LOWERING AND ANTI-INFLAMMATORY STRATEGIES PROMOTE LESION REGRESSION IN APOE3LEIDEN TRANSGENIC MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708370/abstract?rss=yesMS336 REDUCTION OF EXISTING ATHEROSCLEROTIC PLAQUES: LIPID-LOWERING AND ANTI-INFLAMMATORY STRATEGIES PROMOTE LESION REGRESSION IN APOE3LEIDEN TRANSGENIC MICEP.Y. Wielinga, R. Kleemann, J. de Vries-vd Weij, K. Toet, P.C.N. Rensen, L. Verschuren, T. Kooistra10.1016/S1567-5688(10)70837-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations177177MS337 A CLINICAL STUDY OF CHOLESTEROL-INDEPENDENT EFFECTS OF STATIN THERAPY ON VASCULAR INFLAMMATION: STATINS SELECTIVELY AND DOSE-DEPENDENTLY ATTENUATE MACROPHAGE ACTIVATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708382/abstract?rss=yesMS337 A CLINICAL STUDY OF CHOLESTEROL-INDEPENDENT EFFECTS OF STATIN THERAPY ON VASCULAR INFLAMMATION: STATINS SELECTIVELY AND DOSE-DEPENDENTLY ATTENUATE MACROPHAGE ACTIVATIONJ.H.N. Lindeman10.1016/S1567-5688(10)70838-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations177178MS338 ECHOCARDIOGRAPHIC VISUAL VERSUS COMPUTERIZED EVALUATION OF THE DEGREE OF AORTIC VALVE CALCIFICATION IN PATIENTS WITH AORTIC VALVE AND ROOT PATHOLOGYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708394/abstract?rss=yesMS338 ECHOCARDIOGRAPHIC VISUAL VERSUS COMPUTERIZED EVALUATION OF THE DEGREE OF AORTIC VALVE CALCIFICATION IN PATIENTS WITH AORTIC VALVE AND ROOT PATHOLOGYM. Yousry, M.J. Eriksson, A. Rickenlund, J. Petrini, T. Gustavsson, P. Eriksson, A. Hamsten, A. Franco-Cereceda, J. Liska, K. Caidahl10.1016/S1567-5688(10)70839-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations178178MS339 DEVELOPMENT AND CHARACTERIZATION OF A SHAPE-MEMORY POLYMER-BASED CORONARY STENT WITH ENDOTHELIAL PROGENITOR CELL-ADHESIVE CAPACITYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708400/abstract?rss=yesMS339 DEVELOPMENT AND CHARACTERIZATION OF A SHAPE-MEMORY POLYMER-BASED CORONARY STENT WITH ENDOTHELIAL PROGENITOR CELL-ADHESIVE CAPACITYF. Vogt, M. Borinski, F. Schreiber, C. Flege, N. Krott, T. Gries, C. Weber, R. Hoffmann, N. Marx, R. Blindt10.1016/S1567-5688(10)70840-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations178178MS340 IMMUNOSUPPRESSIVE AND ANTI-DYSLIPIDEMIC TREATMENT AFTER KIDNEY AND KIDNEY–PANCREAS TRANSPLANTATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708412/abstract?rss=yesMS340 IMMUNOSUPPRESSIVE AND ANTI-DYSLIPIDEMIC TREATMENT AFTER KIDNEY AND KIDNEY–PANCREAS TRANSPLANTATIONT. Bulum, I. Prkačin, D. Vujanić, M. Knotek10.1016/S1567-5688(10)70841-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations178178MS341 EFFECT OF NIACIN WITH ATORVASTATIN ON SECRETORY PHOSPHOLIPASE A2 IN MEN WITH CORONARY HEART DISEASE AND LIPOPROTEIN(a) EXCESShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708424/abstract?rss=yesMS341 EFFECT OF NIACIN WITH ATORVASTATIN ON SECRETORY PHOSPHOLIPASE A2 IN MEN WITH CORONARY HEART DISEASE AND LIPOPROTEIN(a) EXCESSE. Trukhacheva, M. Ezhov, V. Titov, O. Afanasieva, M. Afanasieva, A. Lyakishev, V. Kukharchuk, S. Pokrovsky10.1016/S1567-5688(10)70842-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations178178MS342 EFFECT OF EVEROLIMUS ON PRE-EXISTING ATHEROSCLEROSIS IN LDLR−/− MICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708436/abstract?rss=yesMS342 EFFECT OF EVEROLIMUS ON PRE-EXISTING ATHEROSCLEROSIS IN LDLR−/− MICED. Brendel, F. Beutner, D. Teupser, M. Müller, R. Baber, F. Jeromin, W. Wilfert, U. Ceglarek, J. Thiery10.1016/S1567-5688(10)70843-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations178179MS343 CAROTID ULTRASOUND CONTRIBUTES TO THE ASSESSMENT OF CORONARY ARTERY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708448/abstract?rss=yesMS343 CAROTID ULTRASOUND CONTRIBUTES TO THE ASSESSMENT OF CORONARY ARTERY DISEASEF. Beutner, D. Teupser, S. Gielen, M. Sandri, M. Scholz, G. Schuler, J. Thiery10.1016/S1567-5688(10)70844-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations179179MS344 DIRECT COMPARISON OF ANGIOGENIC GENE THERAPY AND STEM CELL THERAPY IN PATIENTS WITH CHRONIC LIMB ISCHEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070845X/abstract?rss=yesMS344 DIRECT COMPARISON OF ANGIOGENIC GENE THERAPY AND STEM CELL THERAPY IN PATIENTS WITH CHRONIC LIMB ISCHEMIAK. Talitskiy, O. Bulkina, T. Arefieva, O. Vorobieva, T. Balakhonova, I. Levitskiy, D. Filatov, A. Eliseev, V. Kukharchuk, O. Stukalova, A. Fedorovich, Y. Parfyonova, Y. Karpov10.1016/S1567-5688(10)70845-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations179179MS345 DIFFERENTIAL EFFECTS OF STATINS ON VITAMIN D METABOLITES: IMPLICATIONS FOR INSULIN SENSITIVITYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708461/abstract?rss=yesMS345 DIFFERENTIAL EFFECTS OF STATINS ON VITAMIN D METABOLITES: IMPLICATIONS FOR INSULIN SENSITIVITYJ. Beltowski10.1016/S1567-5688(10)70846-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations179179MS346 COULD PLASMA LEVEL OF ASYMMETRIC DIMETILARJININ BE A MARKER FOR STENT RESTENOSIS?http://www.atherosclerosis-supplements.com/article/PIIS1567568810708473/abstract?rss=yesMS346 COULD PLASMA LEVEL OF ASYMMETRIC DIMETILARJININ BE A MARKER FOR STENT RESTENOSIS?U. Bal, S. Kanyilmaz, A. Yildirir, A. Aydinalp, G. Kaynar, M. Koza, H. Muderrisoglu10.1016/S1567-5688(10)70847-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations179179MS347 ELEVATION OF INTERLEUKIN 6 ASSOCIATED REDUCTION OF LIPOPROTEIN(a) PREDICTS RESTENOSIS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION PERFORMED SUCCESSFUL PRIMARY PTCAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708485/abstract?rss=yesMS347 ELEVATION OF INTERLEUKIN 6 ASSOCIATED REDUCTION OF LIPOPROTEIN(a) PREDICTS RESTENOSIS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION PERFORMED SUCCESSFUL PRIMARY PTCAA. Fujino, T. Watanabe, K. Taira, K. Ashikawa10.1016/S1567-5688(10)70848-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations179180MS348 EFFECT OF SLCO1B1*5 (VAL174ALA) ALLELE ON LIPID LOWERING RESPONSE OF ATORVASTATIN IN THE 4D STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708497/abstract?rss=yesMS348 EFFECT OF SLCO1B1*5 (VAL174ALA) ALLELE ON LIPID LOWERING RESPONSE OF ATORVASTATIN IN THE 4D STUDYM.M. Hoffmann, K. Winkler, C. Drechsler, V. Krane, W. März, C. Wanner10.1016/S1567-5688(10)70849-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations180180MS349 INTRAINDIVIDUAL COMPARISON OF WHOLE BODY MR ANGIOGRAPHY AT 1.5 AND 3 TESLA IN HIGH RISK PATIENTS WITH HEREDITARY HYPERLIPIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708503/abstract?rss=yesMS349 INTRAINDIVIDUAL COMPARISON OF WHOLE BODY MR ANGIOGRAPHY AT 1.5 AND 3 TESLA IN HIGH RISK PATIENTS WITH HEREDITARY HYPERLIPIDEMIAP. Bannas, A.-K. Fink-Wedel, J.-H. Buhk, H. Kooijmann, F.-U. Beil, T. Bley, G. Adam, C. Weber10.1016/S1567-5688(10)70850-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations180180MS350 COMPARISON OF 64-SLICE MDCT AND INVASIVE ANGIOGRAPHY IN DIAGNOSIS OF SIGNIFICANT CORONARY ARTERY STENOSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708515/abstract?rss=yesMS350 COMPARISON OF 64-SLICE MDCT AND INVASIVE ANGIOGRAPHY IN DIAGNOSIS OF SIGNIFICANT CORONARY ARTERY STENOSISR. Javadrashid, A. Salehi, M. Daghigi, M. Tarzamni, N. Aslanabadi10.1016/S1567-5688(10)70851-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations180180MS351 FOLLOW-UP OF CHILDREN AFTER POSITIVE GENETIC TESTING IN THE DUTCH NATIONAL SCREENING PROGRAM FOR FAMILIAL HYPERCHOLESTEROLEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708527/abstract?rss=yesMS351 FOLLOW-UP OF CHILDREN AFTER POSITIVE GENETIC TESTING IN THE DUTCH NATIONAL SCREENING PROGRAM FOR FAMILIAL HYPERCHOLESTEROLEMIAH.J. Avis, R. Huijgen, B.A. Hutten, M.N. Vissers, T.H. Janssen, D.M. Kusters, I. Kindt, J.J. Kastelein, F.A. Wijburg10.1016/S1567-5688(10)70852-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations180180MS352 OXIDATIVE STRESS PARAMETERS IN HDL-LIPOPROTEIN FRACTION IN CHANGED PHYSIOLOGICAL STATEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708539/abstract?rss=yesMS352 OXIDATIVE STRESS PARAMETERS IN HDL-LIPOPROTEIN FRACTION IN CHANGED PHYSIOLOGICAL STATESI. Srećković10.1016/S1567-5688(10)70853-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations180181MS353 THE COMPARATIVE STUDY OF COMMON CAROTID INTIMA-MEDIA THICKNESS IN RUSSIAN AND GERMAN POPULATIONShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708540/abstract?rss=yesMS353 THE COMPARATIVE STUDY OF COMMON CAROTID INTIMA-MEDIA THICKNESS IN RUSSIAN AND GERMAN POPULATIONSI. Sobenin, V. Myasoedova, T. Kirichenko, O. Chuprakova, M. Bauer, R. Erbel, A. Orekhov10.1016/S1567-5688(10)70854-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations181181MS354 INFLUENCE OF PERIPHERAL ARTERIAL DISEASE ON LOWER EXTREMITY ARTERIAL STIFFNESS. THE CZECH POST-MONICA STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708552/abstract?rss=yesMS354 INFLUENCE OF PERIPHERAL ARTERIAL DISEASE ON LOWER EXTREMITY ARTERIAL STIFFNESS. THE CZECH POST-MONICA STUDYP. Wohlfahrt, D. Palous, M. Ingrischova, A. Krajcoviechova, J. Seidlerova, J. Bruthans, M. Galovcova, V. Adamkova, J. Filipovsky, R. Cifkova10.1016/S1567-5688(10)70855-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations181181MS355 IS C-REACTIVE PROTEIN A BETTER PREDICTOR OF RECURRENT CAROTID DISEASE FOLLOWING CAROTID ENDARTERECTOMY THAN ESTABLISHED RISK FACTORS FOR ATHEROCLEROSIS?http://www.atherosclerosis-supplements.com/article/PIIS1567568810708564/abstract?rss=yesMS355 IS C-REACTIVE PROTEIN A BETTER PREDICTOR OF RECURRENT CAROTID DISEASE FOLLOWING CAROTID ENDARTERECTOMY THAN ESTABLISHED RISK FACTORS FOR ATHEROCLEROSIS?I. Lusic, V. Radonić, S. Pavelin, I. Bilic10.1016/S1567-5688(10)70856-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations181181MS356 SINGLE DOSE PHARMACODYNAMICS AND PHARMACOKINETICS OF DRL-17822, A POTENT CETP INHIBITOR, IN HEALTHY SUBJECTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708576/abstract?rss=yesMS356 SINGLE DOSE PHARMACODYNAMICS AND PHARMACOKINETICS OF DRL-17822, A POTENT CETP INHIBITOR, IN HEALTHY SUBJECTSS. Hasham, T. Mangapathiraju, S. Vittal, A. Bapat, M. Rao, S. Sai, A. Shanavas, K. Allenby, R. Kumar10.1016/S1567-5688(10)70857-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations181181MS357 IRBESARTAN REDUCES PLATELET ACTIVATION IN HYPERTENSIVE-HYPERCHOLESTEROLEMIC HAMSTERhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708588/abstract?rss=yesMS357 IRBESARTAN REDUCES PLATELET ACTIVATION IN HYPERTENSIVE-HYPERCHOLESTEROLEMIC HAMSTERN. Alexandru, A. Georgescu, D. Popov, E. Andrei, E. Dragan, M. Simionescu10.1016/S1567-5688(10)70858-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations181182MS358 ONE-MONTH CONSUMPTION OF AN OLIVE LEAF EXTRACT ENHANCES CARDIOVASCULAR STATUS IN HYPERCHOLESTEROLEMIC SUBJECTShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070859X/abstract?rss=yesMS358 ONE-MONTH CONSUMPTION OF AN OLIVE LEAF EXTRACT ENHANCES CARDIOVASCULAR STATUS IN HYPERCHOLESTEROLEMIC SUBJECTSJ. Fonollá, P. Díaz-Ropero, E. de la Fuente, J.C. Quintela10.1016/S1567-5688(10)70859-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations182182MS359 DAL-VESSEL – A RANDOMISED, PLACEBO-CONTROLLED STUDY OF DALCETRAPIB ON ENDOTHELIAL FUNCTION, AS MEASURED BY FLOW MEDIATED DILATATION, IN HIGH-RISK PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708606/abstract?rss=yesMS359 DAL-VESSEL – A RANDOMISED, PLACEBO-CONTROLLED STUDY OF DALCETRAPIB ON ENDOTHELIAL FUNCTION, AS MEASURED BY FLOW MEDIATED DILATATION, IN HIGH-RISK PATIENTST. Lüscher, S. Taddei, T. Münzel, J.W. Jukema, J. Kastelein, J.-C. Kaski, V. Lehnert, T. Burgess, D. Kallend, J. Deanfield10.1016/S1567-5688(10)70860-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations182182MS360 ANTI-ANGIOTENSIN DRUG EVALUATION IN apoE−/− MICE BY USPIO-ENHANCED MRI AT 7 Thttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708618/abstract?rss=yesMS360 ANTI-ANGIOTENSIN DRUG EVALUATION IN apoE−/− MICE BY USPIO-ENHANCED MRI AT 7 TM. Sigovan, A. Bessaad, E. Kaye, E. Lancelot, C. Corot, N. Provost, Z. Majd, M. Breisse, E. Canet-Soulas10.1016/S1567-5688(10)70861-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations182182MS361 FACTORS INFLUENCING THE RISK OF INTENSIFICATION OF ANTI-HYPERGLYCEMIC MEDICATION AMONG ER NIACIN/LAROPIPRANT AND PLACEBO TREATED PATIENTS WITH TYPE 2 DIABETEShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070862X/abstract?rss=yesMS361 FACTORS INFLUENCING THE RISK OF INTENSIFICATION OF ANTI-HYPERGLYCEMIC MEDICATION AMONG ER NIACIN/LAROPIPRANT AND PLACEBO TREATED PATIENTS WITH TYPE 2 DIABETESA. Maclean, H. Giezek, C. Mccrary Sisk, D. Maccubbin10.1016/S1567-5688(10)70862-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations182183MS362 PHARMACOLOGIC INHIBITION OF HYALURONAN SYNTHESIS CAUSES LOSS OF ENDOTHELIAL GLYCOCALYX AND AGGRAVATES ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708631/abstract?rss=yesMS362 PHARMACOLOGIC INHIBITION OF HYALURONAN SYNTHESIS CAUSES LOSS OF ENDOTHELIAL GLYCOCALYX AND AGGRAVATES ATHEROSCLEROSISN. Nagy, T. Freudenberger, H. Jastrow, T. Suvorava, G. Kojda, A.A. Weber, S. Ergün, J.W. Fischer10.1016/S1567-5688(10)70863-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations183183MS363 CHANGES OF sEMG ACTIVITY IN PROXIMAL AND DISTAL LEG MUSCLES IN PATIENTS WITH CLAUDICATION OVER 12-WEEK TREADMILL TRAINING – THE PILOT STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708643/abstract?rss=yesMS363 CHANGES OF sEMG ACTIVITY IN PROXIMAL AND DISTAL LEG MUSCLES IN PATIENTS WITH CLAUDICATION OVER 12-WEEK TREADMILL TRAINING – THE PILOT STUDYP. Mika, A. Mika, L. Oleksy, A. Konik10.1016/S1567-5688(10)70864-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations183183MS364 COSTS AND CLINICAL OUTCOMES IN THE PATIENTS WITH OFF-PUMP VS. ON-PUMP CORONARY ARTERY BYPASS SURGERYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708655/abstract?rss=yesMS364 COSTS AND CLINICAL OUTCOMES IN THE PATIENTS WITH OFF-PUMP VS. ON-PUMP CORONARY ARTERY BYPASS SURGERYT. Emami Meybodi, S.K. Foruzannia, S.J. Mirhosseini, M.H. Abdollahi, H. Hosseini, S.H. Moshtaghion, A. Golzar10.1016/S1567-5688(10)70865-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations183183MS365 ANTIPLATELET THERAPY IN PERIPHERAL ARTERIAL DISEASE: PRESCRIBING PRACTICE REMAINS SUB-OPTIMALhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708667/abstract?rss=yesMS365 ANTIPLATELET THERAPY IN PERIPHERAL ARTERIAL DISEASE: PRESCRIBING PRACTICE REMAINS SUB-OPTIMALB. Alkhaffaf, T. Breslin, S. Ahmad, M. Hadfield10.1016/S1567-5688(10)70866-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations183184MS366 CYTOKINE PROFILES AND OXIDATIVE STRESS IN ACUTE CORONARY SYNDROMEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708679/abstract?rss=yesMS366 CYTOKINE PROFILES AND OXIDATIVE STRESS IN ACUTE CORONARY SYNDROMEM. Sahlawi, M.O. Hamza10.1016/S1567-5688(10)70867-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations184184MS367 THE TWISTED CAROTID BIFURCATION AND MICROTHROMBENDARTERECTOMYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708680/abstract?rss=yesMS367 THE TWISTED CAROTID BIFURCATION AND MICROTHROMBENDARTERECTOMYH. Katano, K. Yamada10.1016/S1567-5688(10)70868-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations184184MS368 ENDOTHELIAL DYSFUNCTION AND HMG-CoA REDUCTASE INHIBITORS IN PATIENTS WITH ARTERIAL HYPERTENSIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708692/abstract?rss=yesMS368 ENDOTHELIAL DYSFUNCTION AND HMG-CoA REDUCTASE INHIBITORS IN PATIENTS WITH ARTERIAL HYPERTENSIONC. Tudor, A. Iana, R.A. Jeberean, R. Buzas, A. Petrus10.1016/S1567-5688(10)70869-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations184184MS369 TYPE 2 DIABETES: BLOOD PRESSURE CONTROL AND ENDOTHELIAL FUNTION ARE INFLUENCED BY NUTRITIONAL EDUCATIONAL PROGRAMhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708709/abstract?rss=yesMS369 TYPE 2 DIABETES: BLOOD PRESSURE CONTROL AND ENDOTHELIAL FUNTION ARE INFLUENCED BY NUTRITIONAL EDUCATIONAL PROGRAMM.C. Masoni, L. Ghiadoni, C. Consani, C. Scarpellini, S. Taddei, O. Giampietro, E. Matteucci10.1016/S1567-5688(10)70870-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations184184MS370 WATER EXTRACTS OF CINNAMON AND CLOVE EXHIBITS POTENT INHIBITION OF PROTEIN GLYCATION AND ANTI-ATHEROSCLEROTIC ACTIVITY IN VITRO, AND IN VIVOhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708710/abstract?rss=yesMS370 WATER EXTRACTS OF CINNAMON AND CLOVE EXHIBITS POTENT INHIBITION OF PROTEIN GLYCATION AND ANTI-ATHEROSCLEROTIC ACTIVITY IN VITRO, AND IN VIVOS.-R. Jin, K. Park, J.-H. Park, S.-H. Jung, K.-H. Cho10.1016/S1567-5688(10)70871-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations184185MS371 EFFECT OF BICYCLE TRAINING ON BLOOD OXYGEN TRANSPORT INDICES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708722/abstract?rss=yesMS371 EFFECT OF BICYCLE TRAINING ON BLOOD OXYGEN TRANSPORT INDICES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTIONA. Karol10.1016/S1567-5688(10)70872-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations185185MS372 ST ELEVATED MYOCARDIAL INFARCTION AFTER INTRAVENOUS INJECTION OF HYOSCINE-N-BUTYLBROMIDEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708734/abstract?rss=yesMS372 ST ELEVATED MYOCARDIAL INFARCTION AFTER INTRAVENOUS INJECTION OF HYOSCINE-N-BUTYLBROMIDES. Kanyilmaz, C. Altin, T. Katircibaşi, A. Yildirir, H. Muderrisoglu10.1016/S1567-5688(10)70873-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations185185MS373 ACHIEVEMENT OF THE TARGET GOAL FOR LDL-CHOLESTEROL BY ROSUVASTATIN IN JAPANESE HYPERCHOLESTEROLEMIC SUBJECTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708746/abstract?rss=yesMS373 ACHIEVEMENT OF THE TARGET GOAL FOR LDL-CHOLESTEROL BY ROSUVASTATIN IN JAPANESE HYPERCHOLESTEROLEMIC SUBJECTSS. Nakano, G. Yoshino10.1016/S1567-5688(10)70874-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations185185MS374 VEGETABLE OILS IN THE PREVENTION OF OCULAR COMPLICATIONS RELATED TO ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708758/abstract?rss=yesMS374 VEGETABLE OILS IN THE PREVENTION OF OCULAR COMPLICATIONS RELATED TO ATHEROSCLEROSIST. Said, O. Helal, H. Berrougui, T.-M. Jennifer, S. Cunnane, A. Khalili10.1016/S1567-5688(10)70875-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations185185MS375 EFFECT OF ROSUVASTATIN ALONE AND COMBINATION OF HMC05 AND ROSUVASTATIN ON ATHEROSCLEROTIC C57BL/6 ApoE KNOCKOUT MICEhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070876X/abstract?rss=yesMS375 EFFECT OF ROSUVASTATIN ALONE AND COMBINATION OF HMC05 AND ROSUVASTATIN ON ATHEROSCLEROTIC C57BL/6 ApoE KNOCKOUT MICEJ.Y. Kim, B.-S. Lee, H.-M.S. Shin, J.E. Park10.1016/S1567-5688(10)70876-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations185186MS376 ENGINEERED BEE HYALURONIDASE AS A POTENTIAL TOOL FOR THE TREATMENT OF ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708771/abstract?rss=yesMS376 ENGINEERED BEE HYALURONIDASE AS A POTENTIAL TOOL FOR THE TREATMENT OF ATHEROSCLEROSISA. Iliás, B. Greiderer-Kleinlercher, S. Reitinger, G. Lepperdinger10.1016/S1567-5688(10)70877-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations186186MS377 COMPARATIVE STUDY OF CAROTID PLAQUES OF PATIENTS AFTER ENDARTERECTOMY PROCEDUREhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708783/abstract?rss=yesMS377 COMPARATIVE STUDY OF CAROTID PLAQUES OF PATIENTS AFTER ENDARTERECTOMY PROCEDURES.V. Kashirina, V.S. Shishkina, E.R. Andreeva, O.P. Ilyinskaya, N.B. Radukhina, V.V. Ahmetov, E.M. Tararak10.1016/S1567-5688(10)70878-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations186186MS378 ALUMINIUM PHTALOCYANINE ACCUMULATION IN ENDARTERECTOMY CAROTID PLAQUES: STUDY IN VITROhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708795/abstract?rss=yesMS378 ALUMINIUM PHTALOCYANINE ACCUMULATION IN ENDARTERECTOMY CAROTID PLAQUES: STUDY IN VITROY. Efremova, G.N. Soboleva, E.R. Andreeva, N.B. Radukhina, E.M. Tararak, Y.A. Karpov10.1016/S1567-5688(10)70879-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations186186MS379 EFFECTS OF ATORVASTATIN ON POSTPRANDIAL TRIGLYCERIDE LEVELS AND CAROTID INTIMA-MEDIA THICKNESS IN NONDIABETIC DYSLIPIDEMIC PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708801/abstract?rss=yesMS379 EFFECTS OF ATORVASTATIN ON POSTPRANDIAL TRIGLYCERIDE LEVELS AND CAROTID INTIMA-MEDIA THICKNESS IN NONDIABETIC DYSLIPIDEMIC PATIENTSS. Isik, N. Helvaci, K. Helvaci, U. Ozuguz, Y. Ates Tutuncu, D. Berker, S. Guler10.1016/S1567-5688(10)70880-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations186186MS380 ARTROFOON AS THE NOVEL IMMUNE MODULATOR FOR IMPROVEMENT RESULTS OF TREATMENT IN PAD PATIENTS AFTER LATE THROMBOSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708813/abstract?rss=yesMS380 ARTROFOON AS THE NOVEL IMMUNE MODULATOR FOR IMPROVEMENT RESULTS OF TREATMENT IN PAD PATIENTS AFTER LATE THROMBOSISA. Svetlikov10.1016/S1567-5688(10)70881-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations186186MS381 THE EFFECT OF ROSUVASTATIN ON THE ARTERIAL PRESSURE OF HYPERLIPIDAEMIC AND HYPERTENSIVE PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708825/abstract?rss=yesMS381 THE EFFECT OF ROSUVASTATIN ON THE ARTERIAL PRESSURE OF HYPERLIPIDAEMIC AND HYPERTENSIVE PATIENTSA. Sianni, A. Ganotopoulou, A. Kosma, E. Kakava, K. Liatsos10.1016/S1567-5688(10)70882-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations187187MS382 BENEFICIAL EFFECT OF ROSUVASTATIN ON THE ARTERIAL PRESSURE REDUCTION OF HYPERLIPIDAEMIC AND HYPERTENSIVE PATIENTS WHO RECEIVE DIFFERENT CATEGORIES OF ANTI-HYPERTENSIVE TREATMENThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708837/abstract?rss=yesMS382 BENEFICIAL EFFECT OF ROSUVASTATIN ON THE ARTERIAL PRESSURE REDUCTION OF HYPERLIPIDAEMIC AND HYPERTENSIVE PATIENTS WHO RECEIVE DIFFERENT CATEGORIES OF ANTI-HYPERTENSIVE TREATMENTA. Sianni, A. Ganotopoulou, A. Kosma, E. Kakava, K. Liatsos10.1016/S1567-5688(10)70883-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations187187MS383 AN IMPACT OF DRUG THERAPY ON CORONARY ARTERY DISEASE COURSE IN PATIENTS UNDERWENT MYOCARDIAL REVASCULARIZATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708849/abstract?rss=yesMS383 AN IMPACT OF DRUG THERAPY ON CORONARY ARTERY DISEASE COURSE IN PATIENTS UNDERWENT MYOCARDIAL REVASCULARIZATIONA. Panov, K. Korzhenevskaya, V. Kozulin, M. Gordeev, N. Tayn10.1016/S1567-5688(10)70884-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations187187MS384 SAFETY AND TOLERABILITY OF ATORVASTATIN: ANALYSIS OF 8755 PATIENTS IN 17 PLACEBO-CONTROLLED TRIALShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708850/abstract?rss=yesMS384 SAFETY AND TOLERABILITY OF ATORVASTATIN: ANALYSIS OF 8755 PATIENTS IN 17 PLACEBO-CONTROLLED TRIALSR. Laskey, L. Tarasenko, R. Fayyad10.1016/S1567-5688(10)70885-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations187187MS385 CORONARY CIRCULATION AND LEFT VENTRICULAR FUNCTION: EFFECT OF REVASCULARIZATION IN PATIENTS WITH PRESERVED LEFT VENTRICLE SYSTOLIC FUNCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708862/abstract?rss=yesMS385 CORONARY CIRCULATION AND LEFT VENTRICULAR FUNCTION: EFFECT OF REVASCULARIZATION IN PATIENTS WITH PRESERVED LEFT VENTRICLE SYSTOLIC FUNCTIONO. Kuryata, Y. Yegorova10.1016/S1567-5688(10)70886-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations187188MS386 TOCOTRIENOL-RICH FRACTION SUPPLEMENTATION BEFORE CHOLESTEROL FEEDING PROVIDES PROTECTION AGAINST EARLY ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708874/abstract?rss=yesMS386 TOCOTRIENOL-RICH FRACTION SUPPLEMENTATION BEFORE CHOLESTEROL FEEDING PROVIDES PROTECTION AGAINST EARLY ATHEROSCLEROSISA.A. Razak, E. Omar, N.A. Muhammad, N.H. Mahamad Rodi, H. Nawawi10.1016/S1567-5688(10)70887-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations188188MS387 FDG-PET/CT AND MRI EVALUATION OF THE EFFECT OF DALCETRAPIB ON ATHEROSCLEROTIC PLAQUE PROGRESSION/REGRESSION: DESIGN OF THE DAL-PLAQUE STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708886/abstract?rss=yesMS387 FDG-PET/CT AND MRI EVALUATION OF THE EFFECT OF DALCETRAPIB ON ATHEROSCLEROTIC PLAQUE PROGRESSION/REGRESSION: DESIGN OF THE DAL-PLAQUE STUDYZ. Fayad, M. Farkouh, A. Tawakol, J. Rudd, M. Woodward, L. Yang, J. Bucerius, C. Calcagno, T. Burgess, J. Pozza, V. Mani, D. Kallend10.1016/S1567-5688(10)70888-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations188188MS388 SAFETY CONSIDERATIONS IN INTERNAL CAROTID ARTERY STENTINGhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708898/abstract?rss=yesMS388 SAFETY CONSIDERATIONS IN INTERNAL CAROTID ARTERY STENTINGK. Papadopoulos, A. Tsanis, S. Volteas, N. Batakis10.1016/S1567-5688(10)70889-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations188188MS389 PITAVASTATIN 4 mg SHOWS COMPARABLE LDL-CHOLESTEROL AND SUPERIOR TRIGLYCERIDE REDUCTION TO SIMVASTATIN 40 mg IN HIGH-RISK PRIMARY HYPERCHOLESTEROLEMIA OR COMBINED DYSLIPIDEMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708904/abstract?rss=yesMS389 PITAVASTATIN 4 mg SHOWS COMPARABLE LDL-CHOLESTEROL AND SUPERIOR TRIGLYCERIDE REDUCTION TO SIMVASTATIN 40 mg IN HIGH-RISK PRIMARY HYPERCHOLESTEROLEMIA OR COMBINED DYSLIPIDEMIAN. Hounslow, D. Budinski, M. Eriksson10.1016/S1567-5688(10)70890-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations188188MS390 TIME OF DAY DOSING DOES NOT INFLUENCE STEADY-STATE PHARMACOKINETICS OR LDL-C REDUCTION PRODUCED BY PITAVASTATINhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708916/abstract?rss=yesMS390 TIME OF DAY DOSING DOES NOT INFLUENCE STEADY-STATE PHARMACOKINETICS OR LDL-C REDUCTION PRODUCED BY PITAVASTATINR.E. Morgan, Y. Inagaki, G.F. Arana, T. Hunt10.1016/S1567-5688(10)70891-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations188189MS391 EFFICACY OF SWITCHING FROM STATIN MONOTHERAPY TO EZETIMIBE/SIMVASTATIN 10/20 mg VERSUS ROSUVASTATIN 10 mg IN HIGH-RISK PATIENTS ANALYZED BY BASELINE LDL-Chttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708928/abstract?rss=yesMS391 EFFICACY OF SWITCHING FROM STATIN MONOTHERAPY TO EZETIMIBE/SIMVASTATIN 10/20 mg VERSUS ROSUVASTATIN 10 mg IN HIGH-RISK PATIENTS ANALYZED BY BASELINE LDL-CP. Brudi, M. Averna, M. Farnier, L. Missault, H. Vaverkova, L.M. Viigimaa, Q. Dong, A. Shah, W. Taggart, A. Johnson-Levonas10.1016/S1567-5688(10)70892-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations189189MS392 MORE UNIFORM CHOLESTEROLEMIC RESPONSE OF WOMEN VS MEN WHEN USING A DIVERSIFIED DRUG APPROACH TO HYPOLIPIDEMIC THERAPYhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070893X/abstract?rss=yesMS392 MORE UNIFORM CHOLESTEROLEMIC RESPONSE OF WOMEN VS MEN WHEN USING A DIVERSIFIED DRUG APPROACH TO HYPOLIPIDEMIC THERAPYG. Mombelli, N. Fabbri, S. Frasson, C. Baldo, V. De Vergori, M. Triolo, C.R. Sirtori10.1016/S1567-5688(10)70893-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations189189MS393 EFFECTS OF EZETIMIBE, INTIAL DOSES OF SATINS, AND ITS COMBINATION ON LIPIDS IN HIGH RISK PATIENTS WITH HYPERLIPIDEAMIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708941/abstract?rss=yesMS393 EFFECTS OF EZETIMIBE, INTIAL DOSES OF SATINS, AND ITS COMBINATION ON LIPIDS IN HIGH RISK PATIENTS WITH HYPERLIPIDEAMIAM. Zubareva, M. Tripoten', T. Rozhkova, E. Solovieva, T. Balakhonova, A. Rogoza, A. Susekov10.1016/S1567-5688(10)70894-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations189189MS394 ARTERIAL FUNCTION AND STRUCTURE IN PATIENTS WITH FAMILIAL COMBINED HYPERLIPIDEMIA. THE EFFECT OF ROSUVASTATINhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708953/abstract?rss=yesMS394 ARTERIAL FUNCTION AND STRUCTURE IN PATIENTS WITH FAMILIAL COMBINED HYPERLIPIDEMIA. THE EFFECT OF ROSUVASTATINC. Masoura, C. Pitsavos, I. Skoumas, K. Aznaouridis, V. Metaxa, L. Papadimitriou, K. Psarros, C. Stefanadis10.1016/S1567-5688(10)70895-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations190190MS395 EVALUATION OF EFFECTIVENESS OF THE COMBINED TREATMENT WITH ATORVASTATIN AND EZETIMIBE IN PATIENTS WITH CHDhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708965/abstract?rss=yesMS395 EVALUATION OF EFFECTIVENESS OF THE COMBINED TREATMENT WITH ATORVASTATIN AND EZETIMIBE IN PATIENTS WITH CHDK. Kapanadze, N. Kipshidze10.1016/S1567-5688(10)70896-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations190190MS396 DETERMINING THE OXIDATIVE BURDEN IN PATIENTS WITH CORONARY ARTERY DISEASE USING A NOVEL DIRECT ACTIVATOR OF HEME-FREE/OXIDIZED SGChttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708977/abstract?rss=yesMS396 DETERMINING THE OXIDATIVE BURDEN IN PATIENTS WITH CORONARY ARTERY DISEASE USING A NOVEL DIRECT ACTIVATOR OF HEME-FREE/OXIDIZED SGCI. Ahrens, J. Habersberger, H. Qian, J.-P. Stasch, C. Bode, H. Schmidt, K. Peter10.1016/S1567-5688(10)70897-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations190190MS397 A NEW CONTOUR ANALYSIS OF PHOTOPLETHYSMOGRAPHIC PULSE MEASURED AT THE FINGERhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708989/abstract?rss=yesMS397 A NEW CONTOUR ANALYSIS OF PHOTOPLETHYSMOGRAPHIC PULSE MEASURED AT THE FINGERH.-T. Wu, B.-S. Lin, C.-C. Liu, A.-B. Liu10.1016/S1567-5688(10)70898-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations190190MS398 THE INFLUENCE OF RAMIPRIL (AMPRILAN) ON THE INFLAMMATION MARKERS AND THE IMMEDIATE PROGNOSIS OF MYOCARDIAL INFARCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810708990/abstract?rss=yesMS398 THE INFLUENCE OF RAMIPRIL (AMPRILAN) ON THE INFLAMMATION MARKERS AND THE IMMEDIATE PROGNOSIS OF MYOCARDIAL INFARCTIONA. Vertkin, A. Skotnikov10.1016/S1567-5688(10)70899-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations190190MS399 PREVALENCE OF SIGNIFICANT CAROTID STENOSIS IN IRANIAN PATIENTS WITH PERIPHERAL VASCULAR DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709004/abstract?rss=yesMS399 PREVALENCE OF SIGNIFICANT CAROTID STENOSIS IN IRANIAN PATIENTS WITH PERIPHERAL VASCULAR DISEASEA. Shakeri Bavil, M. Nemati, S. Daneshmand10.1016/S1567-5688(10)70900-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations190191MS400 KEY LABORATORY DIAGNOSTIC BIOMARKERS OF CORONARY ATHEROSCLEROSIS IN SIBERIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709016/abstract?rss=yesMS400 KEY LABORATORY DIAGNOSTIC BIOMARKERS OF CORONARY ATHEROSCLEROSIS IN SIBERIAY. Ragino, A. Chernjavski, N. Eremenko, E. Schahtshneider, Y. Polonskaja, S. Tcimbal, M. Ivanova, M. Voevoda10.1016/S1567-5688(10)70901-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations191191MS401 RANDOMIZED TRIAL OF LIPID APHERESIS IN PATIENTS WITH ELEVATED ISOLATED LIPOPROTEIN(a) CONCENTRATIONS: STUDY DESIGN OF THE ELAILa TRIALhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709028/abstract?rss=yesMS401 RANDOMIZED TRIAL OF LIPID APHERESIS IN PATIENTS WITH ELEVATED ISOLATED LIPOPROTEIN(a) CONCENTRATIONS: STUDY DESIGN OF THE ELAILa TRIALH. Berthold, A. Rosada, C. Erley, I. Gouni-Berthold, M. Leitzmann, K. Parhofer, G. Schmitz, J. Thiery, A. Vogt, E. Steinhagen-Thiessen10.1016/S1567-5688(10)70902-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations191191MS402 Morus alba EXTRACT AND CURCUMIN REDUCE RESISTIN INDUCED-HUMAN ENDOTHELIAL CELLS ACTIVATION BY A MECHANISM INVOLVING P38 MAPKhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070903X/abstract?rss=yesMS402 Morus alba EXTRACT AND CURCUMIN REDUCE RESISTIN INDUCED-HUMAN ENDOTHELIAL CELLS ACTIVATION BY A MECHANISM INVOLVING P38 MAPKM.M. Pirvulescu, D. Stan, A.-M. Gan, V. Simion, C. Ionescu-Targoviste, I. Manduteanu10.1016/S1567-5688(10)70903-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations191191MS403 MULTIPLE CORONARY ARTERY ANEURYSMS IN SUBJECT CARRIER ASP9/ASN LIPOPROTEIN LIPASE MUTATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709041/abstract?rss=yesMS403 MULTIPLE CORONARY ARTERY ANEURYSMS IN SUBJECT CARRIER ASP9/ASN LIPOPROTEIN LIPASE MUTATIONM. Puntoni, F. Sbrana, F. Bigazzi, B. Pennato, B. dal Pino, D. Iori, S. Bertolini, P. Marraccini, D. Rovai, T. Sampietro10.1016/S1567-5688(10)70904-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations191191MS404 INFLUENCE OF SMOKING AND DIABETES MELLITUS TYPE 2 ON THE DEVELOPMENT OF CORONARY DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709053/abstract?rss=yesMS404 INFLUENCE OF SMOKING AND DIABETES MELLITUS TYPE 2 ON THE DEVELOPMENT OF CORONARY DISEASEB. Sreckovic, V. Dimitrijevic-Sreckovic, J. Perunicic, P. Djordjevic, E. Colak, I. Soldatovic, M. Gajic10.1016/S1567-5688(10)70905-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations191192MS405 THE INFLUENCE OF ONE-YEAR TRAETMENT WITH ATORVASTATIN, ROSUVASTATIN AND SIMVASTATIN ON INTIMA MEDIA THICKNESS IN PATIENTS WITH HEART ISCHEMIC DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709065/abstract?rss=yesMS405 THE INFLUENCE OF ONE-YEAR TRAETMENT WITH ATORVASTATIN, ROSUVASTATIN AND SIMVASTATIN ON INTIMA MEDIA THICKNESS IN PATIENTS WITH HEART ISCHEMIC DISEASEM. Akhvlediani, E. Vorobiova, T. Vakhtangadze, M. Emukhvari, M. Balavadze, T. Kvantaliani10.1016/S1567-5688(10)70906-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations192192MS406 PROTEOMIC ANALYSIS FOR BIOMARKER OF VULNERABLE PLAQUE IN PATIENTS WITH UNSTABLE ANGINAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709077/abstract?rss=yesMS406 PROTEOMIC ANALYSIS FOR BIOMARKER OF VULNERABLE PLAQUE IN PATIENTS WITH UNSTABLE ANGINAH.M. Kwon, K.H. Jung, J.Y. Kim, B.K. Lee, P.K. Min, H.S. Kim10.1016/S1567-5688(10)70907-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations192192MS407 REDUCED MYOCARDIAL GLUCOSE UTILIZATION AFTER FASTING AND HEPARIN INJECTION IN RATShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709089/abstract?rss=yesMS407 REDUCED MYOCARDIAL GLUCOSE UTILIZATION AFTER FASTING AND HEPARIN INJECTION IN RATSR. Bergmann, J. Pietzsch10.1016/S1567-5688(10)70908-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations192192MS408 IMPACT OF PLAQUE HAEMORRHAGE ON PLAQUE STRESS IN PATIENTS WITH CAROTID ARTERY DISEASE – A PATIENT-SPECIFIC MAGNETIC RESONANCE IMAGING STUDYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709090/abstract?rss=yesMS408 IMPACT OF PLAQUE HAEMORRHAGE ON PLAQUE STRESS IN PATIENTS WITH CAROTID ARTERY DISEASE – A PATIENT-SPECIFIC MAGNETIC RESONANCE IMAGING STUDYU. Sadat, Z.Z. Teng, M.J. Graves, J.H. Gillard10.1016/S1567-5688(10)70909-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations192192MS409 AN IMPROVEMENT OF ENDOTHELIAL DYSFUNCTION MARKERS IN CHRONIC KIDNEY DISEASE SIMVASTATIN/EZETIMIBE COMBINED THERAPYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709107/abstract?rss=yesMS409 AN IMPROVEMENT OF ENDOTHELIAL DYSFUNCTION MARKERS IN CHRONIC KIDNEY DISEASE SIMVASTATIN/EZETIMIBE COMBINED THERAPYC. Carru, G. Loriga, G. Farre, A. Zinellu, S. Sotgia, B. Scanu, E. Pisanu, M. Sanna, L. Deiana, A. Satta10.1016/S1567-5688(10)70910-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations192193MS410 SHORT TERM (3 MONTHS) EVALUATION OF RENAL ARTERY STENTING AND ANGIOPLASTY IN PATIENTS WITH HYPERTENSION AND RENAL ARTERY STENOSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709119/abstract?rss=yesMS410 SHORT TERM (3 MONTHS) EVALUATION OF RENAL ARTERY STENTING AND ANGIOPLASTY IN PATIENTS WITH HYPERTENSION AND RENAL ARTERY STENOSISM. Shabestari, F. Sharifipour, M. Dadollahi, M. Haghmoradi10.1016/S1567-5688(10)70911-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations193193MS411 REVASCULARIZATION STRATEGIES AFTER THE SYNTAX TRIAL: THE GLOBAL PICTURE AND A SINGLE CENTER EXPERIENCEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709120/abstract?rss=yesMS411 REVASCULARIZATION STRATEGIES AFTER THE SYNTAX TRIAL: THE GLOBAL PICTURE AND A SINGLE CENTER EXPERIENCEL. Conradi, H. Treede, O. Deutsch, P. Marcsek, M. Ismail, T. Meinertz, H. Reichenspurner10.1016/S1567-5688(10)70912-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations193193MS412 DEVELOPMENT AND EVALUATION OF A NOVEL POLY-L-LACTIC ACID/CAPROLACTONE COPOLYMER CORONARY STENT MANUFACTURED BY SELECTIVE LASER MELTINGhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709132/abstract?rss=yesMS412 DEVELOPMENT AND EVALUATION OF A NOVEL POLY-L-LACTIC ACID/CAPROLACTONE COPOLYMER CORONARY STENT MANUFACTURED BY SELECTIVE LASER MELTINGF. Vogt, C. Flege, S. Hoeges, M. Borinski, V.A. Schulte, R. Hoffmann, N. Marx, R. Poprawe, K. Wissenbach, R. Blindt10.1016/S1567-5688(10)70913-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations193193MS413 ANTIATHEROSCLEROTIC EFFECT OF ACACIA SENEGAL SEED EXTRACT IN CHOLESTEROL-FED RABBITShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709144/abstract?rss=yesMS413 ANTIATHEROSCLEROTIC EFFECT OF ACACIA SENEGAL SEED EXTRACT IN CHOLESTEROL-FED RABBITSA. Purohit, H. Ram10.1016/S1567-5688(10)70914-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations193193MS414 INFLUENCE OF ROENTGEN-CONTRAST METHODS INVESTIGATIONS OF CORONARY ARTERIES IN PATIENTS WITH ISCHEMIC HEART DISEASE ON THE FUNCTIONAL STATE OF KIDNEYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709156/abstract?rss=yesMS414 INFLUENCE OF ROENTGEN-CONTRAST METHODS INVESTIGATIONS OF CORONARY ARTERIES IN PATIENTS WITH ISCHEMIC HEART DISEASE ON THE FUNCTIONAL STATE OF KIDNEYN. Bardachenko, O. Kuryata10.1016/S1567-5688(10)70915-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations193194MS415 HYPERINSULINAEMIA, ENDOTHELIAL DYSFUNCTION, INFLAMMATORY, METABOLIC DISORDERS AND DIABETIC CARDIOMYOPATHYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709168/abstract?rss=yesMS415 HYPERINSULINAEMIA, ENDOTHELIAL DYSFUNCTION, INFLAMMATORY, METABOLIC DISORDERS AND DIABETIC CARDIOMYOPATHYV. Serhiyenko, O. Serhieynko10.1016/S1567-5688(10)70916-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations194194MS416 SENSITIVITY AND SPECIFICITY OF CHOLESTEROL MEASUREMENTS IN FAMILIAL HYPERCHOLESTEROLEMIA DIAGNOSIS IN CZECH POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070917X/abstract?rss=yesMS416 SENSITIVITY AND SPECIFICITY OF CHOLESTEROL MEASUREMENTS IN FAMILIAL HYPERCHOLESTEROLEMIA DIAGNOSIS IN CZECH POPULATIONT. Freiberger, B. Ravčuková, M. Plotěná, L. Fajkusová10.1016/S1567-5688(10)70917-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations194194MS417 BLOOD PRESSURE RESPONSE TO LOW-FAT AND WALNUT PASTE-ENRICHED MEAT VARIES IN VOLUNTEERS WITH PON1 55 AND 192 GENOTYPEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709181/abstract?rss=yesMS417 BLOOD PRESSURE RESPONSE TO LOW-FAT AND WALNUT PASTE-ENRICHED MEAT VARIES IN VOLUNTEERS WITH PON1 55 AND 192 GENOTYPESF.J. Sánchez-Muniz, A. Canales, S. Bastida, M. Nus, J. Librelotto, M. Guillén, D. Corella, J. Benedí10.1016/S1567-5688(10)70918-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations194194MS418 AN IMPROVED DEVICE TO REPRODUCE IN VITRO THE PULSATILE CORONARY FLOW CONDITIONS MEASURED IN HUMANShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709193/abstract?rss=yesMS418 AN IMPROVED DEVICE TO REPRODUCE IN VITRO THE PULSATILE CORONARY FLOW CONDITIONS MEASURED IN HUMANSK. Chodzynski, K. Zouaoui Boudjeltia, G. Coussement, J. Lalemand, M. Vanhaeverbeek10.1016/S1567-5688(10)70919-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations194194MS419 CLINICAL PROFILE OF NEWLY DIAGNOSED DIABETIC PATIENTS IN A RURAL COMMUNITY HEALTH FACILITYhttp://www.atherosclerosis-supplements.com/article/PIIS156756881070920X/abstract?rss=yesMS419 CLINICAL PROFILE OF NEWLY DIAGNOSED DIABETIC PATIENTS IN A RURAL COMMUNITY HEALTH FACILITYA. Kadirvelu, S. Hasim, Z. Mohd Salleh, S. Sadasivan, C. Chan, S. Yasin10.1016/S1567-5688(10)70920-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations194195MS420 DESIGNING A STUDY TO EVALUATE THE EFFECT OF APHERESIS IN PATIENTS WITH ELEVATED LIPOPROTEIN(a)http://www.atherosclerosis-supplements.com/article/PIIS1567568810709211/abstract?rss=yesMS420 DESIGNING A STUDY TO EVALUATE THE EFFECT OF APHERESIS IN PATIENTS WITH ELEVATED LIPOPROTEIN(a)U. Kassner10.1016/S1567-5688(10)70921-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations195195MS421 CORRELATION STUDY OF MORPHOLOGICAL FEATURES OF SILENT AND VULNERABLE PLAQUES VS CLINICAL PARAMETERS OF PATIENTS AFTER CAROTID ENDARTERECTOMYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709223/abstract?rss=yesMS421 CORRELATION STUDY OF MORPHOLOGICAL FEATURES OF SILENT AND VULNERABLE PLAQUES VS CLINICAL PARAMETERS OF PATIENTS AFTER CAROTID ENDARTERECTOMYV.S. Shishkina, S.V. Kashirina, V.N. Sirotkin, E.R. Andreeva, O.P. Ilyinskaya, E.M. Tararak10.1016/S1567-5688(10)70922-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations195195MS422 MARKERS OF SUCCESSFUL THROMBOLYTIC THERAPY DURING THE FIRST WEEK OF ACUTE MYOCARDIAL INFARCTIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709235/abstract?rss=yesMS422 MARKERS OF SUCCESSFUL THROMBOLYTIC THERAPY DURING THE FIRST WEEK OF ACUTE MYOCARDIAL INFARCTIONV. Kapetivadze, R. Tabukashvili, K. Tchaava, N. Gegeshidze, Z. Grigorashvili, I. Kapetivadze10.1016/S1567-5688(10)70923-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations195195MS423 TREATMENT OF ATHEROSCLEROSIS PATIENTS WITH TYPE 2 DIABETES BY SOYBEAN FLAVONOID SUPPLEMENTS AND INDAPAMIDEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709247/abstract?rss=yesMS423 TREATMENT OF ATHEROSCLEROSIS PATIENTS WITH TYPE 2 DIABETES BY SOYBEAN FLAVONOID SUPPLEMENTS AND INDAPAMIDEV. Kapetivadze, R. Tabukashvili, K. Tchaava, N. Gegeshidze, Z. Grigorashvili, I. Kapetivadze10.1016/S1567-5688(10)70924-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations195195MS424 THE EFFECT OF PAIN-FREE TREADMILL TRAINING ON LEVELS OF LACTATE DEHYDROGENASE AND CREATINE KINASE IN PATIENTS WITH INTERMITTENT CLAUDICATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709259/abstract?rss=yesMS424 THE EFFECT OF PAIN-FREE TREADMILL TRAINING ON LEVELS OF LACTATE DEHYDROGENASE AND CREATINE KINASE IN PATIENTS WITH INTERMITTENT CLAUDICATIONP. Mika, R. Nowobilski, R. Januszek, H. Plutecka, M. Sanak, A. Szczeklik10.1016/S1567-5688(10)70925-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations195195MS425 EFFECT OF PLANTS ON THE TREATMENT OF RHEUMATOID ARTHRITIS: A PRAGMATIC RANDOMIZED ETHNOMEDICINAL SURVEY IN FARIDPUR DISTRICT OF BANGLADESHhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709260/abstract?rss=yesMS425 EFFECT OF PLANTS ON THE TREATMENT OF RHEUMATOID ARTHRITIS: A PRAGMATIC RANDOMIZED ETHNOMEDICINAL SURVEY IN FARIDPUR DISTRICT OF BANGLADESHMd.A. Haque Mollik10.1016/S1567-5688(10)70926-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations196196MS426 THE ENDOTHELIUM AS STARTING FOR COMPLICATED ATHEROSCLEROTIC PLAQUEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709272/abstract?rss=yesMS426 THE ENDOTHELIUM AS STARTING FOR COMPLICATED ATHEROSCLEROTIC PLAQUEI. Zota, E. Melnic, A. Munteanu, E. Zota10.1016/S1567-5688(10)70927-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations196196MS427 PSYCHOLOGICAL-VEGETATIVE FRUSTRATION IN PATIENTS WITH CHRONIC CEREBRAL ISCHEMIA (CCI) AMONG THE POPULATION OF UZBEKISTANhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709284/abstract?rss=yesMS427 PSYCHOLOGICAL-VEGETATIVE FRUSTRATION IN PATIENTS WITH CHRONIC CEREBRAL ISCHEMIA (CCI) AMONG THE POPULATION OF UZBEKISTANN. Sultankhodjaeva10.1016/S1567-5688(10)70928-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations196196MS428 CORONARY ATHEROSCLEROSIS AND METABOLIC SYNDROME: THE WAYS TO TREATMENT OPTIMISATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709296/abstract?rss=yesMS428 CORONARY ATHEROSCLEROSIS AND METABOLIC SYNDROME: THE WAYS TO TREATMENT OPTIMISATIONM. Gelmedova10.1016/S1567-5688(10)70929-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations196196MS429 EFFECT OF Cornus mas L. ON ATHEROSCLEROTIC PLAQUE IN HYPERCHOLESTEROLEMIC RABBITShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709302/abstract?rss=yesMS429 EFFECT OF Cornus mas L. ON ATHEROSCLEROTIC PLAQUE IN HYPERCHOLESTEROLEMIC RABBITSS. Asgary, A. Adelnia, S. Kazemi, M. Rafieian-Kopaei, F. Shamsi10.1016/S1567-5688(10)70930-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations196196MS430 CORRELATIONS OF BIORHYTHMS IN SERUM LIPIDS AND LIPOPROTEINS WITH ATHEROSCLEROTIC MANIFESTATIONS IN DYSLIPIDEMIC INDIVIDUALShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709314/abstract?rss=yesMS430 CORRELATIONS OF BIORHYTHMS IN SERUM LIPIDS AND LIPOPROTEINS WITH ATHEROSCLEROTIC MANIFESTATIONS IN DYSLIPIDEMIC INDIVIDUALSM. Rodrigues, F. Dalpino, A. Cassol, C. Samogin, E. de Faria10.1016/S1567-5688(10)70931-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations196197MS431 THE RELATIONSHIP OF STRESS TO PATHOLOGY, PHYSIOLOGY, ANESTHESIA AND ANALGESIAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709326/abstract?rss=yesMS431 THE RELATIONSHIP OF STRESS TO PATHOLOGY, PHYSIOLOGY, ANESTHESIA AND ANALGESIAL. Coleman10.1016/S1567-5688(10)70932-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations197197MS432 COMPUTER SIMULATION OF PLAQUE FORMATION AND DEVELOPMENThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709338/abstract?rss=yesMS432 COMPUTER SIMULATION OF PLAQUE FORMATION AND DEVELOPMENTN. Filipovic, N. Meunier, M. Boynard, M. Kojic, D. Fotiadis10.1016/S1567-5688(10)70933-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations197197MS433 TOTAL ANTIOXIDANT STATUS IN CORONARY ARTERY DISEASE PATIENTShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070934X/abstract?rss=yesMS433 TOTAL ANTIOXIDANT STATUS IN CORONARY ARTERY DISEASE PATIENTSA. Vukasinovic, J. Kotur-Stevuljevic, A. Stefanovic, S. Spasic, V. Spasojevic-Kalimanovska, D. Ristic10.1016/S1567-5688(10)70934-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations197197MS434 THE VALUE OF D-DIMER IN ACUTE AORTIC DISSECTION: THE EXPERIENCE OF CHINAhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709351/abstract?rss=yesMS434 THE VALUE OF D-DIMER IN ACUTE AORTIC DISSECTION: THE EXPERIENCE OF CHINAW. Li, X. Fan, J. Xu, W. Zhang, X. Wang, K. Sun, R. Hui10.1016/S1567-5688(10)70935-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations197197MS435 EVALUATION OF THE EFFECT OF STATINS ON HYPERTENSION CONTROL IN HYPERTENSIVE HYPERCHOLESTEROLEMIC PATIENTS IN CLINICAL PRACTICEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709363/abstract?rss=yesMS435 EVALUATION OF THE EFFECT OF STATINS ON HYPERTENSION CONTROL IN HYPERTENSIVE HYPERCHOLESTEROLEMIC PATIENTS IN CLINICAL PRACTICEM. Morgado, S. Morgado, I. Verde, M. Castelo-Branco10.1016/S1567-5688(10)70936-3Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations197198MS436 SERUM hsCRP CONCENTRATION ≥2.0 mg/L IS ASSOCIATED WITH CAROTID ATHEROSCLEROSIS, IN WOMEN WITH VARYING DEGREES OF GLUCOSE TOLERANCEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709375/abstract?rss=yesMS436 SERUM hsCRP CONCENTRATION ≥2.0 mg/L IS ASSOCIATED WITH CAROTID ATHEROSCLEROSIS, IN WOMEN WITH VARYING DEGREES OF GLUCOSE TOLERANCEU. Prahl, J. Wikstrand, G. Bergström, B. Fagerberg, J. Hulthe10.1016/S1567-5688(10)70937-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations198198MS437 STRONG UP-REGULATION OF RUNX2 IN DCC-SUSCEPTIBLE C3H/HE MICE AFTER FREEZE–THAW-INJURYhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709387/abstract?rss=yesMS437 STRONG UP-REGULATION OF RUNX2 IN DCC-SUSCEPTIBLE C3H/HE MICE AFTER FREEZE–THAW-INJURYA.-K. Sowa, J. Erdmann, H. Schunkert, Z. Aherrahrou10.1016/S1567-5688(10)70938-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations198198MS438 CORONARY ARTERY ECTASIA: CLINICAL AND ANGIOGRAPHICAL EVALUATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709399/abstract?rss=yesMS438 CORONARY ARTERY ECTASIA: CLINICAL AND ANGIOGRAPHICAL EVALUATIONT. Aksu, B. Uygur, N. Arat, H. Kisacik10.1016/S1567-5688(10)70939-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations198198MS439 ASSOCIATION OF RS7138803 IN FAIM2 GENE AND RS7561317 IN TMEM18 GENE WITH ANTHROPOMETRIC VARIABLES IN A HIGH CARDIOVASCULAR-RISK MEDITERRANEAN POPULATIONhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709405/abstract?rss=yesMS439 ASSOCIATION OF RS7138803 IN FAIM2 GENE AND RS7561317 IN TMEM18 GENE WITH ANTHROPOMETRIC VARIABLES IN A HIGH CARDIOVASCULAR-RISK MEDITERRANEAN POPULATIONM. Sotos-Prieto, O. Portoles, C. Ortega-Azorin, P. Carrasco, M. Guillén, C. Saiz, D. Corella10.1016/S1567-5688(10)70940-5Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations198198MS440 HIGHER LEVEL OF IgM ANTI-OXIDIZED LDL ANTIBODIES IS ASSOCIATED WITH A LOWER SEVERITY OF CORONARY ATHEROSCLEROSIS IN PATIENTS ON STATINShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709417/abstract?rss=yesMS440 HIGHER LEVEL OF IgM ANTI-OXIDIZED LDL ANTIBODIES IS ASSOCIATED WITH A LOWER SEVERITY OF CORONARY ATHEROSCLEROSIS IN PATIENTS ON STATINSL. Garrido-Sanchez, P. Chinchurreta, E. Garcia-Fuentes, M. Murri, F.J. Tinahones10.1016/S1567-5688(10)70941-7Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations199199MS441 GENERAL CARDIOVASCULAR RISK IS BETTER ASSOCIATED WITH ARTERIAL STIFFNESS AND CAROTID INTIMA-MEDIA THICKNESS THAN THE FRAMINGHAM RISK IN NON-DIABETIC SUBJECTShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709429/abstract?rss=yesMS441 GENERAL CARDIOVASCULAR RISK IS BETTER ASSOCIATED WITH ARTERIAL STIFFNESS AND CAROTID INTIMA-MEDIA THICKNESS THAN THE FRAMINGHAM RISK IN NON-DIABETIC SUBJECTSY.-K. Kim, Y.-S. Kim, M.-Y. Rhee, M.-M. Lee10.1016/S1567-5688(10)70942-9Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations199199MS442 THE A148G POLYMORPHISM IN THE PARAOXONASE-2 GENE INCREASES THE RISK OF TYPE 2 DIABETIC MELLITUS AND CORONARY HEART DISEASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709430/abstract?rss=yesMS442 THE A148G POLYMORPHISM IN THE PARAOXONASE-2 GENE INCREASES THE RISK OF TYPE 2 DIABETIC MELLITUS AND CORONARY HEART DISEASEA. Likidlilid, T. Peerapatdit, N. Hobang, D. Tresukosol, S. Ratanamaneechat10.1016/S1567-5688(10)70943-0Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations199199MS443 THE ARG399GLN VARIANT IN THE DNA REPAIR ENZYME XRCC1 IS ASSOCIATED WITH INCREASED GENETIC INSTABILITY IN PATIENTS WITH ATHEROSCLEROSIShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709442/abstract?rss=yesMS443 THE ARG399GLN VARIANT IN THE DNA REPAIR ENZYME XRCC1 IS ASSOCIATED WITH INCREASED GENETIC INSTABILITY IN PATIENTS WITH ATHEROSCLEROSISC. Federici, K. Li, K. Salpea, C. Maubaret, S.E. Humphries, M.G. Andreassi10.1016/S1567-5688(10)70944-2Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations199199MS444 5-LIPOXYGENASE-DERIVED LEUKOTRIENE B4 MEDIATES HNE-ENHANCED ROS PRODUCTION IN MURINE MACROPHAGES VIA ACTIVATION OF NADPH OXIDASEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709454/abstract?rss=yesMS444 5-LIPOXYGENASE-DERIVED LEUKOTRIENE B4 MEDIATES HNE-ENHANCED ROS PRODUCTION IN MURINE MACROPHAGES VIA ACTIVATION OF NADPH OXIDASEC.D. Kim, M.R. Yun, H.M. Park, K.W. Seo, S.J. Lee, S.Y. Park, S.S. Bae10.1016/S1567-5688(10)70945-4Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations199199MS445 −203A/C POLYMORPHISM OF CHOLESTEROL 7α-HYDROXYLASE (CYP7A1) GENE AFFECTS CYP7A1 ACTIVITY AFTER SHORT-TERM TREATMENT WITH CHOLESTYRAMINEhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709466/abstract?rss=yesMS445 −203A/C POLYMORPHISM OF CHOLESTEROL 7α-HYDROXYLASE (CYP7A1) GENE AFFECTS CYP7A1 ACTIVITY AFTER SHORT-TERM TREATMENT WITH CHOLESTYRAMINEJ. Kovar, M. Zimolova, M. Lenicek, L. Vitek, M. Jirsa, R. Poledne, J. Pitha10.1016/S1567-5688(10)70946-6Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations199200MS446 COMPARISON OF A1C AND FASTING GLUCOSE TO DIAGNOSE DIABETES AMONG PEOPLE WITH METABOLIC SYNDROME AND FASTING GLUCOSE >100 mg/dLhttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709478/abstract?rss=yesMS446 COMPARISON OF A1C AND FASTING GLUCOSE TO DIAGNOSE DIABETES AMONG PEOPLE WITH METABOLIC SYNDROME AND FASTING GLUCOSE >100 mg/dLE. Liberopoulos, M. Florentin, A. Kei, E. Mountzouri, A. Agouridis, M. Elisaf10.1016/S1567-5688(10)70947-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations200200MS447 ANTIHYPERGLYCEMIC AND ANTIHYPERLIPIDEMIC EFFECTS OF Ziziphus vulgaris L. IN STREPTOZOCIN-INDUCED DIABETIC ADULT MALE WISTAR RATShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070948X/abstract?rss=yesMS447 ANTIHYPERGLYCEMIC AND ANTIHYPERLIPIDEMIC EFFECTS OF Ziziphus vulgaris L. IN STREPTOZOCIN-INDUCED DIABETIC ADULT MALE WISTAR RATSJ. Solati, R. Hajikhani, N. Soleimani10.1016/S1567-5688(10)70948-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations200200MS448 DIFFERENTIAL EFFECT OF SARTANS WITH VARIOUS PPARγ ACTIVATING CAPACITY COMBINED WITH ROSUVASTATIN ON GLUCOSE METABOLISM INDICEShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709491/abstract?rss=yesMS448 DIFFERENTIAL EFFECT OF SARTANS WITH VARIOUS PPARγ ACTIVATING CAPACITY COMBINED WITH ROSUVASTATIN ON GLUCOSE METABOLISM INDICESC. Rizos, H. Milionis, M. Kostapanos, M. Florentin, C. Kostara, M. Elisaf, E. Liberopoulos10.1016/S1567-5688(10)70949-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations200200MS449 EFFECT OF STRESS ON CARDIOVASCULAR ACTIVITY AND SERUM CHOLESTEROL IN NORMOTENSIVE AND HYPERTENSIVE RATShttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709508/abstract?rss=yesMS449 EFFECT OF STRESS ON CARDIOVASCULAR ACTIVITY AND SERUM CHOLESTEROL IN NORMOTENSIVE AND HYPERTENSIVE RATSY. Kuznetzova, O. Semyachkina-Glushkovskaya, V. Berdnikova, I. Semyachkin-Glushkovskij10.1016/S1567-5688(10)70950-8Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations200200MS450 FAR-INFRARED ATTENUATES CYCLIC STRAIN-INDUCED ENDOTHELIN-1 EXPRESSION VIA PI3K/AKT SIGNALING PATHWAY IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLShttp://www.atherosclerosis-supplements.com/article/PIIS156756881070951X/abstract?rss=yesMS450 FAR-INFRARED ATTENUATES CYCLIC STRAIN-INDUCED ENDOTHELIN-1 EXPRESSION VIA PI3K/AKT SIGNALING PATHWAY IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLST.-H. Cheng, C.-H. Chen, Y.-H. Hsu, J.-C. Liu, J.-J. Chen10.1016/S1567-5688(10)70951-XAtherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-01112S1567-5688(10)X0003-4Memory Stick Presentations200201MS451 IMMUNE MODULATION BY KLF2 TO IMPROVE COLLATERAL ARTERY DEVELOPMENThttp://www.atherosclerosis-supplements.com/article/PIIS1567568810709521/abstract?rss=yesMS451 IMMUNE MODULATION BY KLF2 TO IMPROVE COLLATERAL ARTERY DEVELOPMENTC. Yildirim, T.C.T.M. van der Pouw-Kraan, J.M. Baggen, R.D. Fontijn, A.J.G. Horrevoets10.1016/S1567-5688(10)70952-1Atherosclerosis Supplements 11, 2 (2010)2010-06-01Atherosclerosis Supplements2010-06-0111